"","X","miRNA","V2","V3.x","V4.x","V5","V6","V7","V8","V9","V10","V11","mRNA","PCC.cor","p_value","adjusted_p_value","V3.y","Protein.names","Organism","Gene.Ontology..biological.process.","Gene.Ontology.IDs"
"4",4,"Cluster_1140","Porites_evermani_scaffold_1:220724-266805",175,-20.39,2,21,2909,2932,21,"80.95%","85.71%","Peve_00000108",-0.998781804329405,0.0314266250831325,0.903929377050813,"Q6P4S8","Integrator complex subunit 1 (Int1)","Mus musculus (Mouse)","blastocyst growth [GO:0001832]; inner cell mass cell proliferation [GO:0001833]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; snRNA processing [GO:0016180]; U2 snRNA 3'-end processing [GO:0034474]","GO:0001832; GO:0001833; GO:0005634; GO:0016180; GO:0031965; GO:0032039; GO:0034474; GO:0043066; GO:0043154"
"14",14,"Cluster_1140","Porites_evermani_scaffold_1823:47250-69122",180,-22.69,2,21,440,461,19,"84.21%","89.47%","Peve_00011435",-0.998365252615658,0.0364065585365617,0.909359886114279,"P48733","Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form]","Bos taurus (Bovine)","antibacterial innate immune response [GO:0140367]; defense response to Gram-negative bacterium [GO:0050829]","GO:0000922; GO:0005201; GO:0005509; GO:0005576; GO:0005929; GO:0016020; GO:0016323; GO:0016324; GO:0031012; GO:0050829; GO:0060170; GO:0140367"
"25",25,"Cluster_1140","Porites_evermani_scaffold_239:235294-258744",173,-21.7,2,18,1926,1947,16,"87.50%","93.75%","Peve_00017311",-0.999023311227815,0.0281389943499374,0.902057778093395,"O43345","Zinc finger protein 208 (Zinc finger protein 91-like)","Homo sapiens (Human)","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0008270"
"50",50,"Cluster_1140","Porites_evermani_scaffold_502:44702-87413",175,-20.41,2,21,16799,16822,21,"76.19%","90.48%","Peve_00033721",-0.999771409683522,0.0136123249702019,0.714231839928071,"O00339","Matrilin-2","Homo sapiens (Human)","extracellular matrix organization [GO:0030198]","GO:0005201; GO:0005509; GO:0005576; GO:0030198; GO:0031012; GO:0062023; GO:0120216"
"68",68,"Cluster_1167","Porites_evermani_scaffold_100:248550-275221",147,-21.83,2,17,25698,25722,18,"72.22%","72.22%","Peve_00000226",0.999909726776791,0.00855416971793389,0.573710369894872,"Q9JIS1","Regulating synaptic membrane exocytosis protein 2 (Rab-3-interacting molecule 2) (RIM 2)","Rattus norvegicus (Rat)","adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cell differentiation [GO:0030154]; establishment of localization in cell [GO:0051649]; exocytosis [GO:0006887]; insulin secretion [GO:0030073]; intracellular protein transport [GO:0006886]; maintenance of presynaptic active zone structure [GO:0048790]; neurotransmitter secretion [GO:0007269]; positive regulation of dendrite extension [GO:1903861]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of synaptic transmission [GO:0050806]; regulation of calcium-dependent activation of synaptic vesicle fusion [GO:0150037]; regulation of exocytosis [GO:0017157]; regulation of membrane potential [GO:0042391]; regulation of synaptic plasticity [GO:0048167]; spontaneous neurotransmitter secretion [GO:0061669]; synaptic vesicle docking [GO:0016081]; synaptic vesicle priming [GO:0016082]","GO:0006886; GO:0006887; GO:0007188; GO:0007269; GO:0010628; GO:0016081; GO:0016082; GO:0017156; GO:0017157; GO:0019904; GO:0030073; GO:0030154; GO:0030674; GO:0031267; GO:0032991; GO:0042391; GO:0042734; GO:0042995; GO:0044325; GO:0044877; GO:0045202; GO:0046872; GO:0048167; GO:0048788; GO:0048790; GO:0048791; GO:0050806; GO:0051649; GO:0060077; GO:0061669; GO:0097151; GO:0098684; GO:0098831; GO:0098882; GO:0098978; GO:0098982; GO:0140677; GO:0150037; GO:1903861; GO:2000463"
"77",77,"Cluster_1167","Porites_evermani_scaffold_102:155709-177573",155,-24.9,2,21,16316,16341,23,"65.22%","73.91%","Peve_00000536",0.999910457964593,0.0085194555748794,0.573710369894872,"Q96D71","RalBP1-associated Eps domain-containing protein 1 (RalBP1-interacting protein 1)","Homo sapiens (Human)","endocytosis [GO:0006897]; endosomal transport [GO:0016197]","GO:0005509; GO:0005829; GO:0005886; GO:0005905; GO:0006897; GO:0016197; GO:0017124"
"85",85,"Cluster_1167","Porites_evermani_scaffold_1037:147857-154039",145,-20.33,2,16,309,333,17,"76.47%","76.47%","Peve_00000776",0.998287142619543,0.0372664249833469,0.909359886114279,NA,NA,NA,NA,NA
"86",86,"Cluster_1167","Porites_evermani_scaffold_1037:147857-154039",145,-20.33,2,16,4189,4213,17,"76.47%","76.47%","Peve_00000776",0.998287142619543,0.0372664249833469,0.909359886114279,NA,NA,NA,NA,NA
"107",107,"Cluster_1167","Porites_evermani_scaffold_1087:62454-66305",154,-23.08,2,21,3282,3302,19,"63.16%","84.21%","Peve_00001544",0.999909726776791,0.00855416971793915,0.573710369894872,"O35474","EGF-like repeat and discoidin I-like domain-containing protein 3 (Developmentally-regulated endothelial cell locus 1 protein) (Integrin-binding protein DEL1)","Mus musculus (Mouse)","cell adhesion [GO:0007155]; positive regulation of cell-substrate adhesion [GO:0010811]","GO:0005509; GO:0005576; GO:0007155; GO:0010811"
"109",109,"Cluster_1167","Porites_evermani_scaffold_1092:92343-97511",145,-23.57,2,21,3989,4014,23,"69.57%","69.57%","Peve_00001636",0.999909726776791,0.00855416971793915,0.573710369894872,NA,NA,NA,NA,NA
"111",111,"Cluster_1167","Porites_evermani_scaffold_110:194724-220248",150,-20.48,2,19,14629,14648,17,"76.47%","82.35%","Peve_00001859",0.999909726776791,0.00855416971793915,0.573710369894872,"Q90WN7","Synaptonemal complex protein 2-like (SCP-2-like) (145 kDa nucleolar protein)","Xenopus laevis (African clawed frog)","","GO:0000775; GO:0005730"
"121",121,"Cluster_1167","Porites_evermani_scaffold_1117:100998-113772",143,-22.64,2,12,6428,6449,10,"80.00%","90.00%","Peve_00002111",0.999909726776791,0.00855416971793389,0.573710369894872,"Q498D6","Fibroblast growth factor receptor 4 (FGFR-4) (EC 2.7.10.1) (CD antigen CD334)","Rattus norvegicus (Rat)","alveolar secondary septum development [GO:0061144]; cell migration [GO:0016477]; cholesterol homeostasis [GO:0042632]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glucose homeostasis [GO:0042593]; lung development [GO:0030324]; negative regulation of fibroblast growth factor production [GO:0090272]; negative regulation of gene expression [GO:0010629]; organ induction [GO:0001759]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphate ion homeostasis [GO:0055062]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of parathyroid hormone secretion [GO:2000830]; positive regulation of proteolysis [GO:0045862]; protein autophosphorylation [GO:0046777]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of lipid metabolic process [GO:0019216]; regulation of phosphate transport [GO:0010966]; regulation of phosphorus metabolic process [GO:0051174]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vitamin D3 metabolic process [GO:0070640]","GO:0001759; GO:0004714; GO:0005007; GO:0005524; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0005911; GO:0007169; GO:0008201; GO:0008284; GO:0008543; GO:0010628; GO:0010629; GO:0010715; GO:0010966; GO:0016477; GO:0017134; GO:0018108; GO:0019216; GO:0030133; GO:0030324; GO:0033674; GO:0042593; GO:0042632; GO:0043085; GO:0043235; GO:0045862; GO:0046777; GO:0051174; GO:0055062; GO:0061144; GO:0070374; GO:0070640; GO:0070857; GO:0090272; GO:2000573; GO:2000830"
"122",122,"Cluster_1167","Porites_evermani_scaffold_1119:63465-82833",156,-24.16,2,20,18683,18702,18,"72.22%","83.33%","Peve_00002130",0.999909726776791,0.00855416971793389,0.573710369894872,"Q20191","Zinc metalloproteinase nas-13 (EC 3.4.24.-) (Nematode astacin 13)","Caenorhabditis elegans","proteolysis [GO:0006508]","GO:0004222; GO:0005576; GO:0006508; GO:0008270"
"132",132,"Cluster_1167","Porites_evermani_scaffold_1128:3358-23196",144,-20.32,2,21,15594,15618,23,"69.57%","69.57%","Peve_00002245",0.999909726776791,0.00855416971793915,0.573710369894872,NA,NA,NA,NA,NA
"135",135,"Cluster_1167","Porites_evermani_scaffold_11:371284-415897",147,-22.24,2,21,2285,2308,21,"61.90%","71.43%","Peve_00001844",0.999712456515832,0.0152671261208546,0.747661024355386,"P35559","Insulin-degrading enzyme (EC 3.4.24.56) (Insulin protease) (Insulinase) (Insulysin)","Rattus norvegicus (Rat)","amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta metabolic process [GO:0050435]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; bradykinin catabolic process [GO:0010815]; determination of adult lifespan [GO:0008340]; hormone catabolic process [GO:0042447]; insulin catabolic process [GO:1901143]; insulin metabolic process [GO:1901142]; insulin receptor recycling [GO:0038020]; negative regulation of proteolysis [GO:0045861]; peptide catabolic process [GO:0043171]; positive regulation of protein binding [GO:0032092]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of aerobic respiration [GO:1903715]; response to oxidative stress [GO:0006979]; ubiquitin recycling [GO:0010992]","GO:0001540; GO:0004175; GO:0004222; GO:0005524; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006508; GO:0006979; GO:0008233; GO:0008270; GO:0008340; GO:0009897; GO:0009986; GO:0010815; GO:0010992; GO:0016323; GO:0016887; GO:0017046; GO:0019885; GO:0030163; GO:0031597; GO:0031626; GO:0031904; GO:0032092; GO:0038020; GO:0042277; GO:0042447; GO:0042802; GO:0042803; GO:0043171; GO:0043559; GO:0044877; GO:0045861; GO:0050435; GO:0051603; GO:0070062; GO:0097242; GO:0140036; GO:0150094; GO:1901142; GO:1901143; GO:1903715"
"162",162,"Cluster_1167","Porites_evermani_scaffold_1184:86928-113868",156,-24.94,2,21,22156,22177,19,"63.16%","78.95%","Peve_00003099",0.998614570448091,0.0335148667827687,0.909359886114279,"P35546","Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment]","Mus musculus (Mouse)","activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; anatomical structure morphogenesis [GO:0009653]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657]","GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0006919; GO:0007156; GO:0007158; GO:0007169; GO:0007399; GO:0009410; GO:0009653; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030182; GO:0030335; GO:0030424; GO:0030425; GO:0033141; GO:0033619; GO:0033630; GO:0033674; GO:0035799; GO:0035860; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045121; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0098797; GO:2001241"
"173",173,"Cluster_1167","Porites_evermani_scaffold_120:12742-33522",150,-23.47,2,15,5196,5217,13,"76.92%","84.62%","Peve_00003388",0.999335236615113,0.0232141468595536,0.847368488701098,NA,NA,NA,NA,NA
"174",174,"Cluster_1167","Porites_evermani_scaffold_120:12742-33522",154,-26.19,2,21,728,748,19,"68.42%","78.95%","Peve_00003388",0.999335236615113,0.0232141468595536,0.847368488701098,NA,NA,NA,NA,NA
"193",193,"Cluster_1167","Porites_evermani_scaffold_123:44906-53696",165,-25.62,2,20,1942,1962,18,"77.78%","88.89%","Peve_00003793",0.999909726776791,0.00855416971793915,0.573710369894872,"Q96KE9","BTB/POZ domain-containing protein 6 (Lens BTB domain protein)","Homo sapiens (Human)","neurogenesis [GO:0022008]","GO:0005829; GO:0022008"
"206",206,"Cluster_1167","Porites_evermani_scaffold_126:221058-228838",146,-22.27,2,20,1398,1421,20,"65.00%","70.00%","Peve_00004232",0.999909726776791,0.00855416971793915,0.573710369894872,"Q8BG58","Transmembrane prolyl 4-hydroxylase (P4H-TM) (EC 1.14.11.29) (Hypoxia-inducible factor prolyl hydroxylase 4) (HIF-PH4) (HIF-prolyl hydroxylase 4) (HPH-4)","Mus musculus (Mouse)","peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; regulation of erythrocyte differentiation [GO:0045646]","GO:0004656; GO:0005506; GO:0005509; GO:0005783; GO:0005789; GO:0016706; GO:0018401; GO:0031418; GO:0045646"
"212",212,"Cluster_1167","Porites_evermani_scaffold_1281:72035-90441",152,-21.93,2,17,7785,7806,15,"73.33%","80.00%","Peve_00004514",0.999306288894562,0.0237142587257691,0.852510803297052,"Q12830","Nucleosome-remodeling factor subunit BPTF (Bromodomain and PHD finger-containing transcription factor) (Fetal Alz-50 clone 1 protein) (Fetal Alzheimer antigen)","Homo sapiens (Human)","anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; chromatin remodeling [GO:0006338]; embryonic placenta development [GO:0001892]; endoderm development [GO:0007492]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000122; GO:0000785; GO:0000978; GO:0001892; GO:0005634; GO:0005654; GO:0005737; GO:0006338; GO:0006355; GO:0006357; GO:0007420; GO:0007492; GO:0009952; GO:0016589; GO:0035064; GO:0043565; GO:0045944; GO:0046872; GO:0070062; GO:1904949"
"241",241,"Cluster_1167","Porites_evermani_scaffold_1321:96983-107255",141,-22.16,2,14,7167,7188,12,"75.00%","75.00%","Peve_00005112",0.999914846341146,0.00830806449585902,0.573710369894872,NA,NA,NA,NA,NA
"244",244,"Cluster_1167","Porites_evermani_scaffold_13:349130-362704",159,-25.08,2,21,8716,8738,20,"70.00%","80.00%","Peve_00004764",0.999909726776791,0.00855416971794441,0.573710369894872,"O43854","EGF-like repeat and discoidin I-like domain-containing protein 3 (Developmentally-regulated endothelial cell locus 1 protein) (Integrin-binding protein DEL1)","Homo sapiens (Human)","cell adhesion [GO:0007155]; positive regulation of cell-substrate adhesion [GO:0010811]","GO:0005178; GO:0005509; GO:0007155; GO:0010811; GO:0062023; GO:0070062; GO:1903561"
"245",245,"Cluster_1167","Porites_evermani_scaffold_133:54281-61849",152,-22.04,2,19,1775,1795,17,"76.47%","76.47%","Peve_00005214",0.999909726776791,0.00855416971792863,0.573710369894872,"P21804","Fibroblast growth factor receptor 1 (FGFR-1) (bFGF-R-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (Tyrosine kinase receptor CEK1)","Gallus gallus (Chicken)","epicardial cell to mesenchymal cell transition [GO:0003347]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of phospholipase C activity [GO:0010863]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]","GO:0003347; GO:0004714; GO:0005007; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0007169; GO:0008201; GO:0008284; GO:0010863; GO:0017134; GO:0018108; GO:0031410; GO:0033674; GO:0043235; GO:0043406; GO:0045597; GO:0045893"
"246",246,"Cluster_1167","Porites_evermani_scaffold_133:54281-61849",156,-25.71,2,19,2214,2241,23,"73.91%","73.91%","Peve_00005214",0.999909726776791,0.00855416971792863,0.573710369894872,"P21804","Fibroblast growth factor receptor 1 (FGFR-1) (bFGF-R-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (Tyrosine kinase receptor CEK1)","Gallus gallus (Chicken)","epicardial cell to mesenchymal cell transition [GO:0003347]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of phospholipase C activity [GO:0010863]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]","GO:0003347; GO:0004714; GO:0005007; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0007169; GO:0008201; GO:0008284; GO:0010863; GO:0017134; GO:0018108; GO:0031410; GO:0033674; GO:0043235; GO:0043406; GO:0045597; GO:0045893"
"260",260,"Cluster_1167","Porites_evermani_scaffold_137:133620-191883",147,-20.66,2,20,55833,55852,18,"72.22%","77.78%","Peve_00005762",0.998589476055448,0.033817104073598,0.909359886114279,"A1L3F5","C-Maf-inducing protein (c-Mip)","Xenopus laevis (African clawed frog)","","GO:0005634; GO:0005737"
"266",266,"Cluster_1167","Porites_evermani_scaffold_1382:47094-99820",152,-23.21,2,13,41063,41084,11,"90.91%","90.91%","Peve_00005941",0.999909726776791,0.00855416971793915,0.573710369894872,NA,NA,NA,NA,NA
"267",267,"Cluster_1167","Porites_evermani_scaffold_1382:4803-17713",150,-22.13,2,19,11775,11796,17,"70.59%","70.59%","Peve_00005937",0.998112144659499,0.0391244120935113,0.909359886114279,"Q9Y253","DNA polymerase eta (EC 2.7.7.7) (RAD30 homolog A) (Xeroderma pigmentosum variant type protein)","Homo sapiens (Human)","cellular response to UV-C [GO:0071494]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA synthesis involved in DNA repair [GO:0000731]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; pyrimidine dimer repair [GO:0006290]; regulation of DNA repair [GO:0006282]; response to radiation [GO:0009314]; response to UV-C [GO:0010225]","GO:0000731; GO:0003684; GO:0003887; GO:0005634; GO:0005654; GO:0005657; GO:0005829; GO:0006260; GO:0006281; GO:0006282; GO:0006290; GO:0009314; GO:0010225; GO:0035861; GO:0042276; GO:0046872; GO:0070987; GO:0071494"
"268",268,"Cluster_1167","Porites_evermani_scaffold_1382:4803-17713",151,-26.36,2,21,8314,8332,19,"73.68%","78.95%","Peve_00005937",0.998112144659499,0.0391244120935113,0.909359886114279,"Q9Y253","DNA polymerase eta (EC 2.7.7.7) (RAD30 homolog A) (Xeroderma pigmentosum variant type protein)","Homo sapiens (Human)","cellular response to UV-C [GO:0071494]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA synthesis involved in DNA repair [GO:0000731]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; pyrimidine dimer repair [GO:0006290]; regulation of DNA repair [GO:0006282]; response to radiation [GO:0009314]; response to UV-C [GO:0010225]","GO:0000731; GO:0003684; GO:0003887; GO:0005634; GO:0005654; GO:0005657; GO:0005829; GO:0006260; GO:0006281; GO:0006282; GO:0006290; GO:0009314; GO:0010225; GO:0035861; GO:0042276; GO:0046872; GO:0070987; GO:0071494"
"276",276,"Cluster_1167","Porites_evermani_scaffold_1399:52672-62073",140,-24.54,2,9,8551,8572,7,"100.00%","100.00%","Peve_00006147",0.998797149089736,0.031228028253816,0.903929377050813,"Q2KIH4","Ribosome biogenesis regulatory protein homolog","Bos taurus (Bovine)","endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; mitotic metaphase plate congression [GO:0007080]; protein localization to nucleolus [GO:1902570]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055]","GO:0000027; GO:0000055; GO:0000447; GO:0000794; GO:0005730; GO:0007080; GO:0008097; GO:0030687; GO:0042273; GO:1901796; GO:1902570"
"281",281,"Cluster_1167","Porites_evermani_scaffold_1410:23308-33492",143,-20.62,2,15,9801,9820,13,"76.92%","84.62%","Peve_00006405",0.998249339248832,0.0376755410016539,0.909359886114279,NA,NA,NA,NA,NA
"298",298,"Cluster_1167","Porites_evermani_scaffold_144:231118-266564",151,-24.15,2,12,17771,17792,10,"90.00%","100.00%","Peve_00006734",0.997186132942251,0.0477692913024595,0.94460944882157,NA,NA,NA,NA,NA
"317",317,"Cluster_1167","Porites_evermani_scaffold_1472:99423-121953",140,-20.94,2,9,432,453,7,"100.00%","100.00%","Peve_00007130",0.998360755174564,0.0364566178277266,0.909359886114279,"Q9Y2H9","Microtubule-associated serine/threonine-protein kinase 1 (EC 2.7.11.1) (Syntrophin-associated serine/threonine-protein kinase)","Homo sapiens (Human)","brain development [GO:0007420]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]","GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0005856; GO:0005886; GO:0006468; GO:0007010; GO:0007420; GO:0008017; GO:0018105; GO:0030424; GO:0030425; GO:0035556; GO:0043005; GO:0043025; GO:0106310"
"330",330,"Cluster_1167","Porites_evermani_scaffold_1491:82833-107804",153,-24.31,2,15,21935,21957,14,"85.71%","85.71%","Peve_00007364",0.998367533584612,0.036381143649436,0.909359886114279,"P84039","Ectonucleotide pyrophosphatase/phosphodiesterase family member 5 (E-NPP 5) (NPP-5) (EC 3.1.-.-)","Rattus norvegicus (Rat)","cell communication [GO:0007154]","GO:0000210; GO:0005886; GO:0007154; GO:0008270; GO:0016020"
"341",341,"Cluster_1167","Porites_evermani_scaffold_1511:103980-121538",150,-25.62,2,19,212,233,17,"64.71%","76.47%","Peve_00007688",0.99996576416501,0.0052678915078678,0.551398425649056,NA,NA,NA,NA,NA
"358",358,"Cluster_1167","Porites_evermani_scaffold_1539:47953-117642",158,-24.51,2,21,1933,1956,21,"71.43%","80.95%","Peve_00007969",0.999363808240768,0.0227097402921709,0.840566722266011,"P46023","G-protein coupled receptor GRL101","Lymnaea stagnalis (Great pond snail) (Helix stagnalis)","","GO:0004930; GO:0005886"
"370",370,"Cluster_1167","Porites_evermani_scaffold_1557:103274-118663",146,-20.57,2,16,8765,8788,16,"75.00%","75.00%","Peve_00008195",0.999909726776791,0.00855416971793389,0.573710369894872,NA,NA,NA,NA,NA
"371",371,"Cluster_1167","Porites_evermani_scaffold_1562:103818-108216",150,-25.93,2,21,1551,1571,19,"68.42%","73.68%","Peve_00008266",0.999909726776791,0.00855416971793915,0.573710369894872,NA,NA,NA,NA,NA
"372",372,"Cluster_1167","Porites_evermani_scaffold_1570:18614-21383",147,-22.99,2,20,493,511,18,"72.22%","72.22%","Peve_00008387",0.999946883222669,0.0065616475953019,0.573710369894872,"P35384","Extracellular calcium-sensing receptor (CaSR) (Parathyroid cell calcium-sensing receptor) (BoPCaR1) (PCaR1)","Bos taurus (Bovine)","calcium ion import [GO:0070509]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; detection of calcium ion [GO:0005513]; G protein-coupled receptor signaling pathway [GO:0007186]; JNK cascade [GO:0007254]; ossification [GO:0001503]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; regulation of calcium ion transport [GO:0051924]; vasodilation [GO:0042311]","GO:0001503; GO:0004930; GO:0005509; GO:0005513; GO:0005886; GO:0006816; GO:0006874; GO:0007186; GO:0007254; GO:0008284; GO:0010628; GO:0016597; GO:0032781; GO:0042311; GO:0042803; GO:0043679; GO:0051924; GO:0070509"
"386",386,"Cluster_1167","Porites_evermani_scaffold_160:4740-62493",144,-23.14,2,21,43794,43815,19,"57.89%","68.42%","Peve_00008820",0.998248244852637,0.0376873187172547,0.909359886114279,"Q969X6","U3 small nucleolar RNA-associated protein 4 homolog (Cirhin) (UTP4 small subunit processome component)","Homo sapiens (Human)","maturation of SSU-rRNA [GO:0030490]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; regulation of DNA-templated transcription [GO:0006355]","GO:0000462; GO:0001650; GO:0003723; GO:0005654; GO:0005694; GO:0005730; GO:0006355; GO:0030490; GO:0030686; GO:0032040; GO:0034455"
"387",387,"Cluster_1167","Porites_evermani_scaffold_1613:30495-39446",150,-21.16,2,11,6106,6127,9,"100.00%","100.00%","Peve_00008998",-0.997353015680191,0.0463304639479773,0.937216290033208,NA,NA,NA,NA,NA
"392",392,"Cluster_1167","Porites_evermani_scaffold_1632:79867-83735",143,-20.44,2,21,2547,2569,20,"60.00%","70.00%","Peve_00009220",0.999909726776791,0.00855416971793915,0.573710369894872,NA,NA,NA,NA,NA
"393",393,"Cluster_1167","Porites_evermani_scaffold_1633:90128-94145",142,-22.87,2,17,1297,1325,22,"68.18%","68.18%","Peve_00009226",0.99883535025456,0.0307280462571865,0.903929377050813,NA,NA,NA,NA,NA
"395",395,"Cluster_1167","Porites_evermani_scaffold_1636:1-1713",152,-24.01,2,20,669,688,18,"72.22%","77.78%","Peve_00009248",0.998360346309731,0.0364611653409239,0.909359886114279,"O15439","ATP-binding cassette sub-family C member 4 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B) (MOAT-B) (Multidrug resistance-associated protein 4)","Homo sapiens (Human)","bile acid and bile salt transport [GO:0015721]; cAMP transport [GO:0070730]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; leukotriene transport [GO:0071716]; platelet degranulation [GO:0002576]; prostaglandin secretion [GO:0032310]; prostaglandin transport [GO:0015732]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; urate transport [GO:0015747]; xenobiotic metabolic process [GO:0006805]; xenobiotic transmembrane transport [GO:0006855]","GO:0001409; GO:0002576; GO:0005524; GO:0005730; GO:0005794; GO:0005886; GO:0006805; GO:0006855; GO:0008559; GO:0015132; GO:0015143; GO:0015216; GO:0015431; GO:0015432; GO:0015562; GO:0015721; GO:0015732; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0016404; GO:0016887; GO:0031088; GO:0032310; GO:0034634; GO:0042626; GO:0042910; GO:0043225; GO:0055085; GO:0060271; GO:0070730; GO:0071716; GO:0098591; GO:0140115; GO:0140359; GO:0150104"
"404",404,"Cluster_1167","Porites_evermani_scaffold_16:538973-577173",153,-24.83,2,19,10857,10880,19,"68.42%","78.95%","Peve_00008800",0.997722603479927,0.04297312169955,0.916725852445521,"Q7Z333","Probable helicase senataxin (EC 3.6.4.-) (Amyotrophic lateral sclerosis 4 protein) (SEN1 homolog) (Senataxin)","Homo sapiens (Human)","cell differentiation [GO:0030154]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to oxidative stress [GO:0034599]; cellular response to retinoic acid [GO:0071300]; circadian rhythm [GO:0007623]; DNA recombination [GO:0006310]; DNA-templated transcription termination [GO:0006353]; double-strand break repair [GO:0006302]; fibroblast growth factor receptor signaling pathway [GO:0008543]; MAPK cascade [GO:0000165]; mRNA splice site selection [GO:0006376]; negative regulation of apoptotic process [GO:0043066]; nervous system development [GO:0007399]; positive regulation of DNA-templated transcription initiation [GO:2000144]; positive regulation of neuron projection development [GO:0010976]; positive regulation of RNA splicing [GO:0033120]; positive regulation of termination of DNA-templated transcription [GO:0060566]; positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000806]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein kinase B signaling [GO:0043491]; RNA processing [GO:0006396]; spermatogenesis [GO:0007283]; termination of RNA polymerase II transcription [GO:0006369]","GO:0000165; GO:0000228; GO:0000781; GO:0001147; GO:0003677; GO:0003678; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006302; GO:0006310; GO:0006353; GO:0006369; GO:0006376; GO:0006396; GO:0006974; GO:0007283; GO:0007399; GO:0007623; GO:0008543; GO:0010976; GO:0016604; GO:0016787; GO:0030154; GO:0030424; GO:0030426; GO:0033120; GO:0034599; GO:0042802; GO:0043066; GO:0043491; GO:0044344; GO:0045171; GO:0045944; GO:0060566; GO:0070301; GO:0071300; GO:2000144; GO:2000806"
"405",405,"Cluster_1167","Porites_evermani_scaffold_16:538973-577173",158,-25.88,2,17,16894,16914,15,"86.67%","86.67%","Peve_00008800",0.997722603479927,0.04297312169955,0.916725852445521,"Q7Z333","Probable helicase senataxin (EC 3.6.4.-) (Amyotrophic lateral sclerosis 4 protein) (SEN1 homolog) (Senataxin)","Homo sapiens (Human)","cell differentiation [GO:0030154]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to oxidative stress [GO:0034599]; cellular response to retinoic acid [GO:0071300]; circadian rhythm [GO:0007623]; DNA recombination [GO:0006310]; DNA-templated transcription termination [GO:0006353]; double-strand break repair [GO:0006302]; fibroblast growth factor receptor signaling pathway [GO:0008543]; MAPK cascade [GO:0000165]; mRNA splice site selection [GO:0006376]; negative regulation of apoptotic process [GO:0043066]; nervous system development [GO:0007399]; positive regulation of DNA-templated transcription initiation [GO:2000144]; positive regulation of neuron projection development [GO:0010976]; positive regulation of RNA splicing [GO:0033120]; positive regulation of termination of DNA-templated transcription [GO:0060566]; positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000806]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein kinase B signaling [GO:0043491]; RNA processing [GO:0006396]; spermatogenesis [GO:0007283]; termination of RNA polymerase II transcription [GO:0006369]","GO:0000165; GO:0000228; GO:0000781; GO:0001147; GO:0003677; GO:0003678; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006302; GO:0006310; GO:0006353; GO:0006369; GO:0006376; GO:0006396; GO:0006974; GO:0007283; GO:0007399; GO:0007623; GO:0008543; GO:0010976; GO:0016604; GO:0016787; GO:0030154; GO:0030424; GO:0030426; GO:0033120; GO:0034599; GO:0042802; GO:0043066; GO:0043491; GO:0044344; GO:0045171; GO:0045944; GO:0060566; GO:0070301; GO:0071300; GO:2000144; GO:2000806"
"408",408,"Cluster_1167","Porites_evermani_scaffold_16:548896-550171",153,-24.83,2,19,934,957,19,"68.42%","78.95%","Peve_00008801",0.999909726776791,0.00855416971793915,0.573710369894872,NA,NA,NA,NA,NA
"424",424,"Cluster_1167","Porites_evermani_scaffold_1686:24199-25339",150,-25.12,2,21,136,156,19,"68.42%","73.68%","Peve_00009822",0.999955273448146,0.00602115002709614,0.573710369894872,NA,NA,NA,NA,NA
"427",427,"Cluster_1167","Porites_evermani_scaffold_169:171287-220290",144,-23.48,2,15,5838,5858,13,"76.92%","84.62%","Peve_00009873",0.999959878657719,0.00570274956330863,0.561781303084973,"Q9H8V3","Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene)","Homo sapiens (Human)","activation of GTPase activity [GO:0090630]; activation of protein kinase activity [GO:0032147]; bicellular tight junction assembly [GO:0070830]; cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to ionizing radiation [GO:0071479]; intracellular signal transduction [GO:0035556]; mitotic cytokinesis [GO:0000281]; nervous system development [GO:0007399]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cytokinesis [GO:0032467]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein import into nucleus [GO:0042307]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of cytokinesis, actomyosin contractile ring assembly [GO:2000431]; regulation of protein kinase activity [GO:0045859]; regulation of small GTPase mediated signal transduction [GO:0051056]","GO:0000281; GO:0000902; GO:0005085; GO:0005096; GO:0005634; GO:0005654; GO:0005737; GO:0005815; GO:0005829; GO:0005911; GO:0005923; GO:0005938; GO:0007399; GO:0015031; GO:0016604; GO:0030154; GO:0030496; GO:0031267; GO:0032147; GO:0032154; GO:0032467; GO:0035556; GO:0042307; GO:0042803; GO:0043065; GO:0043123; GO:0043547; GO:0045666; GO:0045859; GO:0051056; GO:0051260; GO:0051988; GO:0070301; GO:0070830; GO:0071277; GO:0071479; GO:0072686; GO:0090630; GO:0097149; GO:2000431"
"429",429,"Cluster_1167","Porites_evermani_scaffold_1692:67226-98409",150,-21.22,2,16,2548,2570,15,"73.33%","86.67%","Peve_00009911",0.99887693469296,0.0301743747691789,0.903929377050813,"F6Z5C0","Ubiquitin carboxyl-terminal hydrolase 15 (EC 3.4.19.12) (Deubiquitinating enzyme 15) (Ubiquitin thioesterase 15) (Ubiquitin-specific-processing protease 15)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","BMP signaling pathway [GO:0030509]; histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; monoubiquitinated protein deubiquitination [GO:0035520]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; protein deubiquitination [GO:0016579]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0006511; GO:0007179; GO:0016579; GO:0030509; GO:0035520; GO:0035616; GO:0060389"
"439",439,"Cluster_1167","Porites_evermani_scaffold_171:242188-323091",142,-20.58,2,11,20439,20460,9,"88.89%","88.89%","Peve_00010154",0.999910964622944,0.00849531807985483,0.573710369894872,"A0A0R4IBK5","E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (E3 ubiquitin-lipopolysaccharide ligase rnf213-alpha) (EC 2.3.2.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha)","Danio rerio (Zebrafish) (Brachydanio rerio)","blood circulation [GO:0008015]; defense response to bacterium [GO:0042742]; immune system process [GO:0002376]; lipid droplet formation [GO:0140042]; lipid ubiquitination [GO:0120323]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein K63-linked ubiquitination [GO:0070534]; regulation of lipid metabolic process [GO:0019216]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]; xenophagy [GO:0098792]","GO:0002040; GO:0002376; GO:0004842; GO:0005524; GO:0005730; GO:0005811; GO:0005829; GO:0006511; GO:0008015; GO:0016887; GO:0019216; GO:0042742; GO:0046872; GO:0061630; GO:0070534; GO:0098792; GO:0120323; GO:0140042; GO:2000051"
"450",450,"Cluster_1167","Porites_evermani_scaffold_1723:62624-66717",176,-27.48,2,21,1565,1586,19,"78.95%","89.47%","Peve_00010305",0.999909726776791,0.00855416971793389,0.573710369894872,NA,NA,NA,NA,NA
"451",451,"Cluster_1167","Porites_evermani_scaffold_1723:72515-75635",176,-27.48,2,21,1565,1586,19,"78.95%","89.47%","Peve_00010307",0.999909726776791,0.00855416971793915,0.573710369894872,NA,NA,NA,NA,NA
"452",452,"Cluster_1167","Porites_evermani_scaffold_1725:78691-80248",149,-20.84,2,20,257,277,18,"72.22%","72.22%","Peve_00010322",0.999909726776791,0.00855416971794441,0.573710369894872,"F1PZV2","Major facilitator superfamily domain-containing protein 12","Canis lupus familiaris (Dog) (Canis familiaris)","carbohydrate transport [GO:0008643]; cysteine transmembrane transport [GO:1903712]; melanin biosynthetic process [GO:0042438]; organic substance transport [GO:0071702]; pigment metabolic process involved in pigmentation [GO:0043474]; regulation of melanin biosynthetic process [GO:0048021]","GO:0005764; GO:0005765; GO:0005886; GO:0008643; GO:0015293; GO:0033162; GO:0033229; GO:0042438; GO:0043474; GO:0048021; GO:0071702; GO:1903712"
"465",465,"Cluster_1167","Porites_evermani_scaffold_1765:39038-50394",142,-21.85,2,11,5807,5828,9,"88.89%","88.89%","Peve_00010717",0.999909726776791,0.00855416971793915,0.573710369894872,"P07314","Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain]","Rattus norvegicus (Rat)","aging [GO:0007568]; amino acid metabolic process [GO:0006520]; cellular response to oxidative stress [GO:0034599]; cysteine biosynthetic process [GO:0019344]; fatty acid metabolic process [GO:0006631]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; hepatoblast differentiation [GO:0061017]; hepatocyte differentiation [GO:0070365]; leukotriene D4 biosynthetic process [GO:1901750]; leukotriene metabolic process [GO:0006691]; liver regeneration [GO:0097421]; peptide modification [GO:0031179]; proteolysis [GO:0006508]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; response to alcohol [GO:0097305]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; spermatogenesis [GO:0007283]; zymogen activation [GO:0031638]","GO:0000048; GO:0002682; GO:0002951; GO:0005615; GO:0005886; GO:0006508; GO:0006520; GO:0006536; GO:0006631; GO:0006691; GO:0006750; GO:0006751; GO:0007283; GO:0007568; GO:0016755; GO:0019344; GO:0031179; GO:0031638; GO:0031982; GO:0032355; GO:0032496; GO:0034599; GO:0034612; GO:0036374; GO:0050727; GO:0061017; GO:0070365; GO:0097305; GO:0097421; GO:0102953; GO:0103068; GO:1901750"
"466",466,"Cluster_1167","Porites_evermani_scaffold_177:267211-285408",146,-20.65,2,21,10393,10411,19,"73.68%","78.95%","Peve_00010778",0.999909726776791,0.00855416971793915,0.573710369894872,"Q4V9Y5","Cysteine-rich secretory protein LCCL domain-containing 2","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","","GO:0005576"
"479",479,"Cluster_1167","Porites_evermani_scaffold_1819:41455-79440",145,-20.49,2,10,6629,6650,8,"100.00%","100.00%","Peve_00011363",0.999909726776791,0.00855416971793915,0.573710369894872,"Q96CG8","Collagen triple helix repeat-containing protein 1","Homo sapiens (Human)","cell migration [GO:0016477]; cochlea morphogenesis [GO:0090103]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein binding [GO:0032092]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001649; GO:0005109; GO:0005576; GO:0005581; GO:0005615; GO:0016477; GO:0016528; GO:0017147; GO:0032092; GO:0033687; GO:0033690; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0062023; GO:0090090; GO:0090103; GO:0090177"
"484",484,"Cluster_1167","Porites_evermani_scaffold_1832:77-22964",148,-21.52,2,21,11134,11153,19,"73.68%","73.68%","Peve_00011528",0.999909726776791,0.00855416971793389,0.573710369894872,"Q6V4S5","Protein sidekick-2","Mus musculus (Mouse)","camera-type eye photoreceptor cell differentiation [GO:0060219]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]","GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0045202; GO:0060219"
"485",485,"Cluster_1167","Porites_evermani_scaffold_1832:77-22964",154,-22.48,2,21,7917,7941,22,"72.73%","72.73%","Peve_00011528",0.999909726776791,0.00855416971793389,0.573710369894872,"Q6V4S5","Protein sidekick-2","Mus musculus (Mouse)","camera-type eye photoreceptor cell differentiation [GO:0060219]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]","GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0045202; GO:0060219"
"493",493,"Cluster_1167","Porites_evermani_scaffold_186:233380-279437",142,-21.38,2,11,27625,27646,9,"88.89%","88.89%","Peve_00011810",0.997092796096673,0.0485554673589907,0.947538901194076,"F1MA98","Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)","Rattus norvegicus (Rat)","cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mRNA export from nucleus [GO:0006406]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin formation [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein localization [GO:0032880]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]","GO:0000122; GO:0000776; GO:0003682; GO:0003729; GO:0005634; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006406; GO:0006606; GO:0006611; GO:0006999; GO:0007094; GO:0010965; GO:0015631; GO:0017056; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0032880; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070840; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673"
"494",494,"Cluster_1167","Porites_evermani_scaffold_186:233380-279437",147,-22.92,2,12,25947,25968,10,"90.00%","90.00%","Peve_00011810",0.997092796096673,0.0485554673589907,0.947538901194076,"F1MA98","Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)","Rattus norvegicus (Rat)","cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mRNA export from nucleus [GO:0006406]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin formation [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein localization [GO:0032880]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]","GO:0000122; GO:0000776; GO:0003682; GO:0003729; GO:0005634; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006406; GO:0006606; GO:0006611; GO:0006999; GO:0007094; GO:0010965; GO:0015631; GO:0017056; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0032880; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070840; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673"
"495",495,"Cluster_1167","Porites_evermani_scaffold_186:233380-279437",150,-21.99,2,11,37785,37806,9,"100.00%","100.00%","Peve_00011810",0.997092796096673,0.0485554673589907,0.947538901194076,"F1MA98","Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)","Rattus norvegicus (Rat)","cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mRNA export from nucleus [GO:0006406]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin formation [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein localization [GO:0032880]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]","GO:0000122; GO:0000776; GO:0003682; GO:0003729; GO:0005634; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006406; GO:0006606; GO:0006611; GO:0006999; GO:0007094; GO:0010965; GO:0015631; GO:0017056; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0032880; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070840; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673"
"500",500,"Cluster_1167","Porites_evermani_scaffold_1873:6725-22145",142,-24.37,2,21,6951,6976,23,"65.22%","65.22%","Peve_00011946",0.999909726776791,0.00855416971793915,0.573710369894872,NA,NA,NA,NA,NA
"510",510,"Cluster_1167","Porites_evermani_scaffold_189:323684-330802",147,-24.68,2,12,1303,1324,10,"90.00%","90.00%","Peve_00012138",0.998405703354998,0.0359531878007655,0.909359886114279,"F4KGU4","ATP-dependent RNA helicase DEAH12, chloroplastic (EC 3.6.4.13)","Arabidopsis thaliana (Mouse-ear cress)","","GO:0003723; GO:0003724; GO:0005524; GO:0009507; GO:0016740; GO:0016887; GO:0046872; GO:0140096"
"511",511,"Cluster_1167","Porites_evermani_scaffold_189:323684-330802",149,-22.57,2,20,6975,7000,22,"68.18%","72.73%","Peve_00012138",0.998405703354998,0.0359531878007655,0.909359886114279,"F4KGU4","ATP-dependent RNA helicase DEAH12, chloroplastic (EC 3.6.4.13)","Arabidopsis thaliana (Mouse-ear cress)","","GO:0003723; GO:0003724; GO:0005524; GO:0009507; GO:0016740; GO:0016887; GO:0046872; GO:0140096"
"512",512,"Cluster_1167","Porites_evermani_scaffold_189:81334-102877",150,-20.65,2,20,2452,2474,19,"63.16%","78.95%","Peve_00012115",0.999910871663019,0.00849975187831585,0.573710369894872,"A5PJW8",NA,NA,NA,NA
"525",525,"Cluster_1167","Porites_evermani_scaffold_1926:29075-50388",152,-22.53,2,21,17929,17950,19,"63.16%","73.68%","Peve_00012576",0.999650459187876,0.0168328137218846,0.778099913711208,"Q9QYY8","Spastin (EC 5.6.1.1)","Mus musculus (Mouse)","anterograde axonal transport [GO:0008089]; axonal transport of mitochondrion [GO:0019896]; axonogenesis [GO:0007409]; cytokinetic process [GO:0032506]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exit from mitosis [GO:0010458]; membrane fission [GO:0090148]; metabolic process [GO:0008152]; microtubule bundle formation [GO:0001578]; microtubule severing [GO:0051013]; mitotic cytokinesis [GO:0000281]; mitotic spindle disassembly [GO:0051228]; nuclear membrane reassembly [GO:0031468]; positive regulation of cytokinesis [GO:0032467]; positive regulation of microtubule depolymerization [GO:0031117]; protein hexamerization [GO:0034214]; protein homooligomerization [GO:0051260]","GO:0000281; GO:0000922; GO:0001578; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005783; GO:0005789; GO:0005811; GO:0005813; GO:0005829; GO:0005874; GO:0006888; GO:0007409; GO:0008017; GO:0008089; GO:0008152; GO:0008568; GO:0010458; GO:0015630; GO:0016853; GO:0016887; GO:0019896; GO:0030424; GO:0030496; GO:0031117; GO:0031410; GO:0031468; GO:0031965; GO:0032467; GO:0032506; GO:0034214; GO:0043014; GO:0048471; GO:0048487; GO:0051013; GO:0051228; GO:0051260; GO:0071782; GO:0090148; GO:1904115"
"529",529,"Cluster_1167","Porites_evermani_scaffold_1943:66393-76944",151,-21.35,2,12,9219,9240,10,"90.00%","100.00%","Peve_00012763",0.997216635484962,0.0475095534720038,0.943238620332273,NA,NA,NA,NA,NA
"539",539,"Cluster_1167","Porites_evermani_scaffold_1978:46354-60146",153,-22.38,2,21,8369,8388,19,"73.68%","73.68%","Peve_00013085",0.999909726776791,0.00855416971793915,0.573710369894872,"Q7TN88","Polycystic kidney disease protein 1-like 2 (PC1-like 2 protein) (Polycystin-1L2)","Mus musculus (Mouse)","detection of mechanical stimulus [GO:0050982]","GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982"
"549",549,"Cluster_1167","Porites_evermani_scaffold_200:293418-301645",144,-20.7,2,21,7606,7627,19,"57.89%","68.42%","Peve_00013573",0.999909726776791,0.00855416971793915,0.573710369894872,"B8VIU6","Uncharacterized skeletal organic matrix protein 5 (Uncharacterized SOMP-5)","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0005576"
"562",562,"Cluster_1167","Porites_evermani_scaffold_2044:36711-55313",151,-24.38,2,12,3520,3541,10,"90.00%","100.00%","Peve_00014007",0.999909726776791,0.00855416971793389,0.573710369894872,"Q5EAW4","Protein MCM10 homolog","Xenopus laevis (African clawed frog)","cellular response to DNA damage stimulus [GO:0006974]; DNA replication initiation [GO:0006270]","GO:0003690; GO:0003697; GO:0005634; GO:0006270; GO:0006974; GO:0046872"
"605",605,"Cluster_1167","Porites_evermani_scaffold_2149:41570-47463",157,-25.18,2,21,3322,3348,24,"75.00%","75.00%","Peve_00015040",0.999909726776791,0.00855416971793389,0.573710369894872,NA,NA,NA,NA,NA
"626",626,"Cluster_1167","Porites_evermani_scaffold_220:98201-135547",145,-20.42,2,19,7365,7387,18,"66.67%","72.22%","Peve_00015570",0.998135332124585,0.0388833229901565,0.909359886114279,"G3I6Z6","Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]","Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)","angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355]","GO:0000139; GO:0001525; GO:0005509; GO:0005634; GO:0005796; GO:0005912; GO:0006355; GO:0016324; GO:0030154; GO:0038023; GO:0050793; GO:0060271; GO:0061314"
"645",645,"Cluster_1167","Porites_evermani_scaffold_2253:1760-50464",152,-21.19,2,20,47450,47471,19,"68.42%","84.21%","Peve_00016081",0.998472782168961,0.0351885118974169,0.909359886114279,NA,NA,NA,NA,NA
"651",651,"Cluster_1167","Porites_evermani_scaffold_2275:51004-61933",147,-21.22,2,21,2320,2342,20,"65.00%","70.00%","Peve_00016266",0.997218255892448,0.04749571558219,0.943092358689762,"Q5VT52","Regulation of nuclear pre-mRNA domain-containing protein 2","Homo sapiens (Human)","mRNA 3'-end processing [GO:0031124]","GO:0000993; GO:0005654; GO:0016591; GO:0031124"
"652",652,"Cluster_1167","Porites_evermani_scaffold_2280:26415-33442",143,-23.86,2,20,3532,3554,21,"66.67%","71.43%","Peve_00016327",0.999909726776791,0.00855416971793915,0.573710369894872,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"653",653,"Cluster_1167","Porites_evermani_scaffold_2280:26415-33442",143,-23.86,2,20,825,847,21,"66.67%","71.43%","Peve_00016327",0.999909726776791,0.00855416971793915,0.573710369894872,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"654",654,"Cluster_1167","Porites_evermani_scaffold_228:286470-312010",152,-23.19,2,13,13890,13911,11,"90.91%","90.91%","Peve_00016317",0.999592690559685,0.018170718522517,0.782669382293497,"F8W2M8","Tripeptidyl-peptidase 1 (TPP-1) (EC 3.4.14.9) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I) (TPP-I)","Danio rerio (Zebrafish) (Brachydanio rerio)","central nervous system development [GO:0007417]; locomotory behavior [GO:0007626]; neurogenesis [GO:0022008]; proteolysis [GO:0006508]","GO:0004175; GO:0004252; GO:0005764; GO:0006508; GO:0007417; GO:0007626; GO:0008240; GO:0022008; GO:0046872"
"661",661,"Cluster_1167","Porites_evermani_scaffold_231:166677-180453",147,-20.36,2,20,10152,10173,18,"66.67%","66.67%","Peve_00016655",0.999909726776791,0.00855416971793915,0.573710369894872,"Q7TQ69","Transmembrane channel-like protein 3","Mus musculus (Mouse)","","GO:0005886; GO:0008381"
"674",674,"Cluster_1167","Porites_evermani_scaffold_2350:55197-78591",144,-22.28,2,13,3299,3320,11,"81.82%","81.82%","Peve_00017013",0.999909726776791,0.00855416971793389,0.573710369894872,NA,NA,NA,NA,NA
"692",692,"Cluster_1167","Porites_evermani_scaffold_2403:41495-53165",155,-21.34,2,16,6556,6577,14,"78.57%","85.71%","Peve_00017537",0.99996273202871,0.00549622300675805,0.551398425649056,"Q13118","Krueppel-like factor 10 (EGR-alpha) (Transforming growth factor-beta-inducible early growth response protein 1) (TGFB-inducible early growth response protein 1) (TIEG-1)","Homo sapiens (Human)","bone mineralization [GO:0030282]; cell-cell signaling [GO:0007267]; cellular response to starvation [GO:0009267]; circadian rhythm [GO:0007623]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic stem cell population maintenance [GO:0035019]","GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001046; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0007267; GO:0007623; GO:0008285; GO:0009267; GO:0030282; GO:0035019; GO:0042752; GO:0045672; GO:0045892; GO:0045944; GO:0046872; GO:1990837"
"693",693,"Cluster_1167","Porites_evermani_scaffold_2403:41495-53165",155,-21.34,2,16,7507,7528,14,"78.57%","85.71%","Peve_00017537",0.99996273202871,0.00549622300675805,0.551398425649056,"Q13118","Krueppel-like factor 10 (EGR-alpha) (Transforming growth factor-beta-inducible early growth response protein 1) (TGFB-inducible early growth response protein 1) (TIEG-1)","Homo sapiens (Human)","bone mineralization [GO:0030282]; cell-cell signaling [GO:0007267]; cellular response to starvation [GO:0009267]; circadian rhythm [GO:0007623]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic stem cell population maintenance [GO:0035019]","GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001046; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0007267; GO:0007623; GO:0008285; GO:0009267; GO:0030282; GO:0035019; GO:0042752; GO:0045672; GO:0045892; GO:0045944; GO:0046872; GO:1990837"
"695",695,"Cluster_1167","Porites_evermani_scaffold_2414:48059-55873",154,-22.16,2,19,7281,7302,17,"70.59%","76.47%","Peve_00017626",0.999909726776791,0.00855416971793915,0.573710369894872,"Q7TQP6","Serine/threonine-protein kinase TNNI3K (EC 2.7.11.1) (Cardiac ankyrin repeat kinase) (TNNI3-interacting kinase)","Rattus norvegicus (Rat)","bundle of His cell to Purkinje myocyte communication [GO:0086069]; protein phosphorylation [GO:0006468]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart rate [GO:0002027]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0002027; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006357; GO:0006468; GO:0008022; GO:0031013; GO:0046872; GO:0055117; GO:0061629; GO:0086069; GO:0106310; GO:1903779"
"704",704,"Cluster_1167","Porites_evermani_scaffold_2434:25198-33224",160,-23.96,2,19,1656,1676,17,"76.47%","88.24%","Peve_00017815",0.999624036298081,0.0174574853769298,0.782669382293497,"O35111","Potassium channel subfamily K member 3 (Acid-sensitive potassium channel protein TASK-1) (Cardiac two pore background K(+) channel) (TWIK-related acid-sensitive K(+) channel 1) (Two pore potassium channel KT3.1) (Two pore K(+) channel KT3.1) (cTBAK-1)","Mus musculus (Mouse)","brain development [GO:0007420]; cellular response to hypoxia [GO:0071456]; cellular response to zinc ion [GO:0071294]; cochlea development [GO:0090102]; ion transmembrane transport [GO:0034220]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of resting membrane potential [GO:0060075]; response to xenobiotic stimulus [GO:0009410]; stabilization of membrane potential [GO:0030322]","GO:0005216; GO:0005252; GO:0005886; GO:0006813; GO:0007420; GO:0008022; GO:0009410; GO:0015271; GO:0022841; GO:0030322; GO:0034220; GO:0044548; GO:0051481; GO:0060075; GO:0071294; GO:0071456; GO:0071805; GO:0090102; GO:1903818"
"714",714,"Cluster_1167","Porites_evermani_scaffold_2463:25289-32215",174,-26.85,2,21,5382,5402,19,"84.21%","89.47%","Peve_00018050",0.999909726776791,0.00855416971793389,0.573710369894872,NA,NA,NA,NA,NA
"721",721,"Cluster_1167","Porites_evermani_scaffold_247:60688-69326",142,-21.56,2,11,7593,7614,9,"88.89%","88.89%","Peve_00018084",0.999796415038106,0.0128462194457193,0.696479349653946,"Q5I0I5","U6 snRNA phosphodiesterase 1 (3'-5' RNA exonuclease USB1) (EC 4.6.1.-)","Rattus norvegicus (Rat)","RNA splicing [GO:0008380]; snRNA 3'-end processing [GO:0034472]; U6 snRNA 3'-end processing [GO:0034477]","GO:0000175; GO:0005634; GO:0005654; GO:0008380; GO:0016829; GO:0034472; GO:0034477; GO:0045171; GO:1990838"
"727",727,"Cluster_1167","Porites_evermani_scaffold_2509:50799-58680",147,-24.92,2,21,3123,3145,20,"65.00%","70.00%","Peve_00018512",0.999909726776791,0.00855416971793389,0.573710369894872,NA,NA,NA,NA,NA
"730",730,"Cluster_1167","Porites_evermani_scaffold_2515:47609-49543",149,-21.88,2,14,1584,1605,12,"75.00%","91.67%","Peve_00018567",0.999909726776791,0.00855416971793915,0.573710369894872,NA,NA,NA,NA,NA
"758",758,"Cluster_1167","Porites_evermani_scaffold_2577:48792-51851",148,-21.04,2,21,1411,1429,19,"68.42%","73.68%","Peve_00019043",0.999909726776791,0.00855416971793915,0.573710369894872,NA,NA,NA,NA,NA
"761",761,"Cluster_1167","Porites_evermani_scaffold_2601:11667-41287",152,-23.69,2,13,19920,19941,11,"90.91%","90.91%","Peve_00019304",0.999909726776791,0.00855416971793915,0.573710369894872,NA,NA,NA,NA,NA
"762",762,"Cluster_1167","Porites_evermani_scaffold_2601:11667-41287",154,-21.17,2,19,18500,18521,17,"70.59%","76.47%","Peve_00019304",0.999909726776791,0.00855416971793915,0.573710369894872,NA,NA,NA,NA,NA
"763",763,"Cluster_1167","Porites_evermani_scaffold_2601:11667-41287",159,-24.7,2,20,16534,16554,19,"78.95%","84.21%","Peve_00019304",0.999909726776791,0.00855416971793915,0.573710369894872,NA,NA,NA,NA,NA
"765",765,"Cluster_1167","Porites_evermani_scaffold_2619:42966-57559",150,-22.03,2,20,8513,8535,19,"68.42%","73.68%","Peve_00019413",0.997277672715347,0.0469855010262438,0.940151481590584,"Q6DFB7","Centrosomal protein POC5 (Protein of centriole 5)","Xenopus laevis (African clawed frog)","cell cycle [GO:0007049]","GO:0005737; GO:0005814; GO:0007049"
"771",771,"Cluster_1167","Porites_evermani_scaffold_2649:9720-38474",154,-22.16,2,19,21890,21911,17,"70.59%","76.47%","Peve_00019614",0.999909726776791,0.00855416971794441,0.573710369894872,"Q5GIG6","Serine/threonine-protein kinase TNNI3K (EC 2.7.11.1) (Cardiac ankyrin repeat kinase) (TNNI3-interacting kinase)","Mus musculus (Mouse)","bundle of His cell to Purkinje myocyte communication [GO:0086069]; protein phosphorylation [GO:0006468]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart rate [GO:0002027]","GO:0002027; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0008022; GO:0031013; GO:0046872; GO:0055117; GO:0086069; GO:0106310; GO:1903779"
"776",776,"Cluster_1167","Porites_evermani_scaffold_2659:42876-65073",152,-23.21,2,13,5437,5458,11,"90.91%","90.91%","Peve_00019725",0.998585738294794,0.033861891113506,0.909359886114279,"Q9NV70","Exocyst complex component 1 (Exocyst complex component Sec3)","Homo sapiens (Human)","defense response to virus [GO:0051607]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of protein secretion [GO:0050714]; protein transport [GO:0015031]; regulation of macroautophagy [GO:0016241]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522]","GO:0000145; GO:0000281; GO:0005546; GO:0005737; GO:0005829; GO:0005886; GO:0006887; GO:0006893; GO:0006904; GO:0015031; GO:0016020; GO:0016241; GO:0048015; GO:0048471; GO:0050714; GO:0051607; GO:0090148; GO:0090522; GO:0090543; GO:0098592"
"781",781,"Cluster_1167","Porites_evermani_scaffold_2694:665-5259",156,-23.86,2,18,4141,4165,19,"73.68%","78.95%","Peve_00020003",0.999909726776791,0.00855416971794441,0.573710369894872,"Q5HZP1","Ribonuclease H2 subunit B (RNase H2 subunit B) (Ribonuclease HI subunit B)","Xenopus laevis (African clawed frog)","RNA catabolic process [GO:0006401]","GO:0005634; GO:0006401; GO:0032299"
"785",785,"Cluster_1167","Porites_evermani_scaffold_2707:12897-19323",142,-20.6,2,11,1212,1233,9,"88.89%","88.89%","Peve_00020149",0.99989178672184,0.00936567997820576,0.602207777435852,"Q09596","Probable glutathione S-transferase 5 (EC 2.5.1.18) (GST class-sigma)","Caenorhabditis elegans","glutathione metabolic process [GO:0006749]; innate immune response [GO:0045087]","GO:0004364; GO:0006749; GO:0045087"
"786",786,"Cluster_1167","Porites_evermani_scaffold_2707:30326-36085",145,-23.56,2,21,2151,2179,26,"65.38%","69.23%","Peve_00020151",0.999909726776791,0.00855416971793915,0.573710369894872,"Q09596","Probable glutathione S-transferase 5 (EC 2.5.1.18) (GST class-sigma)","Caenorhabditis elegans","glutathione metabolic process [GO:0006749]; innate immune response [GO:0045087]","GO:0004364; GO:0006749; GO:0045087"
"788",788,"Cluster_1167","Porites_evermani_scaffold_27:125752-133674",146,-23.49,2,21,6446,6471,23,"60.87%","73.91%","Peve_00020080",0.999909726776791,0.00855416971793389,0.573710369894872,NA,NA,NA,NA,NA
"790",790,"Cluster_1167","Porites_evermani_scaffold_2:72037-78579",147,-20.85,2,17,2104,2126,16,"75.00%","75.00%","Peve_00013358",0.999909726776791,0.00855416971793915,0.573710369894872,"P07911","Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form]","Homo sapiens (Human)","antibacterial innate immune response [GO:0140367]; apoptotic signaling pathway [GO:0097190]; autophagy [GO:0006914]; cellular calcium ion homeostasis [GO:0006874]; cellular chloride ion homeostasis [GO:0030644]; cellular defense response [GO:0006968]; cellular phosphate ion homeostasis [GO:0030643]; cellular response to unfolded protein [GO:0034620]; cellular sodium ion homeostasis [GO:0006883]; chaperone-mediated protein folding [GO:0061077]; citric acid secretion [GO:0046720]; collecting duct development [GO:0072044]; connective tissue replacement [GO:0097709]; creatinine homeostasis [GO:0097273]; defense response to Gram-negative bacterium [GO:0050829]; endoplasmic reticulum organization [GO:0007029]; glomerular filtration [GO:0003094]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; inflammatory response [GO:0006954]; juxtaglomerular apparatus development [GO:0072051]; leukocyte cell-cell adhesion [GO:0007159]; lipid metabolic process [GO:0006629]; metanephric ascending thin limb development [GO:0072218]; metanephric distal convoluted tubule development [GO:0072221]; metanephric thick ascending limb development [GO:0072233]; micturition [GO:0060073]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell population proliferation [GO:0008285]; neutrophil migration [GO:1990266]; organ or tissue specific immune response [GO:0002251]; peptidyl-threonine phosphorylation [GO:0018107]; potassium ion homeostasis [GO:0055075]; protein localization to vacuole [GO:0072665]; protein transport into plasma membrane raft [GO:0044861]; regulation of blood pressure [GO:0008217]; regulation of protein transport [GO:0051223]; regulation of urine volume [GO:0035809]; renal sodium ion absorption [GO:0070294]; renal urate salt excretion [GO:0097744]; renal water homeostasis [GO:0003091]; response to lipopolysaccharide [GO:0032496]; response to water deprivation [GO:0009414]; response to xenobiotic stimulus [GO:0009410]; RNA splicing [GO:0008380]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; ubiquitin-dependent ERAD pathway [GO:0030433]; urate transport [GO:0015747]; urea transmembrane transport [GO:0071918]","GO:0000922; GO:0002251; GO:0003091; GO:0003094; GO:0005201; GO:0005509; GO:0005615; GO:0005783; GO:0005796; GO:0005929; GO:0006629; GO:0006874; GO:0006883; GO:0006914; GO:0006954; GO:0006968; GO:0007029; GO:0007157; GO:0007159; GO:0008217; GO:0008285; GO:0008380; GO:0009410; GO:0009414; GO:0009986; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0018107; GO:0019864; GO:0019898; GO:0030433; GO:0030643; GO:0030644; GO:0032496; GO:0033209; GO:0033555; GO:0034620; GO:0035809; GO:0044861; GO:0046720; GO:0050829; GO:0051223; GO:0055075; GO:0060073; GO:0060170; GO:0061077; GO:0070062; GO:0070294; GO:0071918; GO:0072044; GO:0072051; GO:0072218; GO:0072221; GO:0072233; GO:0072665; GO:0097190; GO:0097273; GO:0097709; GO:0097744; GO:0140367; GO:1990266"
"791",791,"Cluster_1167","Porites_evermani_scaffold_272:256924-277049",141,-20.76,2,12,6532,6552,10,"90.00%","90.00%","Peve_00020266",0.999582569792977,0.0183951005418645,0.782669382293497,"Q8TCJ2","Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B (Oligosaccharyl transferase subunit STT3B) (STT3-B) (EC 2.4.99.18) (Source of immunodominant MHC-associated peptides homolog)","Homo sapiens (Human)","co-translational protein modification [GO:0043686]; glycoprotein catabolic process [GO:0006516]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]","GO:0004579; GO:0005783; GO:0005789; GO:0006487; GO:0006516; GO:0006986; GO:0008250; GO:0016020; GO:0018279; GO:0030433; GO:0032991; GO:0034998; GO:0043686; GO:0043687; GO:0046872"
"792",792,"Cluster_1167","Porites_evermani_scaffold_2726:36134-38129",140,-23,2,9,781,802,7,"100.00%","100.00%","Peve_00020314",0.999909726776791,0.00855416971793389,0.573710369894872,"P05099","Cartilage matrix protein (Matrilin-1)","Gallus gallus (Chicken)","extracellular matrix organization [GO:0030198]","GO:0005509; GO:0005576; GO:0030198"
"813",813,"Cluster_1167","Porites_evermani_scaffold_278:205465-226841",145,-20.42,2,19,4394,4416,18,"66.67%","72.22%","Peve_00020723",0.999909726776791,0.00855416971794441,0.573710369894872,"P35546","Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment]","Mus musculus (Mouse)","activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; anatomical structure morphogenesis [GO:0009653]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657]","GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0006919; GO:0007156; GO:0007158; GO:0007169; GO:0007399; GO:0009410; GO:0009653; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030182; GO:0030335; GO:0030424; GO:0030425; GO:0033141; GO:0033619; GO:0033630; GO:0033674; GO:0035799; GO:0035860; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045121; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0098797; GO:2001241"
"823",823,"Cluster_1167","Porites_evermani_scaffold_28:286814-288826",150,-20.1,2,16,1489,1512,16,"75.00%","81.25%","Peve_00020864",0.999909726776791,0.00855416971793915,0.573710369894872,NA,NA,NA,NA,NA
"832",832,"Cluster_1167","Porites_evermani_scaffold_28:484021-526369",145,-21.21,2,10,27661,27682,8,"100.00%","100.00%","Peve_00020874",0.999909726776791,0.00855416971793915,0.573710369894872,"Q5VU97","VWFA and cache domain-containing protein 1 (Cache domain-containing protein 1)","Homo sapiens (Human)","","GO:0005245; GO:0005891"
"840",840,"Cluster_1167","Porites_evermani_scaffold_289:267797-285167",164,-27.14,2,21,6330,6349,19,"84.21%","84.21%","Peve_00021597",0.999909726776791,0.00855416971793915,0.573710369894872,NA,NA,NA,NA,NA
"844",844,"Cluster_1167","Porites_evermani_scaffold_2906:30711-43175",148,-20.91,2,21,8046,8065,19,"68.42%","78.95%","Peve_00021762",0.999909726776791,0.00855416971793915,0.573710369894872,NA,NA,NA,NA,NA
"847",847,"Cluster_1167","Porites_evermani_scaffold_291:243224-251703",141,-21.54,2,12,7110,7130,10,"90.00%","90.00%","Peve_00021789",0.999909726776791,0.00855416971793389,0.573710369894872,NA,NA,NA,NA,NA
"848",848,"Cluster_1167","Porites_evermani_scaffold_291:243224-251703",146,-24.06,2,16,7658,7683,18,"66.67%","77.78%","Peve_00021789",0.999909726776791,0.00855416971793389,0.573710369894872,NA,NA,NA,NA,NA
"863",863,"Cluster_1167","Porites_evermani_scaffold_29:849639-850701",150,-21.33,2,18,217,236,16,"75.00%","81.25%","Peve_00021681",0.999909726776791,0.00855416971794441,0.573710369894872,NA,NA,NA,NA,NA
"870",870,"Cluster_1167","Porites_evermani_scaffold_300:5690-31326",151,-22.89,2,21,8324,8341,19,"68.42%","78.95%","Peve_00022627",0.999909726776791,0.00855416971793389,0.573710369894872,NA,NA,NA,NA,NA
"875",875,"Cluster_1167","Porites_evermani_scaffold_3013:25583-36479",146,-20.73,2,11,113,134,9,"88.89%","100.00%","Peve_00022730",0.999983602976637,0.00364567728204132,0.528605282212205,NA,NA,NA,NA,NA
"876",876,"Cluster_1167","Porites_evermani_scaffold_3020:4519-13956",155,-23.63,2,20,7079,7100,18,"72.22%","72.22%","Peve_00022785",0.999909726776791,0.00855416971793915,0.573710369894872,"O88322","Nidogen-2 (NID-2) (Entactin-2)","Mus musculus (Mouse)","cell-matrix adhesion [GO:0007160]","GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005886; GO:0007160; GO:0009986; GO:0031012; GO:0062023"
"877",877,"Cluster_1167","Porites_evermani_scaffold_302:105070-142029",145,-20.14,2,10,6290,6311,8,"100.00%","100.00%","Peve_00022766",0.999975210971309,0.00448255650740406,0.54328949385489,NA,NA,NA,NA,NA
"884",884,"Cluster_1167","Porites_evermani_scaffold_3038:746-5485",152,-20.8,2,13,2238,2259,11,"90.91%","90.91%","Peve_00022891",0.999909726776791,0.00855416971793389,0.573710369894872,"Q9H0J9","Protein mono-ADP-ribosyltransferase PARP12 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 12) (ARTD12) (Poly [ADP-ribose] polymerase 12) (PARP-12) (Zinc finger CCCH domain-containing protein 1)","Homo sapiens (Human)","protein auto-ADP-ribosylation [GO:0070213]","GO:0003723; GO:0003950; GO:0005634; GO:0016779; GO:0046872; GO:0070213; GO:0140803; GO:1990404"
"886",886,"Cluster_1167","Porites_evermani_scaffold_30:453890-512829",142,-20.4,2,11,32234,32255,9,"88.89%","88.89%","Peve_00022620",0.998032919587633,0.0399371798823631,0.909359886114279,"O75899","Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20)","Homo sapiens (Human)","adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932]","GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712"
"887",887,"Cluster_1167","Porites_evermani_scaffold_305:263380-303659",145,-20.43,2,10,25811,25832,8,"100.00%","100.00%","Peve_00022981",0.99978346420904,0.013248533344867,0.706187587087588,"Q9CR50","RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363)","Mus musculus (Mouse)","positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0002039; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0043231; GO:0051865; GO:0061630"
"890",890,"Cluster_1167","Porites_evermani_scaffold_30:635348-642369",149,-21.19,2,14,197,218,12,"83.33%","83.33%","Peve_00022568",0.998769483347398,0.0315851840875417,0.903929377050813,NA,NA,NA,NA,NA
"895",895,"Cluster_1167","Porites_evermani_scaffold_3073:48421-50044",141,-21.38,2,21,1356,1381,24,"62.50%","66.67%","Peve_00023166",0.999909726776791,0.00855416971793915,0.573710369894872,NA,NA,NA,NA,NA
"896",896,"Cluster_1167","Porites_evermani_scaffold_307:61762-70123",149,-20.2,2,20,7521,7541,18,"72.22%","72.22%","Peve_00023116",-0.998588079170744,0.0338338489230548,0.909359886114279,NA,NA,NA,NA,NA
"903",903,"Cluster_1167","Porites_evermani_scaffold_311:237731-289527",147,-24.41,2,20,37735,37756,18,"61.11%","72.22%","Peve_00023477",0.998446023409574,0.0354955257496804,0.909359886114279,"P12111","Collagen alpha-3(VI) chain","Homo sapiens (Human)","cell adhesion [GO:0007155]; muscle organ development [GO:0007517]; negative regulation of peptidase activity [GO:0010466]","GO:0004867; GO:0005576; GO:0005589; GO:0005615; GO:0005788; GO:0007155; GO:0007517; GO:0010466; GO:0030020; GO:0031012; GO:0042383; GO:0062023; GO:0070062; GO:1903561"
"915",915,"Cluster_1167","Porites_evermani_scaffold_3166:4351-25764",148,-20.54,2,21,10821,10842,19,"63.16%","68.42%","Peve_00023804",0.998790745170331,0.0313110628689443,0.903929377050813,"A7RRG3","Protein AKTIP homolog (Fused toes protein homolog)","Nematostella vectensis (Starlet sea anemone)","",""
"919",919,"Cluster_1167","Porites_evermani_scaffold_3168:7626-31587",156,-22.04,2,18,22197,22219,17,"76.47%","82.35%","Peve_00023820",0.998240206991165,0.0377737084885981,0.909359886114279,"O60645","Exocyst complex component 3 (Exocyst complex component Sec6)","Homo sapiens (Human)","exocyst localization [GO:0051601]; exocytosis [GO:0006887]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; protein transport [GO:0015031]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522]","GO:0000145; GO:0000149; GO:0000281; GO:0005794; GO:0005829; GO:0006887; GO:0006904; GO:0015031; GO:0030426; GO:0030496; GO:0030667; GO:0042734; GO:0045296; GO:0048471; GO:0051601; GO:0090148; GO:0090522"
"935",935,"Cluster_1167","Porites_evermani_scaffold_326:281884-300964",150,-21.4,2,11,1576,1597,9,"100.00%","100.00%","Peve_00024385",0.999909726776791,0.00855416971793389,0.573710369894872,"Q14517","Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form]","Homo sapiens (Human)","actin filament organization [GO:0007015]; anatomical structure morphogenesis [GO:0009653]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; epithelial cell morphogenesis [GO:0003382]; establishment of epithelial cell apical/basal polarity involved in camera-type eye morphogenesis [GO:0003412]; establishment or maintenance of cell polarity [GO:0007163]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; lens development in camera-type eye [GO:0002088]","GO:0002088; GO:0003382; GO:0003412; GO:0005509; GO:0005634; GO:0005886; GO:0005911; GO:0005925; GO:0007015; GO:0007155; GO:0007156; GO:0007163; GO:0007267; GO:0009653; GO:0016324; GO:0016477; GO:0030027; GO:0030175; GO:0048471; GO:0070062; GO:0098609"
"948",948,"Cluster_1167","Porites_evermani_scaffold_332:185042-224473",151,-20.65,2,20,25900,25919,18,"77.78%","77.78%","Peve_00024781",0.999745454039197,0.0143643982890296,0.730880670957694,"P07207","Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein]","Drosophila melanogaster (Fruit fly)","actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222]","GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048"
"955",955,"Cluster_1167","Porites_evermani_scaffold_33:95114-102553",156,-22.04,2,18,6312,6334,17,"76.47%","82.35%","Peve_00024625",0.999909726776791,0.00855416971792863,0.573710369894872,NA,NA,NA,NA,NA
"966",966,"Cluster_1167","Porites_evermani_scaffold_3465:21581-22379",154,-24.01,2,20,532,554,19,"73.68%","73.68%","Peve_00025704",0.999909726776791,0.00855416971793389,0.573710369894872,NA,NA,NA,NA,NA
"983",983,"Cluster_1167","Porites_evermani_scaffold_355:182205-184954",153,-20.67,2,20,174,194,18,"72.22%","77.78%","Peve_00026246",0.999909726776791,0.00855416971794441,0.573710369894872,NA,NA,NA,NA,NA
"986",986,"Cluster_1167","Porites_evermani_scaffold_35:634492-708215",148,-21.14,2,18,33892,33917,20,"65.00%","75.00%","Peve_00025931",0.998327332486837,0.0368265034677488,0.909359886114279,NA,NA,NA,NA,NA
"987",987,"Cluster_1167","Porites_evermani_scaffold_35:682878-730233",145,-26.39,2,10,46407,46428,8,"100.00%","100.00%","Peve_00025932",0.99877228270283,0.0315492290189202,0.903929377050813,NA,NA,NA,NA,NA
"991",991,"Cluster_1167","Porites_evermani_scaffold_3586:3750-21354",151,-20.11,2,21,1839,1861,20,"65.00%","75.00%","Peve_00026446",0.998556066248906,0.0342153531038022,0.909359886114279,"P53708","Integrin alpha-8 [Cleaved into: Integrin alpha-8 heavy chain; Integrin alpha-8 light chain]","Homo sapiens (Human)","brain development [GO:0007420]; cell adhesion mediated by integrin [GO:0033627]; cell projection organization [GO:0030030]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; establishment of protein localization [GO:0045184]; extracellular matrix organization [GO:0030198]; inner ear morphogenesis [GO:0042472]; integrin-mediated signaling pathway [GO:0007229]; kidney development [GO:0001822]; memory [GO:0007613]; mesodermal cell differentiation [GO:0048333]; metanephros development [GO:0001656]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; smooth muscle cell differentiation [GO:0051145]; smooth muscle tissue development [GO:0048745]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]","GO:0001656; GO:0001822; GO:0005178; GO:0005783; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0007420; GO:0007613; GO:0008305; GO:0009897; GO:0009986; GO:0030030; GO:0030198; GO:0030511; GO:0032591; GO:0033627; GO:0034446; GO:0034678; GO:0042472; GO:0043204; GO:0045177; GO:0045184; GO:0045944; GO:0046872; GO:0048333; GO:0048745; GO:0051145; GO:0098609; GO:0098839; GO:0098978"
"992",992,"Cluster_1167","Porites_evermani_scaffold_3:586382-623317",142,-24.37,2,21,6500,6525,23,"65.22%","65.22%","Peve_00022430",0.999909726776791,0.00855416971793915,0.573710369894872,"P42893","Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71)","Rattus norvegicus (Rat)","apoptotic process [GO:0006915]; axonogenesis involved in innervation [GO:0060385]; blood vessel diameter maintenance [GO:0097746]; bradykinin catabolic process [GO:0010815]; calcitonin catabolic process [GO:0010816]; ear development [GO:0043583]; embryonic digit morphogenesis [GO:0042733]; embryonic heart tube development [GO:0035050]; endothelin maturation [GO:0034959]; gene expression [GO:0010467]; heart development [GO:0007507]; hormone catabolic process [GO:0042447]; neuron projection development [GO:0031175]; peptide hormone processing [GO:0016486]; pharyngeal system development [GO:0060037]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of receptor recycling [GO:0001921]; protein processing [GO:0016485]; regulation of blood pressure [GO:0008217]; regulation of ERK1 and ERK2 cascade [GO:0070372]; response to cadmium ion [GO:0046686]; response to hypoxia [GO:0001666]; response to muscle stretch [GO:0035994]; response to xenobiotic stimulus [GO:0009410]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; substance P catabolic process [GO:0010814]; sympathetic neuron axon guidance [GO:0097492]","GO:0001666; GO:0001921; GO:0004175; GO:0004222; GO:0005768; GO:0005769; GO:0005886; GO:0006915; GO:0007507; GO:0008217; GO:0008270; GO:0009410; GO:0009897; GO:0010467; GO:0010613; GO:0010814; GO:0010815; GO:0010816; GO:0016020; GO:0016485; GO:0016486; GO:0030141; GO:0031175; GO:0031410; GO:0031982; GO:0033093; GO:0034959; GO:0035050; GO:0035994; GO:0042447; GO:0042733; GO:0042802; GO:0042803; GO:0043583; GO:0043950; GO:0045745; GO:0046686; GO:0048471; GO:0060037; GO:0060385; GO:0070372; GO:0097492; GO:0097746; GO:1902287"
"993",993,"Cluster_1167","Porites_evermani_scaffold_3:586382-623317",142,-24.37,2,21,6779,6804,23,"65.22%","65.22%","Peve_00022430",0.999909726776791,0.00855416971793915,0.573710369894872,"P42893","Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71)","Rattus norvegicus (Rat)","apoptotic process [GO:0006915]; axonogenesis involved in innervation [GO:0060385]; blood vessel diameter maintenance [GO:0097746]; bradykinin catabolic process [GO:0010815]; calcitonin catabolic process [GO:0010816]; ear development [GO:0043583]; embryonic digit morphogenesis [GO:0042733]; embryonic heart tube development [GO:0035050]; endothelin maturation [GO:0034959]; gene expression [GO:0010467]; heart development [GO:0007507]; hormone catabolic process [GO:0042447]; neuron projection development [GO:0031175]; peptide hormone processing [GO:0016486]; pharyngeal system development [GO:0060037]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of receptor recycling [GO:0001921]; protein processing [GO:0016485]; regulation of blood pressure [GO:0008217]; regulation of ERK1 and ERK2 cascade [GO:0070372]; response to cadmium ion [GO:0046686]; response to hypoxia [GO:0001666]; response to muscle stretch [GO:0035994]; response to xenobiotic stimulus [GO:0009410]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; substance P catabolic process [GO:0010814]; sympathetic neuron axon guidance [GO:0097492]","GO:0001666; GO:0001921; GO:0004175; GO:0004222; GO:0005768; GO:0005769; GO:0005886; GO:0006915; GO:0007507; GO:0008217; GO:0008270; GO:0009410; GO:0009897; GO:0010467; GO:0010613; GO:0010814; GO:0010815; GO:0010816; GO:0016020; GO:0016485; GO:0016486; GO:0030141; GO:0031175; GO:0031410; GO:0031982; GO:0033093; GO:0034959; GO:0035050; GO:0035994; GO:0042447; GO:0042733; GO:0042802; GO:0042803; GO:0043583; GO:0043950; GO:0045745; GO:0046686; GO:0048471; GO:0060037; GO:0060385; GO:0070372; GO:0097492; GO:0097746; GO:1902287"
"994",994,"Cluster_1167","Porites_evermani_scaffold_3:586382-623317",147,-21.27,2,21,29922,29945,21,"61.90%","71.43%","Peve_00022430",0.999909726776791,0.00855416971793915,0.573710369894872,"P42893","Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71)","Rattus norvegicus (Rat)","apoptotic process [GO:0006915]; axonogenesis involved in innervation [GO:0060385]; blood vessel diameter maintenance [GO:0097746]; bradykinin catabolic process [GO:0010815]; calcitonin catabolic process [GO:0010816]; ear development [GO:0043583]; embryonic digit morphogenesis [GO:0042733]; embryonic heart tube development [GO:0035050]; endothelin maturation [GO:0034959]; gene expression [GO:0010467]; heart development [GO:0007507]; hormone catabolic process [GO:0042447]; neuron projection development [GO:0031175]; peptide hormone processing [GO:0016486]; pharyngeal system development [GO:0060037]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of receptor recycling [GO:0001921]; protein processing [GO:0016485]; regulation of blood pressure [GO:0008217]; regulation of ERK1 and ERK2 cascade [GO:0070372]; response to cadmium ion [GO:0046686]; response to hypoxia [GO:0001666]; response to muscle stretch [GO:0035994]; response to xenobiotic stimulus [GO:0009410]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; substance P catabolic process [GO:0010814]; sympathetic neuron axon guidance [GO:0097492]","GO:0001666; GO:0001921; GO:0004175; GO:0004222; GO:0005768; GO:0005769; GO:0005886; GO:0006915; GO:0007507; GO:0008217; GO:0008270; GO:0009410; GO:0009897; GO:0010467; GO:0010613; GO:0010814; GO:0010815; GO:0010816; GO:0016020; GO:0016485; GO:0016486; GO:0030141; GO:0031175; GO:0031410; GO:0031982; GO:0033093; GO:0034959; GO:0035050; GO:0035994; GO:0042447; GO:0042733; GO:0042802; GO:0042803; GO:0043583; GO:0043950; GO:0045745; GO:0046686; GO:0048471; GO:0060037; GO:0060385; GO:0070372; GO:0097492; GO:0097746; GO:1902287"
"1015",1015,"Cluster_1167","Porites_evermani_scaffold_369:214598-252859",152,-21.38,2,21,3165,3185,20,"75.00%","75.00%","Peve_00027017",0.999999471445474,0.000654545796278981,0.239778920002343,"P29146","PC3-like endoprotease variant A (EC 3.4.21.-) (SPC3)","Hydra vulgaris (Hydra) (Hydra attenuata)","proteolysis [GO:0006508]","GO:0004252; GO:0006508"
"1022",1022,"Cluster_1167","Porites_evermani_scaffold_37:190016-191075",153,-21.5,2,21,945,966,20,"75.00%","75.00%","Peve_00027087",0.999856934029782,0.0107688287544455,0.644120398105949,"P67963","Casein kinase I isoform alpha (CKI-alpha) (EC 2.7.11.1) (CK1)","Xenopus laevis (African clawed frog)","cell cycle [GO:0007049]; cell division [GO:0051301]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; protein phosphorylation [GO:0006468]; Wnt signaling pathway [GO:0016055]","GO:0000776; GO:0004674; GO:0005524; GO:0005737; GO:0005819; GO:0006468; GO:0007049; GO:0016055; GO:0016607; GO:0036064; GO:0045104; GO:0051301; GO:0106310; GO:1900226"
"1032",1032,"Cluster_1167","Porites_evermani_scaffold_3763:36576-38103",155,-27.2,2,21,103,121,19,"78.95%","78.95%","Peve_00027409",0.998789595503491,0.0313259464152717,0.903929377050813,NA,NA,NA,NA,NA
"1047",1047,"Cluster_1167","Porites_evermani_scaffold_3864:13732-24860",155,-26.06,2,21,2690,2716,24,"66.67%","70.83%","Peve_00027965",0.999909726776791,0.00855416971793389,0.573710369894872,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"1054",1054,"Cluster_1167","Porites_evermani_scaffold_389:141440-145038",145,-20.42,2,19,1550,1572,18,"66.67%","72.22%","Peve_00028079",0.999909726776791,0.00855416971794441,0.573710369894872,"Q9JME2","Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1)","Mus musculus (Mouse)","apoptotic process [GO:0006915]; carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]; transforming growth factor beta receptor signaling pathway [GO:0007179]","GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0006915; GO:0007179; GO:0007585; GO:0008146; GO:0009791; GO:0016051; GO:0030166; GO:0030204; GO:0030206; GO:0030326; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0048704; GO:0050659; GO:0051216"
"1061",1061,"Cluster_1167","Porites_evermani_scaffold_392:2-22307",167,-29.83,2,17,3185,3207,16,"87.50%","93.75%","Peve_00028300",0.999909726776791,0.00855416971793915,0.573710369894872,"B8V7Q1","Protocadherin-like protein","Acropora millepora (Staghorn coral) (Heteropora millepora)","homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]","GO:0005509; GO:0005886; GO:0007156"
"1063",1063,"Cluster_1167","Porites_evermani_scaffold_3928:2796-3771",156,-21.35,2,21,22,43,19,"63.16%","78.95%","Peve_00028337",-0.998451755265533,0.0354299855648368,0.909359886114279,NA,NA,NA,NA,NA
"1067",1067,"Cluster_1167","Porites_evermani_scaffold_3950:29075-33863",141,-23.25,2,20,1158,1183,22,"63.64%","68.18%","Peve_00028477",0.999909726776791,0.00855416971793915,0.573710369894872,NA,NA,NA,NA,NA
"1087",1087,"Cluster_1167","Porites_evermani_scaffold_401:91046-98333",155,-21.11,2,21,6460,6482,20,"70.00%","75.00%","Peve_00028884",0.999909726776791,0.00855416971793915,0.573710369894872,"Q91287","Fibroblast growth factor receptor 3 (FGFR-3) (EC 2.7.10.1) (PFR3)","Pleurodeles waltl (Iberian ribbed newt)","apoptotic process [GO:0006915]; positive regulation of cell population proliferation [GO:0008284]","GO:0005007; GO:0005524; GO:0005886; GO:0006915; GO:0008284"
"1098",1098,"Cluster_1167","Porites_evermani_scaffold_410:132991-143383",149,-20.73,2,14,8480,8501,12,"83.33%","83.33%","Peve_00029395",0.99850383281095,0.0348288670077051,0.909359886114279,"Q14541","Hepatocyte nuclear factor 4-gamma (HNF-4-gamma) (Nuclear receptor subfamily 2 group A member 2)","Homo sapiens (Human)","anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0004879; GO:0005654; GO:0005829; GO:0006357; GO:0008270; GO:0030154; GO:0045171; GO:0045944; GO:0048856; GO:0072686"
"1109",1109,"Cluster_1167","Porites_evermani_scaffold_417:190030-210560",140,-21.39,2,9,3188,3209,7,"100.00%","100.00%","Peve_00029695",0.999614767519651,0.0176713818866947,0.782669382293497,"P97739","Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71)","Cavia porcellus (Guinea pig)","proteolysis [GO:0006508]","GO:0004222; GO:0005886; GO:0006508; GO:0046872"
"1113",1113,"Cluster_1167","Porites_evermani_scaffold_42:214567-222351",140,-21.2,2,9,4011,4032,7,"100.00%","100.00%","Peve_00029859",0.99913900379337,0.0264196405908856,0.885091958128636,NA,NA,NA,NA,NA
"1121",1121,"Cluster_1167","Porites_evermani_scaffold_4263:3470-22336",142,-21.95,2,11,12508,12529,9,"88.89%","88.89%","Peve_00030203",0.99985976849378,0.0106616149938441,0.641117160078398,"Q9NZJ4","Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29)","Homo sapiens (Human)","negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]","GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0042802; GO:0051087; GO:0070628; GO:0070852; GO:0090084"
"1132",1132,"Cluster_1167","Porites_evermani_scaffold_43:197635-212576",143,-21.56,2,20,10608,10631,21,"71.43%","71.43%","Peve_00030425",0.999405152548207,0.0219593486528571,0.830690932108223,"Q8IZN3","Palmitoyltransferase ZDHHC14 (EC 2.3.1.225) (DHHC domain-containing cysteine-rich protein 14) (DHHC-14) (NEW1 domain-containing protein) (NEW1CP) (Zinc finger DHHC domain-containing protein 14)","Homo sapiens (Human)","peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]","GO:0005783; GO:0005789; GO:0005794; GO:0006612; GO:0016409; GO:0018230; GO:0018345; GO:0019706; GO:0032580"
"1142",1142,"Cluster_1167","Porites_evermani_scaffold_437:223204-240115",140,-20.96,2,9,1553,1574,7,"100.00%","100.00%","Peve_00030753",0.999964126437774,0.00539241950765597,0.551398425649056,NA,NA,NA,NA,NA
"1144",1144,"Cluster_1167","Porites_evermani_scaffold_438:226351-240861",158,-27.26,2,17,13675,13699,18,"83.33%","83.33%","Peve_00030801",0.999909726776791,0.00855416971793915,0.573710369894872,"Q12955","Ankyrin-3 (ANK-3) (Ankyrin-G)","Homo sapiens (Human)","axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]","GO:0000281; GO:0005200; GO:0005764; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0007009; GO:0007165; GO:0007409; GO:0007528; GO:0008092; GO:0008093; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014704; GO:0014731; GO:0016323; GO:0016328; GO:0016529; GO:0019228; GO:0030018; GO:0030315; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0034112; GO:0042383; GO:0043001; GO:0043005; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045184; GO:0045211; GO:0045296; GO:0045838; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0099612; GO:1900827; GO:1902260; GO:2000651; GO:2001259"
"1151",1151,"Cluster_1167","Porites_evermani_scaffold_444:31387-63122",160,-20.83,2,21,15880,15901,19,"68.42%","78.95%","Peve_00031172",0.999909726776791,0.00855416971793915,0.573710369894872,"Q9UMZ3","Phosphatidylinositol phosphatase PTPRQ (EC 3.1.3.-) (Receptor-type tyrosine-protein phosphatase Q) (PTP-RQ) (R-PTP-Q) (EC 3.1.3.48)","Homo sapiens (Human)","peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; regulation of fat cell differentiation [GO:0045598]","GO:0004725; GO:0016020; GO:0043235; GO:0045598; GO:1990264"
"1152",1152,"Cluster_1167","Porites_evermani_scaffold_444:31387-63122",164,-24.22,2,21,10289,10310,19,"73.68%","78.95%","Peve_00031172",0.999909726776791,0.00855416971793915,0.573710369894872,"Q9UMZ3","Phosphatidylinositol phosphatase PTPRQ (EC 3.1.3.-) (Receptor-type tyrosine-protein phosphatase Q) (PTP-RQ) (R-PTP-Q) (EC 3.1.3.48)","Homo sapiens (Human)","peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; regulation of fat cell differentiation [GO:0045598]","GO:0004725; GO:0016020; GO:0043235; GO:0045598; GO:1990264"
"1155",1155,"Cluster_1167","Porites_evermani_scaffold_4456:9425-26219",146,-23.49,2,21,8891,8914,21,"66.67%","71.43%","Peve_00031233",0.999909726776791,0.00855416971793915,0.573710369894872,NA,NA,NA,NA,NA
"1158",1158,"Cluster_1167","Porites_evermani_scaffold_448:117114-126711",148,-20.36,2,21,5047,5068,21,"71.43%","71.43%","Peve_00031346",0.999285062109625,0.0240743824704661,0.856569794819485,"Q5ZJQ8","Ubiquitin-associated domain-containing protein 2 (UBA domain-containing protein 2) (Phosphoglycerate dehydrogenase-like protein 1)","Gallus gallus (Chicken)","negative regulation of canonical Wnt signaling pathway [GO:0090090]; Wnt signaling pathway [GO:0016055]","GO:0005789; GO:0016055; GO:0090090"
"1165",1165,"Cluster_1167","Porites_evermani_scaffold_4557:896-9682",141,-23.52,2,20,8133,8160,24,"62.50%","66.67%","Peve_00031679",0.999909726776791,0.00855416971793389,0.573710369894872,NA,NA,NA,NA,NA
"1177",1177,"Cluster_1167","Porites_evermani_scaffold_4665:11733-23251",142,-24.4,2,20,1133,1155,19,"63.16%","68.42%","Peve_00032175",0.999909726776791,0.00855416971793915,0.573710369894872,"P0C5E4","Phosphatidylinositol phosphatase PTPRQ (EC 3.1.3.-) (Receptor-type tyrosine-protein phosphatase Q) (PTP-RQ) (R-PTP-Q) (EC 3.1.3.48)","Mus musculus (Mouse)","detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; inner ear morphogenesis [GO:0042472]; neuromuscular process controlling balance [GO:0050885]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; regulation of fat cell differentiation [GO:0045598]; vestibular receptor cell morphogenesis [GO:0060116]","GO:0002244; GO:0004725; GO:0016020; GO:0032421; GO:0042472; GO:0043235; GO:0045598; GO:0050885; GO:0050910; GO:0060116; GO:1990264"
"1179",1179,"Cluster_1167","Porites_evermani_scaffold_4679:11921-12719",155,-28.79,2,21,622,648,24,"66.67%","70.83%","Peve_00032218",0.999909726776791,0.00855416971793389,0.573710369894872,NA,NA,NA,NA,NA
"1185",1185,"Cluster_1167","Porites_evermani_scaffold_471:134748-139333",146,-20.32,2,17,1406,1426,15,"73.33%","80.00%","Peve_00032379",0.999829145067882,0.0117683361362963,0.669104173589419,NA,NA,NA,NA,NA
"1196",1196,"Cluster_1167","Porites_evermani_scaffold_477:144331-167138",145,-25.3,2,15,17228,17250,14,"78.57%","78.57%","Peve_00032614",0.999989663831242,0.00289451157471858,0.458622503733527,NA,NA,NA,NA,NA
"1203",1203,"Cluster_1167","Porites_evermani_scaffold_48:251736-262808",146,-24.29,2,20,2375,2398,20,"65.00%","70.00%","Peve_00032739",0.999970447939082,0.00489429426099903,0.551398425649056,NA,NA,NA,NA,NA
"1229",1229,"Cluster_1167","Porites_evermani_scaffold_500:194797-215987",146,-22.05,2,12,3616,3638,11,"90.91%","90.91%","Peve_00033656",0.999008853972955,0.0283465246073945,0.903124690393816,"Q9ERG2","Striatin-3 (Cell cycle autoantigen SG2NA) (S/G2 antigen)","Mus musculus (Mouse)","negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to estradiol [GO:0032355]","GO:0000122; GO:0005516; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005886; GO:0030425; GO:0031267; GO:0032355; GO:0032991; GO:0033147; GO:0043025; GO:0044877; GO:0045892; GO:0045944; GO:0051721; GO:0070016; GO:0090443"
"1233",1233,"Cluster_1167","Porites_evermani_scaffold_502:3458-37745",147,-21.21,2,21,12639,12657,19,"73.68%","73.68%","Peve_00033720",0.999143976900459,0.0263432193593904,0.884162272141201,NA,NA,NA,NA,NA
"1234",1234,"Cluster_1167","Porites_evermani_scaffold_502:3458-37745",153,-22.27,2,18,15592,15613,16,"75.00%","75.00%","Peve_00033720",0.999143976900459,0.0263432193593904,0.884162272141201,NA,NA,NA,NA,NA
"1236",1236,"Cluster_1167","Porites_evermani_scaffold_5036:10556-12587",140,-23,2,9,817,838,7,"100.00%","100.00%","Peve_00033774",0.999909726776791,0.00855416971793389,0.573710369894872,"P05099","Cartilage matrix protein (Matrilin-1)","Gallus gallus (Chicken)","extracellular matrix organization [GO:0030198]","GO:0005509; GO:0005576; GO:0030198"
"1237",1237,"Cluster_1167","Porites_evermani_scaffold_50:37416-43135",149,-22.74,2,21,2645,2664,19,"68.42%","73.68%","Peve_00033616",-0.999269695346556,0.0243317636324826,0.85991842743963,"Q7KZ85","Transcription elongation factor SPT6 (hSPT6) (Histone chaperone suppressor of Ty6) (Tat-cotransactivator 2 protein) (Tat-CT2 protein)","Homo sapiens (Human)","blastocyst formation [GO:0001825]; mRNA processing [GO:0006397]; mRNA transcription by RNA polymerase II [GO:0042789]; mRNA transport [GO:0051028]; nucleosome organization [GO:0034728]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; regulation of isotype switching [GO:0045191]; regulation of mRNA export from nucleus [GO:0010793]; regulation of mRNA processing [GO:0050684]; regulation of muscle cell differentiation [GO:0051147]; RNA splicing [GO:0008380]; transcription elongation by RNA polymerase II promoter [GO:0006368]; transcription elongation-coupled chromatin remodeling [GO:0140673]","GO:0001825; GO:0003677; GO:0003723; GO:0005654; GO:0006368; GO:0006397; GO:0008023; GO:0008380; GO:0010793; GO:0031491; GO:0032968; GO:0034728; GO:0042393; GO:0042789; GO:0045191; GO:0050684; GO:0051028; GO:0051147; GO:0140673"
"1243",1243,"Cluster_1167","Porites_evermani_scaffold_509:117564-127458",147,-21.44,2,19,3557,3576,17,"70.59%","76.47%","Peve_00033968",0.999657786824062,0.0166554307882447,0.775337211553618,"Q0P678","Zinc finger CCCH domain-containing protein 18 (Nuclear protein NHN1)","Mus musculus (Mouse)","RNA destabilization [GO:0050779]","GO:0016607; GO:0030674; GO:0032991; GO:0046872; GO:0050779; GO:0140262; GO:1990904"
"1256",1256,"Cluster_1167","Porites_evermani_scaffold_517:24228-31684",146,-22.07,2,11,5,26,9,"88.89%","100.00%","Peve_00034282",0.998864167162046,0.0303454405378906,0.903929377050813,NA,NA,NA,NA,NA
"1257",1257,"Cluster_1167","Porites_evermani_scaffold_517:24228-31684",153,-22.32,2,14,1201,1222,12,"83.33%","91.67%","Peve_00034282",0.998864167162046,0.0303454405378906,0.903929377050813,NA,NA,NA,NA,NA
"1262",1262,"Cluster_1167","Porites_evermani_scaffold_5195:952-5352",148,-20.4,2,13,27,48,11,"81.82%","90.91%","Peve_00034349",0.999909726776791,0.00855416971793389,0.573710369894872,"Q9CR50","RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363)","Mus musculus (Mouse)","positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0002039; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0043231; GO:0051865; GO:0061630"
"1275",1275,"Cluster_1167","Porites_evermani_scaffold_527:227796-238355",149,-22.1,2,15,2769,2791,14,"78.57%","85.71%","Peve_00034622",0.997048940457244,0.0489205090104163,0.949250660792813,"O00339","Matrilin-2","Homo sapiens (Human)","extracellular matrix organization [GO:0030198]","GO:0005201; GO:0005509; GO:0005576; GO:0030198; GO:0031012; GO:0062023; GO:0120216"
"1313",1313,"Cluster_1167","Porites_evermani_scaffold_5647:1081-3699",151,-20.1,2,21,1432,1455,21,"61.90%","76.19%","Peve_00035933",0.998897096463031,0.0299022459316688,0.903929377050813,NA,NA,NA,NA,NA
"1327",1327,"Cluster_1167","Porites_evermani_scaffold_574:12304-34397",150,-21,2,21,17697,17723,24,"62.50%","75.00%","Peve_00036241",0.999909726776791,0.00855416971793915,0.573710369894872,"A0A0R4IBK5","E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (E3 ubiquitin-lipopolysaccharide ligase rnf213-alpha) (EC 2.3.2.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha)","Danio rerio (Zebrafish) (Brachydanio rerio)","blood circulation [GO:0008015]; defense response to bacterium [GO:0042742]; immune system process [GO:0002376]; lipid droplet formation [GO:0140042]; lipid ubiquitination [GO:0120323]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein K63-linked ubiquitination [GO:0070534]; regulation of lipid metabolic process [GO:0019216]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]; xenophagy [GO:0098792]","GO:0002040; GO:0002376; GO:0004842; GO:0005524; GO:0005730; GO:0005811; GO:0005829; GO:0006511; GO:0008015; GO:0016887; GO:0019216; GO:0042742; GO:0046872; GO:0061630; GO:0070534; GO:0098792; GO:0120323; GO:0140042; GO:2000051"
"1337",1337,"Cluster_1167","Porites_evermani_scaffold_578:64912-99997",145,-22.64,2,10,34659,34680,8,"100.00%","100.00%","Peve_00036304",0.998004045644015,0.0402293194706296,0.909359886114279,"Q5PQN1","Probable E3 ubiquitin-protein ligase HERC4 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 4) (HECT-type E3 ubiquitin transferase HERC4)","Rattus norvegicus (Rat)","cell differentiation [GO:0030154]; negative regulation of smoothened signaling pathway [GO:0045879]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0001650; GO:0005737; GO:0005829; GO:0006511; GO:0007283; GO:0016567; GO:0030154; GO:0045879; GO:0061630"
"1338",1338,"Cluster_1167","Porites_evermani_scaffold_578:64912-99997",160,-21.03,2,17,3987,4008,15,"80.00%","86.67%","Peve_00036304",0.998004045644015,0.0402293194706296,0.909359886114279,"Q5PQN1","Probable E3 ubiquitin-protein ligase HERC4 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 4) (HECT-type E3 ubiquitin transferase HERC4)","Rattus norvegicus (Rat)","cell differentiation [GO:0030154]; negative regulation of smoothened signaling pathway [GO:0045879]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0001650; GO:0005737; GO:0005829; GO:0006511; GO:0007283; GO:0016567; GO:0030154; GO:0045879; GO:0061630"
"1345",1345,"Cluster_1167","Porites_evermani_scaffold_583:40426-55562",147,-22.07,2,12,13365,13386,10,"90.00%","90.00%","Peve_00036499",0.999960220513847,0.00567840213011246,0.560635076887081,"O00571","ATP-dependent RNA helicase DDX3X (EC 3.6.4.13) (CAP-Rf) (DEAD box protein 3, X-chromosomal) (DEAD box, X isoform) (DBX) (Helicase-like protein 2) (HLP2)","Homo sapiens (Human)","cell differentiation [GO:0030154]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to osmotic stress [GO:0071470]; cellular response to virus [GO:0098586]; chromosome segregation [GO:0007059]; cytosolic ribosome assembly [GO:0042256]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; gamete generation [GO:0007276]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway [GO:0097193]; lipid homeostasis [GO:0055088]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of translation [GO:0017148]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of chemokine (C-C motif) ligand 5 production [GO:0071651]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of protein acetylation [GO:1901985]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 8 signaling pathway [GO:0034161]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; positive regulation of translational initiation [GO:0045948]; positive regulation of viral genome replication [GO:0045070]; primary miRNA processing [GO:0031053]; protein localization to cytoplasmic stress granule [GO:1903608]; response to virus [GO:0009615]; RNA secondary structure unwinding [GO:0010501]; stress granule assembly [GO:0034063]; translational initiation [GO:0006413]; Wnt signaling pathway [GO:0016055]","GO:0003677; GO:0003678; GO:0003723; GO:0003724; GO:0003729; GO:0003924; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0006413; GO:0007059; GO:0007276; GO:0008134; GO:0008143; GO:0008190; GO:0008625; GO:0009615; GO:0010494; GO:0010501; GO:0010628; GO:0016055; GO:0016887; GO:0017111; GO:0017148; GO:0030027; GO:0030154; GO:0030307; GO:0030308; GO:0031053; GO:0031252; GO:0031333; GO:0031369; GO:0031954; GO:0032727; GO:0032728; GO:0033592; GO:0034063; GO:0034157; GO:0034161; GO:0034774; GO:0035556; GO:0035613; GO:0036493; GO:0042256; GO:0043015; GO:0043024; GO:0043065; GO:0043066; GO:0043154; GO:0043186; GO:0043273; GO:0043280; GO:0043539; GO:0045070; GO:0045087; GO:0045296; GO:0045727; GO:0045944; GO:0045948; GO:0048027; GO:0055088; GO:0070062; GO:0070878; GO:0071243; GO:0071470; GO:0071651; GO:0071902; GO:0072559; GO:0090263; GO:0097193; GO:0098586; GO:1900087; GO:1900227; GO:1901223; GO:1901224; GO:1901985; GO:1902042; GO:1902523; GO:1903608; GO:1904813; GO:2001243"
"1346",1346,"Cluster_1167","Porites_evermani_scaffold_584:101823-128284",155,-21.68,2,17,6066,6088,16,"81.25%","81.25%","Peve_00036508",0.999909726776791,0.00855416971793915,0.573710369894872,"Q8VI56","Low-density lipoprotein receptor-related protein 4 (LRP-4) (LDLR dan)","Mus musculus (Mouse)","amyloid-beta clearance by cellular catabolic process [GO:0150094]; anatomical structure development [GO:0048856]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; proximal/distal pattern formation [GO:0009954]; receptor clustering [GO:0043113]; regulation of protein phosphorylation [GO:0001932]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0001932; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0016055; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0048699; GO:0048813; GO:0048856; GO:0050731; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150094; GO:1901631; GO:1904395"
"1347",1347,"Cluster_1167","Porites_evermani_scaffold_584:101823-128284",164,-25.05,2,21,23785,23806,19,"68.42%","84.21%","Peve_00036508",0.999909726776791,0.00855416971793915,0.573710369894872,"Q8VI56","Low-density lipoprotein receptor-related protein 4 (LRP-4) (LDLR dan)","Mus musculus (Mouse)","amyloid-beta clearance by cellular catabolic process [GO:0150094]; anatomical structure development [GO:0048856]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; proximal/distal pattern formation [GO:0009954]; receptor clustering [GO:0043113]; regulation of protein phosphorylation [GO:0001932]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0001932; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0016055; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0048699; GO:0048813; GO:0048856; GO:0050731; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150094; GO:1901631; GO:1904395"
"1357",1357,"Cluster_1167","Porites_evermani_scaffold_590:94587-105521",159,-22.63,2,21,9865,9887,20,"65.00%","85.00%","Peve_00036717",0.998121717950127,0.0390250551586088,0.909359886114279,"Q9NU19","TBC1 domain family member 22B","Homo sapiens (Human)","activation of GTPase activity [GO:0090630]","GO:0005096; GO:0071889; GO:0090630"
"1360",1360,"Cluster_1167","Porites_evermani_scaffold_59:181847-185487",152,-26.99,2,14,193,215,13,"84.62%","92.31%","Peve_00036708",0.999952936172769,0.00617647154077515,0.573710369894872,"O60290","Zinc finger protein 862","Homo sapiens (Human)","regulation of DNA-templated transcription [GO:0006355]","GO:0005634; GO:0006355; GO:0046872; GO:0046983"
"1368",1368,"Cluster_1167","Porites_evermani_scaffold_60:391817-395582",164,-24.03,2,21,918,939,19,"68.42%","84.21%","Peve_00037063",0.999909726776791,0.00855416971793389,0.573710369894872,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"1370",1370,"Cluster_1167","Porites_evermani_scaffold_60:479300-512305",145,-22.68,2,15,841,863,14,"78.57%","78.57%","Peve_00037070",0.999984983127836,0.00348887497095565,0.515443117995556,"Q9I9H8","Apoptotic protease-activating factor 1 (APAF-1)","Danio rerio (Zebrafish) (Brachydanio rerio)","anatomical structure development [GO:0048856]; apoptotic signaling pathway [GO:0097190]; regulation of apoptotic process [GO:0042981]","GO:0005524; GO:0042981; GO:0043293; GO:0043531; GO:0048856; GO:0097190"
"1373",1373,"Cluster_1167","Porites_evermani_scaffold_61:100144-116869",141,-20.76,2,12,4528,4548,10,"90.00%","90.00%","Peve_00037343",0.999909726776791,0.00855416971793915,0.573710369894872,NA,NA,NA,NA,NA
"1399",1399,"Cluster_1167","Porites_evermani_scaffold_638:149689-151264",147,-23.48,2,14,248,268,12,"83.33%","91.67%","Peve_00038067",0.999909726776791,0.00855416971793915,0.573710369894872,NA,NA,NA,NA,NA
"1400",1400,"Cluster_1167","Porites_evermani_scaffold_64:130556-189979",145,-21.94,2,10,3214,3235,8,"100.00%","100.00%","Peve_00038130",0.999956604133176,0.00593090373786624,0.572821453072688,"A2RT67","DENN domain-containing protein 3","Mus musculus (Mouse)","endosome to lysosome transport [GO:0008333]; protein catabolic process [GO:0030163]; regulation of Rab protein signal transduction [GO:0032483]","GO:0005085; GO:0008333; GO:0030163; GO:0031410; GO:0032483"
"1403",1403,"Cluster_1167","Porites_evermani_scaffold_643:1198-20855",150,-21.33,2,21,13038,13058,19,"63.16%","78.95%","Peve_00038230",0.999909726776791,0.00855416971793389,0.573710369894872,"A6QLU6","Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133)","Bos taurus (Bovine)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189"
"1410",1410,"Cluster_1167","Porites_evermani_scaffold_65:274100-308935",141,-21.29,2,14,30,51,12,"75.00%","75.00%","Peve_00038393",0.997587196470693,0.0442327011798084,0.92530164628749,"O60293","Zinc finger C3H1 domain-containing protein (Coiled-coil domain-containing protein 131) (Proline/serine-rich coiled-coil protein 2)","Homo sapiens (Human)","RNA processing [GO:0006396]","GO:0000178; GO:0005615; GO:0005634; GO:0006396; GO:0046872"
"1415",1415,"Cluster_1167","Porites_evermani_scaffold_657:36524-59471",151,-22.76,2,12,54,75,10,"90.00%","100.00%","Peve_00038539",0.999588655116799,0.0182605165534585,0.782669382293497,"Q8BX90","Fibronectin type-III domain-containing protein 3A","Mus musculus (Mouse)","cell-cell adhesion [GO:0098609]; fertilization [GO:0009566]; Sertoli cell development [GO:0060009]; spermatid development [GO:0007286]","GO:0000139; GO:0001669; GO:0005737; GO:0005794; GO:0005829; GO:0007286; GO:0009566; GO:0012506; GO:0016020; GO:0031410; GO:0043231; GO:0060009; GO:0098609"
"1428",1428,"Cluster_1167","Porites_evermani_scaffold_67:540219-556885",160,-24.21,2,21,218,237,19,"78.95%","84.21%","Peve_00038834",0.997317155093029,0.0466433836153534,0.93897035826855,"B3EWZ6","MAM and LDL-receptor class A domain-containing protein 2 (Skeletal organic matrix MAM and LDL-receptor 2) (SOM MAM and LDL-receptor 2)","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0005576; GO:0016020"
"1449",1449,"Cluster_1167","Porites_evermani_scaffold_69:452614-494792",155,-21.41,2,20,24627,24649,20,"80.00%","80.00%","Peve_00039250",0.99997853118278,0.00417157404869491,0.54328949385489,"Q38SD2","Leucine-rich repeat serine/threonine-protein kinase 1 (EC 2.7.11.1)","Homo sapiens (Human)","bone resorption [GO:0045453]; intracellular signal transduction [GO:0035556]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; osteoclast development [GO:0036035]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; signal transduction [GO:0007165]","GO:0004674; GO:0004722; GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005829; GO:0007165; GO:0018108; GO:0035556; GO:0036035; GO:0042802; GO:0043231; GO:0045453; GO:0046872; GO:0050731; GO:0050732; GO:0090263; GO:0106310; GO:1902533"
"1450",1450,"Cluster_1167","Porites_evermani_scaffold_6:947827-959929",144,-20.8,2,16,1040,1059,14,"78.57%","78.57%","Peve_00036985",0.997756794620378,0.0426491968770769,0.914386765051354,NA,NA,NA,NA,NA
"1465",1465,"Cluster_1167","Porites_evermani_scaffold_71:528296-609986",152,-23.71,2,21,33046,33065,19,"73.68%","78.95%","Peve_00039811",0.997173310350041,0.0478780594352554,0.945312205299076,"Q4TU93","C-type mannose receptor 2 (Endocytic receptor 180) (Macrophage mannose receptor 2) (CD antigen CD280)","Rattus norvegicus (Rat)","collagen catabolic process [GO:0030574]; endocytosis [GO:0006897]","GO:0005518; GO:0005886; GO:0006897; GO:0030246; GO:0030574; GO:0038023"
"1476",1476,"Cluster_1167","Porites_evermani_scaffold_732:96009-109722",163,-23.61,2,16,5494,5515,14,"85.71%","92.86%","Peve_00040359",0.999909726776791,0.00855416971793915,0.573710369894872,NA,NA,NA,NA,NA
"1484",1484,"Cluster_1167","Porites_evermani_scaffold_745:5073-14901",145,-20.61,2,10,8978,8999,8,"100.00%","100.00%","Peve_00040588",0.999909726776791,0.00855416971793915,0.573710369894872,"Q9DGB6","Toll-like receptor 2 type-2","Gallus gallus (Chicken)","detection of bacterial lipoprotein [GO:0042494]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; toll-like receptor signaling pathway [GO:0002224]","GO:0002224; GO:0004888; GO:0005886; GO:0006954; GO:0038023; GO:0042494; GO:0042497; GO:0045087; GO:0050135; GO:0061809"
"1487",1487,"Cluster_1167","Porites_evermani_scaffold_7:496036-625728",147,-20.62,2,21,112189,112214,23,"65.22%","65.22%","Peve_00039535",0.998015074605896,0.0401179818688438,0.909359886114279,"P46023","G-protein coupled receptor GRL101","Lymnaea stagnalis (Great pond snail) (Helix stagnalis)","","GO:0004930; GO:0005886"
"1496",1496,"Cluster_1167","Porites_evermani_scaffold_763:160978-168986",151,-27.59,2,14,7799,7819,12,"91.67%","91.67%","Peve_00040932",0.999909726776791,0.00855416971793389,0.573710369894872,NA,NA,NA,NA,NA
"1497",1497,"Cluster_1167","Porites_evermani_scaffold_764:106521-112404",152,-20.23,2,21,2076,2097,19,"63.16%","73.68%","Peve_00040948",0.999909726776791,0.00855416971793915,0.573710369894872,NA,NA,NA,NA,NA
"1516",1516,"Cluster_1167","Porites_evermani_scaffold_794:60745-71375",154,-21.37,2,21,3121,3141,19,"73.68%","73.68%","Peve_00041569",0.999301819989969,0.0237905288947379,0.853813685085773,NA,NA,NA,NA,NA
"1517",1517,"Cluster_1167","Porites_evermani_scaffold_79:569988-585773",145,-21.61,2,10,906,927,8,"100.00%","100.00%","Peve_00041482",0.999815936547399,0.0122147776163142,0.681122687635093,"Q9Z1K5","E3 ubiquitin-protein ligase ARIH1 (EC 2.3.2.31) (Protein ariadne-1 homolog) (ARI-1) (RING-type E3 ubiquitin transferase ARIH1) (UbcH7-binding protein) (UbcM4-interacting protein 77) (Ubiquitin-conjugating enzyme E2-binding protein 1)","Mus musculus (Mouse)","positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0000209; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0006511; GO:0008270; GO:0015030; GO:0016567; GO:0016604; GO:0019005; GO:0031462; GO:0031463; GO:0031464; GO:0031624; GO:0031625; GO:0032436; GO:0061630; GO:0097413"
"1544",1544,"Cluster_1167","Porites_evermani_scaffold_85:497215-523235",147,-20.54,2,12,17174,17195,10,"90.00%","90.00%","Peve_00042755",0.999992038326394,0.00254037361647819,0.422009192811724,NA,NA,NA,NA,NA
"1575",1575,"Cluster_1167","Porites_evermani_scaffold_88:511969-531696",154,-20.53,2,21,14087,14107,19,"68.42%","78.95%","Peve_00043299",0.99767924235131,0.0433804490039369,0.91918014323027,"O75152","Zinc finger CCCH domain-containing protein 11A","Homo sapiens (Human)","poly(A)+ mRNA export from nucleus [GO:0016973]","GO:0003723; GO:0003729; GO:0005654; GO:0016973; GO:0046872"
"1576",1576,"Cluster_1167","Porites_evermani_scaffold_88:511969-531696",158,-24.71,2,21,14114,14134,19,"63.16%","89.47%","Peve_00043299",0.99767924235131,0.0433804490039369,0.91918014323027,"O75152","Zinc finger CCCH domain-containing protein 11A","Homo sapiens (Human)","poly(A)+ mRNA export from nucleus [GO:0016973]","GO:0003723; GO:0003729; GO:0005654; GO:0016973; GO:0046872"
"1583",1583,"Cluster_1167","Porites_evermani_scaffold_902:39573-48395",151,-21.47,2,21,8761,8784,21,"66.67%","71.43%","Peve_00043814",0.999909726776791,0.00855416971793915,0.573710369894872,NA,NA,NA,NA,NA
"1584",1584,"Cluster_1167","Porites_evermani_scaffold_902:44806-51787",151,-21.47,2,21,3528,3551,21,"66.67%","71.43%","Peve_00043809",0.999909726776791,0.00855416971793389,0.573710369894872,NA,NA,NA,NA,NA
"1586",1586,"Cluster_1167","Porites_evermani_scaffold_907:0-3214",153,-25.99,2,21,810,833,22,"68.18%","77.27%","Peve_00043856",0.99891562964676,0.0296498971347644,0.903929377050813,NA,NA,NA,NA,NA
"1591",1591,"Cluster_1167","Porites_evermani_scaffold_917:119367-125945",157,-22.8,2,19,1086,1108,18,"72.22%","83.33%","Peve_00044041",0.999909726776791,0.00855416971793915,0.573710369894872,"Q19269","Zinc metalloproteinase nas-14 (EC 3.4.24.-) (Nematode astacin 14)","Caenorhabditis elegans","proteolysis [GO:0006508]","GO:0004222; GO:0005576; GO:0006508; GO:0008270"
"1620",1620,"Cluster_1167","Porites_evermani_scaffold_963:18448-33626",153,-20.1,2,21,11807,11826,19,"68.42%","78.95%","Peve_00044798",0.999909726776791,0.00855416971793389,0.573710369894872,NA,NA,NA,NA,NA
"1624",1624,"Cluster_1167","Porites_evermani_scaffold_966:57013-96531",142,-23.91,2,11,20373,20394,9,"88.89%","88.89%","Peve_00044833",0.998564982655492,0.034109522881364,0.909359886114279,"Q9QXV3","Inhibitor of growth protein 1","Mus musculus (Mouse)","cell cycle [GO:0007049]; negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of stem cell population maintenance [GO:1902459]; protein import into nucleus [GO:0006606]; regulation of cell death [GO:0010941]; regulation of DNA-templated transcription [GO:0006355]","GO:0000122; GO:0005634; GO:0006355; GO:0006606; GO:0007049; GO:0010941; GO:0016580; GO:0030336; GO:0030512; GO:0035064; GO:0045893; GO:0046872; GO:1902455; GO:1902459"
"1633",1633,"Cluster_1167","Porites_evermani_scaffold_975:18265-20126",146,-24.46,2,20,1385,1407,19,"68.42%","68.42%","Peve_00044993",0.999909726776791,0.00855416971793915,0.573710369894872,"Q5XXP2","Melanopsin (Opsin-4)","Phodopus sungorus (Striped hairy-footed hamster) (Djungarian hamster)","hyaloid vascular plexus regression [GO:1990384]; optokinetic behavior [GO:0007634]; phototransduction [GO:0007602]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; visual perception [GO:0007601]","GO:0005502; GO:0005886; GO:0007601; GO:0007602; GO:0007634; GO:0008020; GO:0016020; GO:0030424; GO:0030425; GO:0042752; GO:0043204; GO:0048511; GO:1990384"
"1636",1636,"Cluster_1167","Porites_evermani_scaffold_977:54286-55099",147,-22.81,2,21,75,97,20,"65.00%","70.00%","Peve_00045011",0.999909726776791,0.00855416971793389,0.573710369894872,NA,NA,NA,NA,NA
"1639",1639,"Cluster_1167","Porites_evermani_scaffold_980:64083-149927",152,-23.21,2,13,58494,58515,11,"90.91%","90.91%","Peve_00045068",0.996947347218333,0.0497558748086694,0.952281411175107,"Q96RW7","Hemicentin-1 (Fibulin-6) (FIBL-6)","Homo sapiens (Human)","actin filament reorganization [GO:0090527]; basement membrane organization [GO:0071711]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]","GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711; GO:0090527"
"1642",1642,"Cluster_1167","Porites_evermani_scaffold_9:894357-934309",152,-23.21,2,13,35454,35475,11,"90.91%","90.91%","Peve_00043653",0.999909726776791,0.00855416971793389,0.573710369894872,"D2IYS2","Tyrosine-protein kinase receptor torso (EC 2.7.10.1)","Bombyx mori (Silk moth)","","GO:0004714; GO:0005524; GO:0005886; GO:0046872"
"1644",1644,"Cluster_1167","Porites_evermani_scaffold_992:14284-36865",156,-22.04,2,18,12923,12945,17,"76.47%","82.35%","Peve_00045262",0.999140395172539,0.0263982816855058,0.884795287459298,"O60841","Eukaryotic translation initiation factor 5B (eIF-5B) (EC 3.6.5.3) (Translation initiation factor IF-2)","Homo sapiens (Human)","regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]","GO:0003723; GO:0003743; GO:0003924; GO:0005525; GO:0005737; GO:0005739; GO:0005829; GO:0006413; GO:0006446; GO:0045202; GO:0046872"
"1646",1646,"Cluster_1167","Porites_evermani_scaffold_992:63223-77649",160,-23.56,2,18,2666,2688,17,"82.35%","82.35%","Peve_00045265",0.998095362879249,0.03929797736504,0.909359886114279,"O08759","Ubiquitin-protein ligase E3A (EC 2.3.2.26) (HECT-type ubiquitin transferase E3A) (Oncogenic protein-associated protein E6-AP)","Mus musculus (Mouse)","androgen receptor signaling pathway [GO:0030521]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; locomotory exploration behavior [GO:0035641]; modulation of chemical synaptic transmission [GO:0050804]; motor learning [GO:0061743]; negative regulation of dendritic spine morphogenesis [GO:0061002]; ovarian follicle development [GO:0001541]; positive regulation of Golgi lumen acidification [GO:1905528]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; prostate gland growth [GO:0060736]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; response to cocaine [GO:0042220]; response to hydrogen peroxide [GO:0042542]; response to progesterone [GO:0032570]; rhythmic process [GO:0048511]; sperm entry [GO:0035037]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000209; GO:0000502; GO:0001541; GO:0003713; GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0014068; GO:0016567; GO:0030521; GO:0031398; GO:0032570; GO:0035037; GO:0035641; GO:0042220; GO:0042542; GO:0042752; GO:0045944; GO:0046872; GO:0048511; GO:0050804; GO:0050847; GO:0051865; GO:0060736; GO:0061002; GO:0061630; GO:0061743; GO:0070936; GO:0098978; GO:1905528; GO:1990416; GO:2000058"
"1647",1647,"Cluster_1167","Porites_evermani_scaffold_992:63223-77649",160,-23.56,2,18,3513,3535,17,"82.35%","82.35%","Peve_00045265",0.998095362879249,0.03929797736504,0.909359886114279,"O08759","Ubiquitin-protein ligase E3A (EC 2.3.2.26) (HECT-type ubiquitin transferase E3A) (Oncogenic protein-associated protein E6-AP)","Mus musculus (Mouse)","androgen receptor signaling pathway [GO:0030521]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; locomotory exploration behavior [GO:0035641]; modulation of chemical synaptic transmission [GO:0050804]; motor learning [GO:0061743]; negative regulation of dendritic spine morphogenesis [GO:0061002]; ovarian follicle development [GO:0001541]; positive regulation of Golgi lumen acidification [GO:1905528]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; prostate gland growth [GO:0060736]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; response to cocaine [GO:0042220]; response to hydrogen peroxide [GO:0042542]; response to progesterone [GO:0032570]; rhythmic process [GO:0048511]; sperm entry [GO:0035037]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000209; GO:0000502; GO:0001541; GO:0003713; GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0014068; GO:0016567; GO:0030521; GO:0031398; GO:0032570; GO:0035037; GO:0035641; GO:0042220; GO:0042542; GO:0042752; GO:0045944; GO:0046872; GO:0048511; GO:0050804; GO:0050847; GO:0051865; GO:0060736; GO:0061002; GO:0061630; GO:0061743; GO:0070936; GO:0098978; GO:1905528; GO:1990416; GO:2000058"
"1671",1671,"Cluster_2787","Porites_evermani_scaffold_1021:136748-147968",158,-20.72,2,20,1030,1053,20,"70.00%","80.00%","Peve_00000573",0.997993695501655,0.0403335252007132,0.909359886114279,"P05423","DNA-directed RNA polymerase III subunit RPC4 (RNA polymerase III subunit C4) (DNA-directed RNA polymerase III subunit D) (Protein BN51) (RNA polymerase III 47 kDa subunit) (RPC53 homolog)","Homo sapiens (Human)","defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; transcription by RNA polymerase III [GO:0006383]","GO:0003677; GO:0003682; GO:0005654; GO:0005666; GO:0005829; GO:0006383; GO:0032728; GO:0045087; GO:0045089; GO:0051607"
"1685",1685,"Cluster_2787","Porites_evermani_scaffold_1031:66950-98941",163,-24.91,2,16,31183,31204,14,"78.57%","100.00%","Peve_00000718",0.99999406092141,0.00219409219147524,0.380586526074297,"Q8IWZ3","Ankyrin repeat and KH domain-containing protein 1 (HIV-1 Vpr-binding ankyrin repeat protein) (Multiple ankyrin repeats single KH domain) (hMASK)","Homo sapiens (Human)","innate immune response [GO:0045087]","GO:0003723; GO:0005737; GO:0045087"
"1689",1689,"Cluster_2787","Porites_evermani_scaffold_103:357214-362599",156,-21.16,2,17,5057,5078,15,"73.33%","86.67%","Peve_00000701",0.999443593359727,0.0212378921988233,0.822386609072632,"Q58CQ9","Pantetheinase (EC 3.5.1.92) (Pantetheine hydrolase) (Vascular non-inflammatory molecule 1) (Vanin-1)","Bos taurus (Bovine)","pantothenate metabolic process [GO:0015939]","GO:0005886; GO:0015939; GO:0017159"
"1712",1712,"Cluster_2787","Porites_evermani_scaffold_1055:48324-61687",159,-21.83,2,21,12485,12508,21,"66.67%","80.95%","Peve_00001089",-0.997451283642094,0.0454619602813742,0.933015587291977,"A6QPF8","Transmembrane protein 120B","Bos taurus (Bovine)","fat cell differentiation [GO:0045444]; protein heterooligomerization [GO:0051291]","GO:0005637; GO:0016020; GO:0045444; GO:0051291"
"1735",1735,"Cluster_2787","Porites_evermani_scaffold_1077:119784-121536",151,-24.17,2,21,879,901,20,"65.00%","75.00%","Peve_00001408",0.99783352309857,0.0419131779151554,0.909938612156291,NA,NA,NA,NA,NA
"1748",1748,"Cluster_2787","Porites_evermani_scaffold_1085:24556-34239",178,-27.06,2,21,235,255,19,"89.47%","89.47%","Peve_00001522",0.999999453445442,0.000665597835339763,0.239778920002343,"Q92035","Acetylcholinesterase (BfAChE) (EC 3.1.1.7)","Bungarus fasciatus (Banded krait) (Pseudoboa fasciata)","acetylcholine catabolic process in synaptic cleft [GO:0001507]","GO:0001507; GO:0003990; GO:0005886; GO:0043083; GO:0045202; GO:0090729"
"1754",1754,"Cluster_2787","Porites_evermani_scaffold_1092:144912-154447",165,-26.47,2,21,7381,7403,21,"76.19%","85.71%","Peve_00001631",0.997124687493112,0.0482882830107525,0.946238709759689,"Q8R5B6","SPRY domain-containing SOCS box protein 4 (SSB-4)","Mus musculus (Mouse)","intracellular signal transduction [GO:0035556]; positive regulation of protein polyubiquitination [GO:1902916]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0005829; GO:0006511; GO:0016567; GO:0019005; GO:0035556; GO:0042752; GO:0043161; GO:0048511; GO:1902916; GO:1990756"
"1762",1762,"Cluster_2787","Porites_evermani_scaffold_1105:142501-151223",164,-20.27,2,21,1939,1960,19,"73.68%","78.95%","Peve_00001931",0.99785995039932,0.0416566673105075,0.909359886114279,"O95477","Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) (Cholesterol efflux regulatory protein)","Homo sapiens (Human)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; intracellular cholesterol transport [GO:0032367]; lipid transport [GO:0006869]; lysosome organization [GO:0007040]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein lipidation [GO:0006497]; protein secretion [GO:0009306]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of high-density lipoprotein particle assembly [GO:0090107]; response to laminar fluid shear stress [GO:0034616]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061]","GO:0002790; GO:0005102; GO:0005319; GO:0005524; GO:0005548; GO:0005768; GO:0005789; GO:0005794; GO:0005886; GO:0006497; GO:0006869; GO:0006911; GO:0007040; GO:0007186; GO:0007189; GO:0008203; GO:0008320; GO:0009306; GO:0009897; GO:0010745; GO:0010875; GO:0010887; GO:0015485; GO:0016197; GO:0016887; GO:0019905; GO:0023061; GO:0030139; GO:0031210; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034380; GO:0034616; GO:0042626; GO:0042632; GO:0043231; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0046623; GO:0048471; GO:0051117; GO:0055091; GO:0060155; GO:0071222; GO:0071300; GO:0071404; GO:0071806; GO:0090107; GO:0090108; GO:0090554; GO:0090556; GO:0097708; GO:0120020; GO:0140115; GO:0140328; GO:0140359"
"1763",1763,"Cluster_2787","Porites_evermani_scaffold_110:62142-66001",151,-21.63,2,21,3099,3124,23,"56.52%","78.26%","Peve_00001847",0.99919831613102,0.0254932797372286,0.874128698371413,"Q5F4A9","ADP-ribosylation factor-like protein 6-interacting protein 4 (ARL-6-interacting protein 4) (Aip-4)","Gallus gallus (Chicken)","mRNA processing [GO:0006397]; RNA splicing [GO:0008380]","GO:0005730; GO:0006397; GO:0008380; GO:0016607"
"1764",1764,"Cluster_2787","Porites_evermani_scaffold_110:62142-66001",157,-20.8,2,14,2483,2504,12,"83.33%","100.00%","Peve_00001847",0.99919831613102,0.0254932797372286,0.874128698371413,"Q5F4A9","ADP-ribosylation factor-like protein 6-interacting protein 4 (ARL-6-interacting protein 4) (Aip-4)","Gallus gallus (Chicken)","mRNA processing [GO:0006397]; RNA splicing [GO:0008380]","GO:0005730; GO:0006397; GO:0008380; GO:0016607"
"1784",1784,"Cluster_2787","Porites_evermani_scaffold_1125:42112-57283",156,-23.56,2,13,10369,10390,11,"90.91%","100.00%","Peve_00002221",0.999980672456975,0.00395807614315678,0.54328949385489,"Q96LJ7","Dehydrogenase/reductase SDR family member 1 (EC 1.1.1.-) (Short chain dehydrogenase/reductase family 19C member 1) (Protein SDR19C1)","Homo sapiens (Human)","","GO:0004090; GO:0005783; GO:0016616; GO:0047045"
"1785",1785,"Cluster_2787","Porites_evermani_scaffold_1125:42112-57283",156,-23.56,2,13,6843,6864,11,"90.91%","100.00%","Peve_00002221",0.999980672456975,0.00395807614315678,0.54328949385489,"Q96LJ7","Dehydrogenase/reductase SDR family member 1 (EC 1.1.1.-) (Short chain dehydrogenase/reductase family 19C member 1) (Protein SDR19C1)","Homo sapiens (Human)","","GO:0004090; GO:0005783; GO:0016616; GO:0047045"
"1792",1792,"Cluster_2787","Porites_evermani_scaffold_11:30006-44147",153,-22.66,2,21,12836,12860,22,"68.18%","81.82%","Peve_00001819",0.999817636668151,0.0121582335095889,0.679854262991557,"Q8R151","NFX1-type zinc finger-containing protein 1","Mus musculus (Mouse)","activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; RNA-mediated heterochromatin formation [GO:0031048]","GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607"
"1796",1796,"Cluster_2787","Porites_evermani_scaffold_113:226650-231286",154,-20.56,2,20,2439,2462,20,"65.00%","80.00%","Peve_00002287",-0.999983802832915,0.00362339130752193,0.526496923485016,"A0A250YGJ5","NAD-dependent protein deacylase sirtuin-6 (EC 2.3.1.-) (NAD-dependent protein deacetylase sirtuin-6) (EC 2.3.1.286) (Protein mono-ADP-ribosyltransferase sirtuin-6) (EC 2.4.2.-)","Castor canadensis (American beaver)","cardiac muscle cell differentiation [GO:0055007]; circadian regulation of gene expression [GO:0032922]; determination of adult lifespan [GO:0008340]; double-strand break repair [GO:0006302]; ketone biosynthetic process [GO:0042181]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of glycolytic process [GO:0045820]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; negative regulation of transposition [GO:0010529]; pericentric heterochromatin formation [GO:0031508]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of insulin secretion [GO:0032024]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein localization to chromatin [GO:0120187]; positive regulation of stem cell differentiation [GO:2000738]; protein delipidation [GO:0051697]; protein destabilization [GO:0031648]; regulation of circadian rhythm [GO:0042752]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of lipid catabolic process [GO:0050994]; regulation of lipid metabolic process [GO:0019216]","GO:0000122; GO:0000781; GO:0000785; GO:0003684; GO:0003723; GO:0005634; GO:0005783; GO:0006302; GO:0008340; GO:0010529; GO:0010569; GO:0016779; GO:0019216; GO:0031490; GO:0031491; GO:0031508; GO:0031648; GO:0032024; GO:0032922; GO:0034244; GO:0034979; GO:0042181; GO:0042308; GO:0042752; GO:0042803; GO:0045600; GO:0045721; GO:0045820; GO:0046827; GO:0046872; GO:0046969; GO:0050994; GO:0051697; GO:0055007; GO:0070403; GO:0097372; GO:0106274; GO:0120162; GO:0120187; GO:0140612; GO:0140765; GO:0140773; GO:0140774; GO:1904841; GO:2000738; GO:2000781"
"1798",1798,"Cluster_2787","Porites_evermani_scaffold_1135:5399-10987",151,-20.24,2,13,227,249,12,"91.67%","91.67%","Peve_00002349",0.999743054310315,0.0144319524323624,0.731793424490305,"G8HTB6","ZP domain-containing protein","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0016020"
"1826",1826,"Cluster_2787","Porites_evermani_scaffold_1176:14346-26534",161,-21.69,2,21,5145,5167,21,"76.19%","80.95%","Peve_00002952",0.99978090846462,0.0133264922094828,0.707558044122782,NA,NA,NA,NA,NA
"1841",1841,"Cluster_2787","Porites_evermani_scaffold_119:36299-56804",158,-23.19,2,21,12651,12677,24,"70.83%","75.00%","Peve_00003173",0.999661999574085,0.0165525907644587,0.773765786956118,"Q9W770","Spondin-1 (F-spondin)","Gallus gallus (Chicken)","cell adhesion [GO:0007155]","GO:0005576; GO:0007155; GO:0031012; GO:0046872"
"1855",1855,"Cluster_2787","Porites_evermani_scaffold_120:122543-140300",158,-20.41,2,19,8481,8502,17,"70.59%","82.35%","Peve_00003392",0.997354196901045,0.0463201207098193,0.937163514946439,"Q9Y3Q0","N-acetylated-alpha-linked acidic dipeptidase 2 (EC 3.4.17.21) (Glutamate carboxypeptidase III) (GCPIII) (N-acetylated-alpha-linked acidic dipeptidase II) (NAALADase II)","Homo sapiens (Human)","proteolysis [GO:0006508]","GO:0004180; GO:0004181; GO:0005886; GO:0006508; GO:0008236; GO:0008239; GO:0016020; GO:0016805; GO:0046872"
"1856",1856,"Cluster_2787","Porites_evermani_scaffold_120:122543-140300",158,-22.3,2,17,4206,4226,15,"80.00%","93.33%","Peve_00003392",0.997354196901045,0.0463201207098193,0.937163514946439,"Q9Y3Q0","N-acetylated-alpha-linked acidic dipeptidase 2 (EC 3.4.17.21) (Glutamate carboxypeptidase III) (GCPIII) (N-acetylated-alpha-linked acidic dipeptidase II) (NAALADase II)","Homo sapiens (Human)","proteolysis [GO:0006508]","GO:0004180; GO:0004181; GO:0005886; GO:0006508; GO:0008236; GO:0008239; GO:0016020; GO:0016805; GO:0046872"
"1864",1864,"Cluster_2787","Porites_evermani_scaffold_121:271684-298652",147,-20.91,2,16,21634,21655,14,"71.43%","78.57%","Peve_00003545",0.99717621236632,0.0478534645739355,0.945121679218986,"Q9Y4D8","Probable E3 ubiquitin-protein ligase HECTD4 (EC 2.3.2.26) (HECT domain-containing protein 4) (HECT-type E3 ubiquitin transferase HECTD4)","Homo sapiens (Human)","glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]","GO:0004842; GO:0006006; GO:0016020; GO:0042593"
"1872",1872,"Cluster_2787","Porites_evermani_scaffold_12:236425-265918",146,-21.64,2,21,24166,24192,24,"58.33%","75.00%","Peve_00003302",0.999980135670977,0.00401266394534835,0.54328949385489,"Q7TSG1","Centrosomal protein of 120 kDa (Cep120) (Coiled-coil domain-containing protein 100)","Mus musculus (Mouse)","astral microtubule organization [GO:0030953]; cell population proliferation [GO:0008283]; centrosome cycle [GO:0007098]; cerebral cortex development [GO:0021987]; interkinetic nuclear migration [GO:0022027]; microtubule cytoskeleton organization [GO:0000226]; neurogenesis [GO:0022008]; positive regulation of centriole elongation [GO:1903724]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of cilium assembly [GO:0045724]; positive regulation of establishment of protein localization [GO:1904951]; regulation of microtubule-based process [GO:0032886]; regulation of protein localization [GO:0032880]","GO:0000226; GO:0005737; GO:0005813; GO:0005814; GO:0007098; GO:0008022; GO:0008283; GO:0010825; GO:0021987; GO:0022008; GO:0022027; GO:0030953; GO:0032880; GO:0032886; GO:0045724; GO:1903724; GO:1904951"
"1876",1876,"Cluster_2787","Porites_evermani_scaffold_12:275842-288667",155,-20.25,2,21,6958,6980,20,"65.00%","80.00%","Peve_00003305",0.999819424207648,0.0120984969926468,0.678179842102661,"Q3UZD5","Putative histone-lysine N-methyltransferase PRDM6 (EC 2.1.1.361) (PR domain zinc finger protein 6) (PR domain-containing protein 6) (PR domain-containing protein in smooth muscle)","Mus musculus (Mouse)","chromatin organization [GO:0006325]; histone methylation [GO:0016571]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008]; regulation of gene expression [GO:0010468]","GO:0000122; GO:0005634; GO:0006325; GO:0010468; GO:0016571; GO:0022008; GO:0042802; GO:0045892; GO:0046872; GO:0051151; GO:0140944"
"1883",1883,"Cluster_2787","Porites_evermani_scaffold_1237:38143-69149",154,-20.51,2,21,16953,16973,19,"68.42%","78.95%","Peve_00003898",0.998457229830989,0.0353672740541857,0.909359886114279,"Q07889","Son of sevenless homolog 1 (SOS-1)","Homo sapiens (Human)","axon guidance [GO:0007411]; B cell homeostasis [GO:0001782]; B cell receptor signaling pathway [GO:0050853]; blood vessel morphogenesis [GO:0048514]; cardiac atrium morphogenesis [GO:0003209]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; eyelid development in camera-type eye [GO:0061029]; Fc-epsilon receptor signaling pathway [GO:0038095]; fibroblast growth factor receptor signaling pathway [GO:0008543]; hair follicle development [GO:0001942]; heart trabecula morphogenesis [GO:0061384]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; leukocyte migration [GO:0050900]; midbrain morphogenesis [GO:1904693]; multicellular organism growth [GO:0035264]; neurotrophin TRK receptor signaling pathway [GO:0048011]; pericardium morphogenesis [GO:0003344]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of GTPase activity [GO:0043547]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; Ras protein signal transduction [GO:0007265]; regulation of cell population proliferation [GO:0042127]; regulation of MAP kinase activity [GO:0043405]; regulation of pro-B cell differentiation [GO:2000973]; regulation of T cell differentiation in thymus [GO:0033081]; regulation of T cell proliferation [GO:0042129]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; signal transduction [GO:0007165]; vitellogenesis [GO:0007296]","GO:0001782; GO:0001942; GO:0003209; GO:0003344; GO:0005085; GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0006357; GO:0007165; GO:0007173; GO:0007265; GO:0007296; GO:0007411; GO:0008286; GO:0008543; GO:0014069; GO:0017124; GO:0019221; GO:0033081; GO:0035264; GO:0038095; GO:0042127; GO:0042129; GO:0043025; GO:0043405; GO:0043539; GO:0043547; GO:0045742; GO:0046982; GO:0048009; GO:0048011; GO:0048514; GO:0050853; GO:0050900; GO:0051057; GO:0060021; GO:0061029; GO:0061384; GO:1904693; GO:1905360; GO:2000973"
"1892",1892,"Cluster_2787","Porites_evermani_scaffold_1248:2544-18263",162,-20.74,2,21,633,653,19,"73.68%","84.21%","Peve_00004069",0.998859776055425,0.0304040525129495,0.903929377050813,"Q6P4Z2","Collagen alpha-1(II) chain (Alpha-1 type II collagen)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","","GO:0005201; GO:0005576; GO:0005581; GO:0046872"
"1921",1921,"Cluster_2787","Porites_evermani_scaffold_1282:61917-82195",152,-20.7,2,13,12685,12706,11,"90.91%","90.91%","Peve_00004523",0.999999085687885,0.000860879549426188,0.239778920002343,"Q32LU7","Pentatricopeptide repeat domain-containing protein 3, mitochondrial","Danio rerio (Zebrafish) (Brachydanio rerio)","mitochondrial translation [GO:0032543]; regulation of translation [GO:0006417]","GO:0005739; GO:0005840; GO:0006417; GO:0019843; GO:0032543; GO:0043024; GO:1990904"
"1922",1922,"Cluster_2787","Porites_evermani_scaffold_1282:61917-82195",161,-23.17,2,19,7942,7965,19,"73.68%","84.21%","Peve_00004523",0.999999085687885,0.000860879549426188,0.239778920002343,"Q32LU7","Pentatricopeptide repeat domain-containing protein 3, mitochondrial","Danio rerio (Zebrafish) (Brachydanio rerio)","mitochondrial translation [GO:0032543]; regulation of translation [GO:0006417]","GO:0005739; GO:0005840; GO:0006417; GO:0019843; GO:0032543; GO:0043024; GO:1990904"
"1923",1923,"Cluster_2787","Porites_evermani_scaffold_1286:45484-64530",161,-21.69,2,21,22,44,21,"76.19%","80.95%","Peve_00004566",-0.999636187928725,0.017173026532108,0.782669382293497,NA,NA,NA,NA,NA
"1939",1939,"Cluster_2787","Porites_evermani_scaffold_1303:73970-87601",156,-21.66,2,21,5421,5440,19,"73.68%","84.21%","Peve_00004847",0.99704225336107,0.048975931865785,0.949444666171571,"Q49B93","Sodium-coupled monocarboxylate transporter 2 (Electroneutral sodium monocarboxylate cotransporter) (Low-affinity sodium-lactate cotransporter) (Solute carrier family 5 member 12)","Mus musculus (Mouse)","sodium ion transport [GO:0006814]","GO:0005654; GO:0005886; GO:0006814; GO:0015129; GO:0015293; GO:0016324"
"1940",1940,"Cluster_2787","Porites_evermani_scaffold_1303:73970-87601",159,-28.37,2,20,6127,6146,18,"77.78%","88.89%","Peve_00004847",0.99704225336107,0.048975931865785,0.949444666171571,"Q49B93","Sodium-coupled monocarboxylate transporter 2 (Electroneutral sodium monocarboxylate cotransporter) (Low-affinity sodium-lactate cotransporter) (Solute carrier family 5 member 12)","Mus musculus (Mouse)","sodium ion transport [GO:0006814]","GO:0005654; GO:0005886; GO:0006814; GO:0015129; GO:0015293; GO:0016324"
"1950",1950,"Cluster_2787","Porites_evermani_scaffold_131:346566-359842",162,-21.14,2,21,3062,3082,19,"78.95%","78.95%","Peve_00004912",0.999805909005942,0.0125430986396607,0.689535303834238,"Q7JQD3","Gelsolin-like protein 1 (Actin-modulator) (EWAM) (EWAM-P1)","Lumbricus terrestris (Common earthworm)","actin filament capping [GO:0051693]; actin filament fragmentation [GO:0030043]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]","GO:0003779; GO:0005509; GO:0005737; GO:0005856; GO:0030041; GO:0030043; GO:0045010; GO:0051014; GO:0051015; GO:0051693"
"2017",2017,"Cluster_2787","Porites_evermani_scaffold_1396:72796-105613",164,-20.25,2,17,3410,3431,15,"80.00%","93.33%","Peve_00006122",-0.999839845331302,0.0113938558027464,0.658361276125779,"Q9NU22","Midasin (Dynein-related AAA-ATPase MDN1) (MIDAS-containing protein)","Homo sapiens (Human)","ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit export from nucleus [GO:0000055]","GO:0000027; GO:0000055; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0016020; GO:0016887; GO:0030687; GO:0045111"
"2037",2037,"Cluster_2787","Porites_evermani_scaffold_1418:47244-61595",151,-22.72,2,21,11378,11403,23,"65.22%","69.57%","Peve_00006481",0.999312796815682,0.0236027483638687,0.851916223620059,"P35384","Extracellular calcium-sensing receptor (CaSR) (Parathyroid cell calcium-sensing receptor) (BoPCaR1) (PCaR1)","Bos taurus (Bovine)","calcium ion import [GO:0070509]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; detection of calcium ion [GO:0005513]; G protein-coupled receptor signaling pathway [GO:0007186]; JNK cascade [GO:0007254]; ossification [GO:0001503]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; regulation of calcium ion transport [GO:0051924]; vasodilation [GO:0042311]","GO:0001503; GO:0004930; GO:0005509; GO:0005513; GO:0005886; GO:0006816; GO:0006874; GO:0007186; GO:0007254; GO:0008284; GO:0010628; GO:0016597; GO:0032781; GO:0042311; GO:0042803; GO:0043679; GO:0051924; GO:0070509"
"2046",2046,"Cluster_2787","Porites_evermani_scaffold_14:290348-305812",159,-22.18,2,21,12453,12475,20,"70.00%","80.00%","Peve_00006231",0.999963027291266,0.00547440714279664,0.551398425649056,"Q96JH7","Deubiquitinating protein VCPIP1 (EC 3.4.19.12) (Valosin-containing protein p97/p47 complex-interacting protein 1) (Valosin-containing protein p97/p47 complex-interacting protein p135) (VCP/p47 complex-interacting 135-kDa protein)","Homo sapiens (Human)","cellular response to DNA damage stimulus [GO:0006974]; endoplasmic reticulum membrane fusion [GO:0016320]; Golgi reassembly [GO:0090168]; mitotic cell cycle [GO:0000278]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein ubiquitination [GO:0016567]; protein-DNA covalent cross-linking repair [GO:0106300]; regulation of protein localization to chromatin [GO:1905634]","GO:0000278; GO:0004843; GO:0005634; GO:0005737; GO:0005788; GO:0005795; GO:0006974; GO:0016320; GO:0016567; GO:0016579; GO:0035871; GO:0071108; GO:0090168; GO:0106300; GO:1905634"
"2047",2047,"Cluster_2787","Porites_evermani_scaffold_14:290348-305812",173,-32.92,2,21,13214,13233,19,"84.21%","89.47%","Peve_00006231",0.999963027291266,0.00547440714279664,0.551398425649056,"Q96JH7","Deubiquitinating protein VCPIP1 (EC 3.4.19.12) (Valosin-containing protein p97/p47 complex-interacting protein 1) (Valosin-containing protein p97/p47 complex-interacting protein p135) (VCP/p47 complex-interacting 135-kDa protein)","Homo sapiens (Human)","cellular response to DNA damage stimulus [GO:0006974]; endoplasmic reticulum membrane fusion [GO:0016320]; Golgi reassembly [GO:0090168]; mitotic cell cycle [GO:0000278]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein ubiquitination [GO:0016567]; protein-DNA covalent cross-linking repair [GO:0106300]; regulation of protein localization to chromatin [GO:1905634]","GO:0000278; GO:0004843; GO:0005634; GO:0005737; GO:0005788; GO:0005795; GO:0006974; GO:0016320; GO:0016567; GO:0016579; GO:0035871; GO:0071108; GO:0090168; GO:0106300; GO:1905634"
"2049",2049,"Cluster_2787","Porites_evermani_scaffold_143:411692-427218",160,-20.68,2,20,7660,7679,18,"77.78%","83.33%","Peve_00006612",0.999741217032286,0.0144834602394057,0.732628394312895,"P12955","Xaa-Pro dipeptidase (X-Pro dipeptidase) (EC 3.4.13.9) (Imidodipeptidase) (Peptidase D) (Proline dipeptidase) (Prolidase)","Homo sapiens (Human)","amino acid metabolic process [GO:0006520]; collagen catabolic process [GO:0030574]; proteolysis [GO:0006508]","GO:0004181; GO:0006508; GO:0006520; GO:0008233; GO:0030145; GO:0030574; GO:0070006; GO:0070062; GO:0102009"
"2073",2073,"Cluster_2787","Porites_evermani_scaffold_1464:35547-38082",162,-24.39,2,21,1637,1657,19,"73.68%","84.21%","Peve_00007009",-0.999797200270235,0.012821420582154,0.69597202795206,NA,NA,NA,NA,NA
"2077",2077,"Cluster_2787","Porites_evermani_scaffold_1466:1547-29354",160,-20.78,2,21,27768,27789,19,"68.42%","78.95%","Peve_00007030",0.999928416611485,0.00761734871801782,0.573710369894872,"Q3UQ28","Peroxidasin homolog (EC 1.11.2.-) [Cleaved into: PXDN active fragment]","Mus musculus (Mouse)","angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; hydrogen peroxide catabolic process [GO:0042744]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979]","GO:0001525; GO:0001654; GO:0004601; GO:0005201; GO:0005604; GO:0005615; GO:0005783; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0030198; GO:0030199; GO:0031012; GO:0042744; GO:0043237; GO:0046872; GO:0051260; GO:0062023; GO:0070207; GO:0070831; GO:0071711; GO:0140825"
"2122",2122,"Cluster_2787","Porites_evermani_scaffold_1528:92327-120688",157,-20.71,2,20,15670,15690,18,"72.22%","83.33%","Peve_00007851",0.999117725600671,0.0267441559078376,0.888278112420496,"O95071","E3 ubiquitin-protein ligase UBR5 (EC 2.3.2.26) (E3 ubiquitin-protein ligase, HECT domain-containing 1) (HECT-type E3 ubiquitin transferase UBR5) (Hyperplastic discs protein homolog) (hHYD) (Progestin-induced protein)","Homo sapiens (Human)","cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; positive regulation of protein import into nucleus [GO:0042307]; progesterone receptor signaling pathway [GO:0050847]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; regulation of double-strand break repair [GO:2000779]","GO:0000209; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006281; GO:0006974; GO:0008270; GO:0010628; GO:0016020; GO:0032991; GO:0034450; GO:0042307; GO:0043130; GO:0048471; GO:0050847; GO:0061630; GO:0070936; GO:0090263; GO:0140861; GO:1901315; GO:2000779; GO:2000780"
"2171",2171,"Cluster_2787","Porites_evermani_scaffold_1594:61110-67902",160,-23.38,2,18,79,102,18,"77.78%","83.33%","Peve_00008684",0.99769821407441,0.0432027035935973,0.918140469626035,NA,NA,NA,NA,NA
"2199",2199,"Cluster_2787","Porites_evermani_scaffold_1649:33519-72602",158,-22.37,2,21,6905,6925,19,"68.42%","84.21%","Peve_00009375",0.999957006613217,0.0059033360413808,0.571521101410101,"Q9UKP5","A disintegrin and metalloproteinase with thrombospondin motifs 6 (ADAM-TS 6) (ADAM-TS6) (ADAMTS-6) (EC 3.4.24.-)","Homo sapiens (Human)","aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; extracellular matrix organization [GO:0030198]; kidney development [GO:0001822]; proteolysis [GO:0006508]","GO:0001822; GO:0003279; GO:0004222; GO:0005576; GO:0006508; GO:0008237; GO:0030198; GO:0031012; GO:0035904; GO:0046872; GO:0060976"
"2205",2205,"Cluster_2787","Porites_evermani_scaffold_1655:18837-47102",147,-20.51,2,21,14171,14193,20,"65.00%","70.00%","Peve_00009466",0.999047644234391,0.0277862028185553,0.899096636156394,"P27590","Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form]","Rattus norvegicus (Rat)","antibacterial innate immune response [GO:0140367]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; autophagy [GO:0006914]; calcium ion homeostasis [GO:0055074]; cellular calcium ion homeostasis [GO:0006874]; cellular chloride ion homeostasis [GO:0030644]; cellular phosphate ion homeostasis [GO:0030643]; cellular response to unfolded protein [GO:0034620]; cellular sodium ion homeostasis [GO:0006883]; chaperone-mediated protein folding [GO:0061077]; chemical homeostasis [GO:0048878]; chloride ion homeostasis [GO:0055064]; citric acid secretion [GO:0046720]; collecting duct development [GO:0072044]; connective tissue replacement [GO:0097709]; creatinine homeostasis [GO:0097273]; defense response to Gram-negative bacterium [GO:0050829]; endoplasmic reticulum organization [GO:0007029]; gene expression [GO:0010467]; glomerular filtration [GO:0003094]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; inflammatory response [GO:0006954]; ion homeostasis [GO:0050801]; juxtaglomerular apparatus development [GO:0072051]; kidney development [GO:0001822]; leukocyte cell-cell adhesion [GO:0007159]; lipid metabolic process [GO:0006629]; loop of Henle development [GO:0072070]; metanephric ascending thin limb development [GO:0072218]; metanephric distal convoluted tubule development [GO:0072221]; metanephric thick ascending limb development [GO:0072233]; micturition [GO:0060073]; multicellular organismal homeostasis [GO:0048871]; multicellular organismal response to stress [GO:0033555]; neutrophil migration [GO:1990266]; organ or tissue specific immune response [GO:0002251]; peptidyl-threonine phosphorylation [GO:0018107]; phosphate ion homeostasis [GO:0055062]; potassium ion homeostasis [GO:0055075]; protein localization to vacuole [GO:0072665]; protein phosphorylation [GO:0006468]; protein transport into plasma membrane raft [GO:0044861]; regulation of blood pressure [GO:0008217]; regulation of protein transport [GO:0051223]; regulation of urine volume [GO:0035809]; renal sodium ion absorption [GO:0070294]; renal urate salt excretion [GO:0097744]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; response to lipopolysaccharide [GO:0032496]; response to organic substance [GO:0010033]; response to unfolded protein [GO:0006986]; response to water deprivation [GO:0009414]; response to xenobiotic stimulus [GO:0009410]; RNA splicing [GO:0008380]; sodium ion homeostasis [GO:0055078]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; ubiquitin-dependent ERAD pathway [GO:0030433]; urate transport [GO:0015747]; urea transmembrane transport [GO:0071918]; water homeostasis [GO:0030104]","GO:0000922; GO:0001822; GO:0002251; GO:0003091; GO:0003094; GO:0005201; GO:0005509; GO:0005615; GO:0005783; GO:0005794; GO:0005886; GO:0005929; GO:0006468; GO:0006629; GO:0006874; GO:0006883; GO:0006914; GO:0006915; GO:0006954; GO:0006986; GO:0007029; GO:0007157; GO:0007159; GO:0008217; GO:0008380; GO:0009410; GO:0009414; GO:0009986; GO:0010033; GO:0010467; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0018107; GO:0019864; GO:0030104; GO:0030433; GO:0030643; GO:0030644; GO:0031410; GO:0032496; GO:0033209; GO:0033555; GO:0034620; GO:0034976; GO:0035809; GO:0044861; GO:0045121; GO:0045177; GO:0046720; GO:0048871; GO:0048878; GO:0050801; GO:0050829; GO:0051223; GO:0055062; GO:0055064; GO:0055074; GO:0055075; GO:0055078; GO:0060073; GO:0060170; GO:0061077; GO:0070294; GO:0071918; GO:0072044; GO:0072051; GO:0072070; GO:0072218; GO:0072221; GO:0072233; GO:0072665; GO:0097190; GO:0097273; GO:0097709; GO:0097744; GO:0140367; GO:1990266"
"2206",2206,"Cluster_2787","Porites_evermani_scaffold_1655:18837-47102",155,-21.18,2,21,1996,2019,21,"61.90%","80.95%","Peve_00009466",0.999047644234391,0.0277862028185553,0.899096636156394,"P27590","Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form]","Rattus norvegicus (Rat)","antibacterial innate immune response [GO:0140367]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; autophagy [GO:0006914]; calcium ion homeostasis [GO:0055074]; cellular calcium ion homeostasis [GO:0006874]; cellular chloride ion homeostasis [GO:0030644]; cellular phosphate ion homeostasis [GO:0030643]; cellular response to unfolded protein [GO:0034620]; cellular sodium ion homeostasis [GO:0006883]; chaperone-mediated protein folding [GO:0061077]; chemical homeostasis [GO:0048878]; chloride ion homeostasis [GO:0055064]; citric acid secretion [GO:0046720]; collecting duct development [GO:0072044]; connective tissue replacement [GO:0097709]; creatinine homeostasis [GO:0097273]; defense response to Gram-negative bacterium [GO:0050829]; endoplasmic reticulum organization [GO:0007029]; gene expression [GO:0010467]; glomerular filtration [GO:0003094]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; inflammatory response [GO:0006954]; ion homeostasis [GO:0050801]; juxtaglomerular apparatus development [GO:0072051]; kidney development [GO:0001822]; leukocyte cell-cell adhesion [GO:0007159]; lipid metabolic process [GO:0006629]; loop of Henle development [GO:0072070]; metanephric ascending thin limb development [GO:0072218]; metanephric distal convoluted tubule development [GO:0072221]; metanephric thick ascending limb development [GO:0072233]; micturition [GO:0060073]; multicellular organismal homeostasis [GO:0048871]; multicellular organismal response to stress [GO:0033555]; neutrophil migration [GO:1990266]; organ or tissue specific immune response [GO:0002251]; peptidyl-threonine phosphorylation [GO:0018107]; phosphate ion homeostasis [GO:0055062]; potassium ion homeostasis [GO:0055075]; protein localization to vacuole [GO:0072665]; protein phosphorylation [GO:0006468]; protein transport into plasma membrane raft [GO:0044861]; regulation of blood pressure [GO:0008217]; regulation of protein transport [GO:0051223]; regulation of urine volume [GO:0035809]; renal sodium ion absorption [GO:0070294]; renal urate salt excretion [GO:0097744]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; response to lipopolysaccharide [GO:0032496]; response to organic substance [GO:0010033]; response to unfolded protein [GO:0006986]; response to water deprivation [GO:0009414]; response to xenobiotic stimulus [GO:0009410]; RNA splicing [GO:0008380]; sodium ion homeostasis [GO:0055078]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; ubiquitin-dependent ERAD pathway [GO:0030433]; urate transport [GO:0015747]; urea transmembrane transport [GO:0071918]; water homeostasis [GO:0030104]","GO:0000922; GO:0001822; GO:0002251; GO:0003091; GO:0003094; GO:0005201; GO:0005509; GO:0005615; GO:0005783; GO:0005794; GO:0005886; GO:0005929; GO:0006468; GO:0006629; GO:0006874; GO:0006883; GO:0006914; GO:0006915; GO:0006954; GO:0006986; GO:0007029; GO:0007157; GO:0007159; GO:0008217; GO:0008380; GO:0009410; GO:0009414; GO:0009986; GO:0010033; GO:0010467; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0018107; GO:0019864; GO:0030104; GO:0030433; GO:0030643; GO:0030644; GO:0031410; GO:0032496; GO:0033209; GO:0033555; GO:0034620; GO:0034976; GO:0035809; GO:0044861; GO:0045121; GO:0045177; GO:0046720; GO:0048871; GO:0048878; GO:0050801; GO:0050829; GO:0051223; GO:0055062; GO:0055064; GO:0055074; GO:0055075; GO:0055078; GO:0060073; GO:0060170; GO:0061077; GO:0070294; GO:0071918; GO:0072044; GO:0072051; GO:0072070; GO:0072218; GO:0072221; GO:0072233; GO:0072665; GO:0097190; GO:0097273; GO:0097709; GO:0097744; GO:0140367; GO:1990266"
"2209",2209,"Cluster_2787","Porites_evermani_scaffold_166:34415-39270",153,-20.41,2,21,225,246,20,"75.00%","75.00%","Peve_00009505",0.99959671207991,0.0180807867542241,0.782669382293497,NA,NA,NA,NA,NA
"2234",2234,"Cluster_2787","Porites_evermani_scaffold_1710:101459-103728",172,-23.08,2,21,368,389,19,"78.95%","84.21%","Peve_00010166",-0.999698083700696,0.015644054775235,0.755800904783597,NA,NA,NA,NA,NA
"2249",2249,"Cluster_2787","Porites_evermani_scaffold_1728:39203-46317",155,-20.43,2,20,1175,1194,18,"77.78%","83.33%","Peve_00010342",0.999671024295392,0.0163301036180213,0.769967254188809,NA,NA,NA,NA,NA
"2256",2256,"Cluster_2787","Porites_evermani_scaffold_1734:13418-24059",162,-26.88,2,20,6311,6333,19,"78.95%","78.95%","Peve_00010422",0.996936931004056,0.0498407339402141,0.952955683251839,"Q92485","Acid sphingomyelinase-like phosphodiesterase 3b (ASM-like phosphodiesterase 3b) (EC 3.1.4.-)","Homo sapiens (Human)","inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685]","GO:0004767; GO:0005615; GO:0005886; GO:0006685; GO:0006954; GO:0008081; GO:0008270; GO:0016798; GO:0034122; GO:0045087; GO:0046466; GO:0050728; GO:0070062"
"2275",2275,"Cluster_2787","Porites_evermani_scaffold_1752:86211-100549",154,-20.23,2,16,2126,2148,15,"80.00%","86.67%","Peve_00010591",0.997238292841101,0.0473242711265986,0.9423456331619,NA,NA,NA,NA,NA
"2282",2282,"Cluster_2787","Porites_evermani_scaffold_1767:39877-61461",156,-22.6,2,13,8181,8202,11,"90.91%","100.00%","Peve_00010733",0.999101148305045,0.0269942756006821,0.890996391779975,NA,NA,NA,NA,NA
"2312",2312,"Cluster_2787","Porites_evermani_scaffold_1815:53592-65502",158,-21.35,2,20,10015,10037,19,"68.42%","84.21%","Peve_00011328",0.999984105773436,0.00358934658638763,0.524379672321757,"O80668","Amino acid transporter AVT1A (AtAvt1A)","Arabidopsis thaliana (Mouse-ear cress)","amino acid transmembrane transport [GO:0003333]","GO:0000325; GO:0003333; GO:0015171; GO:0016020"
"2370",2370,"Cluster_2787","Porites_evermani_scaffold_18:85205-89487",155,-22.05,2,21,2236,2259,21,"66.67%","76.19%","Peve_00011078",0.998382772633742,0.0362108907750523,0.909359886114279,NA,NA,NA,NA,NA
"2372",2372,"Cluster_2787","Porites_evermani_scaffold_1885:83547-99277",163,-20.7,2,21,12301,12324,21,"76.19%","76.19%","Peve_00012083",0.999040187210008,0.0278947921741052,0.899751445246142,"Q5ZKE7","UMP-CMP kinase (EC 2.7.4.14) (Deoxycytidylate kinase) (CK) (dCMP kinase) (Nucleoside-diphosphate kinase) (EC 2.7.4.6) (Uridine monophosphate/cytidine monophosphate kinase) (UMP/CMP kinase) (UMP/CMPK)","Gallus gallus (Chicken)","'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; CDP biosynthetic process [GO:0046705]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; UDP biosynthetic process [GO:0006225]","GO:0004127; GO:0004550; GO:0005524; GO:0005634; GO:0005737; GO:0006165; GO:0006207; GO:0006225; GO:0009142; GO:0033862; GO:0036430; GO:0036431; GO:0046705"
"2380",2380,"Cluster_2787","Porites_evermani_scaffold_189:332947-353739",162,-23.16,2,20,10904,10927,20,"75.00%","80.00%","Peve_00012139",0.999990517292289,0.00277243674471523,0.446313889056449,"Q9D4H1","Exocyst complex component 2 (Exocyst complex component Sec5)","Mus musculus (Mouse)","exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; regulation of entry of bacterium into host cell [GO:2000535]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522]","GO:0000145; GO:0000281; GO:0005886; GO:0006887; GO:0006893; GO:0006904; GO:0015031; GO:0019901; GO:0031267; GO:0045921; GO:0047485; GO:0090148; GO:0090522; GO:0090543; GO:2000535"
"2416",2416,"Cluster_2787","Porites_evermani_scaffold_19:345952-356876",157,-21.16,2,19,8636,8659,19,"73.68%","78.95%","Peve_00012279",0.999525998637372,0.0196020761520992,0.798903643537049,"Q5U3U0","Phytanoyl-CoA dioxygenase domain-containing protein 1 (Protein PHYHD1) (EC 1.14.11.-)","Danio rerio (Zebrafish) (Brachydanio rerio)","","GO:0046872; GO:0051213"
"2425",2425,"Cluster_2787","Porites_evermani_scaffold_1946:11511-40641",157,-21.64,2,21,27893,27915,21,"71.43%","80.95%","Peve_00012780",0.999514551705761,0.019837373988273,0.802441025798643,"P20735","Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain]","Sus scrofa (Pig)","glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; zymogen activation [GO:0031638]","GO:0002951; GO:0005886; GO:0006536; GO:0006750; GO:0006751; GO:0031638; GO:0036374; GO:0102953; GO:0103068"
"2464",2464,"Cluster_2787","Porites_evermani_scaffold_2026:590-2575",155,-22.06,2,21,366,390,22,"68.18%","72.73%","Peve_00013818",0.999999565158952,0.000593690915329897,0.239778920002343,"Q07536","Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial (MMSDH) (Malonate-semialdehyde dehydrogenase [acylating]) (EC 1.2.1.18) (EC 1.2.1.27) (Aldehyde dehydrogenase family 6 member A1)","Bos taurus (Bovine)","thymine catabolic process [GO:0006210]; thymine metabolic process [GO:0019859]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]","GO:0000062; GO:0004491; GO:0005739; GO:0006210; GO:0006573; GO:0006574; GO:0018478; GO:0019859; GO:0102662"
"2575",2575,"Cluster_2787","Porites_evermani_scaffold_220:136991-157264",160,-20.15,2,20,2924,2945,19,"78.95%","84.21%","Peve_00015572",0.999927947314274,0.00764227770951619,0.573710369894872,"P07207","Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein]","Drosophila melanogaster (Fruit fly)","actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222]","GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048"
"2578",2578,"Cluster_2787","Porites_evermani_scaffold_220:311455-320174",152,-21.32,2,21,1572,1593,19,"63.16%","73.68%","Peve_00015583",0.997965012193854,0.0406209150714785,0.909359886114279,"P80467","Alcohol dehydrogenase class-3 (EC 1.1.1.1) (Alcohol dehydrogenase class-III) (Glutathione-dependent formaldehyde dehydrogenase) (FALDH) (FDH) (GSH-FDH) (EC 1.1.1.-) (S-(hydroxymethyl)glutathione dehydrogenase) (EC 1.1.1.284)","Saara hardwickii (Indian spiny-tailed lizard) (Uromastyx hardwickii)","ethanol oxidation [GO:0006069]","GO:0004022; GO:0005737; GO:0006069; GO:0008270; GO:0106321; GO:0106322"
"2629",2629,"Cluster_2787","Porites_evermani_scaffold_231:66275-77329",164,-23.36,2,17,8555,8576,15,"73.33%","100.00%","Peve_00016648",0.999756154929201,0.014059210607724,0.724772403897406,"Q4KMD3","U11/U12 small nuclear ribonucleoprotein 35 kDa protein (U11/U12 snRNP 35 kDa protein) (U1 snRNP-binding protein homolog)","Danio rerio (Zebrafish) (Brachydanio rerio)","mRNA splicing, via spliceosome [GO:0000398]","GO:0000398; GO:0003729; GO:0005689; GO:0017069"
"2630",2630,"Cluster_2787","Porites_evermani_scaffold_231:66275-77329",168,-27.59,2,21,571,592,19,"68.42%","89.47%","Peve_00016648",0.999756154929201,0.014059210607724,0.724772403897406,"Q4KMD3","U11/U12 small nuclear ribonucleoprotein 35 kDa protein (U11/U12 snRNP 35 kDa protein) (U1 snRNP-binding protein homolog)","Danio rerio (Zebrafish) (Brachydanio rerio)","mRNA splicing, via spliceosome [GO:0000398]","GO:0000398; GO:0003729; GO:0005689; GO:0017069"
"2642",2642,"Cluster_2787","Porites_evermani_scaffold_2348:61250-76959",151,-20.3,2,21,3861,3884,21,"66.67%","71.43%","Peve_00016980",-0.999963153550721,0.00546505171493988,0.551398425649056,NA,NA,NA,NA,NA
"2698",2698,"Cluster_2787","Porites_evermani_scaffold_2459:26913-64864",157,-20.88,2,21,21473,21498,23,"69.57%","82.61%","Peve_00018009",0.999938989744559,0.00703232203684336,0.573710369894872,"Q8R1A4","Dedicator of cytokinesis protein 7 (Protein moonlight)","Mus musculus (Mouse)","activation of GTPase activity [GO:0090630]; axonogenesis [GO:0007409]; establishment of neuroblast polarity [GO:0045200]; hematopoietic progenitor cell differentiation [GO:0002244]; interkinetic nuclear migration [GO:0022027]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of cold-induced thermogenesis [GO:0120163]; neuron projection development [GO:0031175]; pigmentation [GO:0043473]; positive regulation of GTPase activity [GO:0043547]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; postsynaptic specialization assembly [GO:0098698]; regulation of neurogenesis [GO:0050767]; small GTPase mediated signal transduction [GO:0007264]","GO:0000226; GO:0002244; GO:0005085; GO:0007264; GO:0007409; GO:0008180; GO:0022027; GO:0030424; GO:0031175; GO:0031267; GO:0031594; GO:0033138; GO:0043473; GO:0043547; GO:0045200; GO:0050767; GO:0090630; GO:0098698; GO:0120163; GO:1904754"
"2732",2732,"Cluster_2787","Porites_evermani_scaffold_2529:26065-33846",165,-25.05,2,18,4651,4672,16,"75.00%","93.75%","Peve_00018683",-0.999977403674274,0.00427971502873518,0.54328949385489,"O89112","Glutathione S-transferase LANCL1 (EC 2.5.1.18) (40 kDa erythrocyte membrane protein) (p40) (LanC-like protein 1)","Mus musculus (Mouse)","carbohydrate metabolic process [GO:0005975]; peptide modification [GO:0031179]; regulation of neuron apoptotic process [GO:0043523]; regulation of oxidative stress-induced neuron death [GO:1903203]","GO:0004364; GO:0005737; GO:0005886; GO:0005975; GO:0008270; GO:0017124; GO:0031179; GO:0043295; GO:0043523; GO:0050750; GO:1903203"
"2733",2733,"Cluster_2787","Porites_evermani_scaffold_2531:24772-58037",161,-22.62,2,21,20462,20483,20,"80.00%","80.00%","Peve_00018721",-0.999787569512439,0.0131223383688255,0.703047117306653,"Q9PVW8","Rhamnose-binding lectin (RBL) (Roe lectin) (SAL)","Silurus asotus (Amur catfish) (Parasilurus asotus)","","GO:0005576; GO:0030246"
"2743",2743,"Cluster_2787","Porites_evermani_scaffold_2537:54206-56144",142,-20.21,2,21,1256,1281,23,"60.87%","69.57%","Peve_00018749",0.998587521356217,0.0338405332897438,0.909359886114279,"Q8BQH6","CUB domain-containing protein 2","Mus musculus (Mouse)","","GO:0005576"
"2757",2757,"Cluster_2787","Porites_evermani_scaffold_2559:127-45001",161,-25.21,2,21,15037,15056,19,"68.42%","89.47%","Peve_00018891",0.99879347004041,0.0312757585322912,0.903929377050813,"Q5T4S7","E3 ubiquitin-protein ligase UBR4 (EC 2.3.2.27) (600 kDa retinoblastoma protein-associated factor) (N-recognin-4) (RING-type E3 ubiquitin transferase UBR4) (Retinoblastoma-associated factor of 600 kDa) (RBAF600) (p600) (Zinc finger UBR1-type protein 1)","Homo sapiens (Human)","ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0004842; GO:0005516; GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0006511; GO:0008270; GO:0016020; GO:0035579; GO:0061630; GO:0070821; GO:0101003"
"2775",2775,"Cluster_2787","Porites_evermani_scaffold_2605:53851-69413",156,-24.05,2,21,15342,15361,19,"73.68%","84.21%","Peve_00019318",0.997831174284316,0.0419359003350525,0.910046115299369,"P51029","Protein Wnt-8b","Danio rerio (Zebrafish) (Brachydanio rerio)","canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; commissural neuron axon guidance [GO:0071679]; embryonic pattern specification [GO:0009880]; eye development [GO:0001654]; eye field cell fate commitment involved in camera-type eye formation [GO:0060898]; forebrain development [GO:0030900]; forebrain neuron differentiation [GO:0021879]; hypothalamus development [GO:0021854]; negative regulation of anterior neural cell fate commitment of the neural plate by Wnt signaling pathway [GO:0022002]; neuron differentiation [GO:0030182]; otic placode formation [GO:0043049]; sensory epithelium regeneration [GO:0070654]","GO:0001654; GO:0005109; GO:0005125; GO:0005615; GO:0009880; GO:0021854; GO:0021879; GO:0022002; GO:0030182; GO:0030900; GO:0043049; GO:0045165; GO:0060070; GO:0060898; GO:0070654; GO:0071679"
"2776",2776,"Cluster_2787","Porites_evermani_scaffold_261:48289-68638",154,-27.29,2,21,18691,18719,26,"69.23%","69.23%","Peve_00019345",0.998480857242945,0.0350953363827291,0.909359886114279,"Q80T32","Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) (G-protein coupled receptor PGR25)","Mus musculus (Mouse)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; neurogenesis [GO:0022008]","GO:0004930; GO:0005654; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0022008"
"2824",2824,"Cluster_2787","Porites_evermani_scaffold_2703:46142-58724",148,-20.9,2,21,8579,8598,19,"73.68%","73.68%","Peve_00020132",0.999414316705503,0.0217895237502879,0.829230308546931,NA,NA,NA,NA,NA
"2839",2839,"Cluster_2787","Porites_evermani_scaffold_274:99784-123082",157,-20.05,2,19,15955,15978,19,"68.42%","84.21%","Peve_00020418",0.997336126674048,0.0464780994944581,0.938116783996528,"O43426","Synaptojanin-1 (EC 3.1.3.36) (Synaptic inositol 1,4,5-trisphosphate 5-phosphatase 1)","Homo sapiens (Human)","brain development [GO:0007420]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; learning [GO:0007612]; membrane organization [GO:0061024]; neurotransmitter transport [GO:0006836]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol metabolic process [GO:0046488]; positive regulation of endosome organization [GO:1904980]; positive regulation of gliogenesis [GO:0014015]; positive regulation of receptor-mediated endocytosis [GO:0048260]; response to cytokine [GO:0034097]; response to retinoic acid [GO:0032526]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; synaptic vesicle uncoating [GO:0016191]","GO:0003723; GO:0004438; GO:0004439; GO:0005829; GO:0005874; GO:0006661; GO:0006836; GO:0007420; GO:0007612; GO:0008022; GO:0012506; GO:0014015; GO:0016082; GO:0016191; GO:0017124; GO:0030117; GO:0030132; GO:0032526; GO:0034097; GO:0034595; GO:0034596; GO:0043195; GO:0043647; GO:0043812; GO:0043813; GO:0044877; GO:0046488; GO:0046855; GO:0046856; GO:0048260; GO:0048471; GO:0048488; GO:0048489; GO:0052629; GO:0052658; GO:0061024; GO:0097060; GO:0098688; GO:0098793; GO:1904980; GO:1990175"
"2840",2840,"Cluster_2787","Porites_evermani_scaffold_274:99784-123082",163,-21.28,2,21,11255,11278,21,"76.19%","76.19%","Peve_00020418",0.997336126674048,0.0464780994944581,0.938116783996528,"O43426","Synaptojanin-1 (EC 3.1.3.36) (Synaptic inositol 1,4,5-trisphosphate 5-phosphatase 1)","Homo sapiens (Human)","brain development [GO:0007420]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; learning [GO:0007612]; membrane organization [GO:0061024]; neurotransmitter transport [GO:0006836]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol metabolic process [GO:0046488]; positive regulation of endosome organization [GO:1904980]; positive regulation of gliogenesis [GO:0014015]; positive regulation of receptor-mediated endocytosis [GO:0048260]; response to cytokine [GO:0034097]; response to retinoic acid [GO:0032526]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; synaptic vesicle uncoating [GO:0016191]","GO:0003723; GO:0004438; GO:0004439; GO:0005829; GO:0005874; GO:0006661; GO:0006836; GO:0007420; GO:0007612; GO:0008022; GO:0012506; GO:0014015; GO:0016082; GO:0016191; GO:0017124; GO:0030117; GO:0030132; GO:0032526; GO:0034097; GO:0034595; GO:0034596; GO:0043195; GO:0043647; GO:0043812; GO:0043813; GO:0044877; GO:0046488; GO:0046855; GO:0046856; GO:0048260; GO:0048471; GO:0048488; GO:0048489; GO:0052629; GO:0052658; GO:0061024; GO:0097060; GO:0098688; GO:0098793; GO:1904980; GO:1990175"
"2862",2862,"Cluster_2787","Porites_evermani_scaffold_279:136405-143651",165,-21,2,19,1751,1773,18,"77.78%","88.89%","Peve_00020792",0.999488779325587,0.0203571899357057,0.810097073649321,NA,NA,NA,NA,NA
"2889",2889,"Cluster_2787","Porites_evermani_scaffold_2847:667-54073",148,-20.21,2,13,5306,5327,11,"81.82%","90.91%","Peve_00021264",0.999955012057579,0.00603871890632299,0.573710369894872,"O15050","TPR and ankyrin repeat-containing protein 1 (Lupus brain antigen 1 homolog)","Homo sapiens (Human)","",""
"2903",2903,"Cluster_2787","Porites_evermani_scaffold_2875:42696-60666",153,-21.29,2,15,11361,11383,14,"78.57%","92.86%","Peve_00021477",0.999886728835656,0.0095820603692022,0.60909012362496,"P0DTA4","Propionyl-CoA carboxylase alpha chain, mitochondrial (PCCase subunit alpha) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase subunit alpha)","Sus scrofa (Pig)","short-chain fatty acid catabolic process [GO:0019626]","GO:0004658; GO:0005524; GO:0005759; GO:0019626; GO:0046872"
"2908",2908,"Cluster_2787","Porites_evermani_scaffold_288:108316-149247",158,-23.68,2,20,21026,21050,21,"66.67%","80.95%","Peve_00021504",0.999979738168967,0.00405261361177111,0.54328949385489,"Q5VZB9","Doublesex- and mab-3-related transcription factor A1","Homo sapiens (Human)","germ cell development [GO:0007281]; male mating behavior [GO:0060179]; ovarian follicle development [GO:0001541]; regulation of transcription by RNA polymerase II [GO:0006357]; sex differentiation [GO:0007548]","GO:0000785; GO:0000978; GO:0000981; GO:0001541; GO:0005634; GO:0006357; GO:0007281; GO:0007548; GO:0042802; GO:0046872; GO:0060179; GO:1990837"
"2914",2914,"Cluster_2787","Porites_evermani_scaffold_290:243145-263788",146,-20.6,2,21,19080,19100,19,"63.16%","73.68%","Peve_00021731",0.999642017056776,0.017034886514364,0.781515462136098,NA,NA,NA,NA,NA
"2915",2915,"Cluster_2787","Porites_evermani_scaffold_290:243145-263788",162,-20.6,2,21,15374,15398,22,"72.73%","81.82%","Peve_00021731",0.999642017056776,0.017034886514364,0.781515462136098,NA,NA,NA,NA,NA
"2934",2934,"Cluster_2787","Porites_evermani_scaffold_2941:10330-21275",166,-21.51,2,20,6225,6247,19,"78.95%","84.21%","Peve_00022001",0.999999203932145,0.000803285991715918,0.239778920002343,NA,NA,NA,NA,NA
"2960",2960,"Cluster_2787","Porites_evermani_scaffold_2980:2-10509",167,-23.05,2,21,1769,1791,20,"80.00%","80.00%","Peve_00022290",0.999737413073421,0.0145895257421886,0.734459231692133,"Q9C6W5","ABC transporter G family member 14 (ABC transporter ABCG.14) (AtABCG14) (Protein INSENSITIVE TO TEMPERATURE 211) (White-brown complex homolog protein 14) (AtWBC14)","Arabidopsis thaliana (Mouse-ear cress)","cotyledon vascular tissue pattern formation [GO:0010588]; cytokinin transport [GO:0010184]; cytokinin-activated signaling pathway [GO:0009736]; defense response to bacterium [GO:0042742]; export across plasma membrane [GO:0140115]; export from cell [GO:0140352]; response to hydrogen peroxide [GO:0042542]; stem vascular tissue pattern formation [GO:0010222]; transmembrane transport [GO:0055085]","GO:0005524; GO:0005886; GO:0009736; GO:0010184; GO:0010222; GO:0010588; GO:0015562; GO:0016020; GO:0016887; GO:0042542; GO:0042626; GO:0042742; GO:0055085; GO:0140115; GO:0140352; GO:0140359"
"2981",2981,"Cluster_2787","Porites_evermani_scaffold_3034:401-54010",155,-22.26,2,21,6986,7008,20,"65.00%","80.00%","Peve_00022876",0.999985553864935,0.00342193281993488,0.509926549795741,"Q9JHU4","Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)","Mus musculus (Mouse)","cell division [GO:0051301]; cilium movement [GO:0003341]; cytoplasmic microtubule organization [GO:0031122]; establishment of spindle localization [GO:0051293]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitotic cell cycle [GO:0000278]; nuclear migration [GO:0007097]; P-body assembly [GO:0033962]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; retrograde axonal transport [GO:0008090]; stress granule assembly [GO:0034063]","GO:0000278; GO:0002177; GO:0003341; GO:0005524; GO:0005635; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0005881; GO:0005938; GO:0007018; GO:0007097; GO:0008090; GO:0008569; GO:0030175; GO:0030286; GO:0030424; GO:0031122; GO:0032388; GO:0033962; GO:0034063; GO:0043025; GO:0045505; GO:0051293; GO:0051301; GO:0051959; GO:0060236; GO:0072382; GO:0090235; GO:0120162; GO:1904115; GO:1905832"
"2982",2982,"Cluster_2787","Porites_evermani_scaffold_3034:401-54010",156,-20.59,2,19,11319,11339,17,"76.47%","82.35%","Peve_00022876",0.999985553864935,0.00342193281993488,0.509926549795741,"Q9JHU4","Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)","Mus musculus (Mouse)","cell division [GO:0051301]; cilium movement [GO:0003341]; cytoplasmic microtubule organization [GO:0031122]; establishment of spindle localization [GO:0051293]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitotic cell cycle [GO:0000278]; nuclear migration [GO:0007097]; P-body assembly [GO:0033962]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; retrograde axonal transport [GO:0008090]; stress granule assembly [GO:0034063]","GO:0000278; GO:0002177; GO:0003341; GO:0005524; GO:0005635; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0005881; GO:0005938; GO:0007018; GO:0007097; GO:0008090; GO:0008569; GO:0030175; GO:0030286; GO:0030424; GO:0031122; GO:0032388; GO:0033962; GO:0034063; GO:0043025; GO:0045505; GO:0051293; GO:0051301; GO:0051959; GO:0060236; GO:0072382; GO:0090235; GO:0120162; GO:1904115; GO:1905832"
"3065",3065,"Cluster_2787","Porites_evermani_scaffold_324:42917-60033",150,-21.95,2,21,8721,8746,23,"65.22%","73.91%","Peve_00024262",0.999974516288872,0.00454493189547208,0.54328949385489,"Q32P51","Heterogeneous nuclear ribonucleoprotein A1-like 2 (hnRNP A1-like 2) (hnRNP core protein A1-like 2)","Homo sapiens (Human)","mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]","GO:0000398; GO:0003730; GO:0005737; GO:0051028; GO:0071013"
"3066",3066,"Cluster_2787","Porites_evermani_scaffold_324:42917-60033",158,-20.39,2,21,7005,7028,21,"71.43%","80.95%","Peve_00024262",0.999974516288872,0.00454493189547208,0.54328949385489,"Q32P51","Heterogeneous nuclear ribonucleoprotein A1-like 2 (hnRNP A1-like 2) (hnRNP core protein A1-like 2)","Homo sapiens (Human)","mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]","GO:0000398; GO:0003730; GO:0005737; GO:0051028; GO:0071013"
"3085",3085,"Cluster_2787","Porites_evermani_scaffold_329:125391-148419",163,-20.19,2,21,702,724,20,"75.00%","80.00%","Peve_00024536",0.99951468205366,0.019834710323715,0.802441025798643,"Q5R5L7","Arrestin domain-containing protein 3","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","","GO:0005764; GO:0005769; GO:0005886"
"3153",3153,"Cluster_2787","Porites_evermani_scaffold_342:8215-48865",154,-23.16,2,21,4415,4435,19,"63.16%","84.21%","Peve_00025408",0.997403727712652,0.0458843143728729,0.934400033667991,"Q4VA61","Cell adhesion molecule DSCAML1 (Down syndrome cell adhesion molecule-like protein 1 homolog)","Mus musculus (Mouse)","axon guidance [GO:0007411]; brain development [GO:0007420]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; dendrite self-avoidance [GO:0070593]; embryonic skeletal system morphogenesis [GO:0048704]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell adhesion [GO:0007162]","GO:0005886; GO:0007156; GO:0007162; GO:0007411; GO:0007420; GO:0009986; GO:0016338; GO:0030424; GO:0042803; GO:0045202; GO:0048704; GO:0070593; GO:0098632"
"3175",3175,"Cluster_2787","Porites_evermani_scaffold_3482:33373-40618",156,-22.85,2,19,6786,6809,19,"73.68%","84.21%","Peve_00025813",-0.999374785885544,0.0225129360429094,0.83828463858421,"Q3UMR0","Ankyrin repeat domain-containing protein 27 (VPS9 domain-containing protein) (VPS9-ankyrin-repeat protein)","Mus musculus (Mouse)","early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; endosome to melanosome transport [GO:0035646]; negative regulation of SNARE complex assembly [GO:0035544]; neuron projection morphogenesis [GO:0048812]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of neuron projection development [GO:0010976]; protein transport [GO:0015031]","GO:0000149; GO:0005085; GO:0005096; GO:0005764; GO:0005769; GO:0005770; GO:0005829; GO:0005886; GO:0010976; GO:0015031; GO:0030133; GO:0030659; GO:0031267; GO:0032456; GO:0035544; GO:0035646; GO:0042470; GO:0043005; GO:0043231; GO:0045022; GO:0048812; GO:0050775; GO:0097422"
"3223",3223,"Cluster_2787","Porites_evermani_scaffold_3600:21445-35824",156,-23.56,2,13,9642,9663,11,"90.91%","100.00%","Peve_00026574",0.999746939611819,0.0143224186683252,0.730004405541176,"Q99L04","Dehydrogenase/reductase SDR family member 1 (EC 1.1.1.-) (Short chain dehydrogenase/reductase family 19C member 1) (Protein SDR19C1)","Mus musculus (Mouse)","","GO:0004090; GO:0005739; GO:0005743; GO:0005783; GO:0016616; GO:0047045"
"3241",3241,"Cluster_2787","Porites_evermani_scaffold_3645:6183-38766",154,-20.81,2,21,14996,15016,19,"68.42%","78.95%","Peve_00026798",0.99891167795814,0.0297038832251294,0.903929377050813,"P41216","Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Phytanate--CoA ligase) (EC 6.2.1.24)","Mus musculus (Mouse)","adiponectin-activated signaling pathway [GO:0033211]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; lipid biosynthetic process [GO:0008610]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of long-chain fatty acid import across plasma membrane [GO:0010747]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; response to nutrient [GO:0007584]; response to oleic acid [GO:0034201]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; triglyceride biosynthetic process [GO:0019432]; very long-chain fatty acid metabolic process [GO:0000038]; xenobiotic catabolic process [GO:0042178]","GO:0000038; GO:0001676; GO:0004467; GO:0005524; GO:0005739; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0005886; GO:0006631; GO:0007584; GO:0008610; GO:0010033; GO:0010747; GO:0014070; GO:0015908; GO:0016020; GO:0019432; GO:0033211; GO:0034201; GO:0035338; GO:0042178; GO:0044539; GO:0047676; GO:0050197; GO:0070251; GO:0071902; GO:0090434; GO:0120162"
"3242",3242,"Cluster_2787","Porites_evermani_scaffold_3645:6183-38766",162,-22.73,2,20,11147,11169,19,"78.95%","78.95%","Peve_00026798",0.99891167795814,0.0297038832251294,0.903929377050813,"P41216","Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Phytanate--CoA ligase) (EC 6.2.1.24)","Mus musculus (Mouse)","adiponectin-activated signaling pathway [GO:0033211]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; lipid biosynthetic process [GO:0008610]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of long-chain fatty acid import across plasma membrane [GO:0010747]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; response to nutrient [GO:0007584]; response to oleic acid [GO:0034201]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; triglyceride biosynthetic process [GO:0019432]; very long-chain fatty acid metabolic process [GO:0000038]; xenobiotic catabolic process [GO:0042178]","GO:0000038; GO:0001676; GO:0004467; GO:0005524; GO:0005739; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0005886; GO:0006631; GO:0007584; GO:0008610; GO:0010033; GO:0010747; GO:0014070; GO:0015908; GO:0016020; GO:0019432; GO:0033211; GO:0034201; GO:0035338; GO:0042178; GO:0044539; GO:0047676; GO:0050197; GO:0070251; GO:0071902; GO:0090434; GO:0120162"
"3243",3243,"Cluster_2787","Porites_evermani_scaffold_3657:3-12678",147,-20.54,2,18,1124,1148,19,"68.42%","78.95%","Peve_00026855",0.997509002164895,0.0449440276735495,0.930099826201662,"Q9UKP5","A disintegrin and metalloproteinase with thrombospondin motifs 6 (ADAM-TS 6) (ADAM-TS6) (ADAMTS-6) (EC 3.4.24.-)","Homo sapiens (Human)","aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; extracellular matrix organization [GO:0030198]; kidney development [GO:0001822]; proteolysis [GO:0006508]","GO:0001822; GO:0003279; GO:0004222; GO:0005576; GO:0006508; GO:0008237; GO:0030198; GO:0031012; GO:0035904; GO:0046872; GO:0060976"
"3257",3257,"Cluster_2787","Porites_evermani_scaffold_3702:32338-39320",156,-24.31,2,18,3959,3982,18,"72.22%","83.33%","Peve_00027141",-0.998668319889808,0.0328581633481719,0.909359886114279,"Q95M17","Acidic mammalian chitinase (AMCase) (EC 3.2.1.14) (Chitin-binding protein b04) (CBPb04)","Bos taurus (Bovine)","apoptotic process [GO:0006915]; chitin catabolic process [GO:0006032]; immune system process [GO:0002376]; polysaccharide catabolic process [GO:0000272]; positive regulation of chemokine production [GO:0032722]; production of molecular mediator involved in inflammatory response [GO:0002532]","GO:0000272; GO:0002376; GO:0002532; GO:0004568; GO:0005615; GO:0005737; GO:0006032; GO:0006915; GO:0008061; GO:0032722"
"3258",3258,"Cluster_2787","Porites_evermani_scaffold_3702:32338-39320",156,-24.31,2,18,5147,5170,18,"72.22%","83.33%","Peve_00027141",-0.998668319889808,0.0328581633481719,0.909359886114279,"Q95M17","Acidic mammalian chitinase (AMCase) (EC 3.2.1.14) (Chitin-binding protein b04) (CBPb04)","Bos taurus (Bovine)","apoptotic process [GO:0006915]; chitin catabolic process [GO:0006032]; immune system process [GO:0002376]; polysaccharide catabolic process [GO:0000272]; positive regulation of chemokine production [GO:0032722]; production of molecular mediator involved in inflammatory response [GO:0002532]","GO:0000272; GO:0002376; GO:0002532; GO:0004568; GO:0005615; GO:0005737; GO:0006032; GO:0006915; GO:0008061; GO:0032722"
"3271",3271,"Cluster_2787","Porites_evermani_scaffold_37:456421-474688",147,-20.2,2,21,1363,1388,23,"56.52%","73.91%","Peve_00027053",0.999963682861668,0.00542565587934728,0.551398425649056,"Q5ZK62","Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 (Centaurin-beta-2) (Cnt-b2)","Gallus gallus (Chicken)","cellular response to nerve growth factor stimulus [GO:1990090]; endocytic recycling [GO:0032456]","GO:0005096; GO:0010008; GO:0032456; GO:0046872; GO:1990090"
"3324",3324,"Cluster_2787","Porites_evermani_scaffold_39:210492-230265",160,-20.42,2,21,9618,9639,19,"68.42%","78.95%","Peve_00028185",0.999599913721229,0.0180088686322114,0.782669382293497,"Q96AC1","Fermitin family homolog 2 (Kindlin-2) (Mitogen-inducible gene 2 protein) (MIG-2) (Pleckstrin homology domain-containing family C member 1) (PH domain-containing family C member 1)","Homo sapiens (Human)","adherens junction maintenance [GO:0034334]; cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160]; focal adhesion assembly [GO:0048041]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; limb development [GO:0060173]; negative regulation of cell death [GO:0060548]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of vascular permeability [GO:0043116]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of GTPase activity [GO:0043547]; positive regulation of integrin activation [GO:0033625]; positive regulation of mesenchymal stem cell proliferation [GO:1902462]; positive regulation of myosin light chain kinase activity [GO:0035505]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]; protein localization to cell junction [GO:1902414]; protein localization to membrane [GO:0072657]; regulation of cell morphogenesis [GO:0022604]; regulation of cell shape [GO:0008360]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; Wnt signaling pathway [GO:0016055]","GO:0001725; GO:0003779; GO:0005178; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005912; GO:0005925; GO:0005938; GO:0007155; GO:0007160; GO:0007179; GO:0007229; GO:0008360; GO:0009986; GO:0010718; GO:0016055; GO:0019901; GO:0022604; GO:0030054; GO:0030055; GO:0030335; GO:0031234; GO:0031258; GO:0031674; GO:0033622; GO:0033625; GO:0034334; GO:0034446; GO:0034713; GO:0035505; GO:0043116; GO:0043547; GO:0045599; GO:0045669; GO:0046332; GO:0048041; GO:0051015; GO:0051496; GO:0051894; GO:0051897; GO:0060173; GO:0060548; GO:0070374; GO:0072657; GO:1900026; GO:1900182; GO:1902414; GO:1902462; GO:1903691"
"3351",3351,"Cluster_2787","Porites_evermani_scaffold_399:126945-161736",159,-20.14,2,18,33453,33473,16,"81.25%","87.50%","Peve_00028650",0.999981475796067,0.00387494522615433,0.54328949385489,NA,NA,NA,NA,NA
"3408",3408,"Cluster_2787","Porites_evermani_scaffold_41:540647-557425",151,-23.57,2,21,5094,5116,20,"65.00%","75.00%","Peve_00029338",0.99719372066599,0.0477048115691659,0.944331453217319,"Q8WML3","Histone acetyltransferase KAT6B (EC 2.3.1.48) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 4) (MYST-4)","Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)","histone acetylation [GO:0016573]; negative regulation of DNA-templated transcription [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of DNA-templated transcription [GO:0045893]","GO:0000786; GO:0003677; GO:0003713; GO:0004402; GO:0005634; GO:0006334; GO:0016573; GO:0045892; GO:0045893; GO:0046872; GO:0061733; GO:0070776"
"3452",3452,"Cluster_2787","Porites_evermani_scaffold_4344:787-10878",159,-24.59,2,21,3698,3722,22,"68.18%","77.27%","Peve_00030641",0.998537133427223,0.0344389923541351,0.909359886114279,"O35593","26S proteasome non-ATPase regulatory subunit 14 (EC 3.4.19.-) (26S proteasome regulatory subunit RPN11) (MAD1)","Mus musculus (Mouse)","double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; regulation of proteasomal protein catabolic process [GO:0061136]; response to ethanol [GO:0045471]","GO:0000502; GO:0000724; GO:0004175; GO:0006303; GO:0008237; GO:0008541; GO:0016579; GO:0022624; GO:0031597; GO:0043161; GO:0045471; GO:0046872; GO:0061133; GO:0061136; GO:0070536; GO:0070628; GO:0140492"
"3458",3458,"Cluster_2787","Porites_evermani_scaffold_439:242733-251196",156,-22.96,2,21,2047,2067,20,"75.00%","80.00%","Peve_00030841",0.997836013002892,0.0418890771515329,0.909699887923376,"A0A481NSZ4",NA,NA,NA,NA
"3471",3471,"Cluster_2787","Porites_evermani_scaffold_4448:14951-26298",159,-24.51,2,21,4598,4616,19,"78.95%","84.21%","Peve_00031195",0.99925323466706,0.0246044819355876,0.863533862391494,"Q8CDI7","Coiled-coil domain-containing protein 150","Mus musculus (Mouse)","",""
"3490",3490,"Cluster_2787","Porites_evermani_scaffold_452:199408-201919",165,-21.75,2,20,880,900,18,"83.33%","83.33%","Peve_00031564",0.999359286033301,0.0227903191671166,0.841473937269332,NA,NA,NA,NA,NA
"3497",3497,"Cluster_2787","Porites_evermani_scaffold_45:330840-361745",153,-20.78,2,21,4511,4533,21,"71.43%","76.19%","Peve_00031465",0.997462783776488,0.0453592357210168,0.932422928166732,"Q9HAR2","Adhesion G protein-coupled receptor L3 (Calcium-independent alpha-latrotoxin receptor 3) (CIRL-3) (Latrophilin-3) (Lectomedin-3)","Homo sapiens (Human)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; G protein-coupled receptor signaling pathway [GO:0007186]; neuron migration [GO:0001764]; synapse assembly [GO:0007416]","GO:0001764; GO:0004930; GO:0005509; GO:0005886; GO:0005911; GO:0007166; GO:0007186; GO:0007189; GO:0007416; GO:0007420; GO:0016020; GO:0030246; GO:0030424; GO:0098742; GO:0098978"
"3502",3502,"Cluster_2787","Porites_evermani_scaffold_45:438769-444396",155,-21.41,2,21,249,272,21,"66.67%","76.19%","Peve_00031473",0.999991589178695,0.00261104663249684,0.42960878103792,NA,NA,NA,NA,NA
"3503",3503,"Cluster_2787","Porites_evermani_scaffold_4545:3919-19201",162,-23.08,2,21,12253,12273,19,"73.68%","84.21%","Peve_00031638",0.999978115201414,0.00421179466202015,0.54328949385489,NA,NA,NA,NA,NA
"3507",3507,"Cluster_2787","Porites_evermani_scaffold_455:32427-48166",159,-20.18,2,21,13854,13876,20,"70.00%","80.00%","Peve_00031656",0.998196352178269,0.0382416206805407,0.909359886114279,"P18907","Sodium/potassium-transporting ATPase subunit alpha-1 (Sodium pump subunit alpha-1) (EC 7.2.2.13) (Na(+)/K(+) ATPase alpha-1 subunit)","Equus caballus (Horse)","cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of sodium ion transport [GO:0002028]; sodium ion export across plasma membrane [GO:0036376]","GO:0002028; GO:0005391; GO:0005524; GO:0005886; GO:0005890; GO:0006883; GO:0016020; GO:0016323; GO:0016887; GO:0019829; GO:0030007; GO:0030424; GO:0036376; GO:0042383; GO:0042470; GO:0046872; GO:1902600; GO:1990573"
"3536",3536,"Cluster_2787","Porites_evermani_scaffold_473:239722-245608",166,-25.48,2,21,3311,3331,19,"78.95%","84.21%","Peve_00032481",0.999978115201415,0.00421179466200947,0.54328949385489,NA,NA,NA,NA,NA
"3537",3537,"Cluster_2787","Porites_evermani_scaffold_474:135027-163331",157,-21.83,2,20,18029,18049,18,"66.67%","88.89%","Peve_00032506",-0.999036126103867,0.02795375278729,0.900066868667072,"Q8R4Y8","Rotatin","Mus musculus (Mouse)","centriole replication [GO:0007099]; centriole-centriole cohesion [GO:0010457]; ciliary basal body organization [GO:0032053]; determination of left/right symmetry [GO:0007368]","GO:0005737; GO:0005813; GO:0005814; GO:0007099; GO:0007368; GO:0010457; GO:0016020; GO:0032053; GO:0036064"
"3538",3538,"Cluster_2787","Porites_evermani_scaffold_474:135027-163331",161,-20.87,2,18,15352,15373,16,"75.00%","87.50%","Peve_00032506",-0.999036126103867,0.02795375278729,0.900066868667072,"Q8R4Y8","Rotatin","Mus musculus (Mouse)","centriole replication [GO:0007099]; centriole-centriole cohesion [GO:0010457]; ciliary basal body organization [GO:0032053]; determination of left/right symmetry [GO:0007368]","GO:0005737; GO:0005813; GO:0005814; GO:0007099; GO:0007368; GO:0010457; GO:0016020; GO:0032053; GO:0036064"
"3539",3539,"Cluster_2787","Porites_evermani_scaffold_474:37469-64742",155,-20.07,2,19,21584,21605,18,"77.78%","83.33%","Peve_00032517",0.999599545379435,0.0180171572637455,0.782669382293497,"B3EWZ6","MAM and LDL-receptor class A domain-containing protein 2 (Skeletal organic matrix MAM and LDL-receptor 2) (SOM MAM and LDL-receptor 2)","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0005576; GO:0016020"
"3554",3554,"Cluster_2787","Porites_evermani_scaffold_479:164795-204727",159,-21.87,2,21,33923,33945,20,"70.00%","80.00%","Peve_00032682",0.999628088147808,0.0173631529557996,0.782669382293497,"O15381","Nuclear valosin-containing protein-like (NVLp) (Nuclear VCP-like protein)","Homo sapiens (Human)","positive regulation of protein binding [GO:0032092]; positive regulation of telomerase activity [GO:0051973]; regulation of protein localization to nucleolus [GO:1904749]; ribosomal large subunit biogenesis [GO:0042273]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]","GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005697; GO:0005730; GO:0006364; GO:0016020; GO:0016887; GO:0032092; GO:0042254; GO:0042273; GO:0051973; GO:1904749; GO:1990275"
"3556",3556,"Cluster_2787","Porites_evermani_scaffold_4812:603-7433",145,-20.8,2,21,4159,4180,20,"60.00%","80.00%","Peve_00032828",0.999988003727036,0.00311830595838265,0.481935248631868,"Q5ZKF6","7-methylguanosine phosphate-specific 5'-nucleotidase (7-methylguanosine nucleotidase) (EC 3.1.3.91) (Cytosolic 5'-nucleotidase 3B) (Cytosolic 5'-nucleotidase III-like protein) (cN-III-like protein) (EC 3.1.3.5) (N(7)-methylguanylate 5'-phosphatase)","Gallus gallus (Chicken)","nucleotide metabolic process [GO:0009117]","GO:0000166; GO:0000287; GO:0005737; GO:0009117; GO:0016787"
"3557",3557,"Cluster_2787","Porites_evermani_scaffold_4818:9061-17463",150,-20.67,2,20,3873,3897,21,"57.14%","80.95%","Peve_00032838",0.998122190167769,0.039020147682088,0.909359886114279,"Q0P410","S-adenosylmethionine sensor upstream of mTORC1 (Probable methyltransferase BMT2 homolog) (EC 2.1.1.-)","Danio rerio (Zebrafish) (Brachydanio rerio)","cellular response to amino acid starvation [GO:0034198]; methylation [GO:0032259]; negative regulation of TORC1 signaling [GO:1904262]","GO:0008168; GO:0032259; GO:0034198; GO:1904047; GO:1904262"
"3560",3560,"Cluster_2787","Porites_evermani_scaffold_4827:324-9217",180,-28.74,2,21,2014,2035,19,"78.95%","94.74%","Peve_00032861",0.997807072719316,0.0421683523975289,0.911155492969778,"Q96DI7","U5 small nuclear ribonucleoprotein 40 kDa protein (U5 snRNP 40 kDa protein) (U5-40K) (38 kDa-splicing factor) (Prp8-binding protein) (hPRP8BP) (U5 snRNP-specific 40 kDa protein) (WD repeat-containing protein 57)","Homo sapiens (Human)","mRNA splicing, via spliceosome [GO:0000398]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]","GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005682; GO:0005732; GO:0005829; GO:0006396; GO:0008380; GO:0016607; GO:0046540; GO:0071007; GO:0071013"
"3569",3569,"Cluster_2787","Porites_evermani_scaffold_489:147805-200009",147,-20.35,2,21,2289,2311,20,"65.00%","70.00%","Peve_00033060",0.9990684077698,0.0274815846094019,0.895349114009296,"Q9UKP5","A disintegrin and metalloproteinase with thrombospondin motifs 6 (ADAM-TS 6) (ADAM-TS6) (ADAMTS-6) (EC 3.4.24.-)","Homo sapiens (Human)","aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; extracellular matrix organization [GO:0030198]; kidney development [GO:0001822]; proteolysis [GO:0006508]","GO:0001822; GO:0003279; GO:0004222; GO:0005576; GO:0006508; GO:0008237; GO:0030198; GO:0031012; GO:0035904; GO:0046872; GO:0060976"
"3577",3577,"Cluster_2787","Porites_evermani_scaffold_4940:392-17710",162,-20.45,2,19,13349,13370,17,"70.59%","88.24%","Peve_00033299",0.998005749759204,0.0402121365010448,0.909359886114279,"Q9Y6R4","Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAP three kinase 1) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4)","Homo sapiens (Human)","chorionic trophoblast cell differentiation [GO:0060718]; intracellular signal transduction [GO:0035556]; male germ-line sex determination [GO:0019100]; MAPK cascade [GO:0000165]; placenta development [GO:0001890]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468]; response to UV-C [GO:0010225]","GO:0000165; GO:0001890; GO:0004709; GO:0005524; GO:0005737; GO:0006468; GO:0010225; GO:0010468; GO:0019100; GO:0032212; GO:0035556; GO:0043507; GO:0046872; GO:0048471; GO:0051973; GO:0060718; GO:0106310; GO:1900745; GO:1904355"
"3613",3613,"Cluster_2787","Porites_evermani_scaffold_5137:5005-15592",163,-20.95,2,17,1852,1875,17,"82.35%","88.24%","Peve_00034184",-0.999828291583492,0.0117976939825935,0.669806564206444,"Q03720","Calcium-activated potassium channel slowpoke (dSlo) (BK channel) (Maxi K channel) (MaxiK)","Drosophila melanogaster (Fruit fly)","circadian behavior [GO:0048512]; circadian rhythm [GO:0007623]; male courtship behavior, veined wing generated song production [GO:0045433]; negative regulation of neuromuscular synaptic transmission [GO:1900074]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; response to xenobiotic stimulus [GO:0009410]","GO:0005244; GO:0005886; GO:0006813; GO:0007623; GO:0008582; GO:0009410; GO:0015269; GO:0016020; GO:0034765; GO:0043005; GO:0043025; GO:0045211; GO:0045433; GO:0048512; GO:0060072; GO:1900074"
"3621",3621,"Cluster_2787","Porites_evermani_scaffold_517:212896-216321",156,-20.47,2,18,2773,2795,17,"70.59%","88.24%","Peve_00034279",-0.998798423387131,0.031211479105201,0.903929377050813,"Q5JTD7","Leucine-rich repeat-containing protein 73","Homo sapiens (Human)","",""
"3650",3650,"Cluster_2787","Porites_evermani_scaffold_5358:9785-14651",150,-21.06,2,11,50,71,9,"100.00%","100.00%","Peve_00034941",0.999365959883862,0.0226713007702915,0.840165031394075,NA,NA,NA,NA,NA
"3672",3672,"Cluster_2787","Porites_evermani_scaffold_545:212228-228513",150,-21.46,2,21,9461,9485,22,"63.64%","77.27%","Peve_00035307",0.999619556547579,0.0175611902362094,0.782669382293497,"P49614","Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (N-acetyl-beta-glucosaminidase subunit beta)","Felis catus (Cat) (Felis silvestris catus)","carbohydrate metabolic process [GO:0005975]; ganglioside catabolic process [GO:0006689]; glycosaminoglycan metabolic process [GO:0030203]; single fertilization [GO:0007338]","GO:0004563; GO:0005764; GO:0005975; GO:0006689; GO:0007338; GO:0016020; GO:0030203; GO:0060473; GO:0102148"
"3699",3699,"Cluster_2787","Porites_evermani_scaffold_560:24474-50491",157,-20.59,2,19,17209,17231,18,"72.22%","83.33%","Peve_00035821",0.999361810020579,0.0227453807293251,0.841171820670076,"Q9VT28","Protein furry","Drosophila melanogaster (Fruit fly)","antennal morphogenesis [GO:0048800]; cell morphogenesis [GO:0000902]; chaeta morphogenesis [GO:0008407]; dendrite self-avoidance [GO:0070593]; imaginal disc-derived wing hair organization [GO:0035317]; imaginal disc-derived wing morphogenesis [GO:0007476]; microtubule sliding [GO:0051012]; negative regulation of neuron projection arborization [GO:0150013]; neuron projection development [GO:0031175]; non-sensory hair organization [GO:0035316]; oocyte morphogenesis [GO:0048601]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of dendrite development [GO:0050773]; regulation of dendrite morphogenesis [GO:0048814]; rhabdomere development [GO:0042052]","GO:0000902; GO:0005737; GO:0005938; GO:0007476; GO:0008407; GO:0030424; GO:0030425; GO:0030427; GO:0031175; GO:0035316; GO:0035317; GO:0042052; GO:0044297; GO:0045177; GO:0045860; GO:0045893; GO:0048601; GO:0048800; GO:0048814; GO:0050773; GO:0051012; GO:0070593; GO:0071902; GO:0150013"
"3700",3700,"Cluster_2787","Porites_evermani_scaffold_560:24474-50491",157,-20.59,2,19,17584,17606,18,"72.22%","83.33%","Peve_00035821",0.999361810020579,0.0227453807293251,0.841171820670076,"Q9VT28","Protein furry","Drosophila melanogaster (Fruit fly)","antennal morphogenesis [GO:0048800]; cell morphogenesis [GO:0000902]; chaeta morphogenesis [GO:0008407]; dendrite self-avoidance [GO:0070593]; imaginal disc-derived wing hair organization [GO:0035317]; imaginal disc-derived wing morphogenesis [GO:0007476]; microtubule sliding [GO:0051012]; negative regulation of neuron projection arborization [GO:0150013]; neuron projection development [GO:0031175]; non-sensory hair organization [GO:0035316]; oocyte morphogenesis [GO:0048601]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of dendrite development [GO:0050773]; regulation of dendrite morphogenesis [GO:0048814]; rhabdomere development [GO:0042052]","GO:0000902; GO:0005737; GO:0005938; GO:0007476; GO:0008407; GO:0030424; GO:0030425; GO:0030427; GO:0031175; GO:0035316; GO:0035317; GO:0042052; GO:0044297; GO:0045177; GO:0045860; GO:0045893; GO:0048601; GO:0048800; GO:0048814; GO:0050773; GO:0051012; GO:0070593; GO:0071902; GO:0150013"
"3712",3712,"Cluster_2787","Porites_evermani_scaffold_563:130924-157281",156,-21.49,2,15,7295,7315,13,"92.31%","92.31%","Peve_00035885",0.997398092984475,0.0459341006789982,0.934597365740041,"D3YXS5","Kinesin-like protein KIF28 (Kinesin family member 28) (Kinesin-like protein 6)","Mus musculus (Mouse)","microtubule-based movement [GO:0007018]; mitochondrion organization [GO:0007005]; organelle transport along microtubule [GO:0072384]","GO:0003777; GO:0005524; GO:0005871; GO:0005874; GO:0007005; GO:0007018; GO:0008017; GO:0016887; GO:0031966; GO:0072384"
"3734",3734,"Cluster_2787","Porites_evermani_scaffold_581:103333-107215",158,-23.37,2,21,2095,2118,21,"71.43%","80.95%","Peve_00036426",-0.999557126167793,0.0189474670428339,0.788323450098016,NA,NA,NA,NA,NA
"3740",3740,"Cluster_2787","Porites_evermani_scaffold_584:26082-72074",162,-21.63,2,21,36348,36368,19,"68.42%","89.47%","Peve_00036514",0.99802220152848,0.0400458710105364,0.909359886114279,"Q9QYP1","Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7)","Rattus norvegicus (Rat)","amyloid-beta clearance by cellular catabolic process [GO:0150094]; anatomical structure development [GO:0048856]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; proximal/distal pattern formation [GO:0009954]; receptor clustering [GO:0043113]; regulation of protein phosphorylation [GO:0001932]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0001932; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0016055; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0048699; GO:0048813; GO:0048856; GO:0050731; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150094; GO:1901631; GO:1904395"
"3756",3756,"Cluster_2787","Porites_evermani_scaffold_5963:2-8552",159,-24.52,2,21,7781,7804,21,"66.67%","80.95%","Peve_00036864",0.999926519877196,0.00771760802126556,0.573710369894872,"Q0E908","Hillarin (D-Hillarin) (D-hil)","Drosophila melanogaster (Fruit fly)","","GO:0005938; GO:0032154; GO:0046872"
"3776",3776,"Cluster_2787","Porites_evermani_scaffold_60:344976-352149",152,-20.45,2,21,3728,3749,19,"63.16%","73.68%","Peve_00037061",-0.999649545771953,0.0168547943103946,0.778328904052462,"Q92820","Gamma-glutamyl hydrolase (EC 3.4.19.9) (Conjugase) (GH) (Gamma-Glu-X carboxypeptidase)","Homo sapiens (Human)","tetrahydrofolylpolyglutamate metabolic process [GO:0046900]","GO:0005576; GO:0005615; GO:0005634; GO:0005773; GO:0008238; GO:0008242; GO:0034722; GO:0035578; GO:0035580; GO:0042470; GO:0046900; GO:0070062; GO:1904724"
"3824",3824,"Cluster_2787","Porites_evermani_scaffold_6:387883-415777",160,-22.17,2,21,25975,25996,19,"63.16%","84.21%","Peve_00036941",0.997625825176949,0.043877050934988,0.9223980576249,"Q8C9W3","A disintegrin and metalloproteinase with thrombospondin motifs 2 (ADAM-TS 2) (ADAM-TS2) (ADAMTS-2) (EC 3.4.24.14) (Procollagen I N-proteinase) (PC I-NP) (Procollagen I/II amino propeptide-processing enzyme) (Procollagen N-endopeptidase) (pNPI)","Mus musculus (Mouse)","collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; lung development [GO:0030324]; protein processing [GO:0016485]; skin development [GO:0043588]; spermatogenesis [GO:0007283]","GO:0004222; GO:0005576; GO:0007283; GO:0008233; GO:0008270; GO:0016485; GO:0030198; GO:0030199; GO:0030324; GO:0030574; GO:0031012; GO:0043588; GO:0062023"
"3832",3832,"Cluster_2787","Porites_evermani_scaffold_643:45265-111653",159,-21.88,2,21,44193,44215,20,"65.00%","85.00%","Peve_00038239",0.999697706867341,0.0156538151958382,0.756052270871415,"P26714","Gamma-aminobutyric acid receptor subunit beta (GABA(A) receptor)","Lymnaea stagnalis (Great pond snail) (Helix stagnalis)","","GO:0004890; GO:0005230; GO:0005254; GO:0034707; GO:0045211"
"3856",3856,"Cluster_2787","Porites_evermani_scaffold_662:7746-27666",170,-21.23,2,21,14706,14726,19,"84.21%","84.21%","Peve_00038670",0.998301344116502,0.0371115693761464,0.909359886114279,"P14272","Plasma kallikrein (EC 3.4.21.34) (Fletcher factor) (Kininogenin) (Plasma prekallikrein) [Cleaved into: Plasma kallikrein heavy chain; Plasma kallikrein light chain]","Rattus norvegicus (Rat)","blood coagulation, intrinsic pathway [GO:0007597]; fibrinolysis [GO:0042730]; inflammatory response [GO:0006954]; liver regeneration [GO:0097421]; plasminogen activation [GO:0031639]; positive regulation of fibrinolysis [GO:0051919]; proteolysis [GO:0006508]; zymogen activation [GO:0031638]","GO:0004252; GO:0005615; GO:0006508; GO:0006954; GO:0007597; GO:0031638; GO:0031639; GO:0042730; GO:0051919; GO:0097421"
"3873",3873,"Cluster_2787","Porites_evermani_scaffold_674:160865-184119",150,-23.11,2,21,4173,4193,19,"68.42%","73.68%","Peve_00038927",0.998051613088915,0.0397469000009701,0.909359886114279,"Q14832","Metabotropic glutamate receptor 3 (mGluR3)","Homo sapiens (Human)","chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; gene expression [GO:0010467]; negative regulation of adenylate cyclase activity [GO:0007194]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of synaptic transmission, glutamatergic [GO:0051966]","GO:0001640; GO:0001641; GO:0004930; GO:0005246; GO:0005886; GO:0007194; GO:0007216; GO:0007268; GO:0008066; GO:0010467; GO:0014069; GO:0030424; GO:0042734; GO:0043197; GO:0045211; GO:0051966; GO:0097110; GO:0097449; GO:0098978; GO:0099170"
"3885",3885,"Cluster_2787","Porites_evermani_scaffold_681:60991-73062",147,-20.27,2,21,11407,11430,21,"61.90%","71.43%","Peve_00039096",0.997430536559693,0.0456466991605926,0.933474458367638,"A4IIL4","BRO1 domain-containing protein BROX (BRO1 domain- and CAAX motif-containing protein)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","","GO:0016020"
"3886",3886,"Cluster_2787","Porites_evermani_scaffold_681:60991-73062",156,-21.92,2,19,10181,10205,20,"75.00%","80.00%","Peve_00039096",0.997430536559693,0.0456466991605926,0.933474458367638,"A4IIL4","BRO1 domain-containing protein BROX (BRO1 domain- and CAAX motif-containing protein)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","","GO:0016020"
"3889",3889,"Cluster_2787","Porites_evermani_scaffold_68:353494-359875",161,-21.98,2,18,3680,3701,16,"75.00%","87.50%","Peve_00039063",0.997105325686941,0.0484506705316052,0.946735628940312,"Q8K2J9","BTB/POZ domain-containing protein 6","Mus musculus (Mouse)","neurogenesis [GO:0022008]","GO:0005829; GO:0022008"
"3905",3905,"Cluster_2787","Porites_evermani_scaffold_702:39945-61329",157,-23.34,2,21,7339,7360,20,"75.00%","80.00%","Peve_00039669",0.998598356942047,0.0337104520372765,0.909359886114279,"Q5XK92","Protein CIP2A homolog","Xenopus laevis (African clawed frog)","","GO:0005737; GO:0016020"
"3916",3916,"Cluster_2787","Porites_evermani_scaffold_706:7463-55390",154,-20.72,2,19,3236,3257,17,"70.59%","76.47%","Peve_00039735",0.99963307893818,0.0172462517680552,0.782669382293497,"Q9Y2G3","Phospholipid-transporting ATPase IF (EC 7.6.2.1) (ATPase IR) (ATPase class VI type 11B) (P4-ATPase flippase complex alpha subunit ATP11B)","Homo sapiens (Human)","aminophospholipid transport [GO:0015917]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; phospholipid translocation [GO:0045332]","GO:0000287; GO:0005524; GO:0005637; GO:0005783; GO:0005802; GO:0005886; GO:0006811; GO:0015075; GO:0015917; GO:0016020; GO:0016887; GO:0031901; GO:0034220; GO:0035577; GO:0045332; GO:0055037; GO:0055038; GO:0090555; GO:0090556; GO:0140326; GO:1990531"
"3918",3918,"Cluster_2787","Porites_evermani_scaffold_7:115760-160991",154,-23.56,2,21,20366,20389,21,"71.43%","76.19%","Peve_00039588",0.998194007213558,0.0382664795011216,0.909359886114279,NA,NA,NA,NA,NA
"3933",3933,"Cluster_2787","Porites_evermani_scaffold_725:91371-110010",149,-23.52,2,21,1792,1819,25,"68.00%","72.00%","Peve_00040141",0.999981133900363,0.00391054119681501,0.54328949385489,"Q8BWW4","La-related protein 4 (La ribonucleoprotein domain family member 4)","Mus musculus (Mouse)","cytoskeleton organization [GO:0007010]; positive regulation of translation [GO:0045727]; post-transcriptional regulation of gene expression [GO:0010608]; regulation of cell morphogenesis [GO:0022604]; translation [GO:0006412]","GO:0003723; GO:0003730; GO:0005829; GO:0005844; GO:0006412; GO:0007010; GO:0008143; GO:0010494; GO:0010608; GO:0022604; GO:0022627; GO:0045727"
"3952",3952,"Cluster_2787","Porites_evermani_scaffold_741:36591-64735",157,-20.96,2,14,511,532,12,"83.33%","100.00%","Peve_00040544",0.999182752758358,0.0257395786957529,0.877090006169449,NA,NA,NA,NA,NA
"3966",3966,"Cluster_2787","Porites_evermani_scaffold_753:188689-194217",160,-20.07,2,21,2090,2112,21,"80.95%","80.95%","Peve_00040758",0.998547527735705,0.0343163924254722,0.909359886114279,"Q9VAU9","Zinc finger protein 330 homolog (Nucleolar autoantigen 36 homolog)","Drosophila melanogaster (Fruit fly)","larval lymph gland hemopoiesis [GO:0035167]","GO:0000775; GO:0005634; GO:0005730; GO:0008270; GO:0030496; GO:0035167"
"3989",3989,"Cluster_2787","Porites_evermani_scaffold_768:126103-141725",152,-20.38,2,18,3922,3944,17,"64.71%","88.24%","Peve_00041010",0.997467141500268,0.045320249773458,0.932139733194064,NA,NA,NA,NA,NA
"4000",4000,"Cluster_2787","Porites_evermani_scaffold_774:74911-94008",166,-26.05,2,19,1420,1441,17,"76.47%","88.24%","Peve_00041134",0.999935504551868,0.00723039439541066,0.573710369894872,"B3EWZ9","Hephaestin-like protein (EC 1.-.-.-)","Acropora millepora (Staghorn coral) (Heteropora millepora)","copper ion transport [GO:0006825]","GO:0005507; GO:0005576; GO:0006825; GO:0016020; GO:0016491"
"4002",4002,"Cluster_2787","Porites_evermani_scaffold_77:557471-572619",150,-22.94,2,21,7223,7249,24,"58.33%","79.17%","Peve_00041037",0.998942356327033,0.0292821589318241,0.903929377050813,"Q8BM14","Lipase member K (EC 3.1.1.-) (Lipase-like abhydrolase domain-containing protein 2)","Mus musculus (Mouse)","lipid catabolic process [GO:0016042]","GO:0005576; GO:0016042; GO:0016788; GO:0043231"
"4037",4037,"Cluster_2787","Porites_evermani_scaffold_797:77719-96585",163,-23.12,2,16,18149,18170,14,"85.71%","92.86%","Peve_00041609",0.99948661934441,0.020400154311116,0.810097073649321,NA,NA,NA,NA,NA
"4038",4038,"Cluster_2787","Porites_evermani_scaffold_797:77719-96585",165,-25.08,2,14,17708,17729,12,"100.00%","100.00%","Peve_00041609",0.99948661934441,0.020400154311116,0.810097073649321,NA,NA,NA,NA,NA
"4098",4098,"Cluster_2787","Porites_evermani_scaffold_854:105591-143222",154,-21.98,2,21,2837,2861,22,"63.64%","81.82%","Peve_00042855",0.999964675100817,0.00535102358037463,0.551398425649056,"Q80TT2","BAI1-associated protein 3 (BAP3) (Brain-specific angiogenesis inhibitor I-associated protein 3) (Baiap3)","Mus musculus (Mouse)","dense core granule maturation [GO:1990502]; exocytosis [GO:0006887]; G protein-coupled receptor signaling pathway [GO:0007186]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of neurotransmitter secretion [GO:0001956]; regulation of behavior [GO:0050795]; regulation of dense core granule exocytosis [GO:1905413]; regulation of synaptic transmission, GABAergic [GO:0032228]; retrograde transport, endosome to Golgi [GO:0042147]","GO:0000149; GO:0001956; GO:0005509; GO:0005543; GO:0005829; GO:0005886; GO:0006887; GO:0007186; GO:0019905; GO:0031902; GO:0032228; GO:0032588; GO:0035774; GO:0042147; GO:0050795; GO:0050804; GO:0055038; GO:0098793; GO:0098982; GO:0099503; GO:1905413; GO:1990502"
"4133",4133,"Cluster_2787","Porites_evermani_scaffold_89:529343-540690",155,-21.34,2,21,10790,10808,19,"73.68%","84.21%","Peve_00043472",0.99728265353091,0.0469424791144549,0.939886156491908,"P50416","Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A)","Homo sapiens (Human)","carnitine metabolic process [GO:0009437]; carnitine shuttle [GO:0006853]; cellular response to fatty acid [GO:0071398]; eating behavior [GO:0042755]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; glucose metabolic process [GO:0006006]; liver regeneration [GO:0097421]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of fatty acid beta-oxidation [GO:0032000]; regulation of insulin secretion [GO:0050796]; regulation of lipid storage [GO:0010883]; response to alkaloid [GO:0043279]; response to antibiotic [GO:0046677]; response to ethanol [GO:0045471]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; response to tetrachloromethane [GO:1904772]; response to xenobiotic stimulus [GO:0009410]; triglyceride metabolic process [GO:0006641]","GO:0001676; GO:0004095; GO:0005739; GO:0005741; GO:0006006; GO:0006631; GO:0006635; GO:0006641; GO:0006853; GO:0009410; GO:0009437; GO:0010883; GO:0014070; GO:0016020; GO:0030855; GO:0031667; GO:0032000; GO:0042755; GO:0042802; GO:0043279; GO:0045471; GO:0046677; GO:0050796; GO:0071398; GO:0097421; GO:1904772; GO:1990698"
"4164",4164,"Cluster_2787","Porites_evermani_scaffold_92:189092-201417",159,-24.5,2,21,894,921,25,"68.00%","72.00%","Peve_00044098",0.998576798713468,0.0339687687471795,0.909359886114279,NA,NA,NA,NA,NA
"4165",4165,"Cluster_2787","Porites_evermani_scaffold_92:189092-201417",163,-25.16,2,21,8868,8891,21,"76.19%","76.19%","Peve_00044098",0.998576798713468,0.0339687687471795,0.909359886114279,NA,NA,NA,NA,NA
"4221",4221,"Cluster_2787","Porites_evermani_scaffold_971:74425-138787",165,-20.08,2,21,60845,60864,19,"78.95%","84.21%","Peve_00044958",0.999761494514925,0.0139044219501823,0.720993769905639,"P11532","Dystrophin","Homo sapiens (Human)","actin cytoskeleton organization [GO:0030036]; cardiac muscle cell action potential [GO:0086001]; cardiac muscle contraction [GO:0060048]; maintenance of blood-brain barrier [GO:0035633]; motile cilium assembly [GO:0044458]; muscle cell cellular homeostasis [GO:0046716]; muscle cell development [GO:0055001]; muscle organ development [GO:0007517]; negative regulation of peptidyl-cysteine S-nitrosylation [GO:1902083]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; neuron development [GO:0048666]; peptide biosynthetic process [GO:0043043]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; protein localization [GO:0008104]; protein-containing complex assembly [GO:0065003]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cellular response to growth factor stimulus [GO:0090287]; regulation of heart rate [GO:0002027]; regulation of muscle system process [GO:0090257]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of skeletal muscle contraction [GO:0014819]; regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [GO:0014809]; regulation of voltage-gated calcium channel activity [GO:1901385]; response to muscle stretch [GO:0035994]; skeletal muscle tissue development [GO:0007519]","GO:0002027; GO:0002162; GO:0003779; GO:0005200; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0007517; GO:0007519; GO:0008104; GO:0008270; GO:0008307; GO:0009986; GO:0010880; GO:0010881; GO:0010976; GO:0014809; GO:0014819; GO:0016010; GO:0016013; GO:0017022; GO:0017166; GO:0030018; GO:0030036; GO:0030054; GO:0030055; GO:0030175; GO:0030864; GO:0031527; GO:0032991; GO:0033137; GO:0035633; GO:0035994; GO:0042383; GO:0042995; GO:0043034; GO:0043043; GO:0044306; GO:0044458; GO:0045121; GO:0045202; GO:0045211; GO:0045666; GO:0046716; GO:0048666; GO:0050998; GO:0051015; GO:0055001; GO:0060048; GO:0060314; GO:0065003; GO:0086001; GO:0090257; GO:0090287; GO:1901385; GO:1902083; GO:2000651"
"4235",4235,"Cluster_2787","Porites_evermani_scaffold_984:141538-153700",145,-21.42,2,21,5163,5189,24,"62.50%","75.00%","Peve_00045103",0.998442124139319,0.035540042458098,0.909359886114279,"P61972","Nuclear transport factor 2 (NTF-2)","Rattus norvegicus (Rat)","mRNA transport [GO:0051028]; negative regulation of vascular endothelial growth factor production [GO:1904046]; nucleocytoplasmic transport [GO:0006913]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; protein localization to nuclear pore [GO:0090204]","GO:0005637; GO:0005640; GO:0005654; GO:0005829; GO:0006606; GO:0006611; GO:0006913; GO:0017056; GO:0031267; GO:0031965; GO:0042307; GO:0042802; GO:0044613; GO:0051028; GO:0061608; GO:0090204; GO:1904046"
"4266",4266,"Cluster_2854","Porites_evermani_scaffold_1037:2644-22845",156,-22.12,2,20,20005,20032,24,"75.00%","75.00%","Peve_00000772",0.999952919799256,0.0061775458534996,0.573710369894872,"D2IYS2","Tyrosine-protein kinase receptor torso (EC 2.7.10.1)","Bombyx mori (Silk moth)","","GO:0004714; GO:0005524; GO:0005886; GO:0046872"
"4288",4288,"Cluster_2854","Porites_evermani_scaffold_108:120133-162200",172,-20.31,2,21,5552,5573,19,"78.95%","84.21%","Peve_00001436",0.998208024584781,0.0381176413484374,0.909359886114279,"P01026","Complement C3 [Cleaved into: Complement C3 beta chain; C3-beta-c (C3bc) (Neutrophil chemotactic factor-2) (ENCF-2); Complement C3 alpha chain; C3a anaphylatoxin (Neutrophil chemotactic factor-1) (ENCF-1); Acylation stimulating protein (ASP) (C3adesArg); Complement C3b alpha' chain; Complement C3c alpha' chain fragment 1; Complement C3dg fragment; Complement C3g fragment; Complement C3d fragment; Complement C3f fragment; Complement C3c alpha' chain fragment 2]","Rattus norvegicus (Rat)","amyloid-beta clearance [GO:0097242]; blood coagulation [GO:0007596]; cell surface receptor signaling pathway involved in cell-cell signaling [GO:1905114]; chemotaxis [GO:0006935]; complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; complement-dependent cytotoxicity [GO:0097278]; complement-mediated synapse pruning [GO:0150062]; fatty acid metabolic process [GO:0006631]; inflammatory response [GO:0006954]; neuron remodeling [GO:0016322]; opsonization [GO:0008228]; oviduct epithelium development [GO:0035846]; positive regulation of activation of membrane attack complex [GO:0001970]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic cell clearance [GO:2000427]; positive regulation of developmental growth [GO:0048639]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of lipid storage [GO:0010884]; positive regulation of opsonization [GO:1903028]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of type IIa hypersensitivity [GO:0001798]; positive regulation of vascular endothelial growth factor production [GO:0010575]; proteolysis [GO:0006508]; regulation of complement activation [GO:0030449]; regulation of complement activation, alternative pathway [GO:0030451]; regulation of triglyceride biosynthetic process [GO:0010866]; response to bacterium [GO:0009617]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to glucocorticoid [GO:0051384]; response to magnesium ion [GO:0032026]; response to progesterone [GO:0032570]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; tolerance induction [GO:0002507]; vascular associated smooth muscle cell differentiation [GO:0035886]; vertebrate eye-specific patterning [GO:0150064]","GO:0001798; GO:0001934; GO:0001970; GO:0002507; GO:0004866; GO:0005576; GO:0005615; GO:0005886; GO:0006508; GO:0006631; GO:0006935; GO:0006954; GO:0006956; GO:0006957; GO:0006958; GO:0007596; GO:0008228; GO:0008289; GO:0009410; GO:0009617; GO:0009986; GO:0010575; GO:0010828; GO:0010866; GO:0010884; GO:0016322; GO:0030449; GO:0030451; GO:0031715; GO:0032026; GO:0032355; GO:0032570; GO:0032991; GO:0035846; GO:0035886; GO:0043627; GO:0045745; GO:0045766; GO:0048260; GO:0048639; GO:0050766; GO:0051384; GO:0060041; GO:0060100; GO:0070374; GO:0097242; GO:0097278; GO:0150062; GO:0150064; GO:1903028; GO:1905114; GO:1905370; GO:2000427"
"4289",4289,"Cluster_2854","Porites_evermani_scaffold_108:65765-118569",168,-20.4,2,21,30687,30708,19,"78.95%","78.95%","Peve_00001435",-0.99830812163304,0.0370374381818108,0.909359886114279,NA,NA,NA,NA,NA
"4323",4323,"Cluster_2854","Porites_evermani_scaffold_1152:50707-62111",164,-22.24,2,21,3152,3173,19,"68.42%","84.21%","Peve_00002593",-0.999856496315378,0.0107852903355044,0.6446111333421,"O74212","Acyl-lipid (8-3)-desaturase (EC 1.14.19.30) (Delta(5) fatty acid desaturase) (Delta-5 fatty acid desaturase)","Mortierella alpina (Oleaginous fungus) (Mortierella renispora)","fatty acid biosynthetic process [GO:0006633]","GO:0006633; GO:0016020; GO:0020037; GO:0046872; GO:0102866"
"4344",4344,"Cluster_2854","Porites_evermani_scaffold_1212:50787-71698",171,-26.19,2,20,20700,20721,18,"72.22%","94.44%","Peve_00003572",-0.999998761813949,0.00100181635887822,0.257580124662609,"Q5F361","TBC domain-containing protein kinase-like protein","Gallus gallus (Chicken)","activation of GTPase activity [GO:0090630]; protein phosphorylation [GO:0006468]","GO:0004672; GO:0005096; GO:0005524; GO:0005737; GO:0005819; GO:0006468; GO:0030496; GO:0090630"
"4402",4402,"Cluster_2854","Porites_evermani_scaffold_130:40465-110618",154,-25.08,2,20,27314,27340,23,"65.22%","73.91%","Peve_00004802",-0.999895927074034,0.00918475909477155,0.595915595777701,"A0A8J1M587",NA,NA,NA,NA
"4403",4403,"Cluster_2854","Porites_evermani_scaffold_130:40465-110618",165,-20.59,2,20,23635,23658,20,"80.00%","85.00%","Peve_00004802",-0.999895927074034,0.00918475909477155,0.595915595777701,"A0A8J1M587",NA,NA,NA,NA
"4461",4461,"Cluster_2854","Porites_evermani_scaffold_1422:40321-60442",155,-21.95,2,21,19985,20003,19,"73.68%","84.21%","Peve_00006544",0.999868704185365,0.0103163320854201,0.630000794609239,"Q9ZQ31","Serine/threonine-protein kinase STY13 (EC 2.7.11.1) (AtSTYPK) (Serine/threonine/tyrosine-protein kinase 13)","Arabidopsis thaliana (Mouse-ear cress)","protein phosphorylation [GO:0006468]; regulation of embryonic development [GO:0045995]; seed oilbody biogenesis [GO:0010344]; signal transduction [GO:0007165]","GO:0004672; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005737; GO:0006468; GO:0007165; GO:0010344; GO:0045995; GO:0106310"
"4468",4468,"Cluster_2854","Porites_evermani_scaffold_1427:51814-120640",162,-20.16,2,21,68414,68434,19,"78.95%","78.95%","Peve_00006587",0.9994271673678,0.0215491294262711,0.825526415921874,"A2A8L5","Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) (Leukocyte common antigen related) (LAR)","Mus musculus (Mouse)","cell migration [GO:0016477]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell projection organization [GO:0031345]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of neurotrophin TRK receptor signaling pathway [GO:0051387]; negative regulation of receptor binding [GO:1900121]; nervous system development [GO:0007399]; neuron projection regeneration [GO:0031102]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of apoptotic process [GO:0043065]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of neuron apoptotic process [GO:0043525]; protein dephosphorylation [GO:0006470]; regulation of axon regeneration [GO:0048679]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of synapse structure or activity [GO:0050803]; synaptic membrane adhesion [GO:0099560]","GO:0001960; GO:0004721; GO:0004725; GO:0005001; GO:0005158; GO:0005768; GO:0005886; GO:0006470; GO:0007156; GO:0007399; GO:0008201; GO:0008285; GO:0010975; GO:0016020; GO:0016477; GO:0030426; GO:0030971; GO:0031102; GO:0031345; GO:0035335; GO:0035373; GO:0042059; GO:0042301; GO:0043005; GO:0043025; GO:0043065; GO:0043231; GO:0043525; GO:0044877; GO:0046627; GO:0048679; GO:0050775; GO:0050803; GO:0050839; GO:0051387; GO:0060076; GO:0098839; GO:0099175; GO:0099560; GO:1900121"
"4507",4507,"Cluster_2854","Porites_evermani_scaffold_1519:66691-84603",160,-20.13,2,17,9966,9987,15,"73.33%","93.33%","Peve_00007756",0.999962448044095,0.00551712420276166,0.551398425649056,NA,NA,NA,NA,NA
"4508",4508,"Cluster_2854","Porites_evermani_scaffold_1519:66691-84603",163,-21.08,2,16,2883,2904,14,"85.71%","92.86%","Peve_00007756",0.999962448044095,0.00551712420276166,0.551398425649056,NA,NA,NA,NA,NA
"4509",4509,"Cluster_2854","Porites_evermani_scaffold_1519:66691-84603",163,-21.08,2,16,5654,5675,14,"85.71%","92.86%","Peve_00007756",0.999962448044095,0.00551712420276166,0.551398425649056,NA,NA,NA,NA,NA
"4556",4556,"Cluster_2854","Porites_evermani_scaffold_166:241844-249534",157,-22.74,2,20,7343,7371,25,"72.00%","72.00%","Peve_00009508",0.998612130404786,0.0335443741149563,0.909359886114279,"P83111","Serine beta-lactamase-like protein LACTB, mitochondrial (EC 3.4.-.-)","Homo sapiens (Human)","lipid metabolic process [GO:0006629]; proteolysis [GO:0006508]; regulation of lipid metabolic process [GO:0019216]","GO:0005739; GO:0005829; GO:0006508; GO:0006629; GO:0008233; GO:0019216; GO:0042802"
"4586",4586,"Cluster_2854","Porites_evermani_scaffold_1742:1079-5515",154,-20.1,2,16,4284,4306,15,"80.00%","86.67%","Peve_00010511",0.999962448044095,0.00551712420276981,0.551398425649056,NA,NA,NA,NA,NA
"4600",4600,"Cluster_2854","Porites_evermani_scaffold_1764:63988-79890",162,-22.25,2,16,2117,2139,15,"86.67%","93.33%","Peve_00010711",0.999962448044095,0.00551712420277797,0.551398425649056,NA,NA,NA,NA,NA
"4625",4625,"Cluster_2854","Porites_evermani_scaffold_185:287739-289616",171,-20.09,2,21,497,519,20,"75.00%","90.00%","Peve_00011724",0.999962448044095,0.00551712420276166,0.551398425649056,NA,NA,NA,NA,NA
"4796",4796,"Cluster_2854","Porites_evermani_scaffold_2158:56386-81098",149,-20.71,2,19,9785,9808,19,"63.16%","78.95%","Peve_00015124",0.999962448044095,0.00551712420276166,0.551398425649056,NA,NA,NA,NA,NA
"4841",4841,"Cluster_2854","Porites_evermani_scaffold_2:250493-273812",171,-20.48,2,20,15909,15930,18,"83.33%","83.33%","Peve_00013445",0.999666874556682,0.0164327814720114,0.771576210959321,"B3DJT0","Squamous cell carcinoma antigen recognized by T-cells 3 (SART-3)","Danio rerio (Zebrafish) (Brachydanio rerio)","exocrine pancreas development [GO:0031017]; lymphocyte differentiation [GO:0030098]; mRNA splicing, via spliceosome [GO:0000398]; nucleosome assembly [GO:0006334]; positive regulation of histone deubiquitination [GO:1903586]; spliceosomal complex assembly [GO:0000245]; spliceosomal snRNP assembly [GO:0000387]; thymus development [GO:0048538]","GO:0000245; GO:0000387; GO:0000398; GO:0005634; GO:0005654; GO:0005737; GO:0006334; GO:0015030; GO:0016607; GO:0017070; GO:0030098; GO:0031017; GO:0042393; GO:0048538; GO:0061574; GO:1903586"
"4863",4863,"Cluster_2854","Porites_evermani_scaffold_2326:73642-78484",166,-23.09,2,15,2611,2632,13,"92.31%","100.00%","Peve_00016793",0.998844137775377,0.0306118796323651,0.903929377050813,NA,NA,NA,NA,NA
"4864",4864,"Cluster_2854","Porites_evermani_scaffold_2326:73642-78484",166,-23.09,2,15,3294,3315,13,"92.31%","100.00%","Peve_00016793",0.998844137775377,0.0306118796323651,0.903929377050813,NA,NA,NA,NA,NA
"4867",4867,"Cluster_2854","Porites_evermani_scaffold_233:220847-235186",163,-20.47,2,21,7573,7595,20,"70.00%","85.00%","Peve_00016830",0.997788949392921,0.0423423068696936,0.91245824116165,"O94923","D-glucuronyl C5-epimerase (EC 5.1.3.17) (Heparan sulfate C5-epimerase) (Hsepi) (Heparin/heparan sulfate:glucuronic acid C5-epimerase) (Heparosan-N-sulfate-glucuronate 5-epimerase)","Homo sapiens (Human)","heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin biosynthetic process [GO:0030210]","GO:0000139; GO:0005509; GO:0005794; GO:0015012; GO:0016857; GO:0030210; GO:0042803; GO:0047464"
"4880",4880,"Cluster_2854","Porites_evermani_scaffold_237:92364-121417",152,-20.69,2,20,23994,24015,19,"68.42%","84.21%","Peve_00017150",-0.999275446346948,0.0242357588178883,0.858622359634376,"Q9UI17","Dimethylglycine dehydrogenase, mitochondrial (EC 1.5.8.4) (ME2GLYDH)","Homo sapiens (Human)","amino-acid betaine catabolic process [GO:0006579]; choline catabolic process [GO:0042426]; choline metabolic process [GO:0019695]","GO:0003723; GO:0005737; GO:0005739; GO:0005759; GO:0006579; GO:0009055; GO:0016491; GO:0019695; GO:0042426; GO:0047865"
"4881",4881,"Cluster_2854","Porites_evermani_scaffold_237:92364-121417",152,-20.69,2,20,26508,26529,19,"68.42%","84.21%","Peve_00017150",-0.999275446346948,0.0242357588178883,0.858622359634376,"Q9UI17","Dimethylglycine dehydrogenase, mitochondrial (EC 1.5.8.4) (ME2GLYDH)","Homo sapiens (Human)","amino-acid betaine catabolic process [GO:0006579]; choline catabolic process [GO:0042426]; choline metabolic process [GO:0019695]","GO:0003723; GO:0005737; GO:0005739; GO:0005759; GO:0006579; GO:0009055; GO:0016491; GO:0019695; GO:0042426; GO:0047865"
"4908",4908,"Cluster_2854","Porites_evermani_scaffold_2455:25930-27046",175,-20.64,2,20,982,1003,18,"83.33%","88.89%","Peve_00017979",0.999962448044095,0.00551712420276166,0.551398425649056,NA,NA,NA,NA,NA
"4911",4911,"Cluster_2854","Porites_evermani_scaffold_2479:15739-37295",175,-27.24,2,21,6571,6593,20,"80.00%","90.00%","Peve_00018147",-0.999981086743335,0.00391542548647461,0.54328949385489,NA,NA,NA,NA,NA
"4980",4980,"Cluster_2854","Porites_evermani_scaffold_2755:2019-42713",153,-20.11,2,15,12294,12316,14,"85.71%","85.71%","Peve_00020543",0.998432065435628,0.0356546230703885,0.909359886114279,"Q8IWY4","Signal peptide, CUB and EGF-like domain-containing protein 1","Homo sapiens (Human)","adult heart development [GO:0007512]; blood coagulation [GO:0007596]; endothelial cell differentiation [GO:0045446]; inflammatory response [GO:0006954]; positive regulation of smoothened signaling pathway [GO:0045880]; post-embryonic development [GO:0009791]; signal transduction [GO:0007165]","GO:0005509; GO:0005615; GO:0005886; GO:0006954; GO:0007165; GO:0007512; GO:0007596; GO:0009791; GO:0009897; GO:0009986; GO:0042802; GO:0045446; GO:0045880"
"5000",5000,"Cluster_2854","Porites_evermani_scaffold_2869:21622-30961",171,-20.38,2,20,7907,7928,18,"83.33%","83.33%","Peve_00021417",-0.999791289095414,0.0130069432315257,0.700541156620554,NA,NA,NA,NA,NA
"5029",5029,"Cluster_2854","Porites_evermani_scaffold_2953:20309-27685",151,-20.79,2,21,4803,4826,21,"61.90%","76.19%","Peve_00022083",0.999962448044095,0.00551712420276166,0.551398425649056,"Q5DU56","Protein NLRC3","Mus musculus (Mouse)","I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of tumor necrosis factor production [GO:0032720]; regulation of protein ubiquitination [GO:0031396]; response to lipopolysaccharide [GO:0032496]; T cell activation [GO:0042110]","GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0014067; GO:0031396; GO:0032088; GO:0032496; GO:0032687; GO:0032688; GO:0032691; GO:0032695; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:1900016; GO:1900226; GO:1901223"
"5036",5036,"Cluster_2854","Porites_evermani_scaffold_297:1486-6937",148,-21.98,2,20,289,313,22,"63.64%","77.27%","Peve_00022183",-0.999945152530085,0.00666769007808603,0.573710369894872,"Q8BP00","IQ calmodulin-binding motif-containing protein 1","Mus musculus (Mouse)","cilium assembly [GO:0060271]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]","GO:0001750; GO:0005516; GO:0005654; GO:0005737; GO:0005813; GO:0005929; GO:0015630; GO:0019899; GO:0032391; GO:0045171; GO:0045494; GO:0048496; GO:0060271; GO:0072686"
"5044",5044,"Cluster_2854","Porites_evermani_scaffold_3012:13451-47541",151,-20.1,2,13,20410,20432,12,"91.67%","91.67%","Peve_00022723",-0.999968633848047,0.00504227905314111,0.551398425649056,"B3EWY9","Mucin-like protein","Acropora millepora (Staghorn coral) (Heteropora millepora)","cell-matrix adhesion [GO:0007160]","GO:0005509; GO:0007160; GO:0016020"
"5047",5047,"Cluster_2854","Porites_evermani_scaffold_302:229582-234649",170,-24.15,2,20,594,616,19,"84.21%","84.21%","Peve_00022773",0.999962448044095,0.00551712420276166,0.551398425649056,"Q8VCK5","Kelch-like protein 20 (Kelch-like ECT2-interacting protein)","Mus musculus (Mouse)","Golgi to endosome transport [GO:0006895]; negative regulation of apoptotic process [GO:0043066]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K33-linked ubiquitination [GO:1990390]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]","GO:0003779; GO:0004842; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0006895; GO:0015031; GO:0016567; GO:0016605; GO:0019964; GO:0030424; GO:0030425; GO:0031463; GO:0043066; GO:0043161; GO:0048471; GO:1990390"
"5048",5048,"Cluster_2854","Porites_evermani_scaffold_302:79236-82148",145,-20.62,2,19,618,643,21,"61.90%","71.43%","Peve_00022762",-0.999347892022002,0.0229920915957954,0.844186414712407,"O42819","Ras-related protein SEC4","Candida glabrata (Yeast) (Torulopsis glabrata)","ascospore-type prospore assembly [GO:0031321]; autophagy [GO:0006914]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; membrane addition at site of cytokinesis [GO:0007107]; protein transport [GO:0015031]; vesicle fusion [GO:0006906]","GO:0000131; GO:0003924; GO:0005525; GO:0005886; GO:0006887; GO:0006893; GO:0006906; GO:0006914; GO:0007107; GO:0015031; GO:0030658; GO:0031321; GO:0043332; GO:0062040"
"5078",5078,"Cluster_2854","Porites_evermani_scaffold_308:61592-75589",167,-20.06,2,20,2807,2828,18,"72.22%","88.89%","Peve_00023189",-0.99980197200197,0.0126696782625539,0.692490720386583,"P31400","V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 7.1.2.2) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha)","Manduca sexta (Tobacco hawkmoth) (Tobacco hornworm)","","GO:0005524; GO:0033180; GO:0046933; GO:0046961"
"5132",5132,"Cluster_2854","Porites_evermani_scaffold_325:272627-302040",154,-20.42,2,20,5946,5969,20,"65.00%","80.00%","Peve_00024330",0.998712895978614,0.0323034224717031,0.909137857332831,"Q7SY48","HEAT repeat-containing protein 1 (Protein BAP28)","Danio rerio (Zebrafish) (Brachydanio rerio)","maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase I [GO:0045943]; regulation of RNA stability [GO:0043487]","GO:0000462; GO:0030515; GO:0030686; GO:0032040; GO:0034455; GO:0043066; GO:0043487; GO:0045943"
"5133",5133,"Cluster_2854","Porites_evermani_scaffold_325:272627-302040",154,-20.42,2,20,6063,6086,20,"65.00%","80.00%","Peve_00024330",0.998712895978614,0.0323034224717031,0.909137857332831,"Q7SY48","HEAT repeat-containing protein 1 (Protein BAP28)","Danio rerio (Zebrafish) (Brachydanio rerio)","maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase I [GO:0045943]; regulation of RNA stability [GO:0043487]","GO:0000462; GO:0030515; GO:0030686; GO:0032040; GO:0034455; GO:0043066; GO:0043487; GO:0045943"
"5134",5134,"Cluster_2854","Porites_evermani_scaffold_325:272627-302040",154,-20.42,2,20,6296,6319,20,"65.00%","80.00%","Peve_00024330",0.998712895978614,0.0323034224717031,0.909137857332831,"Q7SY48","HEAT repeat-containing protein 1 (Protein BAP28)","Danio rerio (Zebrafish) (Brachydanio rerio)","maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase I [GO:0045943]; regulation of RNA stability [GO:0043487]","GO:0000462; GO:0030515; GO:0030686; GO:0032040; GO:0034455; GO:0043066; GO:0043487; GO:0045943"
"5135",5135,"Cluster_2854","Porites_evermani_scaffold_325:272627-302040",154,-20.42,2,20,6374,6397,20,"65.00%","80.00%","Peve_00024330",0.998712895978614,0.0323034224717031,0.909137857332831,"Q7SY48","HEAT repeat-containing protein 1 (Protein BAP28)","Danio rerio (Zebrafish) (Brachydanio rerio)","maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase I [GO:0045943]; regulation of RNA stability [GO:0043487]","GO:0000462; GO:0030515; GO:0030686; GO:0032040; GO:0034455; GO:0043066; GO:0043487; GO:0045943"
"5136",5136,"Cluster_2854","Porites_evermani_scaffold_325:272627-302040",154,-20.42,2,20,6413,6436,20,"65.00%","80.00%","Peve_00024330",0.998712895978614,0.0323034224717031,0.909137857332831,"Q7SY48","HEAT repeat-containing protein 1 (Protein BAP28)","Danio rerio (Zebrafish) (Brachydanio rerio)","maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase I [GO:0045943]; regulation of RNA stability [GO:0043487]","GO:0000462; GO:0030515; GO:0030686; GO:0032040; GO:0034455; GO:0043066; GO:0043487; GO:0045943"
"5137",5137,"Cluster_2854","Porites_evermani_scaffold_325:272627-302040",154,-20.42,2,20,6686,6709,20,"65.00%","80.00%","Peve_00024330",0.998712895978614,0.0323034224717031,0.909137857332831,"Q7SY48","HEAT repeat-containing protein 1 (Protein BAP28)","Danio rerio (Zebrafish) (Brachydanio rerio)","maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase I [GO:0045943]; regulation of RNA stability [GO:0043487]","GO:0000462; GO:0030515; GO:0030686; GO:0032040; GO:0034455; GO:0043066; GO:0043487; GO:0045943"
"5138",5138,"Cluster_2854","Porites_evermani_scaffold_325:272627-302040",154,-20.42,2,20,6803,6826,20,"65.00%","80.00%","Peve_00024330",0.998712895978614,0.0323034224717031,0.909137857332831,"Q7SY48","HEAT repeat-containing protein 1 (Protein BAP28)","Danio rerio (Zebrafish) (Brachydanio rerio)","maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase I [GO:0045943]; regulation of RNA stability [GO:0043487]","GO:0000462; GO:0030515; GO:0030686; GO:0032040; GO:0034455; GO:0043066; GO:0043487; GO:0045943"
"5139",5139,"Cluster_2854","Porites_evermani_scaffold_325:272627-302040",154,-20.42,2,20,6881,6904,20,"65.00%","80.00%","Peve_00024330",0.998712895978614,0.0323034224717031,0.909137857332831,"Q7SY48","HEAT repeat-containing protein 1 (Protein BAP28)","Danio rerio (Zebrafish) (Brachydanio rerio)","maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase I [GO:0045943]; regulation of RNA stability [GO:0043487]","GO:0000462; GO:0030515; GO:0030686; GO:0032040; GO:0034455; GO:0043066; GO:0043487; GO:0045943"
"5140",5140,"Cluster_2854","Porites_evermani_scaffold_325:272627-302040",154,-20.75,2,20,8206,8229,20,"65.00%","80.00%","Peve_00024330",0.998712895978614,0.0323034224717031,0.909137857332831,"Q7SY48","HEAT repeat-containing protein 1 (Protein BAP28)","Danio rerio (Zebrafish) (Brachydanio rerio)","maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase I [GO:0045943]; regulation of RNA stability [GO:0043487]","GO:0000462; GO:0030515; GO:0030686; GO:0032040; GO:0034455; GO:0043066; GO:0043487; GO:0045943"
"5145",5145,"Cluster_2854","Porites_evermani_scaffold_328:239189-271116",160,-22.15,2,18,6743,6765,17,"76.47%","88.24%","Peve_00024485",-0.998027654256883,0.0399906121196841,0.909359886114279,"D3UW23","Glutamyl aminopeptidase (EAP) (EC 3.4.11.7) (Aminopeptidase A) (AP-A) (Rhiminopeptidase A)","Bitis rhinoceros (West African gaboon viper) (Vipera rhinoceros)","proteolysis [GO:0006508]","GO:0004177; GO:0005886; GO:0006508; GO:0008237; GO:0008270"
"5147",5147,"Cluster_2854","Porites_evermani_scaffold_3298:6442-10189",169,-22.42,2,19,637,660,19,"78.95%","89.47%","Peve_00024575",-0.997453644368208,0.045440892085478,0.933005102504876,"Q9CQL5","39S ribosomal protein L18, mitochondrial (L18mt) (MRP-L18)","Mus musculus (Mouse)","mitochondrial translation [GO:0032543]; rRNA import into mitochondrion [GO:0035928]","GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0008097; GO:0032543; GO:0035928"
"5203",5203,"Cluster_2854","Porites_evermani_scaffold_362:115039-134143",163,-21.21,2,16,7935,7956,14,"85.71%","92.86%","Peve_00026671",-0.997785330464857,0.0423769572915879,0.912802604012796,"Q90891","Dual specificity mitogen-activated protein kinase kinase 2 (MAP kinase kinase 2) (MAPKK 2) (EC 2.7.12.2) (ERK activator kinase 2) (MAPK/ERK kinase 2) (MEK2)","Gallus gallus (Chicken)","","GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0106310"
"5204",5204,"Cluster_2854","Porites_evermani_scaffold_363:26676-132490",166,-24.15,2,21,55853,55876,21,"80.95%","80.95%","Peve_00026728",-0.9999999977338,4.28592208061732e-05,0.0278278797948653,"O93484","Collagen alpha-2(I) chain (Alpha-2 type I collagen)","Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri)","","GO:0005201; GO:0005576; GO:0005581; GO:0046872"
"5205",5205,"Cluster_2854","Porites_evermani_scaffold_36:447804-488608",171,-20.48,2,20,37459,37480,18,"83.33%","83.33%","Peve_00026513",-0.998903304384371,0.0298179562466768,0.903929377050813,"Q6ITT3","Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C (EC 2.4.1.145) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase IVc) (GnT-IVc) (N-acetylglucosaminyltransferase IVc) (UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IVc)","Sus scrofa (Pig)","protein N-linked glycosylation [GO:0006487]","GO:0000139; GO:0006487; GO:0008375; GO:0008454; GO:0046872"
"5209",5209,"Cluster_2854","Porites_evermani_scaffold_3664:11470-40449",159,-20.37,2,21,28249,28273,22,"68.18%","77.27%","Peve_00026894",-0.997426651890488,0.0456812066416228,0.933493920659362,"Q6YHK3","CD109 antigen (150 kDa TGF-beta-1-binding protein) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7) (Platelet-specific Gov antigen) (p180) (r150) (CD antigen CD109)","Homo sapiens (Human)","hair follicle development [GO:0001942]; keratinocyte proliferation [GO:0043616]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of peptidase activity [GO:0010466]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; protein phosphorylation [GO:0006468]; regulation of keratinocyte differentiation [GO:0045616]; stem cell proliferation [GO:0072089]","GO:0001933; GO:0001942; GO:0004867; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0006468; GO:0009986; GO:0010466; GO:0010839; GO:0030512; GO:0031092; GO:0043616; GO:0045616; GO:0050431; GO:0061045; GO:0072089; GO:0072675; GO:2000647"
"5211",5211,"Cluster_2854","Porites_evermani_scaffold_366:82568-91465",159,-22.36,2,21,7148,7172,22,"63.64%","81.82%","Peve_00026871",-0.999966636237709,0.00520036512853229,0.551398425649056,"P63079","Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3)","Rattus norvegicus (Rat)","brain development [GO:0007420]; cellular response to histamine [GO:0071420]; cellular response to zinc ion [GO:0071294]; cerebellum development [GO:0021549]; chemical synaptic transmission [GO:0007268]; chemical synaptic transmission, postsynaptic [GO:0099565]; chloride transmembrane transport [GO:1902476]; circadian sleep/wake cycle, REM sleep [GO:0042747]; cochlea development [GO:0090102]; exploration behavior [GO:0035640]; gamma-aminobutyric acid signaling pathway [GO:0007214]; hard palate development [GO:0060022]; inhibitory postsynaptic potential [GO:0060080]; inhibitory synapse assembly [GO:1904862]; inner ear receptor cell development [GO:0060119]; innervation [GO:0060384]; ion transmembrane transport [GO:0034220]; learning [GO:0007612]; memory [GO:0007613]; motor behavior [GO:0061744]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; neuron development [GO:0048666]; regulation of membrane potential [GO:0042391]; regulation of neuron apoptotic process [GO:0043523]; regulation of postsynaptic membrane potential [GO:0060078]; reproductive behavior [GO:0019098]; response to anesthetic [GO:0072347]; response to xenobiotic stimulus [GO:0009410]; roof of mouth development [GO:0060021]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; social behavior [GO:0035176]; synaptic transmission, GABAergic [GO:0051932]","GO:0004890; GO:0005216; GO:0005231; GO:0005254; GO:0005886; GO:0007165; GO:0007214; GO:0007268; GO:0007399; GO:0007420; GO:0007605; GO:0007612; GO:0007613; GO:0009410; GO:0009986; GO:0019098; GO:0021549; GO:0022851; GO:0030594; GO:0030659; GO:0034220; GO:0034707; GO:0035176; GO:0035612; GO:0035640; GO:0042391; GO:0042747; GO:0042802; GO:0043005; GO:0043195; GO:0043523; GO:0043524; GO:0045202; GO:0045211; GO:0048666; GO:0050877; GO:0051932; GO:0060021; GO:0060022; GO:0060077; GO:0060078; GO:0060080; GO:0060119; GO:0060384; GO:0061744; GO:0071294; GO:0071420; GO:0072347; GO:0090102; GO:0098982; GO:0099565; GO:0099634; GO:1901215; GO:1902476; GO:1902711; GO:1904315; GO:1904862"
"5245",5245,"Cluster_2854","Porites_evermani_scaffold_3847:19789-23379",167,-20.98,2,20,1188,1209,18,"77.78%","83.33%","Peve_00027870",0.998125484911018,0.0389858902094067,0.909359886114279,NA,NA,NA,NA,NA
"5285",5285,"Cluster_2854","Porites_evermani_scaffold_403:214603-226740",151,-21.41,2,21,9365,9392,25,"64.00%","68.00%","Peve_00028991",-0.999364508377098,0.0226972393627853,0.840410910355847,NA,NA,NA,NA,NA
"5360",5360,"Cluster_2854","Porites_evermani_scaffold_4353:9448-16106",169,-20.83,2,18,2504,2525,16,"81.25%","93.75%","Peve_00030679",0.999962448044095,0.00551712420277797,0.551398425649056,NA,NA,NA,NA,NA
"5373",5373,"Cluster_2854","Porites_evermani_scaffold_4464:4151-26090",157,-20.08,2,21,2468,2487,19,"73.68%","78.95%","Peve_00031287",0.999982172170468,0.00380141253449467,0.542240609525931,"Q5W041","Armadillo repeat-containing protein 3 (Beta-catenin-like protein) (Cancer/testis antigen 81) (CT81) (KU-CT-1)","Homo sapiens (Human)","","GO:0070062"
"5404",5404,"Cluster_2854","Porites_evermani_scaffold_4621:3674-10873",171,-27.89,2,20,5649,5670,18,"83.33%","83.33%","Peve_00032011",0.999962448044095,0.00551712420276981,0.551398425649056,NA,NA,NA,NA,NA
"5412",5412,"Cluster_2854","Porites_evermani_scaffold_4712:10832-22463",159,-22.43,2,21,7647,7669,20,"70.00%","80.00%","Peve_00032395",-0.998857649878391,0.0304323919424018,0.903929377050813,"Q7TN88","Polycystic kidney disease protein 1-like 2 (PC1-like 2 protein) (Polycystin-1L2)","Mus musculus (Mouse)","detection of mechanical stimulus [GO:0050982]","GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982"
"5413",5413,"Cluster_2854","Porites_evermani_scaffold_4712:10832-22463",159,-22.43,2,21,7909,7931,20,"70.00%","80.00%","Peve_00032395",-0.998857649878391,0.0304323919424018,0.903929377050813,"Q7TN88","Polycystic kidney disease protein 1-like 2 (PC1-like 2 protein) (Polycystin-1L2)","Mus musculus (Mouse)","detection of mechanical stimulus [GO:0050982]","GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982"
"5420",5420,"Cluster_2854","Porites_evermani_scaffold_4742:4484-19761",152,-22.87,2,13,5152,5173,11,"81.82%","100.00%","Peve_00032523",0.999962448044095,0.00551712420276166,0.551398425649056,NA,NA,NA,NA,NA
"5484",5484,"Cluster_2854","Porites_evermani_scaffold_520:104290-190485",156,-20.02,2,21,71492,71513,19,"68.42%","73.68%","Peve_00034406",0.997281121151485,0.0469557192682797,0.939935945786585,"O88488","Phosphatidylinositol phosphatase PTPRQ (EC 3.1.3.-) (Protein-tyrosine phosphatase receptor-type expressed by glomerular mesangial cells protein 1) (rPTP-GMC1) (Receptor-type tyrosine-protein phosphatase Q) (PTP-RQ) (R-PTP-Q) (EC 3.1.3.48)","Rattus norvegicus (Rat)","detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; inner ear morphogenesis [GO:0042472]; neuromuscular process controlling balance [GO:0050885]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; regulation of fat cell differentiation [GO:0045598]; vestibular receptor cell morphogenesis [GO:0060116]","GO:0002244; GO:0004725; GO:0005886; GO:0032421; GO:0042472; GO:0043235; GO:0045598; GO:0050885; GO:0050910; GO:0060116; GO:1990264"
"5491",5491,"Cluster_2854","Porites_evermani_scaffold_525:50434-54343",155,-23.11,2,12,1449,1470,10,"100.00%","100.00%","Peve_00034569",0.999603958340296,0.0179176022280377,0.782669382293497,NA,NA,NA,NA,NA
"5530",5530,"Cluster_2854","Porites_evermani_scaffold_55:626675-646385",172,-21.82,2,21,7855,7876,19,"73.68%","89.47%","Peve_00035451",-0.999371623109792,0.022569813346519,0.839052039044429,"Q7Z6B0","Coiled-coil domain-containing protein 91 (GGA-binding partner) (p56 accessory protein)","Homo sapiens (Human)","Golgi to lysosome transport [GO:0090160]; protein transport [GO:0015031]","GO:0005654; GO:0005794; GO:0005802; GO:0005829; GO:0015031; GO:0016020; GO:0090160"
"5546",5546,"Cluster_2854","Porites_evermani_scaffold_566:189344-216993",162,-23.51,2,20,5095,5117,19,"68.42%","89.47%","Peve_00035967",0.999999046646997,0.000879067096608153,0.239778920002343,"O88488","Phosphatidylinositol phosphatase PTPRQ (EC 3.1.3.-) (Protein-tyrosine phosphatase receptor-type expressed by glomerular mesangial cells protein 1) (rPTP-GMC1) (Receptor-type tyrosine-protein phosphatase Q) (PTP-RQ) (R-PTP-Q) (EC 3.1.3.48)","Rattus norvegicus (Rat)","detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; inner ear morphogenesis [GO:0042472]; neuromuscular process controlling balance [GO:0050885]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; regulation of fat cell differentiation [GO:0045598]; vestibular receptor cell morphogenesis [GO:0060116]","GO:0002244; GO:0004725; GO:0005886; GO:0032421; GO:0042472; GO:0043235; GO:0045598; GO:0050885; GO:0050910; GO:0060116; GO:1990264"
"5591",5591,"Cluster_2854","Porites_evermani_scaffold_604:193028-208906",183,-28.51,2,20,1458,1479,18,"88.89%","94.44%","Peve_00037185",-0.999042445184161,0.0278619561486011,0.899642249848007,"P41565","Isocitrate dehydrogenase [NAD] subunit gamma 1, mitochondrial (Isocitric dehydrogenase subunit gamma) (NAD(+)-specific ICDH subunit gamma)","Rattus norvegicus (Rat)","2-oxoglutarate metabolic process [GO:0006103]; isocitrate metabolic process [GO:0006102]; NADH metabolic process [GO:0006734]; negative regulation of growth [GO:0045926]; tricarboxylic acid cycle [GO:0006099]","GO:0000287; GO:0004449; GO:0005524; GO:0005739; GO:0005962; GO:0006099; GO:0006102; GO:0006103; GO:0006734; GO:0045926; GO:0051287"
"5592",5592,"Cluster_2854","Porites_evermani_scaffold_606:62373-63857",171,-23.73,2,20,1366,1387,18,"77.78%","88.89%","Peve_00037231",0.99967338084874,0.016271506544801,0.768900380839141,NA,NA,NA,NA,NA
"5604",5604,"Cluster_2854","Porites_evermani_scaffold_618:70652-96529",159,-22.18,2,21,21288,21312,22,"68.18%","77.27%","Peve_00037537",0.999962448044095,0.00551712420276166,0.551398425649056,"Q9H2X9","Solute carrier family 12 member 5 (Electroneutral potassium-chloride cotransporter 2) (K-Cl cotransporter 2) (hKCC2) (Neuronal K-Cl cotransporter)","Homo sapiens (Human)","cell volume homeostasis [GO:0006884]; cellular chloride ion homeostasis [GO:0030644]; cellular ion homeostasis [GO:0006873]; chemical synaptic transmission [GO:0007268]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; dendritic spine development [GO:0060996]; hypotonic response [GO:0006971]; intracellular pH reduction [GO:0051452]; ion transport [GO:0006811]; learning [GO:0007612]; multicellular organism growth [GO:0035264]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; response to xenobiotic stimulus [GO:0009410]; thermosensory behavior [GO:0040040]","GO:0005886; GO:0006811; GO:0006873; GO:0006884; GO:0006971; GO:0007268; GO:0007612; GO:0008519; GO:0009410; GO:0015108; GO:0015379; GO:0016020; GO:0019901; GO:0030644; GO:0032590; GO:0035264; GO:0040040; GO:0043005; GO:0043025; GO:0043204; GO:0045202; GO:0051452; GO:0055064; GO:0055075; GO:0060996; GO:0071944; GO:1902476; GO:1990573"
"5616",5616,"Cluster_2854","Porites_evermani_scaffold_6:302480-311252",184,-25.94,2,21,7423,7444,19,"89.47%","89.47%","Peve_00037049",-0.997894257144077,0.0413213048798677,0.909359886114279,NA,NA,NA,NA,NA
"5617",5617,"Cluster_2854","Porites_evermani_scaffold_632:63675-91296",159,-20.51,2,20,12628,12646,18,"77.78%","83.33%","Peve_00037939",0.999962448044095,0.00551712420276981,0.551398425649056,"P07949","Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Cadherin family member 12) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment]","Homo sapiens (Human)","activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; axon guidance [GO:0007411]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; lymphocyte migration into lymphoid organs [GO:0097021]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of protein kinase B signaling [GO:0051897]; posterior midgut development [GO:0007497]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657]","GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0006468; GO:0006919; GO:0007156; GO:0007158; GO:0007165; GO:0007169; GO:0007411; GO:0007497; GO:0009410; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030335; GO:0030424; GO:0030425; GO:0033141; GO:0033619; GO:0033630; GO:0033674; GO:0035799; GO:0035860; GO:0038023; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045121; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0097021; GO:0098797; GO:2001241"
"5649",5649,"Cluster_2854","Porites_evermani_scaffold_657:169034-190046",152,-20.14,2,14,9013,9035,13,"84.62%","92.31%","Peve_00038534",-0.998485426650187,0.0350425019077328,0.909359886114279,"Q14517","Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form]","Homo sapiens (Human)","actin filament organization [GO:0007015]; anatomical structure morphogenesis [GO:0009653]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; epithelial cell morphogenesis [GO:0003382]; establishment of epithelial cell apical/basal polarity involved in camera-type eye morphogenesis [GO:0003412]; establishment or maintenance of cell polarity [GO:0007163]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; lens development in camera-type eye [GO:0002088]","GO:0002088; GO:0003382; GO:0003412; GO:0005509; GO:0005634; GO:0005886; GO:0005911; GO:0005925; GO:0007015; GO:0007155; GO:0007156; GO:0007163; GO:0007267; GO:0009653; GO:0016324; GO:0016477; GO:0030027; GO:0030175; GO:0048471; GO:0070062; GO:0098609"
"5744",5744,"Cluster_2854","Porites_evermani_scaffold_800:74917-123292",152,-20.39,2,18,18365,18390,20,"70.00%","75.00%","Peve_00041797",0.999925407085804,0.0077758273230635,0.573710369894872,"Q8VHN7","Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1) (MASS1) (Neurepin) (Protein rueda) (Very large G-protein coupled receptor 1) (VLGR1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta (VLGR1 subunit beta) (Vbeta)]","Mus musculus (Mouse)","cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; negative regulation of adenylate cyclase activity [GO:0007194]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein kinase C signaling [GO:0090037]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]","GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005576; GO:0005737; GO:0005886; GO:0007166; GO:0007194; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010739; GO:0010855; GO:0016020; GO:0016787; GO:0017022; GO:0030501; GO:0031647; GO:0032391; GO:0032420; GO:0043235; GO:0045184; GO:0045202; GO:0045494; GO:0048471; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0051649; GO:0060113; GO:0060122; GO:0060171; GO:0071277; GO:0090037; GO:0097264; GO:0098609; GO:1990075; GO:1990696"
"5755",5755,"Cluster_2854","Porites_evermani_scaffold_805:83177-119600",154,-20.86,2,20,13010,13032,19,"68.42%","78.95%","Peve_00041884",0.999999550681443,0.00060349310788746,0.239778920002343,"P00735","Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain]","Bos taurus (Bovine)","acute-phase response [GO:0006953]; platelet activation [GO:0030168]; positive regulation of blood coagulation [GO:0030194]; protein polymerization [GO:0051258]; proteolysis [GO:0006508]","GO:0004252; GO:0005509; GO:0005615; GO:0006508; GO:0006953; GO:0030168; GO:0030194; GO:0051258; GO:0062023; GO:0070051"
"5773",5773,"Cluster_2854","Porites_evermani_scaffold_8:30287-40842",161,-20.58,2,20,1808,1828,18,"77.78%","83.33%","Peve_00041682",-0.998485426650187,0.0350425019077328,0.909359886114279,"Q4UMH6","Putative ankyrin repeat protein RF_0381","Rickettsia felis (strain ATCC VR-1525 / URRWXCal2) (Rickettsia azadi)","guanosine tetraphosphate metabolic process [GO:0015969]","GO:0015969"
"5774",5774,"Cluster_2854","Porites_evermani_scaffold_8:30287-40842",161,-20.58,2,20,2003,2023,18,"77.78%","83.33%","Peve_00041682",-0.998485426650187,0.0350425019077328,0.909359886114279,"Q4UMH6","Putative ankyrin repeat protein RF_0381","Rickettsia felis (strain ATCC VR-1525 / URRWXCal2) (Rickettsia azadi)","guanosine tetraphosphate metabolic process [GO:0015969]","GO:0015969"
"5801",5801,"Cluster_2854","Porites_evermani_scaffold_86:235811-281668",165,-27.04,2,21,31027,31048,20,"80.00%","85.00%","Peve_00042929",-0.999607236533936,0.0178432877164636,0.782669382293497,"Q04467","Isocitrate dehydrogenase [NADP], mitochondrial (IDH) (EC 1.1.1.42) (ICD-M) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase)","Bos taurus (Bovine)","2-oxoglutarate metabolic process [GO:0006103]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; NADP metabolic process [GO:0006739]; tricarboxylic acid cycle [GO:0006099]","GO:0000287; GO:0004450; GO:0005739; GO:0005743; GO:0005777; GO:0005829; GO:0006097; GO:0006099; GO:0006102; GO:0006103; GO:0006739; GO:0051287"
"5810",5810,"Cluster_2854","Porites_evermani_scaffold_880:170905-173801",167,-21.1,2,20,378,399,18,"72.22%","88.89%","Peve_00043346",0.999962448044095,0.00551712420276166,0.551398425649056,"A0A2B4RNI3",NA,NA,NA,NA
"5814",5814,"Cluster_2854","Porites_evermani_scaffold_8:849871-857495",160,-20.44,2,21,3833,3854,19,"68.42%","78.95%","Peve_00041707",0.999795898790508,0.0128624973090348,0.697089785965063,NA,NA,NA,NA,NA
"5826",5826,"Cluster_2854","Porites_evermani_scaffold_910:59242-80494",152,-20.69,2,20,20578,20599,19,"68.42%","84.21%","Peve_00043948",-0.999925689816771,0.00776107671533052,0.573710369894872,"Q6DRN3","Nucleolar complex protein 3 homolog (NOC3 protein homolog) (NOC3-like protein) (Nucleolar complex-associated protein 3-like protein)","Danio rerio (Zebrafish) (Brachydanio rerio)","DNA replication initiation [GO:0006270]; muscle organ development [GO:0007517]; regulation of lipid metabolic process [GO:0019216]","GO:0003682; GO:0005634; GO:0005730; GO:0006270; GO:0007517; GO:0019216"
"5852",5852,"Cluster_2854","Porites_evermani_scaffold_939:149911-170708",155,-20.93,2,20,16743,16764,18,"61.11%","83.33%","Peve_00044389",0.999986498807432,0.00330812320175955,0.500095982000588,"Q5RHH4","Intraflagellar transport protein 172 homolog","Danio rerio (Zebrafish) (Brachydanio rerio)","cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; photoreceptor cell maintenance [GO:0045494]; pronephros development [GO:0048793]; regulation of TOR signaling [GO:0032006]; retina development in camera-type eye [GO:0060041]","GO:0005929; GO:0005930; GO:0030992; GO:0032006; GO:0036064; GO:0042073; GO:0045494; GO:0048793; GO:0060041; GO:0060271"
"5856",5856,"Cluster_2854","Porites_evermani_scaffold_948:5005-12226",171,-20.09,2,21,4544,4566,20,"75.00%","90.00%","Peve_00044518",0.999901905632251,0.00891703984388479,0.586861520389792,"Q5ZLX5","Zinc finger Ran-binding domain-containing protein 2","Gallus gallus (Chicken)","RNA processing [GO:0006396]","GO:0001530; GO:0003723; GO:0005634; GO:0006396; GO:0046872"
"5861",5861,"Cluster_2854","Porites_evermani_scaffold_957:165003-165423",161,-21.25,2,21,218,242,22,"77.27%","81.82%","Peve_00044684",0.999962448044095,0.00551712420276166,0.551398425649056,NA,NA,NA,NA,NA
"5879",5879,"Cluster_2854","Porites_evermani_scaffold_990:51903-70306",149,-20.36,2,20,11151,11178,24,"66.67%","70.83%","Peve_00045236",-0.999000731937584,0.0284624509847491,0.903848995020577,"Q7TMK9","Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Glycine- and tyrosine-rich RNA-binding protein) (GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein) (pp68)","Mus musculus (Mouse)","cellular response to type II interferon [GO:0071346]; CRD-mediated mRNA stabilization [GO:0070934]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; negative regulation of mRNA modification [GO:0090367]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; negative regulation of translation [GO:0017148]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA demethylation [GO:1901537]; positive regulation of translation [GO:0045727]; RNA splicing [GO:0008380]","GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0006397; GO:0008143; GO:0008380; GO:0016020; GO:0016556; GO:0017148; GO:0043025; GO:0045293; GO:0045727; GO:0048027; GO:0070934; GO:0070937; GO:0071013; GO:0071204; GO:0071346; GO:0090367; GO:0097452; GO:0106002; GO:1900152; GO:1901537; GO:1990635; GO:1990904; GO:2000623; GO:2000767"
"5880",5880,"Cluster_2854","Porites_evermani_scaffold_991:137406-139913",150,-20.16,2,21,518,541,21,"66.67%","76.19%","Peve_00045254",-0.999992320114512,0.00249501275975525,0.416769192445762,NA,NA,NA,NA,NA
"5885",5885,"Cluster_2882","Porites_evermani_scaffold_1000:117768-125055",157,-20.93,2,20,4868,4892,21,"76.19%","76.19%","Peve_00000242",-0.996940885947183,0.0498085306799997,0.952787398997432,"P53990","IST1 homolog (hIST1) (Charged multivesicular body protein 8) (CHMP8) (Putative MAPK-activating protein PM28)","Homo sapiens (Human)","abscission [GO:0009838]; cell division [GO:0051301]; collateral sprouting [GO:0048668]; cytoskeleton-dependent cytokinesis [GO:0061640]; ESCRT III complex disassembly [GO:1904903]; establishment of protein localization [GO:0045184]; multivesicular body assembly [GO:0036258]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of proteolysis [GO:0045862]; protein localization [GO:0008104]; protein transport [GO:0015031]; viral capsid secondary envelopment [GO:0046745]; viral release from host cell [GO:0019076]","GO:0005576; GO:0005635; GO:0005793; GO:0005813; GO:0005829; GO:0008104; GO:0009838; GO:0015031; GO:0019076; GO:0019904; GO:0030496; GO:0035578; GO:0036258; GO:0042802; GO:0043231; GO:0044877; GO:0045184; GO:0045296; GO:0045862; GO:0046745; GO:0048668; GO:0048672; GO:0051301; GO:0061640; GO:0070062; GO:0090541; GO:0090543; GO:1904903"
"5886",5886,"Cluster_2882","Porites_evermani_scaffold_1000:117768-125055",173,-24.97,2,20,5510,5530,18,"88.89%","88.89%","Peve_00000242",-0.996940885947183,0.0498085306799997,0.952787398997432,"P53990","IST1 homolog (hIST1) (Charged multivesicular body protein 8) (CHMP8) (Putative MAPK-activating protein PM28)","Homo sapiens (Human)","abscission [GO:0009838]; cell division [GO:0051301]; collateral sprouting [GO:0048668]; cytoskeleton-dependent cytokinesis [GO:0061640]; ESCRT III complex disassembly [GO:1904903]; establishment of protein localization [GO:0045184]; multivesicular body assembly [GO:0036258]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of proteolysis [GO:0045862]; protein localization [GO:0008104]; protein transport [GO:0015031]; viral capsid secondary envelopment [GO:0046745]; viral release from host cell [GO:0019076]","GO:0005576; GO:0005635; GO:0005793; GO:0005813; GO:0005829; GO:0008104; GO:0009838; GO:0015031; GO:0019076; GO:0019904; GO:0030496; GO:0035578; GO:0036258; GO:0042802; GO:0043231; GO:0044877; GO:0045184; GO:0045296; GO:0045862; GO:0046745; GO:0048668; GO:0048672; GO:0051301; GO:0061640; GO:0070062; GO:0090541; GO:0090543; GO:1904903"
"5921",5921,"Cluster_2882","Porites_evermani_scaffold_1065:79322-108593",153,-20.21,2,21,2131,2153,21,"71.43%","76.19%","Peve_00001230",-0.997937527792035,0.0408944004063604,0.909359886114279,"B3EWZ5","MAM and LDL-receptor class A domain-containing protein 1 (Skeletal organic matrix MAM and LDL-receptor 1) (SOM MAM and LDL-receptor 1)","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0005576; GO:0016020"
"5923",5923,"Cluster_2882","Porites_evermani_scaffold_107:143350-164187",147,-25.6,2,21,15837,15866,27,"59.26%","66.67%","Peve_00001286",-0.999831516694319,0.0116863706387285,0.666814993313648,"Q5R5S4","26S proteasome non-ATPase regulatory subunit 1 (26S proteasome regulatory subunit RPN2) (26S proteasome regulatory subunit S1)","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","regulation of protein catabolic process [GO:0042176]","GO:0022624; GO:0030234; GO:0031625; GO:0042176"
"5924",5924,"Cluster_2882","Porites_evermani_scaffold_107:143350-164187",155,-23.81,2,21,10688,10711,21,"71.43%","71.43%","Peve_00001286",-0.999831516694319,0.0116863706387285,0.666814993313648,"Q5R5S4","26S proteasome non-ATPase regulatory subunit 1 (26S proteasome regulatory subunit RPN2) (26S proteasome regulatory subunit S1)","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","regulation of protein catabolic process [GO:0042176]","GO:0022624; GO:0030234; GO:0031625; GO:0042176"
"5933",5933,"Cluster_2882","Porites_evermani_scaffold_109:341992-387590",168,-21.93,2,18,21250,21272,17,"88.24%","88.24%","Peve_00001600",-0.999968762882795,0.00503189679255099,0.551398425649056,"Q5R826","CSC1-like protein 1 (Transmembrane protein 63A)","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","","GO:0003676; GO:0005227; GO:0005765; GO:0005886; GO:1990760"
"5934",5934,"Cluster_2882","Porites_evermani_scaffold_109:341992-387590",168,-22.63,2,18,14778,14800,17,"88.24%","88.24%","Peve_00001600",-0.999968762882795,0.00503189679255099,0.551398425649056,"Q5R826","CSC1-like protein 1 (Transmembrane protein 63A)","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","","GO:0003676; GO:0005227; GO:0005765; GO:0005886; GO:1990760"
"5935",5935,"Cluster_2882","Porites_evermani_scaffold_109:341992-387590",168,-22.63,2,18,27706,27728,17,"88.24%","88.24%","Peve_00001600",-0.999968762882795,0.00503189679255099,0.551398425649056,"Q5R826","CSC1-like protein 1 (Transmembrane protein 63A)","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","","GO:0003676; GO:0005227; GO:0005765; GO:0005886; GO:1990760"
"5953",5953,"Cluster_2882","Porites_evermani_scaffold_1116:30577-65229",145,-23.03,2,19,28697,28722,21,"66.67%","66.67%","Peve_00002096",-0.998926876388747,0.0294957090939906,0.903929377050813,"Q9JID6","Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Palmitoyl-CoA ligase) (Phytanate--CoA ligase) (EC 6.2.1.24)","Cavia porcellus (Guinea pig)","long-chain fatty acid metabolic process [GO:0001676]; very long-chain fatty acid metabolic process [GO:0000038]","GO:0000038; GO:0001676; GO:0004467; GO:0005524; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0047676; GO:0050197; GO:0070251"
"5959",5959,"Cluster_2882","Porites_evermani_scaffold_1135:16022-27434",161,-20.97,2,14,6866,6887,12,"91.67%","100.00%","Peve_00002350",-0.9974322416173,0.0456315449231137,0.93332862243605,"Q1L8F9","KICSTOR subunit 2","Danio rerio (Zebrafish) (Brachydanio rerio)","cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; negative regulation of TORC1 signaling [GO:1904262]; protein localization to lysosome [GO:0061462]","GO:0005765; GO:0034198; GO:0042149; GO:0061462; GO:0140007; GO:1904262"
"5987",5987,"Cluster_2882","Porites_evermani_scaffold_1213:60237-121032",160,-20.54,2,21,38432,38453,19,"68.42%","78.95%","Peve_00003586",-0.998590344098593,0.033806694422102,0.909359886114279,"Q8IY21","Probable ATP-dependent RNA helicase DDX60 (EC 3.6.4.13) (DEAD box protein 60)","Homo sapiens (Human)","defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; response to virus [GO:0009615]","GO:0003690; GO:0003724; GO:0003725; GO:0003727; GO:0005524; GO:0005737; GO:0005829; GO:0009615; GO:0016887; GO:0045087; GO:0045111; GO:0051607; GO:1900245; GO:1900246"
"5988",5988,"Cluster_2882","Porites_evermani_scaffold_1213:60237-121032",160,-22.57,2,21,31069,31090,19,"73.68%","73.68%","Peve_00003586",-0.998590344098593,0.033806694422102,0.909359886114279,"Q8IY21","Probable ATP-dependent RNA helicase DDX60 (EC 3.6.4.13) (DEAD box protein 60)","Homo sapiens (Human)","defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; response to virus [GO:0009615]","GO:0003690; GO:0003724; GO:0003725; GO:0003727; GO:0005524; GO:0005737; GO:0005829; GO:0009615; GO:0016887; GO:0045087; GO:0045111; GO:0051607; GO:1900245; GO:1900246"
"6023",6023,"Cluster_2882","Porites_evermani_scaffold_129:71470-89430",170,-20.02,2,21,5658,5681,21,"80.95%","85.71%","Peve_00004622",-0.99854349113181,0.0343640557012432,0.909359886114279,"Q13415","Origin recognition complex subunit 1 (Replication control protein 1)","Homo sapiens (Human)","DNA replication initiation [GO:0006270]; mitotic DNA replication checkpoint signaling [GO:0033314]","GO:0000781; GO:0000808; GO:0003677; GO:0003682; GO:0003688; GO:0005524; GO:0005634; GO:0005654; GO:0005664; GO:0005829; GO:0006270; GO:0016887; GO:0033314; GO:0046872"
"6053",6053,"Cluster_2882","Porites_evermani_scaffold_14:146184-158420",145,-22,2,10,8905,8926,8,"100.00%","100.00%","Peve_00006220",-0.998529572564813,0.0345278988141967,0.909359886114279,NA,NA,NA,NA,NA
"6055",6055,"Cluster_2882","Porites_evermani_scaffold_1420:2390-41354",149,-21.12,2,15,26696,26718,14,"78.57%","85.71%","Peve_00006527",-0.999847649720536,0.0111127683729467,0.651110503314638,"Q9H251","Cadherin-23 (Otocadherin)","Homo sapiens (Human)","auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; locomotory behavior [GO:0007626]; photoreceptor cell maintenance [GO:0045494]; post-embryonic animal organ morphogenesis [GO:0048563]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to stimulus [GO:0050896]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]","GO:0001917; GO:0005509; GO:0005813; GO:0006816; GO:0007156; GO:0007601; GO:0007605; GO:0007626; GO:0016020; GO:0016339; GO:0016342; GO:0032420; GO:0032426; GO:0045296; GO:0045494; GO:0048563; GO:0050896; GO:0050953; GO:0050957; GO:0051480; GO:0060088; GO:0060091; GO:0098683; GO:0098684; GO:0098742"
"6066",6066,"Cluster_2882","Porites_evermani_scaffold_1:448044-460031",147,-20.16,2,13,2025,2048,13,"84.62%","84.62%","Peve_00000005",-0.998189752804816,0.0383115390865436,0.909359886114279,"P52564","Dual specificity mitogen-activated protein kinase kinase 6 (MAP kinase kinase 6) (MAPKK 6) (EC 2.7.12.2) (MAPK/ERK kinase 6) (MEK 6) (Stress-activated protein kinase kinase 3) (SAPK kinase 3) (SAPKK-3) (SAPKK3)","Homo sapiens (Human)","apoptotic process [GO:0006915]; bone development [GO:0060348]; cardiac muscle contraction [GO:0060048]; cellular response to sorbitol [GO:0072709]; cellular senescence [GO:0090398]; MAPK cascade [GO:0000165]; negative regulation of cold-induced thermogenesis [GO:0120163]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; osteoblast differentiation [GO:0001649]; ovulation cycle process [GO:0022602]; p38MAPK cascade [GO:0038066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of prostaglandin secretion [GO:0032308]; regulation of cell cycle [GO:0051726]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to ischemia [GO:0002931]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; signal transduction in response to DNA damage [GO:0042770]; stress-activated MAPK cascade [GO:0051403]","GO:0000165; GO:0001649; GO:0002931; GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0005654; GO:0005829; GO:0005856; GO:0006915; GO:0007165; GO:0009410; GO:0019211; GO:0019901; GO:0022602; GO:0032308; GO:0038066; GO:0042770; GO:0042802; GO:0043065; GO:0043406; GO:0043539; GO:0051403; GO:0051726; GO:0051770; GO:0060048; GO:0060348; GO:0070423; GO:0072709; GO:0090398; GO:0106310; GO:0120163; GO:0140537; GO:1901796"
"6068",6068,"Cluster_2882","Porites_evermani_scaffold_1454:42224-51381",157,-22.64,2,14,5207,5228,12,"91.67%","91.67%","Peve_00006896",-0.999754770568984,0.0140990643134194,0.725755651730332,"Q7ZWW7","Tetraspanin-31-B (Tspan-31-B) (Sarcoma-amplified sequence homolog B)","Xenopus laevis (African clawed frog)","","GO:0016020"
"6069",6069,"Cluster_2882","Porites_evermani_scaffold_1454:42224-51381",157,-22.64,2,14,6793,6814,12,"91.67%","91.67%","Peve_00006896",-0.999754770568984,0.0140990643134194,0.725755651730332,"Q7ZWW7","Tetraspanin-31-B (Tspan-31-B) (Sarcoma-amplified sequence homolog B)","Xenopus laevis (African clawed frog)","","GO:0016020"
"6092",6092,"Cluster_2882","Porites_evermani_scaffold_1509:85367-94951",154,-21.57,2,20,5907,5932,22,"68.18%","72.73%","Peve_00007645",-0.99711685553391,0.0483540352291861,0.946452802050405,"Q99M87","DnaJ homolog subfamily A member 3, mitochondrial (DnaJ protein Tid-1) (mTid-1) (Tumorous imaginal discs protein Tid56 homolog)","Mus musculus (Mouse)","activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation-induced cell death of T cells [GO:0006924]; apoptotic process [GO:0006915]; cellular senescence [GO:0090398]; mitochondrial DNA replication [GO:0006264]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of programmed cell death [GO:0043069]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type II interferon-mediated signaling pathway [GO:0060336]; neuromuscular junction development [GO:0007528]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell proliferation [GO:0042102]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]; response to type II interferon [GO:0034341]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; small GTPase mediated signal transduction [GO:0007264]; T cell differentiation in thymus [GO:0033077]","GO:0000122; GO:0005133; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0005884; GO:0005886; GO:0006264; GO:0006457; GO:0006469; GO:0006915; GO:0006919; GO:0006924; GO:0007005; GO:0007264; GO:0007528; GO:0008285; GO:0009408; GO:0019897; GO:0019901; GO:0030544; GO:0030695; GO:0030971; GO:0031398; GO:0031594; GO:0032088; GO:0033077; GO:0034341; GO:0042102; GO:0042645; GO:0043065; GO:0043066; GO:0043069; GO:0043124; GO:0043154; GO:0043231; GO:0044877; GO:0045211; GO:0046872; GO:0050821; GO:0051059; GO:0051082; GO:0060336; GO:0061629; GO:0071340; GO:0090398; GO:0106137; GO:0140297"
"6114",6114,"Cluster_2882","Porites_evermani_scaffold_1570:39597-117948",157,-21.77,2,20,27767,27791,21,"71.43%","80.95%","Peve_00008382",-0.999998674676404,0.00103646856226412,0.264577589483208,"A2A9C3","KICSTOR complex protein SZT2 (Seizure threshold 2 protein) (Transcript increased in glutamate resistance) (TIGR)","Mus musculus (Mouse)","cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; corpus callosum morphogenesis [GO:0021540]; negative regulation of TORC1 signaling [GO:1904262]; pigmentation [GO:0043473]; post-embryonic development [GO:0009791]; protein localization to lysosome [GO:0061462]; regulation of superoxide dismutase activity [GO:1901668]; response to nutrient levels [GO:0031667]","GO:0005765; GO:0005777; GO:0007417; GO:0009791; GO:0021540; GO:0031667; GO:0034198; GO:0042149; GO:0043473; GO:0061462; GO:0061700; GO:0140007; GO:1901668; GO:1904262; GO:1990130"
"6150",6150,"Cluster_2882","Porites_evermani_scaffold_1668:74150-111165",152,-22.3,2,21,18324,18345,19,"63.16%","73.68%","Peve_00009585",-0.999810478284584,0.0123945701379348,0.685731608006455,"P0CI65","Nephrocystin-3","Danio rerio (Zebrafish) (Brachydanio rerio)","cilium assembly [GO:0060271]; convergent extension [GO:0060026]; determination of left/right symmetry [GO:0007368]; heart jogging [GO:0003146]; kidney development [GO:0001822]; Kupffer's vesicle development [GO:0070121]; left/right pattern formation [GO:0060972]; pronephros development [GO:0048793]; visual perception [GO:0007601]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0003146; GO:0005929; GO:0007368; GO:0007601; GO:0016055; GO:0048793; GO:0060026; GO:0060271; GO:0060972; GO:0070121; GO:0097543; GO:0097546"
"6151",6151,"Cluster_2882","Porites_evermani_scaffold_1668:74150-111165",157,-21.9,2,19,19588,19610,18,"77.78%","77.78%","Peve_00009585",-0.999810478284584,0.0123945701379348,0.685731608006455,"P0CI65","Nephrocystin-3","Danio rerio (Zebrafish) (Brachydanio rerio)","cilium assembly [GO:0060271]; convergent extension [GO:0060026]; determination of left/right symmetry [GO:0007368]; heart jogging [GO:0003146]; kidney development [GO:0001822]; Kupffer's vesicle development [GO:0070121]; left/right pattern formation [GO:0060972]; pronephros development [GO:0048793]; visual perception [GO:0007601]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0003146; GO:0005929; GO:0007368; GO:0007601; GO:0016055; GO:0048793; GO:0060026; GO:0060271; GO:0060972; GO:0070121; GO:0097543; GO:0097546"
"6165",6165,"Cluster_2882","Porites_evermani_scaffold_1718:735-18541",158,-25.56,2,16,10999,11021,15,"86.67%","86.67%","Peve_00010241",-0.999280470349742,0.0241515780394229,0.857298733095813,"Q60598","Src substrate cortactin","Mus musculus (Mouse)","actin cytoskeleton reorganization [GO:0031532]; cell motility [GO:0048870]; dendritic spine maintenance [GO:0097062]; extrinsic apoptotic signaling pathway [GO:0097191]; focal adhesion assembly [GO:0048041]; intracellular protein transport [GO:0006886]; lamellipodium organization [GO:0097581]; modification of postsynaptic actin cytoskeleton [GO:0098885]; modification of postsynaptic structure [GO:0099010]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; neuron projection morphogenesis [GO:0048812]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of chemotaxis [GO:0050921]; positive regulation of smooth muscle contraction [GO:0045987]; receptor-mediated endocytosis [GO:0006898]; regulation of actin filament polymerization [GO:0030833]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of axon extension [GO:0030516]; regulation of cell projection assembly [GO:0060491]; substrate-dependent cell migration, cell extension [GO:0006930]","GO:0001726; GO:0002102; GO:0005522; GO:0005737; GO:0005783; GO:0005794; GO:0005829; GO:0005884; GO:0005886; GO:0005905; GO:0005925; GO:0005938; GO:0006886; GO:0006898; GO:0006930; GO:0008076; GO:0030027; GO:0030054; GO:0030426; GO:0030427; GO:0030516; GO:0030833; GO:0030838; GO:0030863; GO:0030864; GO:0031532; GO:0043197; GO:0043231; GO:0045987; GO:0048041; GO:0048812; GO:0048870; GO:0050921; GO:0051015; GO:0060491; GO:0070064; GO:0071933; GO:0097062; GO:0097191; GO:0097581; GO:0098794; GO:0098871; GO:0098885; GO:0098978; GO:0099010; GO:1903146; GO:1990023; GO:2001237"
"6198",6198,"Cluster_2882","Porites_evermani_scaffold_181:180242-245218",163,-22.74,2,21,21594,21617,21,"71.43%","80.95%","Peve_00011277",-0.998762352756012,0.0316765855529158,0.903929377050813,"Q8IWV8","E3 ubiquitin-protein ligase UBR2 (EC 2.3.2.27) (N-recognin-2) (RING-type E3 ubiquitin transferase UBR2) (Ubiquitin-protein ligase E3-alpha-2) (Ubiquitin-protein ligase E3-alpha-II)","Homo sapiens (Human)","cellular response to leucine [GO:0071233]; heterochromatin formation [GO:0031507]; histone H2A ubiquitination [GO:0033522]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transposition [GO:0010529]; protein ubiquitination [GO:0016567]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]","GO:0000151; GO:0000785; GO:0005634; GO:0005737; GO:0005829; GO:0007131; GO:0007140; GO:0007141; GO:0007283; GO:0008270; GO:0010529; GO:0016567; GO:0031507; GO:0032007; GO:0033522; GO:0061630; GO:0070728; GO:0071233; GO:0071596"
"6249",6249,"Cluster_2882","Porites_evermani_scaffold_1975:32972-38039",166,-23.01,2,21,1380,1403,21,"76.19%","85.71%","Peve_00013068",0.997427621442327,0.0456725965588281,0.933493920659362,NA,NA,NA,NA,NA
"6256",6256,"Cluster_2882","Porites_evermani_scaffold_1998:17-68919",149,-23.64,2,14,40830,40851,12,"83.33%","83.33%","Peve_00013326",-0.997240786263881,0.0473028929719221,0.942326285748566,"D4G3R4","tRNA(Glu)-specific nuclease WapA (EC 3.1.-.-) (Cell wall-associated protein) (RNase WapA) (Toxin WapA)","Bacillus subtilis subsp. natto (strain BEST195)","tRNA catabolic process [GO:0016078]","GO:0004519; GO:0004549; GO:0005576; GO:0016078; GO:0090729"
"6257",6257,"Cluster_2882","Porites_evermani_scaffold_1998:17-68919",168,-24.13,2,21,26349,26370,19,"73.68%","84.21%","Peve_00013326",-0.997240786263881,0.0473028929719221,0.942326285748566,"D4G3R4","tRNA(Glu)-specific nuclease WapA (EC 3.1.-.-) (Cell wall-associated protein) (RNase WapA) (Toxin WapA)","Bacillus subtilis subsp. natto (strain BEST195)","tRNA catabolic process [GO:0016078]","GO:0004519; GO:0004549; GO:0005576; GO:0016078; GO:0090729"
"6301",6301,"Cluster_2882","Porites_evermani_scaffold_2171:10531-22046",147,-22.68,2,17,589,615,20,"70.00%","70.00%","Peve_00015249",-0.999160764172372,0.0260835984901328,0.881322544431866,"Q6P5D8","Structural maintenance of chromosomes flexible hinge domain-containing protein 1 (SMC hinge domain-containing protein 1) (EC 3.6.1.-)","Mus musculus (Mouse)","chromosome organization [GO:0051276]; dosage compensation by inactivation of X chromosome [GO:0009048]; double-strand break repair [GO:0006302]; inactivation of X chromosome by heterochromatin formation [GO:0060820]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; nose development [GO:0043584]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]","GO:0000781; GO:0001740; GO:0003677; GO:0005524; GO:0006302; GO:0009048; GO:0016887; GO:0035861; GO:0042803; GO:0043584; GO:0045739; GO:0051276; GO:0060820; GO:2000042; GO:2001034"
"6319",6319,"Cluster_2882","Porites_evermani_scaffold_224:183219-234014",160,-21.56,2,21,36607,36628,19,"68.42%","78.95%","Peve_00015953",-0.999740923544185,0.014491671178143,0.732730416382572,"Q99PF4","Cadherin-23 (Otocadherin)","Mus musculus (Mouse)","auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; photoreceptor cell maintenance [GO:0045494]; post-embryonic animal organ morphogenesis [GO:0048563]; regulation of cytosolic calcium ion concentration [GO:0051480]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]","GO:0001917; GO:0005509; GO:0005813; GO:0005886; GO:0006816; GO:0007155; GO:0007156; GO:0007605; GO:0007626; GO:0016339; GO:0016342; GO:0032420; GO:0032426; GO:0042472; GO:0042491; GO:0045177; GO:0045202; GO:0045296; GO:0045494; GO:0047485; GO:0048563; GO:0048839; GO:0050953; GO:0050957; GO:0051480; GO:0060088; GO:0060091; GO:0060122; GO:0098683; GO:0098684; GO:0098742"
"6378",6378,"Cluster_2882","Porites_evermani_scaffold_2459:26913-64864",164,-22.15,2,17,21733,21754,15,"80.00%","93.33%","Peve_00018009",-0.998541509666997,0.0343874282242607,0.909359886114279,"Q8R1A4","Dedicator of cytokinesis protein 7 (Protein moonlight)","Mus musculus (Mouse)","activation of GTPase activity [GO:0090630]; axonogenesis [GO:0007409]; establishment of neuroblast polarity [GO:0045200]; hematopoietic progenitor cell differentiation [GO:0002244]; interkinetic nuclear migration [GO:0022027]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of cold-induced thermogenesis [GO:0120163]; neuron projection development [GO:0031175]; pigmentation [GO:0043473]; positive regulation of GTPase activity [GO:0043547]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; postsynaptic specialization assembly [GO:0098698]; regulation of neurogenesis [GO:0050767]; small GTPase mediated signal transduction [GO:0007264]","GO:0000226; GO:0002244; GO:0005085; GO:0007264; GO:0007409; GO:0008180; GO:0022027; GO:0030424; GO:0031175; GO:0031267; GO:0031594; GO:0033138; GO:0043473; GO:0043547; GO:0045200; GO:0050767; GO:0090630; GO:0098698; GO:0120163; GO:1904754"
"6379",6379,"Cluster_2882","Porites_evermani_scaffold_2459:26913-64864",164,-22.59,2,17,19663,19684,15,"80.00%","93.33%","Peve_00018009",-0.998541509666997,0.0343874282242607,0.909359886114279,"Q8R1A4","Dedicator of cytokinesis protein 7 (Protein moonlight)","Mus musculus (Mouse)","activation of GTPase activity [GO:0090630]; axonogenesis [GO:0007409]; establishment of neuroblast polarity [GO:0045200]; hematopoietic progenitor cell differentiation [GO:0002244]; interkinetic nuclear migration [GO:0022027]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of cold-induced thermogenesis [GO:0120163]; neuron projection development [GO:0031175]; pigmentation [GO:0043473]; positive regulation of GTPase activity [GO:0043547]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; postsynaptic specialization assembly [GO:0098698]; regulation of neurogenesis [GO:0050767]; small GTPase mediated signal transduction [GO:0007264]","GO:0000226; GO:0002244; GO:0005085; GO:0007264; GO:0007409; GO:0008180; GO:0022027; GO:0030424; GO:0031175; GO:0031267; GO:0031594; GO:0033138; GO:0043473; GO:0043547; GO:0045200; GO:0050767; GO:0090630; GO:0098698; GO:0120163; GO:1904754"
"6398",6398,"Cluster_2882","Porites_evermani_scaffold_2559:127-45001",164,-22,2,19,34876,34901,21,"80.95%","80.95%","Peve_00018891",-0.999873054198373,0.0101439917288081,0.625864793275983,"Q5T4S7","E3 ubiquitin-protein ligase UBR4 (EC 2.3.2.27) (600 kDa retinoblastoma protein-associated factor) (N-recognin-4) (RING-type E3 ubiquitin transferase UBR4) (Retinoblastoma-associated factor of 600 kDa) (RBAF600) (p600) (Zinc finger UBR1-type protein 1)","Homo sapiens (Human)","ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0004842; GO:0005516; GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0006511; GO:0008270; GO:0016020; GO:0035579; GO:0061630; GO:0070821; GO:0101003"
"6402",6402,"Cluster_2882","Porites_evermani_scaffold_2564:58622-70051",158,-23.63,2,21,8369,8389,19,"68.42%","84.21%","Peve_00018941",-0.999999932848589,0.000233304273359623,0.13715989294074,"A3KP59","Ribosomal oxygenase 1 (Bifunctional lysine-specific demethylase and histidyl-hydroxylase NO66) (EC 1.14.11.-, EC 1.14.11.27) (Histone lysine demethylase NO66)","Danio rerio (Zebrafish) (Brachydanio rerio)","chromatin organization [GO:0006325]; histone H3-K36 demethylation [GO:0070544]; histone H3-K4 demethylation [GO:0034720]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of osteoblast differentiation [GO:0045668]","GO:0005506; GO:0005634; GO:0005654; GO:0005730; GO:0006325; GO:0016706; GO:0032453; GO:0034647; GO:0034720; GO:0036139; GO:0045668; GO:0045892; GO:0051864; GO:0070544; GO:0140457; GO:0140680"
"6437",6437,"Cluster_2882","Porites_evermani_scaffold_276:106814-111039",143,-21.94,2,21,1974,1998,22,"63.64%","63.64%","Peve_00020567",0.998597279659724,0.0337234072578845,0.909359886114279,"Q81E85","DEAD-box ATP-dependent RNA helicase CshC (EC 3.6.4.13)","Bacillus cereus (strain ATCC 14579 / DSM 31 / CCUG 7414 / JCM 2152 / NBRC 15305 / NCIMB 9373 / NCTC 2599 / NRRL B-3711)","ribosomal large subunit assembly [GO:0000027]","GO:0000027; GO:0003723; GO:0003724; GO:0005524; GO:0005829; GO:0016887; GO:0033592"
"6446",6446,"Cluster_2882","Porites_evermani_scaffold_28:238495-262304",162,-25.8,2,21,17262,17287,23,"73.91%","78.26%","Peve_00020859",-0.999908910369173,0.00859276408710134,0.575369165819932,"Q8CBC7",NA,NA,NA,NA
"6455",6455,"Cluster_2882","Porites_evermani_scaffold_28:789151-804875",160,-20.35,2,19,2427,2447,17,"82.35%","82.35%","Peve_00020888",-0.999989002458213,0.00298568048308791,0.468149337940133,"Q8N264","Rho GTPase-activating protein 24 (Filamin-A-associated RhoGAP) (FilGAP) (RAC1- and CDC42-specific GTPase-activating protein of 72 kDa) (RC-GAP72) (Rho-type GTPase-activating protein 24) (RhoGAP of 73 kDa) (Sarcoma antigen NY-SAR-88) (p73RhoGAP)","Homo sapiens (Human)","activation of GTPase activity [GO:0090630]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; negative regulation of Rac protein signal transduction [GO:0035021]; negative regulation of ruffle assembly [GO:1900028]; signal transduction [GO:0007165]; wound healing, spreading of epidermal cells [GO:0035313]","GO:0001525; GO:0005096; GO:0005737; GO:0005856; GO:0005912; GO:0005925; GO:0007165; GO:0030154; GO:0035021; GO:0035313; GO:0042995; GO:0090630; GO:1900028"
"6471",6471,"Cluster_2882","Porites_evermani_scaffold_2921:18650-57536",163,-22.39,2,21,31683,31705,20,"75.00%","80.00%","Peve_00021878",-0.99780584165499,0.0421801912909202,0.911235497295089,"E9Q634","Unconventional myosin-Ie (Unconventional myosin 1E)","Mus musculus (Mouse)","actin filament organization [GO:0007015]; endocytosis [GO:0006897]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; nitrogen compound metabolic process [GO:0006807]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; podocyte development [GO:0072015]; post-embryonic hemopoiesis [GO:0035166]; vasculogenesis [GO:0001570]; vesicle transport along actin filament [GO:0030050]","GO:0000146; GO:0001570; GO:0001701; GO:0001822; GO:0003094; GO:0005516; GO:0005524; GO:0005737; GO:0005856; GO:0005886; GO:0005902; GO:0005903; GO:0005912; GO:0006807; GO:0006897; GO:0007015; GO:0015629; GO:0016459; GO:0016887; GO:0030050; GO:0030097; GO:0031982; GO:0032437; GO:0032836; GO:0032991; GO:0035091; GO:0035166; GO:0044877; GO:0045334; GO:0048008; GO:0051015; GO:0072015"
"6538",6538,"Cluster_2882","Porites_evermani_scaffold_330:136308-194123",168,-23.03,2,18,43508,43530,17,"88.24%","88.24%","Peve_00024666",-0.997381924336928,0.0460766625438826,0.935575984585431,"B3DLH6","Myoferlin (Fer-1-like protein 3)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","plasma membrane repair [GO:0001778]","GO:0001778; GO:0005543; GO:0005901; GO:0030659; GO:0031965; GO:0046872"
"6587",6587,"Cluster_2882","Porites_evermani_scaffold_3649:15466-25327",157,-22.73,2,16,3429,3449,14,"85.71%","92.86%","Peve_00026810",-0.999890968595625,0.0094010176895016,0.602954859488328,"P23359","Bone morphogenetic protein 7 (BMP-7) (Osteogenic protein 1) (OP-1)","Mus musculus (Mouse)","allantois development [GO:1905069]; ameloblast differentiation [GO:0036305]; anatomical structure formation involved in morphogenesis [GO:0048646]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; branching involved in salivary gland morphogenesis [GO:0060445]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac muscle tissue development [GO:0048738]; cardiac septum morphogenesis [GO:0060411]; cartilage development [GO:0051216]; cell development [GO:0048468]; cell population proliferation [GO:0008283]; cellular response to BMP stimulus [GO:0071773]; chorio-allantoic fusion [GO:0060710]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic skeletal joint morphogenesis [GO:0060272]; endocardial cushion formation [GO:0003272]; epithelial cell differentiation [GO:0030855]; eye development [GO:0001654]; heart trabecula morphogenesis [GO:0061384]; hindbrain development [GO:0030902]; kidney development [GO:0001822]; mesenchymal cell apoptotic process involved in nephron morphogenesis [GO:1901145]; mesenchymal cell differentiation [GO:0048762]; mesenchyme development [GO:0060485]; mesoderm formation [GO:0001707]; metanephric mesenchymal cell proliferation involved in metanephros development [GO:0072136]; metanephric mesenchyme morphogenesis [GO:0072133]; monocyte aggregation [GO:0070487]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell death [GO:0060548]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of glomerular mesangial cell proliferation [GO:0072125]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis [GO:0072040]; negative regulation of mitotic nuclear division [GO:0045839]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of phosphorylation [GO:0042326]; negative regulation of prostatic bud formation [GO:0060686]; nephrogenic mesenchyme morphogenesis [GO:0072134]; neural fold elevation formation [GO:0021502]; neuron projection morphogenesis [GO:0048812]; odontogenesis of dentin-containing tooth [GO:0042475]; ossification [GO:0001503]; pattern specification process [GO:0007389]; pericardium morphogenesis [GO:0003344]; pharyngeal system development [GO:0060037]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:1905312]; positive regulation of cell death [GO:0010942]; positive regulation of dendrite development [GO:1900006]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of hyaluranon cable assembly [GO:1900106]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to nucleus [GO:0034504]; regulation of branching involved in prostate gland morphogenesis [GO:0060687]; regulation of pathway-restricted SMAD protein phosphorylation [GO:0060393]; regulation of phosphorylation [GO:0042325]; response to estradiol [GO:0032355]; response to peptide hormone [GO:0043434]; response to vitamin D [GO:0033280]; salivary gland morphogenesis [GO:0007435]; SMAD protein signal transduction [GO:0060395]; steroid hormone mediated signaling pathway [GO:0043401]; tube morphogenesis [GO:0035239]; ureteric bud development [GO:0001657]","GO:0001503; GO:0001654; GO:0001657; GO:0001707; GO:0001822; GO:0003272; GO:0003344; GO:0005125; GO:0005615; GO:0007389; GO:0007411; GO:0007435; GO:0008083; GO:0008201; GO:0008283; GO:0008285; GO:0009880; GO:0009887; GO:0010628; GO:0010718; GO:0010800; GO:0010862; GO:0010942; GO:0021502; GO:0030326; GO:0030501; GO:0030509; GO:0030855; GO:0030858; GO:0030902; GO:0031982; GO:0032355; GO:0033280; GO:0034116; GO:0034504; GO:0035239; GO:0036305; GO:0042325; GO:0042326; GO:0042475; GO:0043065; GO:0043401; GO:0043407; GO:0043434; GO:0045665; GO:0045666; GO:0045669; GO:0045746; GO:0045786; GO:0045839; GO:0045892; GO:0045893; GO:0045944; GO:0048468; GO:0048593; GO:0048596; GO:0048646; GO:0048738; GO:0048754; GO:0048762; GO:0048812; GO:0050768; GO:0051216; GO:0060037; GO:0060272; GO:0060391; GO:0060393; GO:0060395; GO:0060411; GO:0060445; GO:0060485; GO:0060548; GO:0060686; GO:0060687; GO:0060710; GO:0061384; GO:0062023; GO:0070487; GO:0070700; GO:0071773; GO:0072040; GO:0072125; GO:0072133; GO:0072134; GO:0072136; GO:0090336; GO:1900006; GO:1900106; GO:1901145; GO:1905069; GO:1905312"
"6615",6615,"Cluster_2882","Porites_evermani_scaffold_38:182952-201689",174,-22.65,2,21,2736,2756,19,"84.21%","89.47%","Peve_00027615",-0.999570935117446,0.0186497122617979,0.78300471784633,"Q96RR1","Twinkle mtDNA helicase (EC 3.6.4.12) (Progressive external ophthalmoplegia 1 protein) (T7 gp4-like protein with intramitochondrial nucleoid localization) (T7-like mitochondrial DNA helicase) (Twinkle protein, mitochondrial)","Homo sapiens (Human)","cellular response to glucose stimulus [GO:0071333]; DNA unwinding involved in DNA replication [GO:0006268]; mitochondrial DNA replication [GO:0006264]; mitochondrial transcription [GO:0006390]; protein hexamerization [GO:0034214]","GO:0002020; GO:0003678; GO:0003697; GO:0005524; GO:0005739; GO:0005759; GO:0006264; GO:0006268; GO:0006390; GO:0016887; GO:0034214; GO:0042645; GO:0042802; GO:0043139; GO:0071333"
"6631",6631,"Cluster_2882","Porites_evermani_scaffold_3907:2267-24640",170,-20.69,2,20,16502,16524,19,"84.21%","84.21%","Peve_00028225",-0.99969815242718,0.0156422740231089,0.755785321447373,"Q9HAR2","Adhesion G protein-coupled receptor L3 (Calcium-independent alpha-latrotoxin receptor 3) (CIRL-3) (Latrophilin-3) (Lectomedin-3)","Homo sapiens (Human)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; G protein-coupled receptor signaling pathway [GO:0007186]; neuron migration [GO:0001764]; synapse assembly [GO:0007416]","GO:0001764; GO:0004930; GO:0005509; GO:0005886; GO:0005911; GO:0007166; GO:0007186; GO:0007189; GO:0007416; GO:0007420; GO:0016020; GO:0030246; GO:0030424; GO:0098742; GO:0098978"
"6641",6641,"Cluster_2882","Porites_evermani_scaffold_3969:1-6132",141,-22.36,2,21,2686,2717,29,"62.07%","65.52%","Peve_00028552",-0.997639910543261,0.0437466503137105,0.921378164792108,NA,NA,NA,NA,NA
"6692",6692,"Cluster_2882","Porites_evermani_scaffold_430:166239-198633",170,-24.01,2,20,2592,2614,19,"84.21%","84.21%","Peve_00030448",-0.999991617818975,0.00260659730591339,0.429142730253057,"Q15700","Disks large homolog 2 (Channel-associated protein of synapse-110) (Chapsyn-110) (Postsynaptic density protein PSD-93)","Homo sapiens (Human)","anterograde axonal protein transport [GO:0099641]; cell-cell adhesion [GO:0098609]; cellular response to potassium ion [GO:0035865]; chemical synaptic transmission [GO:0007268]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; retrograde axonal protein transport [GO:0099642]","GO:0004385; GO:0005829; GO:0005886; GO:0005912; GO:0007268; GO:0014069; GO:0016020; GO:0016323; GO:0019900; GO:0030054; GO:0031594; GO:0035865; GO:0043005; GO:0043113; GO:0043204; GO:0044224; GO:0045197; GO:0097120; GO:0098609; GO:0098839; GO:0099641; GO:0099642; GO:1904115"
"6704",6704,"Cluster_2882","Porites_evermani_scaffold_445:44312-67983",154,-20.85,2,15,10739,10760,13,"84.62%","84.62%","Peve_00031203",-0.999642836282204,0.0170153824605288,0.78115066833064,"Q9DC53","Copine-8 (Copine VIII)","Mus musculus (Mouse)","cellular response to calcium ion [GO:0071277]","GO:0005544; GO:0005886; GO:0046872; GO:0071277"
"6715",6715,"Cluster_2882","Porites_evermani_scaffold_455:32427-48166",148,-20.28,2,15,9020,9040,13,"84.62%","84.62%","Peve_00031656",-0.999987539024059,0.00317812958056457,0.486484762577909,"P18907","Sodium/potassium-transporting ATPase subunit alpha-1 (Sodium pump subunit alpha-1) (EC 7.2.2.13) (Na(+)/K(+) ATPase alpha-1 subunit)","Equus caballus (Horse)","cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of sodium ion transport [GO:0002028]; sodium ion export across plasma membrane [GO:0036376]","GO:0002028; GO:0005391; GO:0005524; GO:0005886; GO:0005890; GO:0006883; GO:0016020; GO:0016323; GO:0016887; GO:0019829; GO:0030007; GO:0030424; GO:0036376; GO:0042383; GO:0042470; GO:0046872; GO:1902600; GO:1990573"
"6726",6726,"Cluster_2882","Porites_evermani_scaffold_4676:11313-19478",151,-20.7,2,18,7032,7052,16,"75.00%","81.25%","Peve_00032212",-0.999999906350369,0.000275516847034453,0.158435603320091,"Q5ZMH1","Septin-2","Gallus gallus (Chicken)","cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; regulation of exocytosis [GO:0017157]; smoothened signaling pathway [GO:0007224]","GO:0003924; GO:0005525; GO:0005737; GO:0005819; GO:0005940; GO:0007224; GO:0008021; GO:0015630; GO:0017157; GO:0030496; GO:0031105; GO:0032153; GO:0032154; GO:0060090; GO:0060170; GO:0060271; GO:0061640"
"6739",6739,"Cluster_2882","Porites_evermani_scaffold_482:105217-125342",169,-23.14,2,20,1382,1402,18,"77.78%","94.44%","Peve_00032842",-0.998941963827773,0.0292875927972194,0.903929377050813,"Q60803","TNF receptor-associated factor 3 (EC 2.3.2.27) (CD40 receptor-associated factor 1) (CRAF1) (CD40-binding protein) (CD40BP) (RING-type E3 ubiquitin transferase TRAF3)","Mus musculus (Mouse)","apoptotic process [GO:0006915]; innate immune response [GO:0045087]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of JNK cascade [GO:0046330]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of cytokine production [GO:0001817]; regulation of defense response to virus [GO:0050688]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of interferon-beta production [GO:0032648]; regulation of proteolysis [GO:0030162]; Toll signaling pathway [GO:0008063]; toll-like receptor signaling pathway [GO:0002224]; tumor necrosis factor-mediated signaling pathway [GO:0033209]","GO:0001817; GO:0002224; GO:0005164; GO:0005739; GO:0005768; GO:0006915; GO:0008063; GO:0008270; GO:0009898; GO:0016740; GO:0019901; GO:0019903; GO:0030162; GO:0031625; GO:0031996; GO:0032088; GO:0032648; GO:0033209; GO:0035631; GO:0042802; GO:0042981; GO:0043122; GO:0045087; GO:0046330; GO:0050688; GO:0070534"
"6780",6780,"Cluster_2882","Porites_evermani_scaffold_529:151180-160920",140,-20.71,2,9,8460,8481,7,"100.00%","100.00%","Peve_00034689",-0.999903510444138,0.00884379702785195,0.584509800176466,"Q99042","D-amino-acid oxidase (DAAO) (DAMOX) (DAO) (EC 1.4.3.3)","Trigonopsis variabilis (Yeast)","D-amino acid metabolic process [GO:0046416]","GO:0003884; GO:0046416; GO:0071949"
"6781",6781,"Cluster_2882","Porites_evermani_scaffold_529:151180-160920",152,-22.44,2,19,985,1009,20,"75.00%","75.00%","Peve_00034689",-0.999903510444138,0.00884379702785195,0.584509800176466,"Q99042","D-amino-acid oxidase (DAAO) (DAMOX) (DAO) (EC 1.4.3.3)","Trigonopsis variabilis (Yeast)","D-amino acid metabolic process [GO:0046416]","GO:0003884; GO:0046416; GO:0071949"
"6785",6785,"Cluster_2882","Porites_evermani_scaffold_534:23666-90765",155,-20.95,2,16,54061,54082,14,"78.57%","85.71%","Peve_00034882",-0.998997016836603,0.0285153198965821,0.903929377050813,"B3EWZ3","Coadhesin","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0016020"
"6849",6849,"Cluster_2882","Porites_evermani_scaffold_60:344976-352149",142,-20.2,2,21,1089,1116,25,"60.00%","68.00%","Peve_00037061",0.999255631731733,0.0245649559507044,0.862975589709272,"Q92820","Gamma-glutamyl hydrolase (EC 3.4.19.9) (Conjugase) (GH) (Gamma-Glu-X carboxypeptidase)","Homo sapiens (Human)","tetrahydrofolylpolyglutamate metabolic process [GO:0046900]","GO:0005576; GO:0005615; GO:0005634; GO:0005773; GO:0008238; GO:0008242; GO:0034722; GO:0035578; GO:0035580; GO:0042470; GO:0046900; GO:0070062; GO:1904724"
"6946",6946,"Cluster_2882","Porites_evermani_scaffold_757:5675-31498",155,-22.05,2,17,475,497,16,"75.00%","87.50%","Peve_00040799",-0.99996501950937,0.00532487399178108,0.551398425649056,"O75970","Multiple PDZ domain protein (Multi-PDZ domain protein 1)","Homo sapiens (Human)","","GO:0005737; GO:0005923; GO:0008022; GO:0014069; GO:0016324; GO:0016327; GO:0030425"
"6947",6947,"Cluster_2882","Porites_evermani_scaffold_757:5675-31498",155,-22.05,2,17,9905,9927,16,"75.00%","87.50%","Peve_00040799",-0.99996501950937,0.00532487399178108,0.551398425649056,"O75970","Multiple PDZ domain protein (Multi-PDZ domain protein 1)","Homo sapiens (Human)","","GO:0005737; GO:0005923; GO:0008022; GO:0014069; GO:0016324; GO:0016327; GO:0030425"
"6952",6952,"Cluster_2882","Porites_evermani_scaffold_768:75432-87644",153,-21.7,2,14,6653,6674,12,"83.33%","91.67%","Peve_00041006",-0.998514567283615,0.0347036686074603,0.909359886114279,NA,NA,NA,NA,NA
"6953",6953,"Cluster_2882","Porites_evermani_scaffold_769:80118-96385",142,-20.86,2,21,6869,6897,26,"61.54%","65.38%","Peve_00041032",-0.999687299962528,0.0159210022998918,0.76221148641831,"Q9NZB2","Constitutive coactivator of PPAR-gamma-like protein 1 (Oxidative stress-associated Src activator) (Protein FAM120A)","Homo sapiens (Human)","","GO:0003723; GO:0005634; GO:0005829; GO:0005886; GO:0016020"
"7030",7030,"Cluster_2882","Porites_evermani_scaffold_9:229073-242928",161,-22.53,2,21,6531,6555,22,"72.73%","86.36%","Peve_00043688",-0.997831704073983,0.0419307762257842,0.910014395738592,"Q6NXT4","Zinc transporter 6 (ZnT-6) (Solute carrier family 30 member 6)","Homo sapiens (Human)","cellular zinc ion homeostasis [GO:0006882]; insulin processing [GO:0030070]; regulation of zinc ion transport [GO:0071579]; zinc ion import into Golgi lumen [GO:1904257]; zinc ion import into organelle [GO:0062111]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829]","GO:0000139; GO:0005385; GO:0005794; GO:0006829; GO:0006882; GO:0015297; GO:0030070; GO:0032588; GO:0062111; GO:0071577; GO:0071579; GO:1904257"
"7031",7031,"Cluster_2882","Porites_evermani_scaffold_926:58294-77033",172,-21.28,2,21,11847,11868,19,"78.95%","84.21%","Peve_00044203",0.998347468552471,0.0366041066840402,0.909359886114279,"P28749","Retinoblastoma-like protein 1 (107 kDa retinoblastoma-associated protein) (p107) (pRb1)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of cellular senescence [GO:2000773]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of lipid kinase activity [GO:0043550]","GO:0000122; GO:0000785; GO:0000977; GO:0005654; GO:0005667; GO:0006325; GO:0007049; GO:0010629; GO:0030154; GO:0043550; GO:1990841; GO:2000134; GO:2000773"
"7043",7043,"Cluster_2882","Porites_evermani_scaffold_95:120248-147568",167,-20.16,2,21,11883,11906,21,"76.19%","80.95%","Peve_00044546",-0.997859033802024,0.0416655904526033,0.909359886114279,"Q95LD9","Aryl hydrocarbon receptor (Ah receptor) (AhR)","Delphinapterus leucas (Beluga whale)","cAMP-mediated signaling [GO:0019933]; cell cycle [GO:0007049]; cellular response to 2,3,7,8-tetrachlorodibenzodioxine [GO:1904613]; cellular response to cAMP [GO:0071320]; cellular response to forskolin [GO:1904322]; circadian regulation of gene expression [GO:0032922]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of T cell mediated immune response to tumor cell [GO:0002841]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of adaptive immune response [GO:0002819]; regulation of B cell proliferation [GO:0030888]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]","GO:0001094; GO:0001223; GO:0002819; GO:0002841; GO:0004879; GO:0005634; GO:0005737; GO:0005829; GO:0007049; GO:0009410; GO:0009636; GO:0017025; GO:0019933; GO:0030888; GO:0032922; GO:0034753; GO:0045892; GO:0045893; GO:0045944; GO:0046982; GO:0051879; GO:0060090; GO:0061629; GO:0070888; GO:0071320; GO:1904322; GO:1904613; GO:1990837"
"7108",7108,"Cluster_29","Porites_evermani_scaffold_120:142812-148604",161,-20.72,2,20,2997,3017,18,"66.67%","94.44%","Peve_00003393",0.999030167120238,0.0280400431950666,0.900780957733848,NA,NA,NA,NA,NA
"7120",7120,"Cluster_29","Porites_evermani_scaffold_1255:136174-139081",155,-20.04,2,20,2429,2450,18,"61.11%","83.33%","Peve_00004159",0.99948900137754,0.0203527679413273,0.810097073649321,NA,NA,NA,NA,NA
"7155",7155,"Cluster_29","Porites_evermani_scaffold_140:71750-95921",169,-22.58,2,21,17104,17128,22,"81.82%","86.36%","Peve_00006246",-0.997689878763426,0.0432808865951937,0.918486173374404,NA,NA,NA,NA,NA
"7197",7197,"Cluster_29","Porites_evermani_scaffold_167:325285-362801",161,-20.96,2,21,22089,22110,20,"75.00%","85.00%","Peve_00009613",0.997569389923622,0.0443956862719401,0.926596703746095,"P27694","Replication protein A 70 kDa DNA-binding subunit (RP-A p70) (Replication factor A protein 1) (RF-A protein 1) (Single-stranded DNA-binding protein) [Cleaved into: Replication protein A 70 kDa DNA-binding subunit, N-terminally processed]","Homo sapiens (Human)","base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; DNA-templated DNA replication [GO:0006261]; double-strand break repair via homologous recombination [GO:0000724]; meiotic cell cycle [GO:0051321]; mismatch repair [GO:0006298]; nucleotide-excision repair [GO:0006289]; protein localization to chromosome [GO:0034502]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]","GO:0000723; GO:0000724; GO:0000781; GO:0003684; GO:0003697; GO:0005634; GO:0005654; GO:0005662; GO:0006260; GO:0006261; GO:0006268; GO:0006281; GO:0006284; GO:0006289; GO:0006298; GO:0006310; GO:0006974; GO:0007004; GO:0016605; GO:0034502; GO:0043047; GO:0046872; GO:0051321; GO:0090734; GO:0098505"
"7236",7236,"Cluster_29","Porites_evermani_scaffold_1901:22-69153",165,-20.56,2,14,36526,36547,12,"100.00%","100.00%","Peve_00012313",-0.997746845316925,0.0427437088338936,0.91504584599282,"Q4G0P3","Hydrocephalus-inducing protein homolog","Homo sapiens (Human)","axonemal central apparatus assembly [GO:1904158]; cilium movement [GO:0003341]; epithelial cell development [GO:0002064]; trachea development [GO:0060438]; ventricular system development [GO:0021591]","GO:0002064; GO:0003341; GO:0005930; GO:0021591; GO:0060438; GO:1904158; GO:1990716; GO:1990718"
"7237",7237,"Cluster_29","Porites_evermani_scaffold_1901:22-69153",178,-23.22,2,21,46170,46190,19,"84.21%","94.74%","Peve_00012313",-0.997746845316925,0.0427437088338936,0.91504584599282,"Q4G0P3","Hydrocephalus-inducing protein homolog","Homo sapiens (Human)","axonemal central apparatus assembly [GO:1904158]; cilium movement [GO:0003341]; epithelial cell development [GO:0002064]; trachea development [GO:0060438]; ventricular system development [GO:0021591]","GO:0002064; GO:0003341; GO:0005930; GO:0021591; GO:0060438; GO:1904158; GO:1990716; GO:1990718"
"7244",7244,"Cluster_29","Porites_evermani_scaffold_1960:13010-25582",159,-22.31,2,21,10070,10093,21,"71.43%","76.19%","Peve_00012947",-0.998676166610317,0.0327611930500019,0.909359886114279,NA,NA,NA,NA,NA
"7281",7281,"Cluster_29","Porites_evermani_scaffold_22:239407-250280",157,-20.87,2,19,3660,3685,21,"71.43%","76.19%","Peve_00015560",-0.999741680546707,0.0144704829734696,0.73240086229425,"Q8NBS9","Thioredoxin domain-containing protein 5 (EC 1.8.4.-) (EC 5.3.4.1) (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Thioredoxin-like protein p46)","Homo sapiens (Human)","negative regulation of apoptotic process [GO:0043066]; protein folding [GO:0006457]","GO:0003756; GO:0005576; GO:0005783; GO:0005788; GO:0006457; GO:0015035; GO:0035578; GO:0043066; GO:0043202; GO:0070062"
"7362",7362,"Cluster_29","Porites_evermani_scaffold_3002:9889-26587",172,-21.47,2,21,632,653,19,"73.68%","89.47%","Peve_00022650",-0.998728025936349,0.0321129567027359,0.907232568269296,"B8VIW9","Fibronectin type III domain-containing protein (Neuroglian-like protein)","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0016020"
"7483",7483,"Cluster_29","Porites_evermani_scaffold_45:406645-423219",171,-22.59,2,21,133,155,20,"75.00%","90.00%","Peve_00031470",0.998537239893341,0.0344377388061273,0.909359886114279,"Q8QHA5","DNA replication ATP-dependent helicase/nuclease DNA2 (DNA replication ATP-dependent helicase-like homolog) [Includes: DNA replication nuclease DNA2 (EC 3.1.-.-); DNA replication ATP-dependent helicase DNA2 (EC 3.6.4.12)]","Xenopus laevis (African clawed frog)","base-excision repair [GO:0006284]; DNA double-strand break processing [GO:0000729]; DNA replication [GO:0006260]; DNA replication checkpoint signaling [GO:0000076]; DNA replication, Okazaki fragment processing [GO:0033567]; DNA replication, removal of RNA primer [GO:0043137]; double-strand break repair via single-strand annealing [GO:0045002]; mitochondrial DNA replication [GO:0006264]; positive regulation of DNA replication [GO:0045740]","GO:0000076; GO:0000729; GO:0003677; GO:0003678; GO:0004518; GO:0005524; GO:0005634; GO:0005739; GO:0006260; GO:0006264; GO:0006284; GO:0016887; GO:0016890; GO:0017108; GO:0017116; GO:0033567; GO:0043137; GO:0043139; GO:0045002; GO:0045740; GO:0046872; GO:0051539"
"7501",7501,"Cluster_29","Porites_evermani_scaffold_4785:13908-20702",163,-20.88,2,18,4092,4112,16,"81.25%","93.75%","Peve_00032670",0.997330421307962,0.046527867385145,0.938457139308314,"P53041","Serine/threonine-protein phosphatase 5 (PP5) (EC 3.1.3.16) (Protein phosphatase T) (PP-T) (PPT)","Homo sapiens (Human)","DNA-templated transcription [GO:0006351]; double-strand break repair [GO:0006302]; MAPK cascade [GO:0000165]; mitotic cell cycle [GO:0000278]; peptidyl-serine dephosphorylation [GO:0070262]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein dephosphorylation [GO:0006470]; response to arachidonic acid [GO:1904550]; response to lead ion [GO:0010288]; response to morphine [GO:0043278]","GO:0000165; GO:0000278; GO:0003723; GO:0004721; GO:0004722; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006302; GO:0006351; GO:0006470; GO:0008289; GO:0010288; GO:0016791; GO:0017018; GO:0032991; GO:0035970; GO:0042802; GO:0043123; GO:0043231; GO:0043278; GO:0043531; GO:0046872; GO:0048156; GO:0051879; GO:0060090; GO:0070262; GO:0101031; GO:1904550"
"7528",7528,"Cluster_29","Porites_evermani_scaffold_5225:6727-14487",161,-20.21,2,20,6992,7012,18,"77.78%","83.33%","Peve_00034473",-0.999931280904205,0.00746339326112324,0.573710369894872,"Q2TBV1","Replication factor C subunit 3 (Activator 1 38 kDa subunit) (A1 38 kDa subunit) (Activator 1 subunit 3) (Replication factor C 38 kDa subunit) (RF-C 38 kDa subunit) (RFC38)","Bos taurus (Bovine)","DNA repair [GO:0006281]; DNA-templated DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; response to organophosphorus [GO:0046683]","GO:0003677; GO:0003689; GO:0005634; GO:0005663; GO:0006261; GO:0006281; GO:0017116; GO:0031390; GO:0046683; GO:1900264"
"7550",7550,"Cluster_29","Porites_evermani_scaffold_57:492821-508267",148,-20.28,2,13,7286,7307,11,"81.82%","90.91%","Peve_00036084",0.997252198201742,0.0472049257556936,0.941841739843215,"P41247","Patatin-like phospholipase domain-containing protein 4 (EC 3.1.1.3) (Calcium-independent phospholipase A2-eta) (iPLA2-eta) (EC 3.1.1.4) (Protein GS2)","Homo sapiens (Human)","lipid homeostasis [GO:0055088]; triglyceride catabolic process [GO:0019433]","GO:0004623; GO:0004806; GO:0005737; GO:0005739; GO:0005811; GO:0005829; GO:0016020; GO:0016411; GO:0019433; GO:0047376; GO:0050253; GO:0051264; GO:0051265; GO:0055088"
"7597",7597,"Cluster_29","Porites_evermani_scaffold_70:586045-623686",164,-20.73,2,21,18980,19002,21,"80.95%","85.71%","Peve_00039612",0.998791189124848,0.0313053135571202,0.903929377050813,"Q5F364","Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter)","Gallus gallus (Chicken)","glutathione transmembrane transport [GO:0034775]; lipid transport [GO:0006869]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]","GO:0005524; GO:0006869; GO:0008559; GO:0016020; GO:0016323; GO:0016887; GO:0034634; GO:0034775; GO:0042626; GO:0042908; GO:0055085"
"7618",7618,"Cluster_29","Porites_evermani_scaffold_787:56996-62330",151,-20.57,2,21,1814,1837,21,"66.67%","71.43%","Peve_00041444",0.999173782819429,0.0258804687412055,0.878621033485623,NA,NA,NA,NA,NA
"7693",7693,"Cluster_4079","Porites_evermani_scaffold_1:1435394-1450173",144,-21.1,2,14,12511,12533,13,"76.92%","84.62%","Peve_00000079",-0.99896049267317,0.0290299659456012,0.903929377050813,"Q9UBX3","Mitochondrial dicarboxylate carrier (DIC) (Solute carrier family 25 member 10)","Homo sapiens (Human)","dicarboxylic acid transport [GO:0006835]; gluconeogenesis [GO:0006094]; ion transport [GO:0006811]; lipid transport [GO:0006869]; malate transmembrane transport [GO:0071423]; mitochondrial transport [GO:0006839]; oxaloacetate transport [GO:0015729]; phosphate ion transmembrane transport [GO:0035435]; succinate transmembrane transport [GO:0071422]; sulfate transport [GO:0008272]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]; thiosulfate transport [GO:0015709]","GO:0005310; GO:0005634; GO:0005654; GO:0005739; GO:0005743; GO:0006094; GO:0006811; GO:0006835; GO:0006839; GO:0006869; GO:0008272; GO:0015114; GO:0015116; GO:0015117; GO:0015131; GO:0015140; GO:0015141; GO:0015297; GO:0015709; GO:0015729; GO:0022857; GO:0035435; GO:0070221; GO:0071422; GO:0071423"
"7714",7714,"Cluster_4079","Porites_evermani_scaffold_1207:17571-43139",155,-20.15,2,18,13273,13297,19,"73.68%","84.21%","Peve_00003488",-0.999800775330523,0.0127079029286043,0.693540545915765,"Q9ULI1","NACHT and WD repeat domain-containing protein 2 (Leucine-rich repeat and WD repeat-containing protein KIAA1239)","Homo sapiens (Human)","",""
"7733",7733,"Cluster_4079","Porites_evermani_scaffold_130:258006-289217",145,-21.25,2,20,9909,9929,18,"61.11%","77.78%","Peve_00004794",-0.997222211495177,0.0474619187732666,0.942888539658333,"P29476","Nitric oxide synthase, brain (EC 1.14.13.39) (BNOS) (Constitutive NOS) (NC-NOS) (NOS type I) (Neuronal NOS) (N-NOS) (nNOS) (Peptidyl-cysteine S-nitrosylase NOS1)","Rattus norvegicus (Rat)","aging [GO:0007568]; arginine catabolic process [GO:0006527]; behavioral response to cocaine [GO:0048148]; brain development [GO:0007420]; calcium ion transport [GO:0006816]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to growth factor stimulus [GO:0071363]; cellular response to mechanical stimulus [GO:0071260]; establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; female pregnancy [GO:0007565]; multicellular organismal response to stress [GO:0033555]; muscle contraction [GO:0006936]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood pressure [GO:0045776]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of heart contraction [GO:0045822]; negative regulation of hepatic stellate cell contraction [GO:0061875]; negative regulation of hydrolase activity [GO:0051346]; negative regulation of insulin secretion [GO:0046676]; negative regulation of iron ion transmembrane transport [GO:0034760]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of potassium ion transport [GO:0043267]; negative regulation of serotonin uptake [GO:0051612]; negative regulation of vasoconstriction [GO:0045906]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; peptidyl-cysteine S-nitrosylation [GO:0018119]; positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process [GO:0140196]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of guanylate cyclase activity [GO:0031284]; positive regulation of histone acetylation [GO:0035066]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neuron death [GO:1901216]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of sodium ion transmembrane transport [GO:1902307]; positive regulation of the force of heart contraction [GO:0098735]; positive regulation of transcription by RNA polymerase II [GO:0045944]; potassium ion transport [GO:0006813]; regulation of heart contraction [GO:0008016]; regulation of neurogenesis [GO:0050767]; regulation of postsynaptic membrane potential [GO:0060078]; regulation of sensory perception of pain [GO:0051930]; regulation of sodium ion transport [GO:0002028]; response to activity [GO:0014823]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to lead ion [GO:0010288]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to nitric oxide [GO:0071731]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; response to peptide hormone [GO:0043434]; response to vitamin E [GO:0033197]; retrograde trans-synaptic signaling by nitric oxide [GO:0098924]; striated muscle contraction [GO:0006941]; synaptic signaling by nitric oxide [GO:0099163]; vasodilation [GO:0042311]; xenobiotic catabolic process [GO:0042178]","GO:0001666; GO:0001917; GO:0002028; GO:0004517; GO:0005516; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005829; GO:0005856; GO:0005886; GO:0006527; GO:0006809; GO:0006813; GO:0006816; GO:0006936; GO:0006941; GO:0007263; GO:0007420; GO:0007565; GO:0007568; GO:0008016; GO:0008270; GO:0008285; GO:0009408; GO:0009725; GO:0010181; GO:0010243; GO:0010288; GO:0012506; GO:0014069; GO:0014070; GO:0014823; GO:0016020; GO:0016491; GO:0016529; GO:0017080; GO:0018119; GO:0019899; GO:0020037; GO:0030018; GO:0030141; GO:0030315; GO:0030425; GO:0031284; GO:0031667; GO:0031965; GO:0032496; GO:0032991; GO:0033017; GO:0033137; GO:0033138; GO:0033197; GO:0033555; GO:0034760; GO:0035066; GO:0035094; GO:0042178; GO:0042311; GO:0042383; GO:0042582; GO:0042802; GO:0043066; GO:0043197; GO:0043267; GO:0043434; GO:0043524; GO:0043627; GO:0044305; GO:0044325; GO:0045121; GO:0045184; GO:0045202; GO:0045471; GO:0045776; GO:0045822; GO:0045893; GO:0045906; GO:0045944; GO:0046676; GO:0046870; GO:0048148; GO:0048306; GO:0048471; GO:0050660; GO:0050661; GO:0050767; GO:0051117; GO:0051219; GO:0051346; GO:0051481; GO:0051612; GO:0051649; GO:0051926; GO:0051930; GO:0060078; GO:0061875; GO:0070402; GO:0071260; GO:0071363; GO:0071731; GO:0071872; GO:0071944; GO:0097110; GO:0098735; GO:0098924; GO:0098978; GO:0099091; GO:0099092; GO:0099163; GO:0140196; GO:1900273; GO:1901216; GO:1902307"
"7768",7768,"Cluster_4079","Porites_evermani_scaffold_144:48875-68291",149,-20.06,2,20,6617,6642,22,"63.64%","77.27%","Peve_00006710",-0.999870677820193,0.0102384994051752,0.627878635187842,NA,NA,NA,NA,NA
"7785",7785,"Cluster_4079","Porites_evermani_scaffold_1513:34009-40174",166,-20.87,2,21,1416,1436,19,"78.95%","84.21%","Peve_00007704",0.999470091301485,0.0207259680810419,0.814976186752212,"Q8CIV7","Transcription factor Ovo-like 2 (mOvo2) (Zinc finger OVO2) (Zinc finger protein 339) (Zinc finger protein mOVO)","Mus musculus (Mouse)","angiogenesis [GO:0001525]; cell population proliferation [GO:0008283]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dorsal/ventral pattern formation [GO:0009953]; embryonic digestive tract morphogenesis [GO:0048557]; endocardium formation [GO:0060214]; epidermal cell differentiation [GO:0009913]; epidermis development [GO:0008544]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula formation [GO:0060347]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of gene expression [GO:0010629]; negative regulation of keratinocyte differentiation [GO:0045617]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transcription by competitive promoter binding [GO:0010944]; neural crest cell migration [GO:0001755]; neural fold formation [GO:0001842]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; regulation of cell cycle [GO:0051726]; regulation of keratinocyte proliferation [GO:0010837]; regulation of SMAD protein signal transduction [GO:0060390]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0001525; GO:0001755; GO:0001842; GO:0001947; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0006357; GO:0007507; GO:0008283; GO:0008285; GO:0008544; GO:0009913; GO:0009953; GO:0010628; GO:0010629; GO:0010719; GO:0010837; GO:0010944; GO:0045617; GO:0045618; GO:0045746; GO:0046872; GO:0048557; GO:0051726; GO:0060214; GO:0060347; GO:0060390; GO:0060716; GO:0071560; GO:1990837; GO:2000647"
"7791",7791,"Cluster_4079","Porites_evermani_scaffold_153:121627-142499",178,-26.11,2,19,5098,5119,17,"82.35%","100.00%","Peve_00007872",-0.998303813951919,0.0370845719252309,0.909359886114279,"Q68F70","Integrator complex subunit 4 (Int4)","Xenopus laevis (African clawed frog)","","GO:0005634"
"7802",7802,"Cluster_4079","Porites_evermani_scaffold_156:281125-332895",143,-21.97,2,21,28195,28222,25,"60.00%","64.00%","Peve_00008249",0.999637653688134,0.0171383953926177,0.782669382293497,"Q8AV57","Protein sidekick-2","Gallus gallus (Chicken)","camera-type eye photoreceptor cell differentiation [GO:0060219]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]","GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0042802; GO:0045202; GO:0060219"
"7868",7868,"Cluster_4079","Porites_evermani_scaffold_1927:71176-71917",152,-21.35,2,21,32,53,19,"63.16%","73.68%","Peve_00012577",0.999637962480495,0.0171310907052322,0.782669382293497,NA,NA,NA,NA,NA
"7880",7880,"Cluster_4079","Porites_evermani_scaffold_1999:61686-88859",150,-20.36,2,11,16791,16812,9,"100.00%","100.00%","Peve_00013338",-0.99990357816145,0.00884069310177129,0.584362857011891,"Q96JG6","Syndetin (Coiled-coil domain-containing protein 132) (EARP/GARPII complex subunit VPS50)","Homo sapiens (Human)","endocytic recycling [GO:0032456]; protein transport [GO:0015031]","GO:0000149; GO:0015031; GO:0016020; GO:0032456; GO:0048471; GO:0055037; GO:0070062; GO:1990745"
"7891",7891,"Cluster_4079","Porites_evermani_scaffold_2067:75247-87223",170,-23.95,2,20,3804,3826,19,"78.95%","89.47%","Peve_00014208",-0.999976270387259,0.00438572407632336,0.54328949385489,"Q3UQ28","Peroxidasin homolog (EC 1.11.2.-) [Cleaved into: PXDN active fragment]","Mus musculus (Mouse)","angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; hydrogen peroxide catabolic process [GO:0042744]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979]","GO:0001525; GO:0001654; GO:0004601; GO:0005201; GO:0005604; GO:0005615; GO:0005783; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0030198; GO:0030199; GO:0031012; GO:0042744; GO:0043237; GO:0046872; GO:0051260; GO:0062023; GO:0070207; GO:0070831; GO:0071711; GO:0140825"
"7902",7902,"Cluster_4079","Porites_evermani_scaffold_210:297886-324065",146,-21.21,2,21,11519,11539,19,"63.16%","73.68%","Peve_00014607",-0.999140905722226,0.0263904399617349,0.884795287459298,"Q8K370","Acyl-CoA dehydrogenase family member 10 (ACAD-10) (EC 1.3.99.-)","Mus musculus (Mouse)","fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]","GO:0003995; GO:0005737; GO:0005739; GO:0033539; GO:0050660"
"7947",7947,"Cluster_4079","Porites_evermani_scaffold_2464:6167-42356",148,-20.43,2,20,8025,8044,18,"66.67%","77.78%","Peve_00018051",-0.998721687740386,0.0321928830822343,0.907987904402525,"Q92072","DNA (cytosine-5)-methyltransferase 1 (Dnmt1) (EC 2.1.1.37) (DNA methyltransferase GgaI) (DNA MTase GgaI) (M.GgaI) (MCMT)","Gallus gallus (Chicken)","positive regulation of DNA methylation-dependent heterochromatin formation [GO:0090309]","GO:0003677; GO:0003886; GO:0005634; GO:0008270; GO:0090309; GO:1990841"
"7973",7973,"Cluster_4079","Porites_evermani_scaffold_2761:25878-48089",163,-23.36,2,20,956,977,18,"72.22%","83.33%","Peve_00020593",-0.999401709222497,0.0220228200533377,0.831702977566352,"Q53QZ3","Rho GTPase-activating protein 15 (ArhGAP15) (Rho-type GTPase-activating protein 15)","Homo sapiens (Human)","regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]","GO:0005096; GO:0005737; GO:0005829; GO:0007165; GO:0008360; GO:0016020; GO:0043087; GO:0051056"
"7989",7989,"Cluster_4079","Porites_evermani_scaffold_2875:24908-28459",150,-20.36,2,11,3021,3042,9,"100.00%","100.00%","Peve_00021480",-0.999949503052708,0.00639778307294428,0.573710369894872,"Q5PRC1","LHFPL tetraspan subfamily member 6 protein","Danio rerio (Zebrafish) (Brachydanio rerio)","","GO:0016020"
"8046",8046,"Cluster_4079","Porites_evermani_scaffold_3:269835-415931",150,-20.84,2,16,84119,84142,16,"68.75%","87.50%","Peve_00022405",-0.999648379930316,0.0168828077485472,0.778762172672388,"Q80TQ5","Pleckstrin homology domain-containing family M member 2 (PH domain-containing family M member 2)","Mus musculus (Mouse)","autophagosome-lysosome fusion [GO:0061909]; Golgi organization [GO:0007030]; late endosome to lysosome transport [GO:1902774]; lysosome localization [GO:0032418]; natural killer cell mediated cytotoxicity [GO:0042267]; positive regulation of membrane tubulation [GO:1903527]; regulation of protein localization [GO:0032880]","GO:0005764; GO:0005765; GO:0007030; GO:0010008; GO:0019894; GO:0032418; GO:0032880; GO:0042267; GO:0044754; GO:0061909; GO:1902774; GO:1903527"
"8047",8047,"Cluster_4079","Porites_evermani_scaffold_3:269835-415931",179,-23.85,2,20,35301,35322,18,"88.89%","88.89%","Peve_00022405",-0.999648379930316,0.0168828077485472,0.778762172672388,"Q80TQ5","Pleckstrin homology domain-containing family M member 2 (PH domain-containing family M member 2)","Mus musculus (Mouse)","autophagosome-lysosome fusion [GO:0061909]; Golgi organization [GO:0007030]; late endosome to lysosome transport [GO:1902774]; lysosome localization [GO:0032418]; natural killer cell mediated cytotoxicity [GO:0042267]; positive regulation of membrane tubulation [GO:1903527]; regulation of protein localization [GO:0032880]","GO:0005764; GO:0005765; GO:0007030; GO:0010008; GO:0019894; GO:0032418; GO:0032880; GO:0042267; GO:0044754; GO:0061909; GO:1902774; GO:1903527"
"8131",8131,"Cluster_4079","Porites_evermani_scaffold_4106:3041-24134",148,-20.23,2,18,14132,14154,17,"64.71%","82.35%","Peve_00029427",-0.999890925187699,0.00940288891868048,0.602964340913104,"P16157","Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin)","Homo sapiens (Human)","cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]","GO:0005198; GO:0005200; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0014731; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030507; GO:0031430; GO:0043005; GO:0044325; GO:0045199; GO:0051117; GO:0072659"
"8196",8196,"Cluster_4079","Porites_evermani_scaffold_510:170745-183739",158,-21.05,2,17,2275,2298,17,"82.35%","88.24%","Peve_00034064",0.999679374900727,0.0161215013418805,0.766332216045467,"Q9JLG8","Calpain-15 (EC 3.4.22.-) (Small optic lobes homolog)","Mus musculus (Mouse)","proteolysis [GO:0006508]","GO:0004198; GO:0005737; GO:0006508; GO:0046872"
"8230",8230,"Cluster_4079","Porites_evermani_scaffold_573:169644-195805",160,-20.26,2,20,3028,3052,21,"76.19%","85.71%","Peve_00036216",-0.997122511412326,0.0483065609820818,0.946322577595136,"Q5VU97","VWFA and cache domain-containing protein 1 (Cache domain-containing protein 1)","Homo sapiens (Human)","","GO:0005245; GO:0005891"
"8248",8248,"Cluster_4079","Porites_evermani_scaffold_6075:221-8035",176,-27.94,2,21,3716,3737,19,"73.68%","94.74%","Peve_00037268",-0.998526996122875,0.0345581424096249,0.909359886114279,"Q10751","Angiotensin-converting enzyme (ACE) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II)","Gallus gallus (Chicken)","angiotensin maturation [GO:0002003]; bradykinin catabolic process [GO:0010815]; cell population proliferation [GO:0008283]; hormone catabolic process [GO:0042447]; hormone metabolic process [GO:0042445]; kidney development [GO:0001822]; positive regulation of systemic arterial blood pressure [GO:0003084]; primitive erythrocyte differentiation [GO:0060319]; regulation of blood pressure [GO:0008217]; regulation of synaptic plasticity [GO:0048167]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; substance P catabolic process [GO:0010814]","GO:0001822; GO:0002003; GO:0003081; GO:0003084; GO:0004180; GO:0004222; GO:0005737; GO:0005886; GO:0008217; GO:0008237; GO:0008241; GO:0008270; GO:0008283; GO:0010814; GO:0010815; GO:0016020; GO:0031404; GO:0042445; GO:0042447; GO:0048167; GO:0060319; GO:0070573"
"8250",8250,"Cluster_4079","Porites_evermani_scaffold_610:32554-39796",171,-22.4,2,21,2639,2661,20,"75.00%","90.00%","Peve_00037364",-0.998597154918296,0.0337249070566547,0.909359886114279,"Q01460","Di-N-acetylchitobiase (EC 3.2.1.-)","Rattus norvegicus (Rat)","chitin catabolic process [GO:0006032]; oligosaccharide catabolic process [GO:0009313]","GO:0004568; GO:0005764; GO:0006032; GO:0008061; GO:0009313; GO:0016798"
"8311",8311,"Cluster_4079","Porites_evermani_scaffold_708:79952-100157",163,-20.09,2,16,13778,13799,14,"85.71%","92.86%","Peve_00039765",-0.997379354968361,0.0460992766018146,0.935872558354947,NA,NA,NA,NA,NA
"8346",8346,"Cluster_4079","Porites_evermani_scaffold_791:81686-117465",147,-20.94,2,21,18731,18753,20,"60.00%","75.00%","Peve_00041522",-0.999917309077773,0.0081870422438826,0.573710369894872,"O75581","Low-density lipoprotein receptor-related protein 6 (LRP-6)","Homo sapiens (Human)","canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in neural crest cell differentiation [GO:0044335]; canonical Wnt signaling pathway involved in regulation of cell proliferation [GO:0044340]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; chemical synaptic transmission [GO:0007268]; dopaminergic neuron differentiation [GO:0071542]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; response to peptide hormone [GO:0043434]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]; Wnt signaling pathway involved in somitogenesis [GO:0090244]","GO:0001933; GO:0005041; GO:0005102; GO:0005109; GO:0005576; GO:0005783; GO:0005886; GO:0006469; GO:0007204; GO:0007268; GO:0009986; GO:0014029; GO:0014033; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0031410; GO:0031901; GO:0034392; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043434; GO:0044335; GO:0044340; GO:0045121; GO:0045202; GO:0045787; GO:0045893; GO:0045944; GO:0051091; GO:0060070; GO:0071397; GO:0071542; GO:0071901; GO:0071936; GO:0072659; GO:0090118; GO:0090244; GO:0098609; GO:1904928; GO:1904948; GO:1904953; GO:1990851; GO:1990909"
"8348",8348,"Cluster_4079","Porites_evermani_scaffold_79:49265-88431",150,-21.58,2,19,6753,6774,17,"64.71%","76.47%","Peve_00041469",-0.998917582509894,0.029623181749673,0.903929377050813,"Q4U2V3","Cytosolic carboxypeptidase 1 (EC 3.4.17.-) (EC 3.4.17.24) (ATP/GTP-binding protein 1) (Protein deglutamylase CCP1)","Danio rerio (Zebrafish) (Brachydanio rerio)","C-terminal protein deglutamylation [GO:0035609]; cerebellar Purkinje cell differentiation [GO:0021702]; chordate embryonic development [GO:0043009]; eye photoreceptor cell differentiation [GO:0001754]; mitochondrion organization [GO:0007005]; neuromuscular process [GO:0050905]; olfactory bulb development [GO:0021772]; protein side chain deglutamylation [GO:0035610]; proteolysis [GO:0006508]; T cell differentiation in thymus [GO:0033077]","GO:0001754; GO:0004181; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006508; GO:0007005; GO:0008270; GO:0015631; GO:0021702; GO:0021772; GO:0033077; GO:0035609; GO:0035610; GO:0043009; GO:0050905"
"8384",8384,"Cluster_4079","Porites_evermani_scaffold_90:256169-269137",160,-21.51,2,17,7640,7661,15,"80.00%","86.67%","Peve_00043735",-0.997254902330616,0.0471816820647028,0.941693828213016,"Q96RW7","Hemicentin-1 (Fibulin-6) (FIBL-6)","Homo sapiens (Human)","actin filament reorganization [GO:0090527]; basement membrane organization [GO:0071711]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]","GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711; GO:0090527"
"8414",8414,"Cluster_4080","Porites_evermani_scaffold_1006:91430-107870",165,-22.19,2,18,6900,6921,16,"81.25%","87.50%","Peve_00000338",-0.999804588326262,0.0125857020309173,0.690230613076756,NA,NA,NA,NA,NA
"8460",8460,"Cluster_4080","Porites_evermani_scaffold_112:74240-91563",180,-25.28,2,21,14363,14384,19,"73.68%","100.00%","Peve_00002136",-0.999928334539756,0.00762171423750272,0.573710369894872,"Q6L9W6","Beta-1,4-N-acetylgalactosaminyltransferase 3 (B4GalNAcT3) (Beta4GalNAc-T3) (Beta4GalNAcT3) (EC 2.4.1.244) (Beta-1,4-N-acetylgalactosaminyltransferase III) (N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 2) (NGalNAc-T2)","Homo sapiens (Human)","","GO:0005794; GO:0008376; GO:0032580; GO:0033842; GO:0043231"
"8476",8476,"Cluster_4080","Porites_evermani_scaffold_11:537321-570703",167,-20.2,2,19,17347,17366,17,"88.24%","88.24%","Peve_00001724",0.998901289172471,0.0298453443927078,0.903929377050813,"Q9DBV3","Probable ATP-dependent RNA helicase DHX34 (EC 3.6.4.13) (DEAH box protein 34) (DExH-box helicase 34)","Mus musculus (Mouse)","negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of phosphorylation [GO:0042327]","GO:0000184; GO:0000956; GO:0003723; GO:0003724; GO:0005524; GO:0016887; GO:0042327; GO:0044877; GO:2000623"
"8479",8479,"Cluster_4080","Porites_evermani_scaffold_1162:38293-88512",142,-20.39,2,21,1951,1977,24,"62.50%","66.67%","Peve_00002773",0.997843062548644,0.0418207666049359,0.909453341483137,NA,NA,NA,NA,NA
"8533",8533,"Cluster_4080","Porites_evermani_scaffold_1355:50264-85030",166,-21.05,2,20,12079,12101,19,"73.68%","89.47%","Peve_00005576",-0.999254790480881,0.0245788348473907,0.863232416698613,"P16086","Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain)","Rattus norvegicus (Rat)","actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; actin filament capping [GO:0051693]","GO:0005509; GO:0005516; GO:0005829; GO:0005886; GO:0005916; GO:0008091; GO:0016020; GO:0016328; GO:0019905; GO:0030018; GO:0030036; GO:0030054; GO:0030507; GO:0030863; GO:0030864; GO:0031532; GO:0032437; GO:0032991; GO:0033010; GO:0033270; GO:0042995; GO:0044877; GO:0051015; GO:0051693; GO:0098794; GO:0098978"
"8555",8555,"Cluster_4080","Porites_evermani_scaffold_144:167117-228873",175,-22.05,2,20,6156,6177,18,"83.33%","88.89%","Peve_00006728",-0.999848093384746,0.0110965752378794,0.650674186418027,"Q9NYQ6","Cadherin EGF LAG seven-pass G-type receptor 1 (Cadherin family member 9) (Flamingo homolog 2) (hFmi2)","Homo sapiens (Human)","apical protein localization [GO:0045176]; cell-cell adhesion [GO:0098609]; central nervous system development [GO:0007417]; establishment of body hair planar orientation [GO:0048105]; establishment of planar polarity [GO:0001736]; establishment of planar polarity of embryonic epithelium [GO:0042249]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; lateral sprouting involved in lung morphogenesis [GO:0060490]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060488]; planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060489]; protein localization involved in establishment of planar polarity [GO:0090251]; regulation of actin cytoskeleton organization [GO:0032956]; Rho protein signal transduction [GO:0007266]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001736; GO:0001764; GO:0001843; GO:0004930; GO:0005509; GO:0005654; GO:0005886; GO:0007156; GO:0007266; GO:0007417; GO:0016020; GO:0032956; GO:0042249; GO:0045176; GO:0048105; GO:0060071; GO:0060488; GO:0060489; GO:0060490; GO:0090251; GO:0098609"
"8570",8570,"Cluster_4080","Porites_evermani_scaffold_14:840346-924774",163,-20.13,2,21,15131,15156,23,"73.91%","73.91%","Peve_00006196",0.998560855420922,0.0341585503936042,0.909359886114279,NA,NA,NA,NA,NA
"8584",8584,"Cluster_4080","Porites_evermani_scaffold_1530:70847-78697",159,-23.97,2,21,521,542,21,"80.95%","80.95%","Peve_00007902",0.997270750279292,0.0470452285126639,0.940564386922415,"Q9Y6N5","Sulfide:quinone oxidoreductase, mitochondrial (SQOR) (EC 1.8.5.8) (Sulfide dehydrogenase-like) (Sulfide quinone oxidoreductase)","Homo sapiens (Human)","sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]","GO:0005739; GO:0005743; GO:0048038; GO:0070221; GO:0070224; GO:0071949; GO:0106436"
"8675",8675,"Cluster_4080","Porites_evermani_scaffold_190:332317-341386",168,-23.1,2,19,796,816,17,"88.24%","88.24%","Peve_00012307",-0.999918356914133,0.00813500419649827,0.573710369894872,NA,NA,NA,NA,NA
"8690",8690,"Cluster_4080","Porites_evermani_scaffold_194:265460-274588",162,-21.71,2,21,82,108,24,"70.83%","79.17%","Peve_00012703",0.997227364175877,0.0474178580287118,0.942888539658333,"F1R345","ATP-dependent DNA helicase DDX11 (EC 3.6.4.12) (DEAD/H-box protein 11)","Danio rerio (Zebrafish) (Brachydanio rerio)","DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; establishment of sister chromatid cohesion [GO:0034085]; nucleolar chromatin organization [GO:1990700]; regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901836]; rRNA transcription [GO:0009303]","GO:0000922; GO:0003677; GO:0003678; GO:0003723; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0005815; GO:0006260; GO:0006281; GO:0009303; GO:0016887; GO:0030496; GO:0032508; GO:0034085; GO:0046872; GO:0051539; GO:1901836; GO:1990700"
"8692",8692,"Cluster_4080","Porites_evermani_scaffold_194:8111-23984",158,-21.55,2,21,2301,2319,19,"84.21%","84.21%","Peve_00012719",0.999429934477363,0.0214970141452558,0.825175158091499,"B6ELU0","tRNA-cytidine(32) 2-sulfurtransferase (EC 2.8.1.-) (Two-thiocytidine biosynthesis protein A) (tRNA 2-thiocytidine biosynthesis protein TtcA)","Aliivibrio salmonicida (strain LFI1238) (Vibrio salmonicida (strain LFI1238))","tRNA thio-modification [GO:0034227]","GO:0000049; GO:0000287; GO:0005524; GO:0005737; GO:0016783; GO:0034227; GO:0051539"
"8732",8732,"Cluster_4080","Porites_evermani_scaffold_2:1261429-1281199",170,-23.53,2,20,4244,4266,19,"84.21%","84.21%","Peve_00013409",-0.998898361532229,0.0298850883946755,0.903929377050813,NA,NA,NA,NA,NA
"8759",8759,"Cluster_4080","Porites_evermani_scaffold_2215:24564-43737",175,-23.87,2,20,19072,19093,18,"83.33%","88.89%","Peve_00015721",-0.999206561952058,0.0253618162499516,0.872109822299967,"P35546","Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment]","Mus musculus (Mouse)","activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; anatomical structure morphogenesis [GO:0009653]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657]","GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0006919; GO:0007156; GO:0007158; GO:0007169; GO:0007399; GO:0009410; GO:0009653; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030182; GO:0030335; GO:0030424; GO:0030425; GO:0033141; GO:0033619; GO:0033630; GO:0033674; GO:0035799; GO:0035860; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045121; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0098797; GO:2001241"
"8764",8764,"Cluster_4080","Porites_evermani_scaffold_2235:29131-35931",167,-21.08,2,21,2734,2757,21,"71.43%","85.71%","Peve_00015911",-0.999376658725259,0.0224791882994187,0.83791231209107,NA,NA,NA,NA,NA
"8796",8796,"Cluster_4080","Porites_evermani_scaffold_240:164428-169917",156,-20.29,2,21,535,557,21,"71.43%","85.71%","Peve_00017494",0.997741273347202,0.0427965479072764,0.915285127771048,NA,NA,NA,NA,NA
"8797",8797,"Cluster_4080","Porites_evermani_scaffold_242:182435-186693",164,-20.3,2,19,1606,1626,17,"82.35%","88.24%","Peve_00017682",-0.997058648097944,0.0488399400893447,0.948902825232569,NA,NA,NA,NA,NA
"8799",8799,"Cluster_4080","Porites_evermani_scaffold_2438:42952-48952",162,-21.73,2,16,4636,4658,15,"86.67%","93.33%","Peve_00017835",0.998633668363016,0.0332830137632564,0.909359886114279,NA,NA,NA,NA,NA
"8835",8835,"Cluster_4080","Porites_evermani_scaffold_2666:51020-63887",161,-20.51,2,21,3205,3226,20,"80.00%","80.00%","Peve_00019789",-0.999355096644234,0.0228647144397872,0.842545105232163,NA,NA,NA,NA,NA
"8875",8875,"Cluster_4080","Porites_evermani_scaffold_2944:29899-58501",153,-20.18,2,19,25718,25745,23,"65.22%","73.91%","Peve_00022013",-0.997406235601708,0.0458621382726491,0.934400033667991,"Q14BI7","ATP-dependent RNA helicase TDRD9 (EC 3.6.4.13) (Tudor domain-containing protein 9)","Mus musculus (Mouse)","cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; fertilization [GO:0009566]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of transposition [GO:0010529]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]","GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007140; GO:0007141; GO:0007283; GO:0009566; GO:0010529; GO:0016887; GO:0030154; GO:0034587; GO:0043046; GO:0071547"
"8984",8984,"Cluster_4080","Porites_evermani_scaffold_371:101316-161435",163,-21.19,2,21,11717,11739,20,"75.00%","80.00%","Peve_00027166",0.99929968757124,0.0238268365839392,0.854412577141166,"Q86TZ1","Tetratricopeptide repeat protein 6 (TPR repeat protein 6)","Homo sapiens (Human)","",""
"9007",9007,"Cluster_4080","Porites_evermani_scaffold_388:248085-269523",158,-20.63,2,21,4141,4164,21,"76.19%","76.19%","Peve_00028046",-0.998817341146261,0.0309647569613873,0.903929377050813,"P28476","Gamma-aminobutyric acid receptor subunit rho-2 (GABA(A) receptor subunit rho-2) (GABA(C) receptor)","Homo sapiens (Human)","chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; visual perception [GO:0007601]","GO:0004890; GO:0005231; GO:0005254; GO:0005886; GO:0007165; GO:0007214; GO:0007268; GO:0007601; GO:0019904; GO:0030594; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0098982; GO:1902476; GO:1902711; GO:1904315"
"9060",9060,"Cluster_4080","Porites_evermani_scaffold_449:100563-101796",163,-20.13,2,21,609,634,23,"73.91%","73.91%","Peve_00031400",-0.996950551911195,0.0497297376498826,0.9522653317698,NA,NA,NA,NA,NA
"9067",9067,"Cluster_4080","Porites_evermani_scaffold_4626:1265-21621",174,-21.59,2,21,2191,2211,19,"84.21%","89.47%","Peve_00032019",-0.999998527738398,0.00109241503020378,0.275560959970807,"Q4U0G1","CLIP-associating protein 1-A (Cytoplasmic linker-associated protein 1-A) (XCLASP1)","Xenopus laevis (African clawed frog)","cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule anchoring [GO:0034453]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; regulation of cellular component organization [GO:0051128]","GO:0000776; GO:0005794; GO:0005815; GO:0005819; GO:0005874; GO:0007020; GO:0007049; GO:0031023; GO:0034453; GO:0051128; GO:0051301"
"9106",9106,"Cluster_4080","Porites_evermani_scaffold_5162:7762-10377",160,-20.78,2,18,1796,1818,17,"76.47%","88.24%","Peve_00034256",-0.997042840627744,0.0489710670892613,0.949405675019865,"Q5GH73","XK-related protein 6","Homo sapiens (Human)","apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]","GO:0005886; GO:0016020; GO:0043652; GO:0070782; GO:1902742"
"9133",9133,"Cluster_4080","Porites_evermani_scaffold_56:403602-465666",160,-21.3,2,21,60275,60296,19,"63.16%","84.21%","Peve_00035796",-0.999045638011453,0.0278154591389635,0.899357024842471,"Q91ZX7","Prolow-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR) (CD antigen CD91) [Cleaved into: Low-density lipoprotein receptor-related protein 1 85 kDa subunit (LRP-85); Low-density lipoprotein receptor-related protein 1 515 kDa subunit (LRP-515); Low-density lipoprotein receptor-related protein 1 intracellular domain (LRPICD)]","Mus musculus (Mouse)","amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta clearance by transcytosis [GO:0150093]; aorta morphogenesis [GO:0035909]; apoptotic cell clearance [GO:0043277]; astrocyte activation involved in immune response [GO:0002265]; cardiac septum development [GO:0003279]; cell population proliferation [GO:0008283]; cellular lipid catabolic process [GO:0044242]; cellular response to amyloid-beta [GO:1904646]; chemoattraction of axon [GO:0061642]; cholesterol metabolic process [GO:0008203]; coronary vasculature development [GO:0060976]; enzyme-linked receptor protein signaling pathway [GO:0007167]; lysosomal transport [GO:0007041]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron projection development [GO:0010977]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of Wnt signaling pathway [GO:0030178]; phagocytosis [GO:0006909]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of axon extension [GO:0045773]; positive regulation of axon extension involved in regeneration [GO:0048691]; positive regulation of cell death [GO:0010942]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol import [GO:1904109]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of collateral sprouting of injured axon [GO:0048694]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lipid transport [GO:0032370]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein transport [GO:0051222]; positive regulation of Schwann cell migration [GO:1900149]; positive regulation of transcytosis [GO:1904300]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cholesterol transport [GO:0032374]; regulation of phospholipase A2 activity [GO:0032429]; regulation of pulmonary blood vessel remodeling [GO:1905109]; transport across blood-brain barrier [GO:0150104]","GO:0002020; GO:0002265; GO:0003279; GO:0005102; GO:0005509; GO:0005634; GO:0005768; GO:0005769; GO:0005794; GO:0005856; GO:0005886; GO:0005905; GO:0006898; GO:0006909; GO:0007041; GO:0007167; GO:0007204; GO:0007205; GO:0008203; GO:0008283; GO:0009897; GO:0010629; GO:0010812; GO:0010875; GO:0010942; GO:0010976; GO:0010977; GO:0014912; GO:0015026; GO:0016020; GO:0016323; GO:0016964; GO:0030136; GO:0030178; GO:0030425; GO:0030512; GO:0031623; GO:0032050; GO:0032092; GO:0032370; GO:0032374; GO:0032376; GO:0032429; GO:0032593; GO:0032956; GO:0034185; GO:0035774; GO:0035909; GO:0038024; GO:0043025; GO:0043066; GO:0043235; GO:0043277; GO:0043524; GO:0044242; GO:0044295; GO:0044877; GO:0045177; GO:0045773; GO:0045807; GO:0048691; GO:0048694; GO:0050766; GO:0051222; GO:0051481; GO:0051895; GO:0060392; GO:0060394; GO:0060548; GO:0060976; GO:0061642; GO:0062136; GO:0070374; GO:0097242; GO:0150093; GO:0150094; GO:0150104; GO:1900149; GO:1900223; GO:1903078; GO:1904109; GO:1904300; GO:1904646; GO:1904754; GO:1905109; GO:1905167; GO:2000343; GO:2000587"
"9176",9176,"Cluster_4080","Porites_evermani_scaffold_643:147717-174501",155,-20.48,2,21,20367,20391,22,"63.64%","77.27%","Peve_00038235",0.999939235636971,0.00701813624141062,0.573710369894872,NA,NA,NA,NA,NA
"9257",9257,"Cluster_4080","Porites_evermani_scaffold_841:77603-89852",170,-23.35,2,19,187,208,17,"76.47%","94.12%","Peve_00042598",0.999998740813851,0.00101027623087008,0.259287951467205,"Q8IYQ7","Threonine synthase-like 1 (TSH1)","Homo sapiens (Human)","","GO:0005737"
"9279",9279,"Cluster_4080","Porites_evermani_scaffold_907:33404-54517",162,-23.71,2,21,5620,5640,19,"73.68%","84.21%","Peve_00043869",-0.999525297608678,0.0196165672785278,0.799010461456448,"Q6P7A9","Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase)","Rattus norvegicus (Rat)","cardiac muscle contraction [GO:0060048]; diaphragm contraction [GO:0002086]; glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]; glycophagy [GO:0061723]; heart morphogenesis [GO:0003007]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; muscle cell cellular homeostasis [GO:0046716]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; regulation of the force of heart contraction [GO:0002026]; striated muscle contraction [GO:0006941]; tissue development [GO:0009888]; vacuolar sequestering [GO:0043181]","GO:0002026; GO:0002086; GO:0003007; GO:0004553; GO:0004558; GO:0005764; GO:0005765; GO:0005977; GO:0005980; GO:0006941; GO:0007040; GO:0007626; GO:0009888; GO:0016020; GO:0030246; GO:0032450; GO:0043181; GO:0043202; GO:0046716; GO:0050884; GO:0050885; GO:0060048; GO:0061723; GO:0090599; GO:0120282"
"9289",9289,"Cluster_4080","Porites_evermani_scaffold_925:98962-115569",171,-21.95,2,21,15769,15791,20,"80.00%","85.00%","Peve_00044186",-0.998724970832171,0.0321515071827361,0.907547563764044,"Q9GK13","Methylmalonyl-CoA mutase, mitochondrial (MCM) (EC 5.4.99.2) (Methylmalonyl-CoA isomerase)","Bos taurus (Bovine)","propionate metabolic process, methylmalonyl pathway [GO:0019678]","GO:0003924; GO:0004494; GO:0005737; GO:0005739; GO:0005759; GO:0019678; GO:0031419; GO:0042802; GO:0042803; GO:0046872"
"9315",9315,"Cluster_4080","Porites_evermani_scaffold_99:73447-80613",154,-20.07,2,20,5199,5225,23,"65.22%","73.91%","Peve_00045195",-0.999995246146368,0.0019629904910923,0.362847063101065,"O60235","Transmembrane protease serine 11D (EC 3.4.21.-) (Airway trypsin-like protease) [Cleaved into: Transmembrane protease serine 11D non-catalytic chain; Transmembrane protease serine 11D catalytic chain]","Homo sapiens (Human)","proteolysis [GO:0006508]; respiratory gaseous exchange by respiratory system [GO:0007585]","GO:0004252; GO:0005576; GO:0005886; GO:0006508; GO:0007585; GO:0008233; GO:0070062"
"9370",9370,"Cluster_4115","Porites_evermani_scaffold_1258:38743-63943",166,-20.09,2,20,15666,15688,19,"73.68%","89.47%","Peve_00004184",-0.999876450878514,0.0100073576944104,0.621311970928136,"D3ZTD8","Semaphorin-5A (Semaphorin-F) (Sema F)","Rattus norvegicus (Rat)","axon extension [GO:0048675]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; branching involved in blood vessel morphogenesis [GO:0001569]; branching morphogenesis of an epithelial tube [GO:0048754]; cell chemotaxis [GO:0060326]; detection of light stimulus involved in visual perception [GO:0050908]; diencephalon development [GO:0021536]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of cell adhesion [GO:0007162]; negative regulation of endothelial cell apoptotic process [GO:2000352]; neural crest cell migration [GO:0001755]; neuron projection extension [GO:1990138]; neuron projection guidance [GO:0097485]; positive chemotaxis [GO:0050918]; positive regulation of actin filament depolymerization [GO:0030836]; positive regulation of angiogenesis [GO:0045766]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of protein kinase B signaling [GO:0051897]; semaphorin-plexin signaling pathway [GO:0071526]; signal clustering [GO:1990256]","GO:0001569; GO:0001755; GO:0001938; GO:0002043; GO:0007162; GO:0007411; GO:0007413; GO:0008046; GO:0016020; GO:0021536; GO:0030215; GO:0030335; GO:0030836; GO:0035373; GO:0043395; GO:0045499; GO:0045545; GO:0045766; GO:0048675; GO:0048754; GO:0048842; GO:0048843; GO:0050908; GO:0050918; GO:0051897; GO:0060326; GO:0071526; GO:0090263; GO:0097485; GO:1990138; GO:1990256; GO:2000352; GO:2001028"
"9411",9411,"Cluster_4115","Porites_evermani_scaffold_1426:67773-124244",150,-23.05,2,21,12669,12693,22,"63.64%","77.27%","Peve_00006584",-0.999747628800907,0.0143029015872161,0.729378959833813,"A0A0R4IBK5","E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (E3 ubiquitin-lipopolysaccharide ligase rnf213-alpha) (EC 2.3.2.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha)","Danio rerio (Zebrafish) (Brachydanio rerio)","blood circulation [GO:0008015]; defense response to bacterium [GO:0042742]; immune system process [GO:0002376]; lipid droplet formation [GO:0140042]; lipid ubiquitination [GO:0120323]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein K63-linked ubiquitination [GO:0070534]; regulation of lipid metabolic process [GO:0019216]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]; xenophagy [GO:0098792]","GO:0002040; GO:0002376; GO:0004842; GO:0005524; GO:0005730; GO:0005811; GO:0005829; GO:0006511; GO:0008015; GO:0016887; GO:0019216; GO:0042742; GO:0046872; GO:0061630; GO:0070534; GO:0098792; GO:0120323; GO:0140042; GO:2000051"
"9412",9412,"Cluster_4115","Porites_evermani_scaffold_1426:67773-124244",150,-23.05,2,21,12975,12999,22,"63.64%","77.27%","Peve_00006584",-0.999747628800907,0.0143029015872161,0.729378959833813,"A0A0R4IBK5","E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (E3 ubiquitin-lipopolysaccharide ligase rnf213-alpha) (EC 2.3.2.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha)","Danio rerio (Zebrafish) (Brachydanio rerio)","blood circulation [GO:0008015]; defense response to bacterium [GO:0042742]; immune system process [GO:0002376]; lipid droplet formation [GO:0140042]; lipid ubiquitination [GO:0120323]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein K63-linked ubiquitination [GO:0070534]; regulation of lipid metabolic process [GO:0019216]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]; xenophagy [GO:0098792]","GO:0002040; GO:0002376; GO:0004842; GO:0005524; GO:0005730; GO:0005811; GO:0005829; GO:0006511; GO:0008015; GO:0016887; GO:0019216; GO:0042742; GO:0046872; GO:0061630; GO:0070534; GO:0098792; GO:0120323; GO:0140042; GO:2000051"
"9413",9413,"Cluster_4115","Porites_evermani_scaffold_1426:67773-124244",158,-20.57,2,20,21595,21617,19,"73.68%","78.95%","Peve_00006584",-0.999747628800907,0.0143029015872161,0.729378959833813,"A0A0R4IBK5","E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (E3 ubiquitin-lipopolysaccharide ligase rnf213-alpha) (EC 2.3.2.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha)","Danio rerio (Zebrafish) (Brachydanio rerio)","blood circulation [GO:0008015]; defense response to bacterium [GO:0042742]; immune system process [GO:0002376]; lipid droplet formation [GO:0140042]; lipid ubiquitination [GO:0120323]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein K63-linked ubiquitination [GO:0070534]; regulation of lipid metabolic process [GO:0019216]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]; xenophagy [GO:0098792]","GO:0002040; GO:0002376; GO:0004842; GO:0005524; GO:0005730; GO:0005811; GO:0005829; GO:0006511; GO:0008015; GO:0016887; GO:0019216; GO:0042742; GO:0046872; GO:0061630; GO:0070534; GO:0098792; GO:0120323; GO:0140042; GO:2000051"
"9414",9414,"Cluster_4115","Porites_evermani_scaffold_1426:67773-124244",158,-20.57,2,20,30226,30248,19,"73.68%","78.95%","Peve_00006584",-0.999747628800907,0.0143029015872161,0.729378959833813,"A0A0R4IBK5","E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (E3 ubiquitin-lipopolysaccharide ligase rnf213-alpha) (EC 2.3.2.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha)","Danio rerio (Zebrafish) (Brachydanio rerio)","blood circulation [GO:0008015]; defense response to bacterium [GO:0042742]; immune system process [GO:0002376]; lipid droplet formation [GO:0140042]; lipid ubiquitination [GO:0120323]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein K63-linked ubiquitination [GO:0070534]; regulation of lipid metabolic process [GO:0019216]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]; xenophagy [GO:0098792]","GO:0002040; GO:0002376; GO:0004842; GO:0005524; GO:0005730; GO:0005811; GO:0005829; GO:0006511; GO:0008015; GO:0016887; GO:0019216; GO:0042742; GO:0046872; GO:0061630; GO:0070534; GO:0098792; GO:0120323; GO:0140042; GO:2000051"
"9415",9415,"Cluster_4115","Porites_evermani_scaffold_143:373407-388484",167,-20.18,2,21,6252,6274,20,"75.00%","85.00%","Peve_00006632",-0.99980442800439,0.0125908639931623,0.69030974741484,"O00268","Transcription initiation factor TFIID subunit 4 (RNA polymerase II TBP-associated factor subunit C) (TBP-associated factor 4) (Transcription initiation factor TFIID 130 kDa subunit) (TAF(II)130) (TAFII-130) (TAFII130) (Transcription initiation factor TFIID 135 kDa subunit) (TAF(II)135) (TAFII-135) (TAFII135)","Homo sapiens (Human)","DNA-templated transcription initiation [GO:0006352]; histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; mRNA transcription by RNA polymerase II [GO:0042789]; ovarian follicle development [GO:0001541]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; protein phosphorylation [GO:0006468]; regulation of DNA repair [GO:0006282]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase II promoter [GO:0006367]","GO:0000785; GO:0001541; GO:0001673; GO:0003677; GO:0005634; GO:0005654; GO:0005669; GO:0005829; GO:0006282; GO:0006352; GO:0006357; GO:0006366; GO:0006367; GO:0006468; GO:0017162; GO:0032991; GO:0033276; GO:0035521; GO:0035522; GO:0042789; GO:0043966; GO:0045893; GO:0046982; GO:0051123; GO:0060261; GO:0071339"
"9419",9419,"Cluster_4115","Porites_evermani_scaffold_1461:82467-95358",153,-21.64,2,21,11830,11858,26,"69.23%","73.08%","Peve_00006979",-0.998530137261281,0.0345212665811469,0.909359886114279,"K7Z9Q9","Nematocyst expressed protein 6 (NEP-6) (NEP6) (EC 3.4.24.-) (Astacin-like metalloprotease toxin)","Nematostella vectensis (Starlet sea anemone)","proteolysis [GO:0006508]","GO:0004222; GO:0005576; GO:0006508; GO:0008270; GO:0042151; GO:0090729"
"9432",9432,"Cluster_4115","Porites_evermani_scaffold_1523:19443-49510",162,-21.56,2,21,4840,4864,22,"68.18%","86.36%","Peve_00007814",-0.999587054165567,0.0182960193839233,0.782669382293497,"G3V9H8","Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment]","Rattus norvegicus (Rat)","cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657]","GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0007156; GO:0007158; GO:0007169; GO:0007399; GO:0009410; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030182; GO:0030335; GO:0030424; GO:0030425; GO:0033141; GO:0033619; GO:0033630; GO:0033674; GO:0035799; GO:0035860; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045121; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0098797"
"9437",9437,"Cluster_4115","Porites_evermani_scaffold_1542:90040-108930",166,-20.68,2,21,14894,14914,19,"73.68%","89.47%","Peve_00008020",-0.999844732028352,0.0112186779245671,0.654163278594465,"Q3V050","Multidrug and toxin extrusion protein 2 (MATE-2) (mMATE-2) (H(+)/organic cation antiporter kidney-specific) (Solute carrier family 47 member 2)","Mus musculus (Mouse)","organic cation transport [GO:0015695]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]","GO:0005886; GO:0015101; GO:0015179; GO:0015297; GO:0015299; GO:0015695; GO:0016020; GO:0016323; GO:0016324; GO:0022857; GO:0042910; GO:0061459; GO:1990961"
"9468",9468,"Cluster_4115","Porites_evermani_scaffold_1688:92344-100980",161,-21.74,2,21,1035,1056,20,"80.00%","80.00%","Peve_00009844",-0.999212697173606,0.0252635585306647,0.871317023606713,"O34678","Uncharacterized oxidoreductase YtbE (EC 1.-.-.-)","Bacillus subtilis (strain 168)","","GO:0016491"
"9513",9513,"Cluster_4115","Porites_evermani_scaffold_1933:30153-42058",169,-22.8,2,19,3677,3700,19,"78.95%","89.47%","Peve_00012652",-0.999793718708922,0.0129310117729925,0.698606267633189,"Q9BT22","Chitobiosyldiphosphodolichol beta-mannosyltransferase (EC 2.4.1.142) (Asparagine-linked glycosylation protein 1 homolog) (Beta-1,4-mannosyltransferase) (GDP-Man:GlcNAc2-PP-dolichol mannosyltransferase) (GDP-mannose-dolichol diphosphochitobiose mannosyltransferase) (Mannosyltransferase-1) (MT-1) (hMat-1)","Homo sapiens (Human)","dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein glycosylation [GO:0006486]","GO:0000030; GO:0004578; GO:0005783; GO:0005789; GO:0006486; GO:0006488; GO:0016020"
"9515",9515,"Cluster_4115","Porites_evermani_scaffold_1936:56252-63287",161,-20.38,2,21,3591,3612,20,"75.00%","85.00%","Peve_00012675",-0.999427644522255,0.0215401517719704,0.825375642876058,"P17972","Potassium voltage-gated channel protein Shaw (Shaw2)","Drosophila melanogaster (Fruit fly)","potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]; sleep [GO:0030431]","GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0016020; GO:0022843; GO:0030424; GO:0030431; GO:0032590; GO:0032809; GO:0034765; GO:0051260; GO:0071805"
"9531",9531,"Cluster_4115","Porites_evermani_scaffold_2021:61756-78817",148,-20.68,2,17,12268,12289,15,"66.67%","80.00%","Peve_00013797",0.997419073679286,0.0457484490353859,0.933976570634822,"Q9H270","Vacuolar protein sorting-associated protein 11 homolog (hVPS11) (RING finger protein 108)","Homo sapiens (Human)","autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; organelle fusion [GO:0048284]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein ubiquitination [GO:0016567]; regulation of organelle assembly [GO:1902115]; regulation of protein stability [GO:0031647]; regulation of SNARE complex assembly [GO:0035542]; vacuole organization [GO:0007033]; vesicle docking involved in exocytosis [GO:0006904]","GO:0000166; GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005776; GO:0006886; GO:0006904; GO:0006914; GO:0007032; GO:0007033; GO:0008333; GO:0010008; GO:0016567; GO:0019904; GO:0019905; GO:0030136; GO:0030139; GO:0030674; GO:0030897; GO:0031647; GO:0031902; GO:0033147; GO:0033263; GO:0034058; GO:0035542; GO:0045732; GO:0046872; GO:0048284; GO:0061630; GO:1902115; GO:1903955; GO:2000643"
"9658",9658,"Cluster_589","Porites_evermani_scaffold_101:193885-201856",153,-20.16,2,18,606,627,16,"68.75%","81.25%","Peve_00000388",-0.99908203483763,0.0272798167389145,0.893954905948901,"Q6P988","Palmitoleoyl-protein carboxylesterase NOTUM (EC 3.1.1.98) (hNOTUM)","Homo sapiens (Human)","bone development [GO:0060348]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Wnt signaling pathway [GO:0030178]; protein depalmitoleylation [GO:1990697]; regulation of bone mineralization [GO:0030500]; Wnt signaling pathway [GO:0016055]","GO:0004629; GO:0005576; GO:0005788; GO:0016055; GO:0030178; GO:0030500; GO:0060348; GO:0090090; GO:1990697; GO:1990699"
"9660",9660,"Cluster_589","Porites_evermani_scaffold_101:386769-488223",155,-21.18,2,21,42266,42289,21,"66.67%","76.19%","Peve_00000404",-0.999785556767188,0.0131843600602164,0.704152747004529,"Q0KL02","Triple functional domain protein (EC 2.7.11.1)","Mus musculus (Mouse)","axon guidance [GO:0007411]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of fat cell differentiation [GO:0045599]; neuron projection morphogenesis [GO:0048812]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein phosphorylation [GO:0006468]","GO:0004674; GO:0005085; GO:0005524; GO:0005737; GO:0005769; GO:0006468; GO:0007411; GO:0019898; GO:0019899; GO:0042995; GO:0045599; GO:0048786; GO:0048812; GO:0050804; GO:0098685; GO:0098794; GO:0098978; GO:0099170; GO:0106310"
"9734",9734,"Cluster_589","Porites_evermani_scaffold_1086:11996-55345",159,-23.55,2,20,4032,4053,18,"72.22%","77.78%","Peve_00001538",-0.999928007864221,0.00763906587701203,0.573710369894872,"B1AVH7","TBC1 domain family member 2A","Mus musculus (Mouse)","activation of GTPase activity [GO:0090630]; positive regulation of GTPase activity [GO:0043547]","GO:0005096; GO:0005654; GO:0005829; GO:0005886; GO:0030054; GO:0031410; GO:0043547; GO:0045296; GO:0070161; GO:0090630"
"9738",9738,"Cluster_589","Porites_evermani_scaffold_1086:79-9555",155,-23.55,2,12,4073,4094,10,"100.00%","100.00%","Peve_00001529",-0.999983125832285,0.00369834065949377,0.533166802342694,"Q9CXR1","Dehydrogenase/reductase SDR family member 7 (EC 1.1.1.-) (Retinal short-chain dehydrogenase/reductase 4) (retSDR4) (Short chain dehydrogenase/reductase family 34C member 1) (Protein SDR34C1)","Mus musculus (Mouse)","","GO:0004090; GO:0005789; GO:0016616; GO:0052650"
"9756",9756,"Cluster_589","Porites_evermani_scaffold_1103:85856-91611",148,-21.08,2,14,2581,2603,13,"76.92%","92.31%","Peve_00001905",-0.999880668455908,0.0098350612688182,0.615776980998388,"Q920A6","Retinoid-inducible serine carboxypeptidase (EC 3.4.16.-) (Serine carboxypeptidase 1)","Rattus norvegicus (Rat)","blood vessel diameter maintenance [GO:0097746]; negative regulation of blood pressure [GO:0045776]; proteolysis [GO:0006508]; retinoic acid metabolic process [GO:0042573]","GO:0004185; GO:0005576; GO:0005829; GO:0006508; GO:0042573; GO:0045776; GO:0097746"
"9763",9763,"Cluster_589","Porites_evermani_scaffold_1:109875-149116",149,-20.55,2,20,21960,21985,22,"68.18%","72.73%","Peve_00000035",-0.997855251545262,0.0417023908348541,0.909359886114279,"F8WK50",NA,NA,NA,NA
"9769",9769,"Cluster_589","Porites_evermani_scaffold_11:152602-173462",155,-23.55,2,12,17895,17916,10,"100.00%","100.00%","Peve_00001787",-0.999947166297972,0.00654413958551676,0.573710369894872,"Q58DA0","26S proteasome non-ATPase regulatory subunit 4 (26S proteasome regulatory subunit RPN10)","Bos taurus (Bovine)","proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]","GO:0005634; GO:0005829; GO:0008540; GO:0022624; GO:0031593; GO:0043161"
"9770",9770,"Cluster_589","Porites_evermani_scaffold_1116:30577-65229",140,-20.46,2,9,24617,24638,7,"100.00%","100.00%","Peve_00002096",-0.998981183536662,0.0287395508786692,0.903929377050813,"Q9JID6","Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Palmitoyl-CoA ligase) (Phytanate--CoA ligase) (EC 6.2.1.24)","Cavia porcellus (Guinea pig)","long-chain fatty acid metabolic process [GO:0001676]; very long-chain fatty acid metabolic process [GO:0000038]","GO:0000038; GO:0001676; GO:0004467; GO:0005524; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0047676; GO:0050197; GO:0070251"
"9771",9771,"Cluster_589","Porites_evermani_scaffold_1116:30577-65229",174,-26.78,2,21,29806,29826,19,"84.21%","89.47%","Peve_00002096",-0.998981183536662,0.0287395508786692,0.903929377050813,"Q9JID6","Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Palmitoyl-CoA ligase) (Phytanate--CoA ligase) (EC 6.2.1.24)","Cavia porcellus (Guinea pig)","long-chain fatty acid metabolic process [GO:0001676]; very long-chain fatty acid metabolic process [GO:0000038]","GO:0000038; GO:0001676; GO:0004467; GO:0005524; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0047676; GO:0050197; GO:0070251"
"9780",9780,"Cluster_589","Porites_evermani_scaffold_1128:109236-127279",146,-22.11,2,21,17578,17605,25,"64.00%","68.00%","Peve_00002249",-0.998449405815817,0.0354568646881138,0.909359886114279,NA,NA,NA,NA,NA
"9784",9784,"Cluster_589","Porites_evermani_scaffold_11:287947-305770",154,-30.52,2,21,424,453,27,"66.67%","70.37%","Peve_00001835",-0.999446677970449,0.0211789355546999,0.821402964913383,"Q8C5P5","5'-nucleotidase domain-containing protein 1 (EC 3.1.3.-) (Cytosolic 5'-nucleotidase II-like protein 1)","Mus musculus (Mouse)","","GO:0008253; GO:0046872"
"9825",9825,"Cluster_589","Porites_evermani_scaffold_1157:40988-58787",151,-20.47,2,21,12666,12688,20,"70.00%","70.00%","Peve_00002659",-0.999266042083102,0.0243925535392527,0.860691627780599,"B9U3F2","Protein dispatched homolog 3 (Patched domain-containing protein 2) (Thyroid hormone receptor up-regulated protein 1) (TRUP1)","Gallus gallus (Chicken)","cell differentiation [GO:0030154]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of lipid metabolic process [GO:0045834]; positive regulation of neural precursor cell proliferation [GO:2000179]; response to hormone [GO:0009725]","GO:0005737; GO:0005783; GO:0005789; GO:0008203; GO:0009725; GO:0016020; GO:0030154; GO:0030659; GO:0031965; GO:0042632; GO:0045665; GO:0045834; GO:2000179"
"9858",9858,"Cluster_589","Porites_evermani_scaffold_1202:20715-87245",161,-23.5,2,18,8296,8317,16,"68.75%","93.75%","Peve_00003439",-0.999980738177473,0.00395134096014511,0.54328949385489,"P11029","Acetyl-CoA carboxylase (ACC) (EC 6.4.1.2) [Includes: Biotin carboxylase (EC 6.3.4.14)]","Gallus gallus (Chicken)","epigenetic regulation of gene expression [GO:0040029]; fatty acid biosynthetic process [GO:0006633]; malonyl-CoA biosynthetic process [GO:2001295]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; regulation of biological quality [GO:0065008]; response to carbohydrate [GO:0009743]; response to fatty acid [GO:0070542]; response to thyroid hormone [GO:0097066]; transport [GO:0006810]","GO:0003989; GO:0004075; GO:0005102; GO:0005524; GO:0005737; GO:0005739; GO:0006633; GO:0006810; GO:0009374; GO:0009743; GO:0010628; GO:0032810; GO:0040029; GO:0045893; GO:0046872; GO:0046966; GO:0050692; GO:0065008; GO:0070542; GO:0097066; GO:2001295"
"9869",9869,"Cluster_589","Porites_evermani_scaffold_1216:107507-126585",165,-25.29,2,20,13241,13261,18,"83.33%","83.33%","Peve_00003610",-0.999328962832057,0.0233234449403613,0.848644972258352,"P18293","Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A)","Mus musculus (Mouse)","blood vessel diameter maintenance [GO:0097746]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; intracellular signal transduction [GO:0035556]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; protein phosphorylation [GO:0006468]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]","GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0006468; GO:0007165; GO:0007166; GO:0007168; GO:0008217; GO:0010753; GO:0016941; GO:0017046; GO:0019934; GO:0035556; GO:0042417; GO:0042562; GO:0043235; GO:0048662; GO:0097746; GO:1990620"
"9892",9892,"Cluster_589","Porites_evermani_scaffold_124:41681-68522",151,-20.51,2,21,19453,19478,23,"65.22%","69.57%","Peve_00003922",-0.999972698911671,0.00470420337225242,0.551398425649056,"Q9D032","Single-stranded DNA-binding protein 3 (Lck-associated signal transducer) (Sequence-specific single-stranded-DNA-binding protein)","Mus musculus (Mouse)","cell differentiation [GO:0030154]; head development [GO:0060322]; head morphogenesis [GO:0060323]; hematopoietic progenitor cell differentiation [GO:0002244]; mesendoderm development [GO:0048382]; midbrain-hindbrain boundary initiation [GO:0021547]; positive regulation of anterior head development [GO:2000744]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prechordal plate formation [GO:0021501]; protein-containing complex assembly [GO:0065003]","GO:0002244; GO:0003697; GO:0003713; GO:0005634; GO:0005667; GO:0008284; GO:0021501; GO:0021547; GO:0030154; GO:0032991; GO:0045893; GO:0045944; GO:0048382; GO:0060322; GO:0060323; GO:0065003; GO:2000744"
"9899",9899,"Cluster_589","Porites_evermani_scaffold_1260:67617-83983",155,-23.55,2,12,15551,15572,10,"100.00%","100.00%","Peve_00004241",0.999725519885309,0.0149162790118723,0.741060622317634,NA,NA,NA,NA,NA
"9906",9906,"Cluster_589","Porites_evermani_scaffold_1269:84151-113764",144,-20.14,2,20,10718,10742,22,"68.18%","68.18%","Peve_00004323",-0.997216726294282,0.0475087780886808,0.943238620332273,"Q6RFZ7","Pleckstrin homology domain-containing family G member 5 (PH domain-containing family G member 5) (Neuronal RhoA GEF protein) (Transcript highly enriched in cortex and hippocampus)","Rattus norvegicus (Rat)","endothelial cell chemotaxis [GO:0035767]; endothelial cell migration [GO:0043542]; regulation of protein catabolic process at presynapse, modulating synaptic transmission [GO:0099575]; regulation protein catabolic process at presynapse [GO:0140251]; Rho protein signal transduction [GO:0007266]","GO:0005085; GO:0005737; GO:0005886; GO:0005911; GO:0007266; GO:0030027; GO:0030139; GO:0030424; GO:0035767; GO:0043542; GO:0045202; GO:0048471; GO:0098793; GO:0099575; GO:0140251"
"9927",9927,"Cluster_589","Porites_evermani_scaffold_1299:89780-133481",150,-20.28,2,11,9849,9870,9,"100.00%","100.00%","Peve_00004712",-0.999587847267624,0.0182784401020463,0.782669382293497,"O35474","EGF-like repeat and discoidin I-like domain-containing protein 3 (Developmentally-regulated endothelial cell locus 1 protein) (Integrin-binding protein DEL1)","Mus musculus (Mouse)","cell adhesion [GO:0007155]; positive regulation of cell-substrate adhesion [GO:0010811]","GO:0005509; GO:0005576; GO:0007155; GO:0010811"
"10029",10029,"Cluster_589","Porites_evermani_scaffold_1422:116569-128038",155,-23.93,2,12,9229,9250,10,"100.00%","100.00%","Peve_00006541",-0.998797162930987,0.0312278485462182,0.903929377050813,"Q9SSA4",NA,NA,NA,NA
"10033",10033,"Cluster_589","Porites_evermani_scaffold_1:429393-438909",158,-22.32,2,20,1386,1408,19,"68.42%","84.21%","Peve_00000003",0.999999238634054,0.000785582630254667,0.239778920002343,"O35654","DNA polymerase delta subunit 2 (DNA polymerase delta subunit p50)","Mus musculus (Mouse)","DNA biosynthetic process [GO:0071897]; DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA-templated DNA replication [GO:0006261]; error-prone translesion synthesis [GO:0042276]","GO:0003677; GO:0005654; GO:0006260; GO:0006261; GO:0006271; GO:0016035; GO:0042276; GO:0042575; GO:0043625; GO:0071897"
"10040",10040,"Cluster_589","Porites_evermani_scaffold_14:373399-411679",147,-20.11,2,12,37004,37025,10,"90.00%","90.00%","Peve_00006234",-0.998186646628078,0.0383444040360386,0.909359886114279,"Q8IVV2","Lipoxygenase homology domain-containing protein 1","Homo sapiens (Human)","sensory perception of sound [GO:0007605]","GO:0007605; GO:0032420"
"10077",10077,"Cluster_589","Porites_evermani_scaffold_1493:76627-110244",159,-20.78,2,19,23307,23326,17,"76.47%","88.24%","Peve_00007386",-0.99829893378936,0.0371378974490168,0.909359886114279,"Q13619","Cullin-4A (CUL-4A)","Homo sapiens (Human)","cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; G1/S transition of mitotic cell cycle [GO:0000082]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of granulocyte differentiation [GO:0030853]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; regulation of nucleotide-excision repair [GO:2000819]; regulation of protein metabolic process [GO:0051246]; rhythmic process [GO:0048511]; ribosome biogenesis [GO:0042254]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; somatic stem cell population maintenance [GO:0035019]","GO:0000082; GO:0001701; GO:0005634; GO:0005654; GO:0006281; GO:0006974; GO:0008283; GO:0008284; GO:0016567; GO:0030097; GO:0030674; GO:0030853; GO:0031146; GO:0031461; GO:0031464; GO:0031625; GO:0034644; GO:0035019; GO:0042254; GO:0043161; GO:0048511; GO:0051246; GO:0080008; GO:0097193; GO:1900087; GO:2000001; GO:2000819"
"10080",10080,"Cluster_589","Porites_evermani_scaffold_1497:96955-111162",159,-22.31,2,21,13479,13501,20,"75.00%","75.00%","Peve_00007420",-0.999164233414202,0.0260296228053412,0.880395372085238,"Q68UT7","Hormonally up-regulated neu tumor-associated kinase (EC 2.7.11.1)","Pan troglodytes (Chimpanzee)","intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]","GO:0004674; GO:0005524; GO:0006468; GO:0035556; GO:0106310"
"10113",10113,"Cluster_589","Porites_evermani_scaffold_1544:403-45872",155,-23.55,2,12,833,854,10,"100.00%","100.00%","Peve_00008033",-0.99781958887419,0.0420477981551328,0.910836595233947,"Q9Z0R4","Intersectin-1 (EH and SH3 domains protein 1)","Mus musculus (Mouse)","clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; exocytosis [GO:0006887]; negative regulation of neuron apoptotic process [GO:0043524]; neuron apoptotic process [GO:0051402]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of protein kinase B signaling [GO:0051897]; protein localization [GO:0008104]; protein transport [GO:0015031]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of postsynapse organization [GO:0099175]; small GTPase mediated signal transduction [GO:0007264]; synaptic vesicle endocytosis [GO:0048488]","GO:0005085; GO:0005509; GO:0005635; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0006887; GO:0006897; GO:0007264; GO:0008104; GO:0015031; GO:0016197; GO:0019209; GO:0030027; GO:0030139; GO:0043025; GO:0043197; GO:0043524; GO:0044305; GO:0045202; GO:0048488; GO:0051402; GO:0051897; GO:0055037; GO:0060090; GO:0060124; GO:0060999; GO:0070064; GO:0097440; GO:0097708; GO:0098833; GO:0098871; GO:0098978; GO:0099175; GO:0150007; GO:1905274; GO:2001288"
"10175",10175,"Cluster_589","Porites_evermani_scaffold_1626:3502-18794",158,-23.1,2,21,15044,15064,19,"68.42%","84.21%","Peve_00009118",-0.999996395310917,0.00170934276007991,0.362847063101065,NA,NA,NA,NA,NA
"10205",10205,"Cluster_589","Porites_evermani_scaffold_1662:33788-65045",152,-23.49,2,14,24529,24551,13,"84.62%","92.31%","Peve_00009537",-0.997692016354942,0.0432608500055966,0.918350840181857,"P54762","Ephrin type-B receptor 1 (EC 2.7.10.1) (ELK) (EPH tyrosine kinase 2) (EPH-like kinase 6) (EK6) (hEK6) (Neuronally-expressed EPH-related tyrosine kinase) (NET) (Tyrosine-protein kinase receptor EPH-2)","Homo sapiens (Human)","angiogenesis [GO:0001525]; axon guidance [GO:0007411]; camera-type eye morphogenesis [GO:0048593]; cell chemotaxis [GO:0060326]; cell-substrate adhesion [GO:0031589]; central nervous system projection neuron axonogenesis [GO:0021952]; dendritic spine development [GO:0060996]; dendritic spine morphogenesis [GO:0060997]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; ephrin receptor signaling pathway [GO:0048013]; establishment of cell polarity [GO:0030010]; hindbrain tangential cell migration [GO:0021934]; immunological synapse formation [GO:0001771]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of satellite cell differentiation [GO:1902725]; negative regulation of skeletal muscle satellite cell proliferation [GO:1902723]; neural precursor cell proliferation [GO:0061351]; neurogenesis [GO:0022008]; optic nerve morphogenesis [GO:0021631]; positive regulation of kinase activity [GO:0033674]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of JNK cascade [GO:0046328]; regulation of neuron death [GO:1901214]; retinal ganglion cell axon guidance [GO:0031290]; skeletal muscle satellite cell activation [GO:0014719]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]","GO:0001525; GO:0001771; GO:0004714; GO:0005005; GO:0005524; GO:0005576; GO:0005783; GO:0005829; GO:0005886; GO:0007169; GO:0007411; GO:0008046; GO:0014719; GO:0021631; GO:0021934; GO:0021952; GO:0022008; GO:0030010; GO:0030424; GO:0030425; GO:0031290; GO:0031589; GO:0031901; GO:0032433; GO:0033674; GO:0043005; GO:0043235; GO:0044877; GO:0045121; GO:0046328; GO:0046777; GO:0048013; GO:0048593; GO:0050804; GO:0050965; GO:0051965; GO:0060326; GO:0060996; GO:0060997; GO:0061351; GO:0070062; GO:0070372; GO:0098978; GO:1901214; GO:1902723; GO:1902725"
"10208",10208,"Cluster_589","Porites_evermani_scaffold_1664:45060-67834",156,-21.33,2,19,11849,11869,17,"76.47%","82.35%","Peve_00009560",-0.999329024199359,0.0233223783156091,0.848644972258352,"Q02218","2-oxoglutarate dehydrogenase complex component E1 (E1o) (OGDC-E1) (OGDH-E1) (EC 1.2.4.2) (2-oxoglutarate dehydrogenase, mitochondrial) (Alpha-ketoglutarate dehydrogenase) (Alpha-KGDH-E1) (Thiamine diphosphate (ThDP)-dependent 2-oxoglutarate dehydrogenase)","Homo sapiens (Human)","2-oxoglutarate metabolic process [GO:0006103]; cerebellar cortex development [GO:0021695]; generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; hippocampus development [GO:0021766]; histone succinylation [GO:0106077]; NADH metabolic process [GO:0006734]; olfactory bulb mitral cell layer development [GO:0061034]; pyramidal neuron development [GO:0021860]; striatum development [GO:0021756]; succinyl-CoA metabolic process [GO:0006104]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; thalamus development [GO:0021794]; tricarboxylic acid cycle [GO:0006099]","GO:0004591; GO:0005634; GO:0005739; GO:0005759; GO:0006091; GO:0006096; GO:0006099; GO:0006103; GO:0006104; GO:0006734; GO:0021695; GO:0021756; GO:0021766; GO:0021794; GO:0021860; GO:0022028; GO:0030976; GO:0031072; GO:0031966; GO:0034602; GO:0045252; GO:0046872; GO:0051087; GO:0061034; GO:0106077"
"10270",10270,"Cluster_589","Porites_evermani_scaffold_1771:7581-45699",151,-22.9,2,12,23936,23957,10,"90.00%","100.00%","Peve_00010789",-0.999232776560249,0.0249392749233984,0.86745289293403,NA,NA,NA,NA,NA
"10271",10271,"Cluster_589","Porites_evermani_scaffold_1771:7581-45699",154,-21.88,2,18,33449,33468,16,"81.25%","81.25%","Peve_00010789",-0.999232776560249,0.0249392749233984,0.86745289293403,NA,NA,NA,NA,NA
"10273",10273,"Cluster_589","Porites_evermani_scaffold_1772:1-57398",148,-21.28,2,21,31802,31823,19,"63.16%","68.42%","Peve_00010793",-0.999994709169113,0.0020708910558741,0.364311022785359,"P69527","Aminopeptidase O (AP-O) (EC 3.4.11.-)","Rattus norvegicus (Rat)","proteolysis [GO:0006508]","GO:0005730; GO:0006508; GO:0008270; GO:0070006"
"10276",10276,"Cluster_589","Porites_evermani_scaffold_17:780811-782080",164,-23.04,2,21,875,896,19,"68.42%","84.21%","Peve_00009990",-0.999175061941466,0.0258604245822689,0.878501136000008,"D3ZAT9","Failed axon connections homolog","Rattus norvegicus (Rat)","","GO:0005737; GO:0016020"
"10281",10281,"Cluster_589","Porites_evermani_scaffold_178:323031-333196",158,-25.24,2,21,5208,5232,22,"72.73%","77.27%","Peve_00010869",-0.998079664911893,0.039459643129889,0.909359886114279,"A0A1U9YHZ9","Cytochrome P450 monooxygenase verC (EC 1.-.-.-) (Verticillin biosynthesis cluster protein C)","Clonostachys rogersoniana","","GO:0004497; GO:0005506; GO:0016020; GO:0016705; GO:0020037"
"10312",10312,"Cluster_589","Porites_evermani_scaffold_1834:41810-48055",151,-21.69,2,14,4289,4309,12,"91.67%","91.67%","Peve_00011539",-0.998233319205703,0.0378475807060832,0.909359886114279,"Q92546","RAB6A-GEF complex partner protein 2 (Retrograde Golgi transport protein RGP1 homolog)","Homo sapiens (Human)","negative regulation of protein catabolic process [GO:0042177]; positive regulation of GTPase activity [GO:0043547]; retrograde transport, endosome to Golgi [GO:0042147]","GO:0000139; GO:0005085; GO:0005829; GO:0005886; GO:0016020; GO:0031267; GO:0032588; GO:0032991; GO:0034066; GO:0042147; GO:0042177; GO:0043547"
"10318",10318,"Cluster_589","Porites_evermani_scaffold_1856:44330-63231",153,-21.78,2,20,2406,2429,20,"70.00%","80.00%","Peve_00011766",0.999699471908932,0.0156080459251346,0.755215913266851,NA,NA,NA,NA,NA
"10350",10350,"Cluster_589","Porites_evermani_scaffold_192:148666-167238",155,-23.55,2,12,7509,7530,10,"100.00%","100.00%","Peve_00012512",-0.999625065689112,0.0174335681460817,0.782669382293497,"Q92541","RNA polymerase-associated protein RTF1 homolog","Homo sapiens (Human)","blastocyst growth [GO:0001832]; endodermal cell fate commitment [GO:0001711]; histone H3-K4 trimethylation [GO:0080182]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K4 methylation [GO:0051571]; stem cell population maintenance [GO:0019827]; transcription elongation by RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055]","GO:0000122; GO:0001711; GO:0001832; GO:0003697; GO:0003723; GO:0005654; GO:0005730; GO:0006368; GO:0016055; GO:0016593; GO:0019827; GO:0051571; GO:0080182; GO:1990269"
"10367",10367,"Cluster_589","Porites_evermani_scaffold_1961:21045-89678",145,-21.15,2,16,24286,24312,19,"73.68%","73.68%","Peve_00012952",0.9999039238855,0.0088248292997023,0.583837684785988,"P46023","G-protein coupled receptor GRL101","Lymnaea stagnalis (Great pond snail) (Helix stagnalis)","","GO:0004930; GO:0005886"
"10391",10391,"Cluster_589","Porites_evermani_scaffold_1998:17-68919",142,-20.8,2,20,29747,29775,25,"60.00%","64.00%","Peve_00013326",-0.999852555868755,0.0109323670007376,0.647820986329688,"D4G3R4","tRNA(Glu)-specific nuclease WapA (EC 3.1.-.-) (Cell wall-associated protein) (RNase WapA) (Toxin WapA)","Bacillus subtilis subsp. natto (strain BEST195)","tRNA catabolic process [GO:0016078]","GO:0004519; GO:0004549; GO:0005576; GO:0016078; GO:0090729"
"10392",10392,"Cluster_589","Porites_evermani_scaffold_1998:17-68919",155,-22.9,2,20,10384,10405,18,"66.67%","77.78%","Peve_00013326",-0.999852555868755,0.0109323670007376,0.647820986329688,"D4G3R4","tRNA(Glu)-specific nuclease WapA (EC 3.1.-.-) (Cell wall-associated protein) (RNase WapA) (Toxin WapA)","Bacillus subtilis subsp. natto (strain BEST195)","tRNA catabolic process [GO:0016078]","GO:0004519; GO:0004549; GO:0005576; GO:0016078; GO:0090729"
"10393",10393,"Cluster_589","Porites_evermani_scaffold_1998:17-68919",159,-20.01,2,20,21273,21294,18,"61.11%","88.89%","Peve_00013326",-0.999852555868755,0.0109323670007376,0.647820986329688,"D4G3R4","tRNA(Glu)-specific nuclease WapA (EC 3.1.-.-) (Cell wall-associated protein) (RNase WapA) (Toxin WapA)","Bacillus subtilis subsp. natto (strain BEST195)","tRNA catabolic process [GO:0016078]","GO:0004519; GO:0004549; GO:0005576; GO:0016078; GO:0090729"
"10394",10394,"Cluster_589","Porites_evermani_scaffold_1998:17-68919",171,-22.09,2,20,54588,54609,18,"72.22%","94.44%","Peve_00013326",-0.999852555868755,0.0109323670007376,0.647820986329688,"D4G3R4","tRNA(Glu)-specific nuclease WapA (EC 3.1.-.-) (Cell wall-associated protein) (RNase WapA) (Toxin WapA)","Bacillus subtilis subsp. natto (strain BEST195)","tRNA catabolic process [GO:0016078]","GO:0004519; GO:0004549; GO:0005576; GO:0016078; GO:0090729"
"10411",10411,"Cluster_589","Porites_evermani_scaffold_202:289112-306901",151,-22.44,2,21,15836,15858,20,"70.00%","70.00%","Peve_00013778",-0.999143355797822,0.0263527758842851,0.884249165328432,"Q26619","cAMP-dependent protein kinase type II regulatory subunit","Strongylocentrotus purpuratus (Purple sea urchin)","negative regulation of cAMP-dependent protein kinase activity [GO:2000480]","GO:0004862; GO:0005737; GO:0005952; GO:0030552; GO:0034236; GO:2000480"
"10413",10413,"Cluster_589","Porites_evermani_scaffold_2027:81886-90963",153,-20.31,2,17,2738,2757,15,"80.00%","86.67%","Peve_00013831",-0.998607432161838,0.0336011168386757,0.909359886114279,NA,NA,NA,NA,NA
"10417",10417,"Cluster_589","Porites_evermani_scaffold_2028:5370-91915",149,-21.32,2,21,62397,62423,24,"66.67%","75.00%","Peve_00013835",-0.999640099755155,0.0170804464428046,0.782312023486667,NA,NA,NA,NA,NA
"10418",10418,"Cluster_589","Porites_evermani_scaffold_2028:5370-91915",155,-20.56,2,21,36347,36369,20,"65.00%","80.00%","Peve_00013835",-0.999640099755155,0.0170804464428046,0.782312023486667,NA,NA,NA,NA,NA
"10419",10419,"Cluster_589","Porites_evermani_scaffold_2028:5370-91915",155,-21.34,2,12,29439,29460,10,"100.00%","100.00%","Peve_00013835",-0.999640099755155,0.0170804464428046,0.782312023486667,NA,NA,NA,NA,NA
"10422",10422,"Cluster_589","Porites_evermani_scaffold_2038:80329-91715",160,-23.84,2,20,29,48,18,"72.22%","88.89%","Peve_00013933",0.99738806395724,0.0460225803266885,0.935124938815665,"Q8TB22","Spermatogenesis-associated protein 20 (Sperm-specific protein 411) (Ssp411)","Homo sapiens (Human)","carbohydrate metabolic process [GO:0005975]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]","GO:0005576; GO:0005975; GO:0007283; GO:0030154"
"10444",10444,"Cluster_589","Porites_evermani_scaffold_206:83720-93495",151,-21.81,2,12,4650,4671,10,"90.00%","100.00%","Peve_00014141",-0.999771117558368,0.0136210204052954,0.714322965451251,"P08842","Steryl-sulfatase (EC 3.1.6.2) (Arylsulfatase C) (ASC) (Estrone sulfatase) (Steroid sulfatase) (Steryl-sulfate sulfohydrolase)","Homo sapiens (Human)","epidermis development [GO:0008544]; female pregnancy [GO:0007565]; steroid catabolic process [GO:0006706]","GO:0004065; GO:0004773; GO:0005764; GO:0005768; GO:0005783; GO:0005788; GO:0005789; GO:0005794; GO:0005886; GO:0006706; GO:0007565; GO:0008484; GO:0008544; GO:0016020; GO:0043231; GO:0046872"
"10447",10447,"Cluster_589","Porites_evermani_scaffold_20:703793-731406",158,-20.64,2,21,157,180,21,"71.43%","80.95%","Peve_00013491",-0.999122952793073,0.0266648013275948,0.887262532171098,"Q8WXD9","Caskin-1 (CASK-interacting protein 1)","Homo sapiens (Human)","signal transduction [GO:0007165]","GO:0005737; GO:0007165; GO:0016020; GO:0042802"
"10449",10449,"Cluster_589","Porites_evermani_scaffold_2087:7516-77182",155,-23.55,2,12,6816,6837,10,"100.00%","100.00%","Peve_00014398",-0.999822631423906,0.011990571412601,0.674878265873359,"P31696","Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]","Gallus gallus (Chicken)","actin cytoskeleton reorganization [GO:0031532]; brain development [GO:0007420]; cell differentiation [GO:0030154]; filopodium assembly [GO:0046847]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; negative regulation of neuron projection development [GO:0010977]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neuron cell-cell adhesion [GO:0007158]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor clustering [GO:0043113]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]","GO:0002162; GO:0005509; GO:0005539; GO:0005576; GO:0005604; GO:0005615; GO:0005886; GO:0007158; GO:0007213; GO:0007399; GO:0007420; GO:0007528; GO:0008201; GO:0010977; GO:0030154; GO:0030297; GO:0030424; GO:0030548; GO:0031012; GO:0031532; GO:0031594; GO:0033691; GO:0035374; GO:0038023; GO:0043113; GO:0043236; GO:0043237; GO:0043395; GO:0043547; GO:0045121; GO:0045178; GO:0045202; GO:0045887; GO:0045944; GO:0046847; GO:0050840; GO:0051491; GO:0071340; GO:0098684; GO:0098965; GO:0098978"
"10458",10458,"Cluster_589","Porites_evermani_scaffold_21:133770-165877",153,-21.82,2,20,11563,11583,18,"66.67%","83.33%","Peve_00014560",-0.997728095293297,0.0429212571353912,0.916288292153006,"Q9GZV8","PR domain zinc finger protein 14 (EC 2.1.1.-) (PR domain-containing protein 14)","Homo sapiens (Human)","cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; embryo implantation [GO:0007566]; fertilization [GO:0009566]; fibroblast growth factor receptor signaling pathway [GO:0008543]; germ cell development [GO:0007281]; germ-line stem cell population maintenance [GO:0030718]; histone H3-R26 methylation [GO:0034972]; homeostasis of number of cells within a tissue [GO:0048873]; inactivation of paternal X chromosome [GO:0060817]; inner cell mass cell fate commitment [GO:0001827]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of DNA methylation [GO:0044030]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000122; GO:0000902; GO:0000977; GO:0001708; GO:0001827; GO:0003723; GO:0005634; GO:0005654; GO:0006357; GO:0007281; GO:0007566; GO:0008168; GO:0008543; GO:0009566; GO:0010468; GO:0030718; GO:0031490; GO:0034972; GO:0040037; GO:0044030; GO:0046872; GO:0048873; GO:0060817; GO:1902093; GO:1902459"
"10459",10459,"Cluster_589","Porites_evermani_scaffold_21:133770-165877",168,-26.6,2,21,20304,20325,19,"68.42%","89.47%","Peve_00014560",-0.997728095293297,0.0429212571353912,0.916288292153006,"Q9GZV8","PR domain zinc finger protein 14 (EC 2.1.1.-) (PR domain-containing protein 14)","Homo sapiens (Human)","cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; embryo implantation [GO:0007566]; fertilization [GO:0009566]; fibroblast growth factor receptor signaling pathway [GO:0008543]; germ cell development [GO:0007281]; germ-line stem cell population maintenance [GO:0030718]; histone H3-R26 methylation [GO:0034972]; homeostasis of number of cells within a tissue [GO:0048873]; inactivation of paternal X chromosome [GO:0060817]; inner cell mass cell fate commitment [GO:0001827]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of DNA methylation [GO:0044030]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000122; GO:0000902; GO:0000977; GO:0001708; GO:0001827; GO:0003723; GO:0005634; GO:0005654; GO:0006357; GO:0007281; GO:0007566; GO:0008168; GO:0008543; GO:0009566; GO:0010468; GO:0030718; GO:0031490; GO:0034972; GO:0040037; GO:0044030; GO:0046872; GO:0048873; GO:0060817; GO:1902093; GO:1902459"
"10531",10531,"Cluster_589","Porites_evermani_scaffold_2206:28890-40783",166,-25.39,2,21,2780,2800,19,"78.95%","84.21%","Peve_00015640",-0.998674298211381,0.0327843088431138,0.909359886114279,NA,NA,NA,NA,NA
"10584",10584,"Cluster_589","Porites_evermani_scaffold_2327:62378-64345",151,-21,2,18,683,707,19,"73.68%","78.95%","Peve_00016798",-0.998993337809364,0.0285675790922425,0.903929377050813,NA,NA,NA,NA,NA
"10601",10601,"Cluster_589","Porites_evermani_scaffold_2372:1-20689",155,-23.41,2,12,16552,16573,10,"100.00%","100.00%","Peve_00017180",-0.99953411064578,0.0194336052474065,0.796664198789063,"Q9QZD4","DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4)","Mus musculus (Mouse)","cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of double-stranded telomeric DNA binding [GO:1905768]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of telomere maintenance [GO:0032205]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair involved in interstrand cross-link repair [GO:1901255]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; regulation of autophagy [GO:0010506]; resolution of meiotic recombination intermediates [GO:0000712]; response to UV [GO:0009411]; telomere maintenance [GO:0000723]; telomeric DNA-containing double minutes formation [GO:0061819]; UV protection [GO:0009650]","GO:0000014; GO:0000109; GO:0000110; GO:0000712; GO:0000723; GO:0000724; GO:0000781; GO:0001094; GO:0003677; GO:0003684; GO:0003697; GO:0004520; GO:0005634; GO:0006281; GO:0006289; GO:0006295; GO:0006296; GO:0006303; GO:0008022; GO:0009411; GO:0009650; GO:0010506; GO:0032205; GO:0034644; GO:0042802; GO:0047485; GO:0061819; GO:0070522; GO:1901255; GO:1904357; GO:1905765; GO:1905768; GO:1990599; GO:1990841"
"10646",10646,"Cluster_589","Porites_evermani_scaffold_2457:23942-47000",157,-20.26,2,20,15894,15914,18,"77.78%","77.78%","Peve_00017997",-0.998300622150393,0.0371194573895678,0.909359886114279,"E9PSK7","C-Jun-amino-terminal kinase-interacting protein 3 (JIP-3) (JNK-interacting protein 3) (JNK MAP kinase scaffold protein 3)","Rattus norvegicus (Rat)","anterograde axonal protein transport [GO:0099641]; axon development [GO:0061564]; axon guidance [GO:0007411]; axon regeneration [GO:0031103]; forebrain development [GO:0030900]; in utero embryonic development [GO:0001701]; JNK cascade [GO:0007254]; lung alveolus development [GO:0048286]; lung morphogenesis [GO:0060425]; negative regulation of apoptotic process [GO:0043066]; neuron projection development [GO:0031175]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron migration [GO:2001224]; post-embryonic development [GO:0009791]; protein localization [GO:0008104]; protein stabilization [GO:0050821]; regulation of gene expression [GO:0010468]; regulation of JNK cascade [GO:0046328]; respiratory gaseous exchange by respiratory system [GO:0007585]; vesicle-mediated transport [GO:0016192]","GO:0000139; GO:0001701; GO:0005078; GO:0005737; GO:0005790; GO:0005886; GO:0007254; GO:0007411; GO:0007585; GO:0008104; GO:0008432; GO:0009791; GO:0010468; GO:0016192; GO:0019894; GO:0030159; GO:0030424; GO:0030425; GO:0030426; GO:0030673; GO:0030900; GO:0031103; GO:0031175; GO:0031410; GO:0031434; GO:0031435; GO:0043005; GO:0043066; GO:0043507; GO:0044297; GO:0045666; GO:0046328; GO:0046330; GO:0048286; GO:0048471; GO:0050821; GO:0060425; GO:0061564; GO:0099641; GO:1904115; GO:2001224"
"10673",10673,"Cluster_589","Porites_evermani_scaffold_253:230234-243371",153,-20.17,2,20,8535,8558,20,"65.00%","85.00%","Peve_00018700",-0.999441541479478,0.0212770196606704,0.82289133055867,NA,NA,NA,NA,NA
"10682",10682,"Cluster_589","Porites_evermani_scaffold_254:302220-309561",163,-22.58,2,20,6396,6417,18,"72.22%","83.33%","Peve_00018779",-0.999955310845228,0.00601863225853882,0.573710369894872,NA,NA,NA,NA,NA
"10696",10696,"Cluster_589","Porites_evermani_scaffold_256:288708-327627",151,-20.7,2,21,27135,27159,22,"59.09%","77.27%","Peve_00018907",-0.999777949171651,0.0134161948226009,0.709934960002653,"Q7Z460","CLIP-associating protein 1 (Cytoplasmic linker-associated protein 1) (Multiple asters homolog 1) (Protein Orbit homolog 1) (hOrbit1)","Homo sapiens (Human)","astral microtubule organization [GO:0030953]; cell division [GO:0051301]; establishment of epithelial cell polarity [GO:0090162]; establishment of mitotic spindle localization [GO:0040001]; establishment of spindle orientation [GO:0051294]; establishment or maintenance of cell polarity [GO:0007163]; exit from mitosis [GO:0010458]; Golgi organization [GO:0007030]; microtubule anchoring [GO:0034453]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of microtubule polymerization or depolymerization [GO:0031111]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of exocytosis [GO:0045921]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of microtubule polymerization [GO:0031116]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of focal adhesion assembly [GO:0051893]; regulation of gastrulation [GO:0010470]; regulation of microtubule cytoskeleton organization [GO:0070507]; vesicle targeting [GO:0006903]","GO:0000226; GO:0000776; GO:0001578; GO:0002162; GO:0005794; GO:0005813; GO:0005815; GO:0005828; GO:0005829; GO:0005876; GO:0005881; GO:0005938; GO:0006903; GO:0007020; GO:0007026; GO:0007030; GO:0007052; GO:0007163; GO:0008017; GO:0010458; GO:0010470; GO:0010634; GO:0010717; GO:0016020; GO:0030953; GO:0030981; GO:0031023; GO:0031111; GO:0031116; GO:0031592; GO:0034453; GO:0035371; GO:0040001; GO:0043515; GO:0045180; GO:0045921; GO:0051010; GO:0051294; GO:0051301; GO:0051497; GO:0051893; GO:0070507; GO:0072686; GO:0090091; GO:0090162; GO:0090307; GO:1903690; GO:1904261"
"10697",10697,"Cluster_589","Porites_evermani_scaffold_2567:210-64017",151,-20.43,2,21,12349,12371,20,"70.00%","70.00%","Peve_00018950",-0.999807400018563,0.0124948259803537,0.688437055323061,"Q8BW94","Dynein axonemal heavy chain 3 (Axonemal beta dynein heavy chain 3) (Ciliary dynein heavy chain 3)","Mus musculus (Mouse)","cilium movement [GO:0003341]; microtubule-based movement [GO:0007018]","GO:0003341; GO:0005524; GO:0005874; GO:0007018; GO:0008569; GO:0030286; GO:0036156; GO:0045505; GO:0051959; GO:0097729"
"10739",10739,"Cluster_589","Porites_evermani_scaffold_2678:7151-13898",159,-21.1,2,19,4476,4497,18,"77.78%","88.89%","Peve_00019866",-0.998329663228134,0.0368008298358006,0.909359886114279,"Q4V7T8","Ropporin-1-like protein","Xenopus laevis (African clawed frog)","","GO:0031514"
"10754",10754,"Cluster_589","Porites_evermani_scaffold_272:170008-189424",155,-23.79,2,12,14061,14082,10,"100.00%","100.00%","Peve_00020262",-0.99785634131814,0.0416917909524945,0.909359886114279,NA,NA,NA,NA,NA
"10766",10766,"Cluster_589","Porites_evermani_scaffold_274:183385-234969",155,-23.55,2,12,14533,14554,10,"100.00%","100.00%","Peve_00020426",-0.999957293079344,0.00588363598503261,0.570680688799154,"Q7RTX7","Cation channel sperm-associated protein 4 (CatSper4)","Homo sapiens (Human)","establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; regulation of ion transmembrane transport [GO:0034765]; sodium ion transport [GO:0006814]; sperm capacitation [GO:0048240]","GO:0001669; GO:0005227; GO:0005245; GO:0005886; GO:0006814; GO:0030317; GO:0034765; GO:0036128; GO:0048240; GO:0051649; GO:0097228"
"10801",10801,"Cluster_589","Porites_evermani_scaffold_28:238495-262304",150,-20.5,2,15,8237,8258,13,"76.92%","84.62%","Peve_00020859",-0.996961236510919,0.0496424958855588,0.9519960538532,"Q8CBC7",NA,NA,NA,NA
"10802",10802,"Cluster_589","Porites_evermani_scaffold_28:238495-262304",155,-22.1,2,20,20579,20600,18,"66.67%","77.78%","Peve_00020859",-0.996961236510919,0.0496424958855588,0.9519960538532,"Q8CBC7",NA,NA,NA,NA
"10813",10813,"Cluster_589","Porites_evermani_scaffold_2856:46006-53230",152,-20.67,2,13,2184,2205,11,"90.91%","90.91%","Peve_00021321",-0.999608964288524,0.0178039958559197,0.782669382293497,"Q9ES87","Prostasin (EC 3.4.21.-) (Channel-activating protease 1) (CAP1) (Serine protease 8) [Cleaved into: Prostasin light chain; Prostasin heavy chain]","Rattus norvegicus (Rat)","hair follicle development [GO:0001942]; positive regulation of sodium ion transmembrane transport [GO:1902307]; positive regulation of sodium ion transport [GO:0010765]; proteolysis [GO:0006508]; response to mineralocorticoid [GO:0051385]; response to peptide hormone [GO:0043434]; response to xenobiotic stimulus [GO:0009410]; transepithelial transport [GO:0070633]","GO:0001942; GO:0004252; GO:0005615; GO:0005886; GO:0006508; GO:0009410; GO:0010765; GO:0017080; GO:0019897; GO:0043434; GO:0045121; GO:0051385; GO:0070633; GO:1902307"
"10883",10883,"Cluster_589","Porites_evermani_scaffold_3054:12255-47493",158,-21.52,2,21,23274,23294,19,"68.42%","84.21%","Peve_00023009",-0.999888189689019,0.00952006897884497,0.606638706706886,"Q9BXW9","Fanconi anemia group D2 protein (Protein FACD2)","Homo sapiens (Human)","brain morphogenesis [GO:0048854]; cellular response to oxidative stress [GO:0034599]; double-strand break repair involved in meiotic recombination [GO:1990918]; gamete generation [GO:0007276]; homologous chromosome pairing at meiosis [GO:0007129]; interstrand cross-link repair [GO:0036297]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; neuronal stem cell population maintenance [GO:0097150]; regulation of CD40 signaling pathway [GO:2000348]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of inflammatory response [GO:0050727]; regulation of regulatory T cell differentiation [GO:0045589]; response to gamma radiation [GO:0010332]","GO:0000785; GO:0000793; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0007129; GO:0007276; GO:0010332; GO:0016604; GO:0031573; GO:0034599; GO:0036297; GO:0045589; GO:0048854; GO:0050727; GO:0051090; GO:0070182; GO:0097150; GO:1990391; GO:1990918; GO:2000348"
"10892",10892,"Cluster_589","Porites_evermani_scaffold_3080:2797-10911",155,-23.55,2,12,2260,2281,10,"100.00%","100.00%","Peve_00023210",-0.999777306658689,0.0134355916697332,0.710394865680069,"Q9LP51","CBL-interacting serine/threonine-protein kinase 18 (EC 2.7.11.1) (SNF1-related kinase 3.20) (SOS2-like protein kinase PKS22)","Arabidopsis thaliana (Mouse-ear cress)","protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]","GO:0004674; GO:0005524; GO:0006468; GO:0007165; GO:0106310"
"10917",10917,"Cluster_589","Porites_evermani_scaffold_314:175295-204756",157,-26.02,2,20,11813,11836,20,"75.00%","80.00%","Peve_00023658",-0.999935069797174,0.00725472326117394,0.573710369894872,"P34528","Putative serine protease K12H4.7 (EC 3.4.-.-)","Caenorhabditis elegans","innate immune response [GO:0045087]; proteolysis [GO:0006508]","GO:0006508; GO:0008236; GO:0008239; GO:0045087"
"10938",10938,"Cluster_589","Porites_evermani_scaffold_3187:13513-37867",161,-20.86,2,18,6956,6977,16,"68.75%","93.75%","Peve_00023919",-0.99985376195666,0.0108875609000238,0.647758385899893,NA,NA,NA,NA,NA
"10944",10944,"Cluster_589","Porites_evermani_scaffold_32:15271-210297",147,-20.51,2,21,94663,94688,23,"56.52%","73.91%","Peve_00024001",-0.999351520326823,0.022928031864249,0.843538272975541,"Q9UPN3","Microtubule-actin cross-linking factor 1, isoforms 1/2/3/4/5 (620 kDa actin-binding protein) (ABP620) (Actin cross-linking family protein 7) (Macrophin-1) (Trabeculin-alpha)","Homo sapiens (Human)","Golgi to plasma membrane protein transport [GO:0043001]; intermediate filament cytoskeleton organization [GO:0045104]; positive regulation of axon extension [GO:0045773]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of cell migration [GO:0030334]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of microtubule-based process [GO:0032886]; regulation of neuron projection arborization [GO:0150011]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]","GO:0003723; GO:0003779; GO:0005198; GO:0005509; GO:0005737; GO:0005794; GO:0005856; GO:0005874; GO:0005886; GO:0010632; GO:0015629; GO:0016020; GO:0016055; GO:0030177; GO:0030334; GO:0032587; GO:0032886; GO:0042060; GO:0043001; GO:0045104; GO:0045296; GO:0045773; GO:0051011; GO:0051015; GO:0051893; GO:0150011"
"10947",10947,"Cluster_589","Porites_evermani_scaffold_32:213454-235475",165,-26.24,2,21,1967,1989,21,"80.95%","80.95%","Peve_00024022",-0.999959954319607,0.00569736979190693,0.561651935893748,"Q920F3","KH domain-containing, RNA-binding, signal transduction-associated protein 2 (Sam68-like mammalian protein 1) (SLM-1) (rSLM-1)","Rattus norvegicus (Rat)","mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]","GO:0000381; GO:0003729; GO:0005634; GO:0006397; GO:0008143; GO:0008266; GO:0017124; GO:0042169; GO:0048024"
"10952",10952,"Cluster_589","Porites_evermani_scaffold_322:53663-113122",158,-23.94,2,21,16494,16514,19,"73.68%","78.95%","Peve_00024151",-0.998853181277421,0.0304918673324897,0.903929377050813,"P27393","Collagen alpha-2(IV) chain","Ascaris suum (Pig roundworm) (Ascaris lumbricoides)","anatomical structure development [GO:0048856]","GO:0005201; GO:0005576; GO:0005581; GO:0005604; GO:0048856"
"10957",10957,"Cluster_589","Porites_evermani_scaffold_323:146586-160782",159,-23.62,2,21,11578,11600,20,"65.00%","85.00%","Peve_00024196",-0.999884477330218,0.00967682551674024,0.611343259425713,"Q3TIV5","Zinc finger CCCH domain-containing protein 15 (DRG family-regulatory protein 1) (Epo-immediate response gene protein FM22)","Mus musculus (Mouse)","cytokine-mediated signaling pathway [GO:0019221]; cytoplasmic translation [GO:0002181]; positive regulation of GTPase activity [GO:0043547]","GO:0002181; GO:0005634; GO:0005829; GO:0019221; GO:0043547; GO:0046872"
"11002",11002,"Cluster_589","Porites_evermani_scaffold_33:409206-419206",168,-25.12,2,21,9581,9602,19,"63.16%","94.74%","Peve_00024584",-0.99705953567446,0.0488325669958464,0.948900092293838,"A1L252","Ran-binding protein 9 (RanBP9)","Danio rerio (Zebrafish) (Brachydanio rerio)","cell surface receptor signaling pathway [GO:0007166]; cytoskeleton organization [GO:0007010]; retina development in camera-type eye [GO:0060041]","GO:0005634; GO:0005737; GO:0005886; GO:0007010; GO:0007166; GO:0060041"
"11061",11061,"Cluster_589","Porites_evermani_scaffold_352:2116-25539",164,-26.78,2,21,6585,6606,19,"73.68%","78.95%","Peve_00026073",-0.997524165059795,0.0448069733359102,0.929433050844325,"O60879","Protein diaphanous homolog 2 (Diaphanous-related formin-2) (DRF2)","Homo sapiens (Human)","actin filament polymerization [GO:0030041]; female gamete generation [GO:0007292]; oogenesis [GO:0048477]","GO:0003779; GO:0005102; GO:0005730; GO:0005769; GO:0005783; GO:0005829; GO:0005884; GO:0007292; GO:0030041; GO:0031267; GO:0043231; GO:0048477"
"11113",11113,"Cluster_589","Porites_evermani_scaffold_365:84057-193213",162,-25.21,2,20,77454,77476,19,"68.42%","89.47%","Peve_00026823",-0.999206634909042,0.0253606500537378,0.872109822299967,"Q9WUU9","Germinal-center associated nuclear protein (GANP) (EC 2.3.1.48) (GC-associated DNA primase)","Mus musculus (Mouse)","mRNA export from nucleus [GO:0006406]; nucleosome organization [GO:0034728]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein transport [GO:0015031]; somatic hypermutation of immunoglobulin genes [GO:0016446]","GO:0003676; GO:0003682; GO:0004402; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0006406; GO:0010484; GO:0015031; GO:0016446; GO:0016973; GO:0031965; GO:0034728; GO:0042393; GO:0044615; GO:0070390"
"11121",11121,"Cluster_589","Porites_evermani_scaffold_367:160992-173010",163,-25.41,2,16,5880,5901,14,"78.57%","100.00%","Peve_00026919",-0.99967165119342,0.0163145359755303,0.769678756304143,"Q8N5G2","Macoilin (Macoilin-1) (Transmembrane protein 57)","Homo sapiens (Human)","brain development [GO:0007420]; chemotaxis [GO:0006935]; neuronal signal transduction [GO:0023041]","GO:0005634; GO:0006935; GO:0007420; GO:0008017; GO:0023041; GO:0030424; GO:0030867; GO:0031965; GO:0044306; GO:0045202"
"11138",11138,"Cluster_589","Porites_evermani_scaffold_37:224857-231811",159,-21.19,2,21,1073,1095,20,"70.00%","80.00%","Peve_00027092",-0.999032384036177,0.0280079716781816,0.900535408784329,"Q15836","Vesicle-associated membrane protein 3 (VAMP-3) (Cellubrevin) (CEB) (Synaptobrevin-3)","Homo sapiens (Human)","calcium-ion regulated exocytosis [GO:0017156]; cellular response to type II interferon [GO:0071346]; exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; membrane fusion [GO:0061025]; negative regulation of secretion by cell [GO:1903531]; positive regulation of receptor recycling [GO:0001921]; protein-containing complex assembly [GO:0065003]; retrograde transport, endosome to Golgi [GO:0042147]; SNARE complex assembly [GO:0035493]; substrate adhesion-dependent cell spreading [GO:0034446]; vesicle docking involved in exocytosis [GO:0006904]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]","GO:0001921; GO:0005484; GO:0005829; GO:0005886; GO:0006887; GO:0006904; GO:0006906; GO:0009986; GO:0016020; GO:0016192; GO:0017075; GO:0017156; GO:0019905; GO:0030133; GO:0030136; GO:0030141; GO:0030669; GO:0030670; GO:0031201; GO:0031901; GO:0032588; GO:0034446; GO:0035493; GO:0042147; GO:0043001; GO:0043005; GO:0043231; GO:0045202; GO:0048471; GO:0055037; GO:0055038; GO:0061025; GO:0065003; GO:0071346; GO:1903531"
"11151",11151,"Cluster_589","Porites_evermani_scaffold_3753:2794-17569",171,-30.88,2,21,6009,6032,21,"76.19%","85.71%","Peve_00027364",-0.999589838554501,0.0182342281155101,0.782669382293497,"Q32N90","MBT domain-containing protein 1","Xenopus laevis (African clawed frog)","chromatin organization [GO:0006325]; double-strand break repair via homologous recombination [GO:0000724]; regulation of DNA-templated transcription [GO:0006355]","GO:0000724; GO:0005634; GO:0006325; GO:0006355; GO:0008270; GO:0035064; GO:0035267"
"11173",11173,"Cluster_589","Porites_evermani_scaffold_383:35108-49202",162,-24.35,2,20,74,96,19,"73.68%","84.21%","Peve_00027784",-0.999886982142555,0.00957134004917052,0.608817017563522,NA,NA,NA,NA,NA
"11181",11181,"Cluster_589","Porites_evermani_scaffold_3869:0-4513",163,-23.13,2,21,1144,1166,20,"70.00%","85.00%","Peve_00027984",-0.999076479898258,0.0273622449372687,0.894374732389502,"A7SLW1","Branched-chain-amino-acid aminotransferase (EC 2.6.1.42)","Nematostella vectensis (Starlet sea anemone)","leucine biosynthetic process [GO:0009098]; valine biosynthetic process [GO:0009099]","GO:0004084; GO:0005739; GO:0009098; GO:0009099; GO:0050048; GO:0052654; GO:0052655; GO:0052656"
"11195",11195,"Cluster_589","Porites_evermani_scaffold_392:148700-189243",151,-20.31,2,21,39394,39416,20,"70.00%","70.00%","Peve_00028312",-0.999574579742918,0.0185703291440558,0.782669382293497,"A2VEC9","SCO-spondin (SCO-spondin pseudogene)","Homo sapiens (Human)","cell adhesion [GO:0007155]; positive regulation of immune system process [GO:0002684]; positive regulation of response to stimulus [GO:0048584]","GO:0002684; GO:0005615; GO:0007155; GO:0030414; GO:0031012; GO:0048584"
"11196",11196,"Cluster_589","Porites_evermani_scaffold_392:148700-189243",155,-23.93,2,12,8879,8900,10,"100.00%","100.00%","Peve_00028312",-0.999574579742918,0.0185703291440558,0.782669382293497,"A2VEC9","SCO-spondin (SCO-spondin pseudogene)","Homo sapiens (Human)","cell adhesion [GO:0007155]; positive regulation of immune system process [GO:0002684]; positive regulation of response to stimulus [GO:0048584]","GO:0002684; GO:0005615; GO:0007155; GO:0030414; GO:0031012; GO:0048584"
"11203",11203,"Cluster_589","Porites_evermani_scaffold_3946:3606-35068",154,-21.46,2,20,21365,21387,19,"68.42%","78.95%","Peve_00028439",0.998146330451858,0.0387684455398104,0.909359886114279,"Q8TD57","Dynein axonemal heavy chain 3 (Axonemal beta dynein heavy chain 3) (HsADHC3) (Ciliary dynein heavy chain 3) (Dnahc3-b)","Homo sapiens (Human)","cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]","GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0007018; GO:0008569; GO:0030286; GO:0045505; GO:0051959; GO:0060285; GO:0097729"
"11204",11204,"Cluster_589","Porites_evermani_scaffold_3946:3606-35068",156,-20.64,2,21,27112,27133,19,"63.16%","78.95%","Peve_00028439",0.998146330451858,0.0387684455398104,0.909359886114279,"Q8TD57","Dynein axonemal heavy chain 3 (Axonemal beta dynein heavy chain 3) (HsADHC3) (Ciliary dynein heavy chain 3) (Dnahc3-b)","Homo sapiens (Human)","cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]","GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0007018; GO:0008569; GO:0030286; GO:0045505; GO:0051959; GO:0060285; GO:0097729"
"11205",11205,"Cluster_589","Porites_evermani_scaffold_3946:3606-35068",157,-22.93,2,14,10575,10596,12,"83.33%","100.00%","Peve_00028439",0.998146330451858,0.0387684455398104,0.909359886114279,"Q8TD57","Dynein axonemal heavy chain 3 (Axonemal beta dynein heavy chain 3) (HsADHC3) (Ciliary dynein heavy chain 3) (Dnahc3-b)","Homo sapiens (Human)","cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]","GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0007018; GO:0008569; GO:0030286; GO:0045505; GO:0051959; GO:0060285; GO:0097729"
"11260",11260,"Cluster_589","Porites_evermani_scaffold_4139:19266-29517",154,-27.02,2,21,3810,3835,23,"60.87%","82.61%","Peve_00029564",-0.997056019656118,0.0488617680288714,0.948986088425024,NA,NA,NA,NA,NA
"11314",11314,"Cluster_589","Porites_evermani_scaffold_4:376143-387018",168,-26.71,2,21,9877,9898,19,"78.95%","78.95%","Peve_00028686",-0.998297465612058,0.0371539252592634,0.909359886114279,"Q9YGY0","Axin-1 (Axis inhibition protein 1) (xAxin)","Xenopus laevis (African clawed frog)","negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification [GO:2000054]; positive regulation of JNK cascade [GO:0046330]; Wnt signaling pathway [GO:0016055]","GO:0005634; GO:0005737; GO:0005886; GO:0016055; GO:0042803; GO:0046330; GO:0090090; GO:2000054"
"11317",11317,"Cluster_589","Porites_evermani_scaffold_438:184371-219797",145,-24.08,2,20,1096,1124,25,"64.00%","68.00%","Peve_00030794",-0.997644305172583,0.0437058858615953,0.921295277281368,"P16157","Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin)","Homo sapiens (Human)","cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]","GO:0005198; GO:0005200; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0014731; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030507; GO:0031430; GO:0043005; GO:0044325; GO:0045199; GO:0051117; GO:0072659"
"11318",11318,"Cluster_589","Porites_evermani_scaffold_442:25054-27928",168,-26.73,2,21,609,628,19,"84.21%","89.47%","Peve_00031069",-0.999998494006473,0.00110485866962805,0.277435798056123,"Q9JM13","Rab5 GDP/GTP exchange factor (Rabex-5)","Mus musculus (Mouse)","dendritic transport [GO:0098935]; establishment of localization in cell [GO:0051649]; Kit signaling pathway [GO:0038109]; mast cell degranulation [GO:0043303]; mast cell migration [GO:0097531]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of Kit signaling pathway [GO:1900235]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of mast cell activation [GO:0033004]; negative regulation of mast cell cytokine production [GO:0032764]; negative regulation of mast cell degranulation [GO:0043305]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of receptor-mediated endocytosis [GO:0048261]; protein phosphorylation [GO:0006468]; protein targeting to membrane [GO:0006612]; Ras protein signal transduction [GO:0007265]; receptor-mediated endocytosis [GO:0006898]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]","GO:0001933; GO:0002686; GO:0003677; GO:0005085; GO:0005730; GO:0005769; GO:0005829; GO:0006468; GO:0006612; GO:0006898; GO:0007265; GO:0008270; GO:0030139; GO:0030425; GO:0031267; GO:0031982; GO:0032715; GO:0032764; GO:0033004; GO:0038109; GO:0043303; GO:0043305; GO:0046580; GO:0048261; GO:0050728; GO:0051649; GO:0055037; GO:0060368; GO:0061630; GO:0097531; GO:0098935; GO:1900235"
"11331",11331,"Cluster_589","Porites_evermani_scaffold_448:138666-156060",156,-20.64,2,21,3005,3026,19,"68.42%","73.68%","Peve_00031348",-0.999396101484241,0.0221257988667709,0.832893428623956,NA,NA,NA,NA,NA
"11336",11336,"Cluster_589","Porites_evermani_scaffold_449:10867-80503",151,-20.12,2,21,34671,34695,22,"63.64%","72.73%","Peve_00031401",0.998108703054888,0.0391600694548189,0.909359886114279,"A0A0R4IC37","Cleavage and polyadenylation specificity factor subunit 1 (Cleavage and polyadenylation specific factor 1)","Danio rerio (Zebrafish) (Brachydanio rerio)","definitive hemopoiesis [GO:0060216]; mRNA polyadenylation [GO:0006378]; retinal ganglion cell axon guidance [GO:0031290]","GO:0003676; GO:0005634; GO:0005654; GO:0005847; GO:0006378; GO:0031290; GO:0060216"
"11337",11337,"Cluster_589","Porites_evermani_scaffold_449:10867-80503",153,-20.89,2,18,7883,7904,16,"68.75%","81.25%","Peve_00031401",0.998108703054888,0.0391600694548189,0.909359886114279,"A0A0R4IC37","Cleavage and polyadenylation specificity factor subunit 1 (Cleavage and polyadenylation specific factor 1)","Danio rerio (Zebrafish) (Brachydanio rerio)","definitive hemopoiesis [GO:0060216]; mRNA polyadenylation [GO:0006378]; retinal ganglion cell axon guidance [GO:0031290]","GO:0003676; GO:0005634; GO:0005654; GO:0005847; GO:0006378; GO:0031290; GO:0060216"
"11344",11344,"Cluster_589","Porites_evermani_scaffold_453:27444-40690",162,-24.3,2,21,6610,6630,19,"73.68%","84.21%","Peve_00031585",-0.9976593899819,0.0435656698968128,0.920311455812568,"Q9XSK8","Tumor protein p73 (p53-like transcription factor) (p53-related protein)","Chlorocebus aethiops (Green monkey) (Cercopithecus aethiops)","apoptotic process [GO:0006915]; cell cycle [GO:0007049]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein tetramerization [GO:0051262]","GO:0000976; GO:0000981; GO:0005634; GO:0005737; GO:0006915; GO:0007049; GO:0045944; GO:0046872; GO:0051262"
"11391",11391,"Cluster_589","Porites_evermani_scaffold_4750:1187-6432",156,-21.82,2,20,1314,1335,19,"78.95%","78.95%","Peve_00032544",-0.999481814417645,0.020495406622061,0.811311640546993,"Q17R14","Unconventional myosin-Id","Bos taurus (Bovine)","cellular localization [GO:0051641]; early endosome to recycling endosome transport [GO:0061502]; protein transport [GO:0015031]","GO:0000146; GO:0005516; GO:0005524; GO:0005768; GO:0005769; GO:0005790; GO:0005829; GO:0005903; GO:0005938; GO:0015031; GO:0016323; GO:0016459; GO:0030424; GO:0030673; GO:0031410; GO:0043005; GO:0043025; GO:0043204; GO:0043209; GO:0048306; GO:0051015; GO:0051641; GO:0061502; GO:0097440"
"11446",11446,"Cluster_589","Porites_evermani_scaffold_5050:31-15806",165,-24.72,2,18,2570,2591,16,"81.25%","87.50%","Peve_00033832",-0.996995037508954,0.0493654910801766,0.950602150282626,"Q91WC3","Long-chain-fatty-acid--CoA ligase 6 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 6) (LACS 6)","Mus musculus (Mouse)","fatty acid transport [GO:0015908]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; neuroblast proliferation [GO:0007405]; phospholipid biosynthetic process [GO:0008654]; positive regulation of long-chain fatty acid import across plasma membrane [GO:0010747]; positive regulation of neuron projection development [GO:0010976]; triglyceride biosynthetic process [GO:0019432]; very long-chain fatty acid metabolic process [GO:0000038]","GO:0000038; GO:0001676; GO:0004467; GO:0005524; GO:0005634; GO:0005739; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0007405; GO:0008654; GO:0010747; GO:0010976; GO:0015908; GO:0016020; GO:0019432; GO:0019899; GO:0035338; GO:0042803; GO:0047676"
"11514",11514,"Cluster_589","Porites_evermani_scaffold_545:176886-197842",158,-23.15,2,21,11641,11664,21,"66.67%","85.71%","Peve_00035302",-0.997050387361796,0.0489085087732169,0.949245450063721,"A7SFP1","Leucine-rich repeat protein soc-2 homolog","Nematostella vectensis (Starlet sea anemone)","positive regulation of Ras protein signal transduction [GO:0046579]; signal transduction [GO:0007165]","GO:0007165; GO:0046579"
"11517",11517,"Cluster_589","Porites_evermani_scaffold_5490:1649-10306",151,-22.31,2,21,4260,4282,20,"65.00%","75.00%","Peve_00035430",-0.998833073220515,0.0307580759903037,0.903929377050813,"Q9NRM2","Zinc finger protein 277 (Nuclear receptor-interacting factor 4)","Homo sapiens (Human)","cellular response to hydrogen peroxide [GO:0070301]; regulation of cellular senescence [GO:2000772]","GO:0000978; GO:0005634; GO:0046872; GO:0070301; GO:2000772"
"11543",11543,"Cluster_589","Porites_evermani_scaffold_561:168718-184403",151,-20.38,2,16,8701,8722,14,"71.43%","85.71%","Peve_00035839",-0.999999999503679,2.00574810710951e-05,0.0131777650637095,"P59750","Merlin (Moesin-ezrin-radixin-like protein) (Neurofibromin-2) (Schwannomin)","Papio anubis (Olive baboon)","actin cytoskeleton organization [GO:0030036]; cell-cell junction organization [GO:0045216]; ectoderm development [GO:0007398]; hippocampus development [GO:0021766]; lens fiber cell differentiation [GO:0070306]; MAPK cascade [GO:0000165]; mesoderm formation [GO:0001707]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of Schwann cell proliferation [GO:0010626]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast proliferation [GO:0033687]; positive regulation of cell differentiation [GO:0045597]; positive regulation of stress fiber assembly [GO:0051496]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of hippo signaling [GO:0035330]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of protein localization to nucleus [GO:1900180]; regulation of protein stability [GO:0031647]; regulation of stem cell proliferation [GO:0072091]; Schwann cell proliferation [GO:0014010]","GO:0000165; GO:0001707; GO:0001726; GO:0003779; GO:0005730; GO:0005769; GO:0005829; GO:0005912; GO:0006469; GO:0007398; GO:0010626; GO:0014010; GO:0021766; GO:0022408; GO:0030027; GO:0030036; GO:0030175; GO:0030864; GO:0031647; GO:0032154; GO:0033687; GO:0033689; GO:0035330; GO:0042475; GO:0042532; GO:0042981; GO:0043005; GO:0043409; GO:0044297; GO:0045177; GO:0045216; GO:0045597; GO:0048471; GO:0051496; GO:0051726; GO:0070306; GO:0072091; GO:1900180; GO:2000177"
"11549",11549,"Cluster_589","Porites_evermani_scaffold_563:75162-107076",164,-24.35,2,18,3168,3190,17,"82.35%","88.24%","Peve_00035882",-0.997065128093373,0.0487860852220372,0.948498055920838,"O43747","AP-1 complex subunit gamma-1 (Adaptor protein complex AP-1 subunit gamma-1) (Adaptor-related protein complex 1 subunit gamma-1) (Clathrin assembly protein complex 1 gamma-1 large chain) (Gamma1-adaptin) (Golgi adaptor HA1/AP1 adaptin subunit gamma-1)","Homo sapiens (Human)","basolateral protein secretion [GO:0110010]; endosome to melanosome transport [GO:0035646]; Golgi to lysosome transport [GO:0090160]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; melanosome organization [GO:0032438]; platelet dense granule organization [GO:0060155]; positive regulation of natural killer cell degranulation [GO:0043323]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; vesicle-mediated transport [GO:0016192]","GO:0000139; GO:0005737; GO:0005765; GO:0005769; GO:0005794; GO:0005829; GO:0005905; GO:0006886; GO:0006896; GO:0016020; GO:0016192; GO:0019894; GO:0030121; GO:0030136; GO:0030659; GO:0030665; GO:0030742; GO:0031267; GO:0032438; GO:0032588; GO:0035615; GO:0035646; GO:0043231; GO:0043323; GO:0045954; GO:0048471; GO:0055037; GO:0060155; GO:0090160; GO:0110010; GO:0140312; GO:1903232"
"11579",11579,"Cluster_589","Porites_evermani_scaffold_58:475042-506922",149,-21.03,2,14,1128,1149,12,"83.33%","83.33%","Peve_00036365",-0.998965392859537,0.0289614503733394,0.903929377050813,"Q8K337","Type II inositol 1,4,5-trisphosphate 5-phosphatase (EC 3.1.3.36) (Inositol polyphosphate-5-phosphatase B) (Phosphoinositide 5-phosphatase) (5PTase)","Mus musculus (Mouse)","flagellated sperm motility [GO:0030317]; in utero embryonic development [GO:0001701]; inositol phosphate dephosphorylation [GO:0046855]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of protein processing [GO:0070613]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]","GO:0001701; GO:0004439; GO:0004445; GO:0005793; GO:0005829; GO:0007165; GO:0007283; GO:0016020; GO:0030317; GO:0030670; GO:0031901; GO:0046855; GO:0046856; GO:0046872; GO:0052658; GO:0070613"
"11580",11580,"Cluster_589","Porites_evermani_scaffold_58:475042-506922",160,-24.58,2,19,3653,3673,17,"76.47%","88.24%","Peve_00036365",-0.998965392859537,0.0289614503733394,0.903929377050813,"Q8K337","Type II inositol 1,4,5-trisphosphate 5-phosphatase (EC 3.1.3.36) (Inositol polyphosphate-5-phosphatase B) (Phosphoinositide 5-phosphatase) (5PTase)","Mus musculus (Mouse)","flagellated sperm motility [GO:0030317]; in utero embryonic development [GO:0001701]; inositol phosphate dephosphorylation [GO:0046855]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of protein processing [GO:0070613]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]","GO:0001701; GO:0004439; GO:0004445; GO:0005793; GO:0005829; GO:0007165; GO:0007283; GO:0016020; GO:0030317; GO:0030670; GO:0031901; GO:0046855; GO:0046856; GO:0046872; GO:0052658; GO:0070613"
"11589",11589,"Cluster_589","Porites_evermani_scaffold_590:184463-225363",153,-21.02,2,16,35177,35201,17,"82.35%","82.35%","Peve_00036728",-0.99983803306911,0.0114581409192838,0.660322078232589,"Q5XPI4","E3 ubiquitin-protein ligase RNF123 (EC 2.3.2.27) (Kip1 ubiquitination-promoting complex protein 1) (RING finger protein 123) (RING-type E3 ubiquitin transferase RNF123)","Homo sapiens (Human)","proteolysis involved in protein catabolic process [GO:0051603]","GO:0004842; GO:0005737; GO:0005829; GO:0031965; GO:0046872; GO:0051603"
"11610",11610,"Cluster_589","Porites_evermani_scaffold_5991:2614-5497",155,-23.93,2,12,1600,1621,10,"100.00%","100.00%","Peve_00036931",-0.997510697025279,0.0449287288934107,0.929989129351794,NA,NA,NA,NA,NA
"11616",11616,"Cluster_589","Porites_evermani_scaffold_602:136997-146184",153,-20.68,2,17,485,506,16,"81.25%","87.50%","Peve_00037142",-0.997740919047806,0.0427999055313171,0.915308660158613,NA,NA,NA,NA,NA
"11617",11617,"Cluster_589","Porites_evermani_scaffold_602:136997-146184",154,-23.11,2,21,5733,5760,25,"68.00%","72.00%","Peve_00037142",-0.997740919047806,0.0427999055313171,0.915308660158613,NA,NA,NA,NA,NA
"11618",11618,"Cluster_589","Porites_evermani_scaffold_602:149354-161663",158,-23.26,2,21,8354,8374,19,"73.68%","78.95%","Peve_00037143",-0.999906073477919,0.00872554657337131,0.580392122221314,NA,NA,NA,NA,NA
"11626",11626,"Cluster_589","Porites_evermani_scaffold_60:513808-523638",155,-23.45,2,21,3516,3538,20,"70.00%","75.00%","Peve_00037071",-0.996979263784725,0.0494949519124735,0.951128005711722,"Q9DDA9","Protein kinase C and casein kinase substrate in neurons protein 2 (x-PACSIN2)","Xenopus laevis (African clawed frog)","actin cytoskeleton organization [GO:0030036]; caveola assembly [GO:0070836]; endocytosis [GO:0006897]; plasma membrane tubulation [GO:0097320]","GO:0005769; GO:0005856; GO:0005901; GO:0006897; GO:0030036; GO:0032587; GO:0055038; GO:0070300; GO:0070836; GO:0097320"
"11656",11656,"Cluster_589","Porites_evermani_scaffold_618:110242-158674",155,-21.61,2,17,43952,43974,16,"81.25%","81.25%","Peve_00037538",-0.998807256137127,0.031096527330944,0.903929377050813,"O54991","Contactin-associated protein 1 (Caspr) (Caspr1) (MHDNIV) (NCP1) (Neurexin IV) (Neurexin-4) (Paranodin)","Mus musculus (Mouse)","axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; central nervous system myelination [GO:0022010]; cytoskeleton organization [GO:0007010]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; neuromuscular junction development, skeletal muscle fiber [GO:0098529]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; neuronal action potential propagation [GO:0019227]; paranodal junction assembly [GO:0030913]; paranodal junction maintenance [GO:1990227]; postsynaptic density organization [GO:0097106]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; regulation of synapse maturation [GO:0090128]","GO:0002175; GO:0005886; GO:0005918; GO:0007005; GO:0007010; GO:0007155; GO:0007409; GO:0016020; GO:0017124; GO:0019227; GO:0022010; GO:0022011; GO:0030424; GO:0030913; GO:0031175; GO:0033010; GO:0033270; GO:0042552; GO:0043209; GO:0048786; GO:0048812; GO:0050884; GO:0050885; GO:0050905; GO:0071205; GO:0090128; GO:0097106; GO:0098529; GO:0098978; GO:1990227"
"11657",11657,"Cluster_589","Porites_evermani_scaffold_618:110242-158674",155,-21.61,2,17,44413,44435,16,"81.25%","81.25%","Peve_00037538",-0.998807256137127,0.031096527330944,0.903929377050813,"O54991","Contactin-associated protein 1 (Caspr) (Caspr1) (MHDNIV) (NCP1) (Neurexin IV) (Neurexin-4) (Paranodin)","Mus musculus (Mouse)","axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; central nervous system myelination [GO:0022010]; cytoskeleton organization [GO:0007010]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; neuromuscular junction development, skeletal muscle fiber [GO:0098529]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; neuronal action potential propagation [GO:0019227]; paranodal junction assembly [GO:0030913]; paranodal junction maintenance [GO:1990227]; postsynaptic density organization [GO:0097106]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; regulation of synapse maturation [GO:0090128]","GO:0002175; GO:0005886; GO:0005918; GO:0007005; GO:0007010; GO:0007155; GO:0007409; GO:0016020; GO:0017124; GO:0019227; GO:0022010; GO:0022011; GO:0030424; GO:0030913; GO:0031175; GO:0033010; GO:0033270; GO:0042552; GO:0043209; GO:0048786; GO:0048812; GO:0050884; GO:0050885; GO:0050905; GO:0071205; GO:0090128; GO:0097106; GO:0098529; GO:0098978; GO:1990227"
"11658",11658,"Cluster_589","Porites_evermani_scaffold_618:110242-158674",155,-21.7,2,20,21437,21458,18,"61.11%","83.33%","Peve_00037538",-0.998807256137127,0.031096527330944,0.903929377050813,"O54991","Contactin-associated protein 1 (Caspr) (Caspr1) (MHDNIV) (NCP1) (Neurexin IV) (Neurexin-4) (Paranodin)","Mus musculus (Mouse)","axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; central nervous system myelination [GO:0022010]; cytoskeleton organization [GO:0007010]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; neuromuscular junction development, skeletal muscle fiber [GO:0098529]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; neuronal action potential propagation [GO:0019227]; paranodal junction assembly [GO:0030913]; paranodal junction maintenance [GO:1990227]; postsynaptic density organization [GO:0097106]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; regulation of synapse maturation [GO:0090128]","GO:0002175; GO:0005886; GO:0005918; GO:0007005; GO:0007010; GO:0007155; GO:0007409; GO:0016020; GO:0017124; GO:0019227; GO:0022010; GO:0022011; GO:0030424; GO:0030913; GO:0031175; GO:0033010; GO:0033270; GO:0042552; GO:0043209; GO:0048786; GO:0048812; GO:0050884; GO:0050885; GO:0050905; GO:0071205; GO:0090128; GO:0097106; GO:0098529; GO:0098978; GO:1990227"
"11690",11690,"Cluster_589","Porites_evermani_scaffold_6:364257-373065",161,-24.26,2,20,2826,2846,18,"77.78%","83.33%","Peve_00036939",-0.998665116899834,0.0328976640349452,0.909359886114279,"P25867","Ubiquitin-conjugating enzyme E2-17 kDa (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme D1) (Protein effete) (Ubiquitin carrier protein) (Ubiquitin-protein ligase)","Drosophila melanogaster (Fruit fly)","anaphase-promoting complex-dependent catabolic process [GO:0031145]; chromosome organization [GO:0051276]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; female germ-line stem cell asymmetric division [GO:0048132]; germ-line stem cell population maintenance [GO:0030718]; male meiotic nuclear division [GO:0007140]; mitotic cell cycle [GO:0000278]; negative regulation of smoothened signaling pathway [GO:0045879]; neuron remodeling [GO:0016322]; peptidoglycan recognition protein signaling pathway [GO:0061057]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of protein stability [GO:0031647]; regulation of R7 cell differentiation [GO:0045676]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000209; GO:0000278; GO:0001745; GO:0001751; GO:0005524; GO:0005634; GO:0005829; GO:0006511; GO:0007140; GO:0016322; GO:0016567; GO:0030718; GO:0031145; GO:0031625; GO:0031647; GO:0045676; GO:0045879; GO:0048132; GO:0051276; GO:0061057; GO:0061631; GO:0097039"
"11698",11698,"Cluster_589","Porites_evermani_scaffold_639:79164-95029",153,-22.29,2,14,3883,3904,12,"83.33%","91.67%","Peve_00038083",-0.99930576829184,0.02372315639259,0.852710447681109,"A0JPQ9","Chitinase domain-containing protein 1","Rattus norvegicus (Rat)","carbohydrate metabolic process [GO:0005975]; innate immune response [GO:0045087]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]","GO:0005576; GO:0005615; GO:0005764; GO:0005770; GO:0005802; GO:0005975; GO:0008061; GO:0045087; GO:0070492; GO:1900016"
"11708",11708,"Cluster_589","Porites_evermani_scaffold_650:147034-184168",168,-22.68,2,21,30624,30645,19,"78.95%","78.95%","Peve_00038409",-0.999186863532982,0.0256747529162409,0.876388672460388,"Q0IHW8","Clustered mitochondria protein homolog","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","intracellular distribution of mitochondria [GO:0048312]; mitochondrion organization [GO:0007005]","GO:0003729; GO:0005737; GO:0007005; GO:0048312"
"11709",11709,"Cluster_589","Porites_evermani_scaffold_65:157527-162373",162,-23.46,2,21,1791,1811,19,"73.68%","84.21%","Peve_00038381",-0.997824775952123,0.0419977355083024,0.910535005294959,"P63081","V-type proton ATPase 16 kDa proteolipid subunit c (V-ATPase 16 kDa proteolipid subunit c) (Vacuolar proton pump 16 kDa proteolipid subunit c)","Rattus norvegicus (Rat)","negative regulation of autophagic cell death [GO:1904093]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of Wnt signaling pathway [GO:0030177]","GO:0000220; GO:0005764; GO:0005794; GO:0008021; GO:0016020; GO:0030177; GO:0030665; GO:0030672; GO:0031625; GO:0033176; GO:0046961; GO:0070374; GO:1902495; GO:1904093; GO:1904949"
"11712",11712,"Cluster_589","Porites_evermani_scaffold_65:362040-411718",153,-21.91,2,19,32950,32973,19,"73.68%","73.68%","Peve_00038399",-0.999121107324343,0.0266928445164863,0.887761277390521,NA,NA,NA,NA,NA
"11715",11715,"Cluster_589","Porites_evermani_scaffold_6:562147-586985",163,-26.01,2,21,11463,11485,20,"75.00%","80.00%","Peve_00036956",-0.998056688305508,0.0396950824876416,0.909359886114279,"Q5F471","Serine/threonine-protein phosphatase 6 regulatory subunit 3 (SAPS domain family member 3)","Gallus gallus (Chicken)","regulation of phosphoprotein phosphatase activity [GO:0043666]","GO:0005634; GO:0005829; GO:0019888; GO:0019903; GO:0043666"
"11720",11720,"Cluster_589","Porites_evermani_scaffold_658:41038-83373",155,-21.64,2,16,34333,34354,14,"78.57%","85.71%","Peve_00038545",-0.999984274571916,0.00357023602887492,0.52296348009917,NA,NA,NA,NA,NA
"11721",11721,"Cluster_589","Porites_evermani_scaffold_658:41038-83373",155,-21.64,2,16,41141,41162,14,"78.57%","85.71%","Peve_00038545",-0.999984274571916,0.00357023602887492,0.52296348009917,NA,NA,NA,NA,NA
"11743",11743,"Cluster_589","Porites_evermani_scaffold_6:725144-728211",158,-23.98,2,20,76,98,19,"73.68%","78.95%","Peve_00036966",-0.997544099912725,0.0446261468380649,0.928133778105176,NA,NA,NA,NA,NA
"11771",11771,"Cluster_589","Porites_evermani_scaffold_6:963817-965286",175,-30.53,2,21,773,796,21,"80.95%","85.71%","Peve_00036987",-0.999964196617774,0.00538714225743854,0.551398425649056,NA,NA,NA,NA,NA
"11794",11794,"Cluster_589","Porites_evermani_scaffold_714:156764-171877",163,-23.88,2,21,6070,6092,20,"70.00%","85.00%","Peve_00039910",-0.997528607450278,0.0447667401252105,0.929124691165952,"P58027","Amine oxidase [flavin-containing] A (EC 1.4.3.21) (EC 1.4.3.4) (Monoamine oxidase type A) (MAO-A)","Canis lupus familiaris (Dog) (Canis familiaris)","catecholamine metabolic process [GO:0006584]; neurotransmitter catabolic process [GO:0042135]","GO:0005739; GO:0005741; GO:0006584; GO:0008131; GO:0042135; GO:0050660; GO:0052595; GO:0052596; GO:0097621"
"11795",11795,"Cluster_589","Porites_evermani_scaffold_71:462319-484746",157,-22.32,2,21,19358,19379,20,"75.00%","80.00%","Peve_00039806",-0.997836125155212,0.0418879912592066,0.909699887923376,"Q84M95","Probable serine/threonine-protein kinase PBL28 (EC 2.7.11.1) (PBS1-like protein 28)","Arabidopsis thaliana (Mouse-ear cress)","defense response [GO:0006952]; protein phosphorylation [GO:0006468]","GO:0000976; GO:0004674; GO:0005524; GO:0005886; GO:0006468; GO:0006952; GO:0106310"
"11803",11803,"Cluster_589","Porites_evermani_scaffold_72:212463-232062",155,-23.41,2,12,19339,19360,10,"100.00%","100.00%","Peve_00040028",-0.998577594827018,0.0339592644007571,0.909359886114279,"Q9NYQ6","Cadherin EGF LAG seven-pass G-type receptor 1 (Cadherin family member 9) (Flamingo homolog 2) (hFmi2)","Homo sapiens (Human)","apical protein localization [GO:0045176]; cell-cell adhesion [GO:0098609]; central nervous system development [GO:0007417]; establishment of body hair planar orientation [GO:0048105]; establishment of planar polarity [GO:0001736]; establishment of planar polarity of embryonic epithelium [GO:0042249]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; lateral sprouting involved in lung morphogenesis [GO:0060490]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060488]; planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060489]; protein localization involved in establishment of planar polarity [GO:0090251]; regulation of actin cytoskeleton organization [GO:0032956]; Rho protein signal transduction [GO:0007266]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001736; GO:0001764; GO:0001843; GO:0004930; GO:0005509; GO:0005654; GO:0005886; GO:0007156; GO:0007266; GO:0007417; GO:0016020; GO:0032956; GO:0042249; GO:0045176; GO:0048105; GO:0060071; GO:0060488; GO:0060489; GO:0060490; GO:0090251; GO:0098609"
"11809",11809,"Cluster_589","Porites_evermani_scaffold_72:488545-516512",155,-21.51,2,12,1125,1146,10,"100.00%","100.00%","Peve_00040009",-0.999293986677338,0.0239236325741865,0.855610912323647,NA,NA,NA,NA,NA
"11855",11855,"Cluster_589","Porites_evermani_scaffold_76:149786-197508",155,-23.41,2,12,34798,34819,10,"100.00%","100.00%","Peve_00040857",-0.999803825754728,0.0126102360468861,0.69089496211305,"Q9P2J5","Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS)","Homo sapiens (Human)","cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; glutaminyl-tRNA aminoacylation [GO:0006425]; leucyl-tRNA aminoacylation [GO:0006429]; positive regulation of GTPase activity [GO:0043547]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; regulation of cell size [GO:0008361]; tRNA aminoacylation for protein translation [GO:0006418]","GO:0002161; GO:0004819; GO:0004823; GO:0005096; GO:0005524; GO:0005737; GO:0005764; GO:0005783; GO:0005829; GO:0006418; GO:0006425; GO:0006429; GO:0008361; GO:0012505; GO:0016604; GO:0017101; GO:0032008; GO:0034198; GO:0043547; GO:0071230; GO:0071233; GO:1904263; GO:1990253"
"11859",11859,"Cluster_589","Porites_evermani_scaffold_768:13001-26209",151,-25.53,2,21,1147,1171,22,"59.09%","77.27%","Peve_00041013",-0.997768884296408,0.0425340705521016,0.913643277704532,"P35556","Fibrillin-2 [Cleaved into: Placensin]","Homo sapiens (Human)","anatomical structure morphogenesis [GO:0009653]; bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583]","GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0009653; GO:0030023; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:0062023; GO:1901163"
"11862",11862,"Cluster_589","Porites_evermani_scaffold_77:111804-118354",156,-25.08,2,13,1051,1072,11,"90.91%","100.00%","Peve_00041060",-0.99900949229162,0.0283373937535365,0.903124690393816,"Q6P0C6","LHFPL tetraspan subfamily member 2a protein","Danio rerio (Zebrafish) (Brachydanio rerio)","development of primary female sexual characteristics [GO:0046545]; development of primary male sexual characteristics [GO:0046546]; positive regulation of fertilization [GO:1905516]; single fertilization [GO:0007338]","GO:0007338; GO:0016020; GO:0046545; GO:0046546; GO:1905516"
"11872",11872,"Cluster_589","Porites_evermani_scaffold_776:65603-84109",162,-25.32,2,21,7298,7324,24,"70.83%","79.17%","Peve_00041178",0.998539575899744,0.0344102228351361,0.909359886114279,NA,NA,NA,NA,NA
"11873",11873,"Cluster_589","Porites_evermani_scaffold_776:65603-84109",162,-26.84,2,21,1024,1050,24,"70.83%","79.17%","Peve_00041178",0.998539575899744,0.0344102228351361,0.909359886114279,NA,NA,NA,NA,NA
"11879",11879,"Cluster_589","Porites_evermani_scaffold_781:77082-85670",150,-20.07,2,15,4706,4727,13,"69.23%","92.31%","Peve_00041309",-0.99798821144982,0.0403886300754286,0.909359886114279,"Q3ZCF5","Ornithine aminotransferase, mitochondrial (EC 2.6.1.13) (Ornithine--oxo-acid aminotransferase)","Bos taurus (Bovine)","L-proline biosynthetic process [GO:0055129]","GO:0004587; GO:0005759; GO:0030170; GO:0042802; GO:0050155; GO:0055129"
"11892",11892,"Cluster_589","Porites_evermani_scaffold_791:122044-149659",158,-28.63,2,21,26220,26245,23,"73.91%","73.91%","Peve_00041525",-0.999765542200734,0.013785926177826,0.718611308062303,"P07207","Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein]","Drosophila melanogaster (Fruit fly)","actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222]","GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048"
"11905",11905,"Cluster_589","Porites_evermani_scaffold_79:97383-117735",151,-20.43,2,21,4748,4770,20,"70.00%","70.00%","Peve_00041486",-0.999783179861348,0.0132572295746792,0.706310704847038,"Q99JW4","LIM and senescent cell antigen-like-containing domain protein 1 (Particularly interesting new Cys-His protein 1) (PINCH-1)","Mus musculus (Mouse)","cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; cell-matrix adhesion [GO:0007160]; cholangiocyte proliferation [GO:1990705]; chordate embryonic development [GO:0043009]; establishment of protein localization [GO:0045184]; establishment or maintenance of cell polarity [GO:0007163]; hepatocyte apoptotic process [GO:0097284]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of cholangiocyte proliferation [GO:1904055]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of hepatocyte proliferation [GO:2000346]; negative regulation of neural precursor cell proliferation [GO:2000178]; neural precursor cell proliferation [GO:0061351]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; tumor necrosis factor-mediated signaling pathway [GO:0033209]","GO:0005737; GO:0005886; GO:0005911; GO:0005925; GO:0007160; GO:0007163; GO:0007229; GO:0008270; GO:0010628; GO:0010811; GO:0019901; GO:0032991; GO:0033209; GO:0043009; GO:0043547; GO:0044877; GO:0045184; GO:0045216; GO:0045892; GO:0048471; GO:0051894; GO:0061351; GO:0097284; GO:0098609; GO:1900026; GO:1901224; GO:1903944; GO:1904055; GO:1990705; GO:2000178; GO:2000346; GO:2001046"
"11912",11912,"Cluster_589","Porites_evermani_scaffold_804:11646-36775",155,-22.2,2,12,23794,23815,10,"100.00%","100.00%","Peve_00041875",-0.999706181714714,0.0154328155265098,0.751559768011606,"Q6PCL9","Poly(A) polymerase gamma (PAP-gamma) (EC 2.7.7.19) (Polynucleotide adenylyltransferase gamma) (SRP RNA 3'-adenylating enzyme) (Signal recognition particle RNA-adenylating enzyme) (SRP RNA-adenylating enzyme)","Mus musculus (Mouse)","mRNA polyadenylation [GO:0006378]; RNA polyadenylation [GO:0043631]","GO:0003723; GO:0004652; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006378; GO:0016604; GO:0043631; GO:0046872"
"11922",11922,"Cluster_589","Porites_evermani_scaffold_810:72177-101268",155,-21.07,2,21,13385,13409,22,"63.64%","77.27%","Peve_00042017",-0.999385177691432,0.0223250367837388,0.835635226341236,"Q13614","Myotubularin-related protein 2 (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (EC 3.1.3.95) (Phosphatidylinositol-3-phosphate phosphatase) (EC 3.1.3.64)","Homo sapiens (Human)","dendritic spine maintenance [GO:0097062]; inositol phosphate dephosphorylation [GO:0046855]; myelin assembly [GO:0032288]; negative regulation of endocytosis [GO:0045806]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of myelination [GO:0031642]; negative regulation of receptor catabolic process [GO:2000645]; negative regulation of receptor internalization [GO:0002091]; neuron development [GO:0048666]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of early endosome to late endosome transport [GO:2000643]; protein dephosphorylation [GO:0006470]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]","GO:0002091; GO:0004438; GO:0005634; GO:0005737; GO:0005774; GO:0005829; GO:0006470; GO:0006661; GO:0008021; GO:0008138; GO:0014069; GO:0030424; GO:0030425; GO:0031642; GO:0031901; GO:0032288; GO:0042802; GO:0043197; GO:0043231; GO:0045806; GO:0046855; GO:0046856; GO:0048471; GO:0048666; GO:0052629; GO:0060304; GO:0070062; GO:0090394; GO:0097060; GO:0097062; GO:2000643; GO:2000645"
"11929",11929,"Cluster_589","Porites_evermani_scaffold_8:184318-203838",155,-23.55,2,12,12314,12335,10,"100.00%","100.00%","Peve_00041749",-0.99787477055967,0.0415121261197676,0.909359886114279,"Q8BKX6","Serine/threonine-protein kinase SMG1 (SMG-1) (EC 2.7.11.1) (Lambda/iota protein kinase C-interacting protein) (Lambda-interacting protein) (Nonsense mediated mRNA decay-associated PI3K-related kinase SMG1)","Mus musculus (Mouse)","DNA repair [GO:0006281]; negative regulation of macroautophagy [GO:0016242]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of telomere maintenance [GO:0032204]; TOR signaling [GO:0031929]","GO:0000184; GO:0004674; GO:0004697; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006468; GO:0016242; GO:0018105; GO:0031929; GO:0031931; GO:0031932; GO:0032204; GO:0033391; GO:0042162; GO:0046777; GO:0046854; GO:0046872; GO:0106310; GO:2001020"
"11959",11959,"Cluster_589","Porites_evermani_scaffold_857:143739-167016",156,-20.02,2,17,12383,12404,15,"73.33%","86.67%","Peve_00042902",-0.999894247471614,0.00925857881553049,0.598206644113041,"Q5ZJ54","T-complex protein 1 subunit zeta (TCP-1-zeta) (CCT-zeta)","Gallus gallus (Chicken)","protein folding [GO:0006457]","GO:0005524; GO:0005832; GO:0006457; GO:0016887; GO:0051082; GO:0140662"
"11963",11963,"Cluster_589","Porites_evermani_scaffold_858:1529-40113",156,-21.49,2,17,4476,4497,15,"80.00%","80.00%","Peve_00042905",-0.999625976379842,0.0174123814581667,0.782669382293497,"Q9VKA4","Probable G-protein coupled receptor CG31760","Drosophila melanogaster (Fruit fly)","","GO:0004930; GO:0005886"
"11964",11964,"Cluster_589","Porites_evermani_scaffold_858:43768-51448",155,-23.41,2,12,3177,3198,10,"100.00%","100.00%","Peve_00042906",-0.99799654661434,0.0403048469112576,0.909359886114279,"Q9UKT8","F-box/WD repeat-containing protein 2 (F-box and WD-40 domain-containing protein 2) (Protein MD6)","Homo sapiens (Human)","protein modification process [GO:0036211]; proteolysis [GO:0006508]","GO:0004842; GO:0005829; GO:0006508; GO:0036211"
"11968",11968,"Cluster_589","Porites_evermani_scaffold_86:374250-390238",153,-21.52,2,14,8489,8510,12,"83.33%","91.67%","Peve_00042937",-0.999999785578752,0.000416897257778453,0.224454777561094,NA,NA,NA,NA,NA
"11969",11969,"Cluster_589","Porites_evermani_scaffold_86:374250-390238",155,-21.82,2,12,15265,15286,10,"100.00%","100.00%","Peve_00042937",-0.999999785578752,0.000416897257778453,0.224454777561094,NA,NA,NA,NA,NA
"11973",11973,"Cluster_589","Porites_evermani_scaffold_864:87916-157515",151,-20.02,2,12,62406,62427,10,"90.00%","100.00%","Peve_00043039",-0.999975784536428,0.00443039441481932,0.54328949385489,"P27884","Voltage-dependent P/Q-type calcium channel subunit alpha-1A (Brain calcium channel I) (BI) (Calcium channel, L type, alpha-1 polypeptide isoform 4) (Voltage-gated calcium channel subunit alpha Cav2.1)","Oryctolagus cuniculus (Rabbit)","calcium ion transmembrane transport [GO:0070588]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of ion transmembrane transport [GO:0034765]","GO:0005245; GO:0005886; GO:0005891; GO:0007204; GO:0008022; GO:0034765; GO:0046872; GO:0070588"
"12005",12005,"Cluster_589","Porites_evermani_scaffold_911:2139-25808",159,-24.42,2,20,3345,3366,18,"61.11%","88.89%","Peve_00043949",-0.999465915219043,0.0208074832265374,0.816390317707038,"Q92508","Piezo-type mechanosensitive ion channel component 1 (Membrane protein induced by beta-amyloid treatment) (Mib) (Protein FAM38A)","Homo sapiens (Human)","cation transport [GO:0006812]; cellular response to mechanical stimulus [GO:0071260]; detection of mechanical stimulus [GO:0050982]; positive regulation of cell-cell adhesion mediated by integrin [GO:0033634]; positive regulation of integrin activation [GO:0033625]; positive regulation of myotube differentiation [GO:0010831]; regulation of membrane potential [GO:0042391]","GO:0005261; GO:0005783; GO:0005789; GO:0005886; GO:0006812; GO:0008381; GO:0010831; GO:0016020; GO:0031258; GO:0033116; GO:0033625; GO:0033634; GO:0042391; GO:0050982; GO:0071260"
"12177",12177,"Cluster_796","Porites_evermani_scaffold_11:30006-44147",158,-21.2,2,20,680,702,19,"73.68%","78.95%","Peve_00001819",0.998906823578492,0.0297700675484845,0.903929377050813,"Q8R151","NFX1-type zinc finger-containing protein 1","Mus musculus (Mouse)","activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; RNA-mediated heterochromatin formation [GO:0031048]","GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607"
"12178",12178,"Cluster_796","Porites_evermani_scaffold_11:30006-44147",159,-23.48,2,20,705,726,18,"72.22%","77.78%","Peve_00001819",0.998906823578492,0.0297700675484845,0.903929377050813,"Q8R151","NFX1-type zinc finger-containing protein 1","Mus musculus (Mouse)","activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; RNA-mediated heterochromatin formation [GO:0031048]","GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607"
"12182",12182,"Cluster_796","Porites_evermani_scaffold_114:202334-230272",159,-21.63,2,21,2487,2509,20,"75.00%","75.00%","Peve_00002405",0.999465467582815,0.020816201937894,0.816419796298782,NA,NA,NA,NA,NA
"12226",12226,"Cluster_796","Porites_evermani_scaffold_1211:38165-39041",161,-25.43,2,19,825,847,18,"77.78%","83.33%","Peve_00003564",0.998855998692393,0.0304543821236996,0.903929377050813,"P90994","Glutathione-independent glyoxalase DJR-1.1 (EC 4.2.1.130) (Protein DJ-1 homolog 1)","Caenorhabditis elegans","cellular response to glyoxal [GO:0036471]; cellular response to methylglyoxal [GO:0097238]; glycolate biosynthetic process [GO:0046295]; glyoxal metabolic process [GO:1903189]; lactate biosynthetic process [GO:0019249]; methylglyoxal metabolic process [GO:0009438]; negative regulation of neuron death [GO:1901215]; response to oxidative stress [GO:0006979]; response to toxic substance [GO:0009636]","GO:0005634; GO:0005737; GO:0005739; GO:0006979; GO:0009438; GO:0009636; GO:0019172; GO:0019249; GO:0036471; GO:0046295; GO:0097238; GO:1901215; GO:1903189"
"12233",12233,"Cluster_796","Porites_evermani_scaffold_12:236425-265918",165,-22.73,2,18,370,391,16,"81.25%","87.50%","Peve_00003302",0.998226961786262,0.0379156371127279,0.909359886114279,"Q7TSG1","Centrosomal protein of 120 kDa (Cep120) (Coiled-coil domain-containing protein 100)","Mus musculus (Mouse)","astral microtubule organization [GO:0030953]; cell population proliferation [GO:0008283]; centrosome cycle [GO:0007098]; cerebral cortex development [GO:0021987]; interkinetic nuclear migration [GO:0022027]; microtubule cytoskeleton organization [GO:0000226]; neurogenesis [GO:0022008]; positive regulation of centriole elongation [GO:1903724]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of cilium assembly [GO:0045724]; positive regulation of establishment of protein localization [GO:1904951]; regulation of microtubule-based process [GO:0032886]; regulation of protein localization [GO:0032880]","GO:0000226; GO:0005737; GO:0005813; GO:0005814; GO:0007098; GO:0008022; GO:0008283; GO:0010825; GO:0021987; GO:0022008; GO:0022027; GO:0030953; GO:0032880; GO:0032886; GO:0045724; GO:1903724; GO:1904951"
"12234",12234,"Cluster_796","Porites_evermani_scaffold_12:236425-265918",170,-25.85,2,20,8357,8380,20,"80.00%","85.00%","Peve_00003302",0.998226961786262,0.0379156371127279,0.909359886114279,"Q7TSG1","Centrosomal protein of 120 kDa (Cep120) (Coiled-coil domain-containing protein 100)","Mus musculus (Mouse)","astral microtubule organization [GO:0030953]; cell population proliferation [GO:0008283]; centrosome cycle [GO:0007098]; cerebral cortex development [GO:0021987]; interkinetic nuclear migration [GO:0022027]; microtubule cytoskeleton organization [GO:0000226]; neurogenesis [GO:0022008]; positive regulation of centriole elongation [GO:1903724]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of cilium assembly [GO:0045724]; positive regulation of establishment of protein localization [GO:1904951]; regulation of microtubule-based process [GO:0032886]; regulation of protein localization [GO:0032880]","GO:0000226; GO:0005737; GO:0005813; GO:0005814; GO:0007098; GO:0008022; GO:0008283; GO:0010825; GO:0021987; GO:0022008; GO:0022027; GO:0030953; GO:0032880; GO:0032886; GO:0045724; GO:1903724; GO:1904951"
"12242",12242,"Cluster_796","Porites_evermani_scaffold_1239:77883-85953",161,-26.26,2,20,5850,5876,23,"73.91%","78.26%","Peve_00003917",0.999626324993561,0.017404264339196,0.782669382293497,NA,NA,NA,NA,NA
"12245",12245,"Cluster_796","Porites_evermani_scaffold_1241:55995-98627",149,-22.14,2,21,7673,7692,19,"68.42%","73.68%","Peve_00003987",0.997067200526471,0.0487688488234394,0.9484938778958,"F4IYM4","Protein DEFECTIVE IN EXINE FORMATION 1","Arabidopsis thaliana (Mouse-ear cress)","cell wall organization [GO:0071555]; pollen exine formation [GO:0010584]; pollen wall assembly [GO:0010208]","GO:0000137; GO:0005509; GO:0005783; GO:0005829; GO:0005886; GO:0010208; GO:0010584; GO:0016020; GO:0071555"
"12258",12258,"Cluster_796","Porites_evermani_scaffold_1258:133206-134874",165,-23.89,2,20,1070,1090,18,"83.33%","83.33%","Peve_00004183",0.999177291635325,0.0258254475535218,0.878144618656955,NA,NA,NA,NA,NA
"12298",12298,"Cluster_796","Porites_evermani_scaffold_1303:73970-87601",150,-20.66,2,21,6267,6287,19,"68.42%","73.68%","Peve_00004847",0.999938723829808,0.00704763080771654,0.573710369894872,"Q49B93","Sodium-coupled monocarboxylate transporter 2 (Electroneutral sodium monocarboxylate cotransporter) (Low-affinity sodium-lactate cotransporter) (Solute carrier family 5 member 12)","Mus musculus (Mouse)","sodium ion transport [GO:0006814]","GO:0005654; GO:0005886; GO:0006814; GO:0015129; GO:0015293; GO:0016324"
"12314",12314,"Cluster_796","Porites_evermani_scaffold_132:339319-400204",158,-24.69,2,21,30000,30026,24,"70.83%","75.00%","Peve_00005087",0.99852948442121,0.0345289339261551,0.909359886114279,"A2AJ88","Patatin-like phospholipase domain-containing protein 7 (EC 3.1.1.-) (EC 3.1.1.5) (Neuropathy target esterase-related esterase) (NRE) (NTE-related esterase)","Mus musculus (Mouse)","phosphatidylcholine catabolic process [GO:0034638]","GO:0004622; GO:0005783; GO:0005789; GO:0005811; GO:0034638; GO:0102545"
"12321",12321,"Cluster_796","Porites_evermani_scaffold_1334:115374-128538",154,-23.01,2,21,352,372,19,"73.68%","73.68%","Peve_00005282",0.999216124702012,0.0252084988049993,0.870844476309606,"A1L1W9","Monocarboxylate transporter 10 (MCT 10) (Solute carrier family 16 member 10)","Danio rerio (Zebrafish) (Brachydanio rerio)","aromatic amino acid transport [GO:0015801]; thyroid hormone transport [GO:0070327]","GO:0005302; GO:0015173; GO:0015192; GO:0015196; GO:0015349; GO:0015801; GO:0016020; GO:0016323; GO:0070327"
"12338",12338,"Cluster_796","Porites_evermani_scaffold_13:637258-660149",160,-21.97,2,21,6510,6531,19,"73.68%","73.68%","Peve_00004716",0.999155814489371,0.0261604147169285,0.88215006671225,"O35474","EGF-like repeat and discoidin I-like domain-containing protein 3 (Developmentally-regulated endothelial cell locus 1 protein) (Integrin-binding protein DEL1)","Mus musculus (Mouse)","cell adhesion [GO:0007155]; positive regulation of cell-substrate adhesion [GO:0010811]","GO:0005509; GO:0005576; GO:0007155; GO:0010811"
"12345",12345,"Cluster_796","Porites_evermani_scaffold_137:34491-68522",152,-21.1,2,19,4704,4727,19,"73.68%","78.95%","Peve_00005764",0.997349443062599,0.0463617331849258,0.937527087266077,"Q8IY22","C-Maf-inducing protein (c-Mip) (Truncated c-Maf-inducing protein) (Tc-Mip)","Homo sapiens (Human)","in utero embryonic development [GO:0001701]","GO:0001701; GO:0005654; GO:0005829"
"12354",12354,"Cluster_796","Porites_evermani_scaffold_1393:277-31359",150,-20.08,2,20,13650,13673,20,"70.00%","70.00%","Peve_00006089",0.997686227424772,0.0433150908007001,0.91864596019626,"B0JZG0","Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Sodium-dependent vitamin C transporter 2)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","sodium ion transport [GO:0006814]","GO:0006814; GO:0015229; GO:0015293; GO:0098590"
"12368",12368,"Cluster_796","Porites_evermani_scaffold_1420:2390-41354",157,-20.88,2,21,20816,20838,21,"76.19%","76.19%","Peve_00006527",0.999861274283444,0.0106042175759821,0.639852969602429,"Q9H251","Cadherin-23 (Otocadherin)","Homo sapiens (Human)","auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; locomotory behavior [GO:0007626]; photoreceptor cell maintenance [GO:0045494]; post-embryonic animal organ morphogenesis [GO:0048563]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to stimulus [GO:0050896]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]","GO:0001917; GO:0005509; GO:0005813; GO:0006816; GO:0007156; GO:0007601; GO:0007605; GO:0007626; GO:0016020; GO:0016339; GO:0016342; GO:0032420; GO:0032426; GO:0045296; GO:0045494; GO:0048563; GO:0050896; GO:0050953; GO:0050957; GO:0051480; GO:0060088; GO:0060091; GO:0098683; GO:0098684; GO:0098742"
"12414",12414,"Cluster_796","Porites_evermani_scaffold_150:50904-73625",155,-22.37,2,19,6501,6520,17,"76.47%","82.35%","Peve_00007538",0.997223297346734,0.0474526370163822,0.942888539658333,"Q5A8K2","Alanine--tRNA ligase (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS)","Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)","alanyl-tRNA aminoacylation [GO:0006419]; mitochondrial alanyl-tRNA aminoacylation [GO:0070143]; tRNA modification [GO:0006400]","GO:0000049; GO:0002161; GO:0004813; GO:0005524; GO:0005737; GO:0005739; GO:0006400; GO:0006419; GO:0008270; GO:0016597; GO:0070143"
"12415",12415,"Cluster_796","Porites_evermani_scaffold_150:50904-73625",155,-22.37,2,19,9301,9320,17,"76.47%","82.35%","Peve_00007538",0.997223297346734,0.0474526370163822,0.942888539658333,"Q5A8K2","Alanine--tRNA ligase (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS)","Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)","alanyl-tRNA aminoacylation [GO:0006419]; mitochondrial alanyl-tRNA aminoacylation [GO:0070143]; tRNA modification [GO:0006400]","GO:0000049; GO:0002161; GO:0004813; GO:0005524; GO:0005737; GO:0005739; GO:0006400; GO:0006419; GO:0008270; GO:0016597; GO:0070143"
"12556",12556,"Cluster_796","Porites_evermani_scaffold_180:372972-379637",160,-23.44,2,13,5180,5201,11,"100.00%","100.00%","Peve_00011165",0.999614579643084,0.0176756907745432,0.782669382293497,NA,NA,NA,NA,NA
"12557",12557,"Cluster_796","Porites_evermani_scaffold_1811:19803-89275",163,-27.82,2,21,61810,61832,20,"75.00%","80.00%","Peve_00011299",0.999469239597005,0.0207426189429382,0.815244448838541,NA,NA,NA,NA,NA
"12595",12595,"Cluster_796","Porites_evermani_scaffold_1883:84726-88460",153,-22.39,2,20,1751,1774,20,"75.00%","75.00%","Peve_00012067",0.999880217269511,0.00985363702675541,0.616189877019716,"P97846","Contactin-associated protein 1 (Caspr) (Caspr1) (Neurexin IV) (Neurexin-4) (Paranodin) (p190)","Rattus norvegicus (Rat)","axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; central nervous system myelination [GO:0022010]; cytoskeleton organization [GO:0007010]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; neuromuscular junction development, skeletal muscle fiber [GO:0098529]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; neuronal action potential propagation [GO:0019227]; paranodal junction assembly [GO:0030913]; paranodal junction maintenance [GO:1990227]; postsynaptic density organization [GO:0097106]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; regulation of synapse maturation [GO:0090128]","GO:0002175; GO:0007005; GO:0007010; GO:0007155; GO:0007409; GO:0016020; GO:0017124; GO:0019227; GO:0022010; GO:0022011; GO:0030424; GO:0030913; GO:0031175; GO:0033010; GO:0033270; GO:0042552; GO:0048786; GO:0048812; GO:0050884; GO:0050885; GO:0050905; GO:0071205; GO:0090128; GO:0097106; GO:0098529; GO:0098978; GO:1990227"
"12622",12622,"Cluster_796","Porites_evermani_scaffold_1946:11511-40641",152,-22.72,2,18,17767,17790,18,"72.22%","77.78%","Peve_00012780",0.999398003365372,0.0220909270698022,0.832346845851212,"P20735","Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain]","Sus scrofa (Pig)","glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; zymogen activation [GO:0031638]","GO:0002951; GO:0005886; GO:0006536; GO:0006750; GO:0006751; GO:0031638; GO:0036374; GO:0102953; GO:0103068"
"12638",12638,"Cluster_796","Porites_evermani_scaffold_200:209580-253306",153,-20.32,2,19,21327,21351,20,"70.00%","75.00%","Peve_00013567",0.999437004579206,0.0213632798510106,0.823948557854313,"Q03701","CCAAT/enhancer-binding protein zeta (CCAAT-box-binding transcription factor) (CBF) (CCAAT-binding factor)","Homo sapiens (Human)","positive regulation of transcription by RNA polymerase II [GO:0045944]","GO:0003713; GO:0003723; GO:0005634; GO:0016602; GO:0045944"
"12653",12653,"Cluster_796","Porites_evermani_scaffold_2028:5370-91915",163,-20.44,2,21,37855,37877,20,"75.00%","80.00%","Peve_00013835",0.99796247257867,0.0406462627328843,0.909359886114279,NA,NA,NA,NA,NA
"12654",12654,"Cluster_796","Porites_evermani_scaffold_2028:5370-91915",163,-20.44,2,21,41784,41806,20,"75.00%","80.00%","Peve_00013835",0.99796247257867,0.0406462627328843,0.909359886114279,NA,NA,NA,NA,NA
"12658",12658,"Cluster_796","Porites_evermani_scaffold_20:342423-361642",162,-21.96,2,21,4299,4319,19,"78.95%","78.95%","Peve_00013537",0.998658860227375,0.032974687712477,0.909359886114279,NA,NA,NA,NA,NA
"12668",12668,"Cluster_796","Porites_evermani_scaffold_206:272486-294940",146,-20.58,2,20,11485,11507,19,"63.16%","73.68%","Peve_00014158",0.99872883403273,0.0321027520963933,0.907109338565727,"A8E7C5","Phosphatidylinositide phosphatase SAC2 (EC 3.1.3.25) (Inositol polyphosphate 5-phosphatase F) (Sac domain-containing inositol phosphatase 2) (Sac domain-containing phosphoinositide 4-phosphatase 2) (hSAC2)","Danio rerio (Zebrafish) (Brachydanio rerio)","clathrin-dependent endocytosis [GO:0072583]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of endocytic recycling [GO:2001135]","GO:0005769; GO:0005905; GO:0008934; GO:0042803; GO:0043812; GO:0045334; GO:0046856; GO:0052832; GO:0052833; GO:0055037; GO:0072583; GO:2001135"
"12675",12675,"Cluster_796","Porites_evermani_scaffold_2099:53962-65142",150,-22.09,2,21,7116,7132,19,"73.68%","73.68%","Peve_00014504",-0.998184766923426,0.0383642786220211,0.909359886114279,"Q570Y9","DEP domain-containing mTOR-interacting protein (DEP domain-containing protein 6)","Mus musculus (Mouse)","intracellular signal transduction [GO:0035556]; negative regulation of cell size [GO:0045792]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of TORC2 signaling [GO:1903940]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]","GO:0006469; GO:0032007; GO:0035556; GO:0045792; GO:1903940; GO:1904262; GO:2001236"
"12776",12776,"Cluster_796","Porites_evermani_scaffold_23:834055-840895",149,-20.6,2,20,1455,1480,22,"68.18%","72.73%","Peve_00016520",-0.999291205491492,0.0239707127888751,0.856164162085951,NA,NA,NA,NA,NA
"12795",12795,"Cluster_796","Porites_evermani_scaffold_243:160318-174373",146,-21.97,2,21,7765,7789,22,"68.18%","68.18%","Peve_00017768",0.997539179225125,0.0446708496942226,0.928382133004496,"Q8CGF6","WD repeat-containing protein 47 (Neuronal enriched MAP interacting protein) (Nemitin)","Mus musculus (Mouse)","adult locomotory behavior [GO:0008344]; anterior commissure morphogenesis [GO:0021960]; autophagy [GO:0006914]; brain development [GO:0007420]; cerebral cortex development [GO:0021987]; cerebral cortex radial glia-guided migration [GO:0021801]; corpus callosum development [GO:0022038]; detection of hot stimulus involved in thermoception [GO:0120168]; locomotory behavior [GO:0007626]; microtubule cytoskeleton organization [GO:0000226]; motor behavior [GO:0061744]; negative regulation of microtubule depolymerization [GO:0007026]; neural precursor cell proliferation [GO:0061351]; neuron projection development [GO:0031175]; neuronal stem cell population maintenance [GO:0097150]","GO:0000226; GO:0005737; GO:0005874; GO:0006914; GO:0007026; GO:0007420; GO:0007626; GO:0008344; GO:0021801; GO:0021960; GO:0021987; GO:0022038; GO:0030424; GO:0030425; GO:0030426; GO:0031175; GO:0043005; GO:0043025; GO:0044877; GO:0047485; GO:0061351; GO:0061744; GO:0097150; GO:0120168"
"12805",12805,"Cluster_796","Porites_evermani_scaffold_2458:34482-45155",153,-22.91,2,21,7676,7695,19,"68.42%","78.95%","Peve_00018006",0.999947127706681,0.00654652918637522,0.573710369894872,"P61291","Proteasome activator complex subunit 3 (Activator of multicatalytic protease subunit 3) (Proteasome activator 28 subunit gamma) (PA28g) (PA28gamma)","Sus scrofa (Pig)","apoptotic process [GO:0006915]; cell cycle [GO:0007049]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of endopeptidase activity [GO:0010950]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of proteasomal protein catabolic process [GO:0061136]","GO:0002039; GO:0005654; GO:0005737; GO:0006915; GO:0007049; GO:0008537; GO:0010950; GO:0061133; GO:0061136; GO:0097371; GO:2000045; GO:2001237"
"12843",12843,"Cluster_796","Porites_evermani_scaffold_255:231604-257113",142,-23.14,2,21,3549,3577,26,"61.54%","65.38%","Peve_00018843",0.999875921852262,0.0100287605540851,0.622145995500794,"Q499Y0","Exportin-4","Xenopus laevis (African clawed frog)","protein transport [GO:0015031]","GO:0005049; GO:0005634; GO:0005737; GO:0015031"
"12853",12853,"Cluster_796","Porites_evermani_scaffold_2567:210-64017",159,-21.6,2,21,26685,26708,21,"71.43%","76.19%","Peve_00018950",0.997477004983485,0.0452318831953428,0.931751799954478,"Q8BW94","Dynein axonemal heavy chain 3 (Axonemal beta dynein heavy chain 3) (Ciliary dynein heavy chain 3)","Mus musculus (Mouse)","cilium movement [GO:0003341]; microtubule-based movement [GO:0007018]","GO:0003341; GO:0005524; GO:0005874; GO:0007018; GO:0008569; GO:0030286; GO:0036156; GO:0045505; GO:0051959; GO:0097729"
"12883",12883,"Cluster_796","Porites_evermani_scaffold_26:378057-392680",200,-44.77,2,21,4515,4536,19,"100.00%","100.00%","Peve_00019270",0.999970454473499,0.00489375312637141,0.551398425649056,NA,NA,NA,NA,NA
"12929",12929,"Cluster_796","Porites_evermani_scaffold_28:238495-262304",145,-20.61,2,18,17535,17556,16,"68.75%","68.75%","Peve_00020859",0.99991937319529,0.00808421329013364,0.573710369894872,"Q8CBC7",NA,NA,NA,NA
"12943",12943,"Cluster_796","Porites_evermani_scaffold_2845:51180-53185",156,-21.43,2,21,1285,1304,19,"78.95%","78.95%","Peve_00021252",-0.999173333875069,0.0258875001330152,0.878746116748851,NA,NA,NA,NA,NA
"12944",12944,"Cluster_796","Porites_evermani_scaffold_2847:667-54073",148,-20.99,2,21,41113,41138,24,"70.83%","70.83%","Peve_00021264",0.997162801221593,0.047967019964389,0.945590536869992,"O15050","TPR and ankyrin repeat-containing protein 1 (Lupus brain antigen 1 homolog)","Homo sapiens (Human)","",""
"12945",12945,"Cluster_796","Porites_evermani_scaffold_2847:667-54073",154,-22.28,2,20,39131,39154,20,"70.00%","75.00%","Peve_00021264",0.997162801221593,0.047967019964389,0.945590536869992,"O15050","TPR and ankyrin repeat-containing protein 1 (Lupus brain antigen 1 homolog)","Homo sapiens (Human)","",""
"12946",12946,"Cluster_796","Porites_evermani_scaffold_2850:4933-22771",163,-23.32,2,21,6109,6131,20,"75.00%","80.00%","Peve_00021291",0.997541134302608,0.0446530937966655,0.928257810831701,"Q32LP4","Sodium-driven chloride bicarbonate exchanger (Solute carrier family 4 member 10)","Bos taurus (Bovine)","bicarbonate transport [GO:0015701]; brain morphogenesis [GO:0048854]; ion homeostasis [GO:0050801]; locomotory exploration behavior [GO:0035641]; multicellular organism growth [GO:0035264]; post-embryonic development [GO:0009791]; proton transmembrane transport [GO:1902600]; pyramidal neuron development [GO:0021860]; regulation of intracellular pH [GO:0051453]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to light stimulus [GO:0009416]; transmembrane transport [GO:0055085]; visual perception [GO:0007601]","GO:0005886; GO:0007601; GO:0008510; GO:0009416; GO:0009791; GO:0015701; GO:0016323; GO:0016324; GO:0021860; GO:0022857; GO:0030425; GO:0035264; GO:0035641; GO:0036477; GO:0043025; GO:0043204; GO:0043679; GO:0045202; GO:0048172; GO:0048854; GO:0050801; GO:0051453; GO:0055085; GO:0097440; GO:0097441; GO:0097442; GO:0098794; GO:0140892; GO:1902600"
"12951",12951,"Cluster_796","Porites_evermani_scaffold_28:789151-804875",143,-20.98,2,21,7593,7621,26,"61.54%","61.54%","Peve_00020888",0.999984936983132,0.0034942312800772,0.516028655133572,"Q8N264","Rho GTPase-activating protein 24 (Filamin-A-associated RhoGAP) (FilGAP) (RAC1- and CDC42-specific GTPase-activating protein of 72 kDa) (RC-GAP72) (Rho-type GTPase-activating protein 24) (RhoGAP of 73 kDa) (Sarcoma antigen NY-SAR-88) (p73RhoGAP)","Homo sapiens (Human)","activation of GTPase activity [GO:0090630]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; negative regulation of Rac protein signal transduction [GO:0035021]; negative regulation of ruffle assembly [GO:1900028]; signal transduction [GO:0007165]; wound healing, spreading of epidermal cells [GO:0035313]","GO:0001525; GO:0005096; GO:0005737; GO:0005856; GO:0005912; GO:0005925; GO:0007165; GO:0030154; GO:0035021; GO:0035313; GO:0042995; GO:0090630; GO:1900028"
"12961",12961,"Cluster_796","Porites_evermani_scaffold_2921:18650-57536",151,-20.3,2,21,12767,12786,20,"75.00%","75.00%","Peve_00021878",0.997752634359215,0.0426887420878948,0.914691543244598,"E9Q634","Unconventional myosin-Ie (Unconventional myosin 1E)","Mus musculus (Mouse)","actin filament organization [GO:0007015]; endocytosis [GO:0006897]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; nitrogen compound metabolic process [GO:0006807]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; podocyte development [GO:0072015]; post-embryonic hemopoiesis [GO:0035166]; vasculogenesis [GO:0001570]; vesicle transport along actin filament [GO:0030050]","GO:0000146; GO:0001570; GO:0001701; GO:0001822; GO:0003094; GO:0005516; GO:0005524; GO:0005737; GO:0005856; GO:0005886; GO:0005902; GO:0005903; GO:0005912; GO:0006807; GO:0006897; GO:0007015; GO:0015629; GO:0016459; GO:0016887; GO:0030050; GO:0030097; GO:0031982; GO:0032437; GO:0032836; GO:0032991; GO:0035091; GO:0035166; GO:0044877; GO:0045334; GO:0048008; GO:0051015; GO:0072015"
"12982",12982,"Cluster_796","Porites_evermani_scaffold_2976:32404-36589",146,-20.07,2,20,1957,1979,19,"68.42%","68.42%","Peve_00022240",0.998510728175668,0.0347484966903348,0.909359886114279,NA,NA,NA,NA,NA
"12998",12998,"Cluster_796","Porites_evermani_scaffold_3034:401-54010",149,-22.79,2,21,33312,33336,22,"72.73%","72.73%","Peve_00022876",0.997463790305685,0.0453502338779849,0.932382960211634,"Q9JHU4","Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)","Mus musculus (Mouse)","cell division [GO:0051301]; cilium movement [GO:0003341]; cytoplasmic microtubule organization [GO:0031122]; establishment of spindle localization [GO:0051293]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitotic cell cycle [GO:0000278]; nuclear migration [GO:0007097]; P-body assembly [GO:0033962]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; retrograde axonal transport [GO:0008090]; stress granule assembly [GO:0034063]","GO:0000278; GO:0002177; GO:0003341; GO:0005524; GO:0005635; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0005881; GO:0005938; GO:0007018; GO:0007097; GO:0008090; GO:0008569; GO:0030175; GO:0030286; GO:0030424; GO:0031122; GO:0032388; GO:0033962; GO:0034063; GO:0043025; GO:0045505; GO:0051293; GO:0051301; GO:0051959; GO:0060236; GO:0072382; GO:0090235; GO:0120162; GO:1904115; GO:1905832"
"13131",13131,"Cluster_796","Porites_evermani_scaffold_352:2116-25539",164,-20.81,2,21,18176,18197,19,"73.68%","78.95%","Peve_00026073",0.999794078297198,0.0129197358397774,0.6983004053542,"O60879","Protein diaphanous homolog 2 (Diaphanous-related formin-2) (DRF2)","Homo sapiens (Human)","actin filament polymerization [GO:0030041]; female gamete generation [GO:0007292]; oogenesis [GO:0048477]","GO:0003779; GO:0005102; GO:0005730; GO:0005769; GO:0005783; GO:0005829; GO:0005884; GO:0007292; GO:0030041; GO:0031267; GO:0043231; GO:0048477"
"13147",13147,"Cluster_796","Porites_evermani_scaffold_3608:13209-17960",151,-21.64,2,18,2813,2833,16,"75.00%","81.25%","Peve_00026597",0.99930424184617,0.023749225802111,0.85317692934954,"P22027","ATP synthase subunit s, mitochondrial (ATP synthase-coupling factor B) (FB) (Distal membrane arm assembly complex 2-like protein) (Mitochondrial ATP synthase regulatory component factor B)","Bos taurus (Bovine)","ATP biosynthetic process [GO:0006754]; proton transmembrane transport [GO:1902600]","GO:0005737; GO:0005743; GO:0006754; GO:0045263; GO:0046872; GO:1902600"
"13156",13156,"Cluster_796","Porites_evermani_scaffold_365:84057-193213",170,-26.68,2,21,87700,87724,22,"81.82%","81.82%","Peve_00026823",0.99870790080121,0.0323660591219525,0.909244498015575,"Q9WUU9","Germinal-center associated nuclear protein (GANP) (EC 2.3.1.48) (GC-associated DNA primase)","Mus musculus (Mouse)","mRNA export from nucleus [GO:0006406]; nucleosome organization [GO:0034728]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein transport [GO:0015031]; somatic hypermutation of immunoglobulin genes [GO:0016446]","GO:0003676; GO:0003682; GO:0004402; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0006406; GO:0010484; GO:0015031; GO:0016446; GO:0016973; GO:0031965; GO:0034728; GO:0042393; GO:0044615; GO:0070390"
"13186",13186,"Cluster_796","Porites_evermani_scaffold_379:99159-111345",165,-28.56,2,20,311,334,20,"80.00%","85.00%","Peve_00027528",0.997445198830811,0.0455162190256704,0.933081084148054,NA,NA,NA,NA,NA
"13189",13189,"Cluster_796","Porites_evermani_scaffold_3810:6586-15178",162,-21.26,2,21,697,717,19,"78.95%","78.95%","Peve_00027704",0.999428282268221,0.0215281467469597,0.825175158091499,NA,NA,NA,NA,NA
"13196",13196,"Cluster_796","Porites_evermani_scaffold_383:35108-49202",154,-21.51,2,20,10107,10130,20,"70.00%","75.00%","Peve_00027784",0.997140486812467,0.0481553691265201,0.945590536869992,NA,NA,NA,NA,NA
"13220",13220,"Cluster_796","Porites_evermani_scaffold_3921:33-16186",147,-23.89,2,21,3030,3047,19,"68.42%","73.68%","Peve_00028320",0.999195193052596,0.0255428945461616,0.874749654447263,"Q8K2C7","Protein OS-9","Mus musculus (Mouse)","endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein retention in ER lumen [GO:0006621]; protein targeting [GO:0006605]; protein ubiquitination [GO:0016567]; response to endoplasmic reticulum stress [GO:0034976]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0002020; GO:0005783; GO:0005788; GO:0006511; GO:0006605; GO:0006621; GO:0016567; GO:0030246; GO:0030433; GO:0030968; GO:0030970; GO:0034976; GO:1904153"
"13237",13237,"Cluster_796","Porites_evermani_scaffold_3969:1-6132",155,-26.61,2,21,85,107,20,"70.00%","75.00%","Peve_00028552",0.997584742184647,0.0442552011106836,0.925509732146748,NA,NA,NA,NA,NA
"13273",13273,"Cluster_796","Porites_evermani_scaffold_4135:1110-19108",153,-23.18,2,20,5168,5188,18,"72.22%","77.78%","Peve_00029553",0.997579534055322,0.044302909403768,0.925966041019024,"Q9QYE5","Protein jagged-2 (Jagged2)","Mus musculus (Mouse)","auditory receptor cell fate commitment [GO:0009912]; cell differentiation [GO:0030154]; cell fate determination [GO:0001709]; epithelial cell apoptotic process involved in palatal shelf morphogenesis [GO:1990134]; gamma-delta T cell differentiation [GO:0042492]; in utero embryonic development [GO:0001701]; morphogenesis of embryonic epithelium [GO:0016331]; Notch signaling pathway [GO:0007219]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of Notch signaling pathway [GO:0045747]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; respiratory system process [GO:0003016]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; spermatogenesis [GO:0007283]; T cell differentiation [GO:0030217]; thymic T cell selection [GO:0045061]","GO:0001501; GO:0001701; GO:0001709; GO:0003016; GO:0005112; GO:0005509; GO:0005886; GO:0007219; GO:0007283; GO:0007605; GO:0008083; GO:0009912; GO:0016020; GO:0016331; GO:0030154; GO:0030155; GO:0030217; GO:0042127; GO:0042475; GO:0042492; GO:0045061; GO:0045747; GO:0048471; GO:1990134"
"13276",13276,"Cluster_796","Porites_evermani_scaffold_41:512356-537181",145,-22.58,2,10,14196,14217,8,"100.00%","100.00%","Peve_00029337",0.999786507142086,0.0131551111881724,0.70385628957585,"Q6DIR8","Paladin","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","","GO:0005829"
"13277",13277,"Cluster_796","Porites_evermani_scaffold_415:4257-24195",165,-21.2,2,19,16357,16379,18,"83.33%","83.33%","Peve_00029613",0.99908589935091,0.0272223251762608,0.89352352371634,"P49283","Protein Malvolio","Drosophila melanogaster (Fruit fly)","copper ion homeostasis [GO:0055070]; copper ion import [GO:0015677]; iron ion homeostasis [GO:0055072]; iron ion transmembrane transport [GO:0034755]; manganese ion homeostasis [GO:0055071]; metal ion transport [GO:0030001]; positive regulation of iron ion transmembrane transport [GO:0034761]; response to manganese ion [GO:0010042]; sensory perception of sweet taste [GO:0050916]; transition metal ion homeostasis [GO:0055076]; transition metal ion transport [GO:0000041]; viral entry into host cell [GO:0046718]","GO:0000041; GO:0005375; GO:0005381; GO:0005384; GO:0005768; GO:0005886; GO:0010042; GO:0015086; GO:0015293; GO:0015677; GO:0016020; GO:0016324; GO:0030001; GO:0034755; GO:0034761; GO:0046718; GO:0050916; GO:0055070; GO:0055071; GO:0055072; GO:0055076"
"13338",13338,"Cluster_796","Porites_evermani_scaffold_4461:12868-26144",150,-20.56,2,21,4638,4663,23,"65.22%","73.91%","Peve_00031279",-0.999788315113122,0.0130992885452887,0.702492819331413,NA,NA,NA,NA,NA
"13340",13340,"Cluster_796","Porites_evermani_scaffold_449:10867-80503",157,-22.95,2,20,38656,38679,20,"75.00%","80.00%","Peve_00031401",-0.999574748753192,0.0185666397208717,0.782669382293497,"A0A0R4IC37","Cleavage and polyadenylation specificity factor subunit 1 (Cleavage and polyadenylation specific factor 1)","Danio rerio (Zebrafish) (Brachydanio rerio)","definitive hemopoiesis [GO:0060216]; mRNA polyadenylation [GO:0006378]; retinal ganglion cell axon guidance [GO:0031290]","GO:0003676; GO:0005634; GO:0005654; GO:0005847; GO:0006378; GO:0031290; GO:0060216"
"13349",13349,"Cluster_796","Porites_evermani_scaffold_45:452363-472859",150,-20.02,2,19,13339,13360,17,"70.59%","70.59%","Peve_00031438",0.999463033231593,0.0208635525823051,0.817190070029867,"Q9WV92","Band 4.1-like protein 3 (4.1B) (Differentially expressed in adenocarcinoma of the lung protein 1) (DAL-1) (DAL1P) (mDAL-1) (Erythrocyte membrane protein band 4.1-like 3) [Cleaved into: Band 4.1-like protein 3, N-terminally processed]","Mus musculus (Mouse)","actomyosin structure organization [GO:0031032]; apoptotic process [GO:0006915]; axon development [GO:0061564]; cortical actin cytoskeleton organization [GO:0030866]; cortical cytoskeleton organization [GO:0030865]; myelin maintenance [GO:0043217]; neuron projection morphogenesis [GO:0048812]; paranodal junction assembly [GO:0030913]; paranodal junction maintenance [GO:1990227]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; protein localization to plasma membrane [GO:0072659]; regulation of cell shape [GO:0008360]","GO:0002175; GO:0003779; GO:0005200; GO:0005829; GO:0005856; GO:0005886; GO:0005911; GO:0006915; GO:0008360; GO:0014069; GO:0030054; GO:0030865; GO:0030866; GO:0030913; GO:0031032; GO:0033270; GO:0043217; GO:0044224; GO:0048812; GO:0061564; GO:0071205; GO:0072659; GO:0106006; GO:1990227"
"13352",13352,"Cluster_796","Porites_evermani_scaffold_45:6053-12413",159,-22.12,2,20,2372,2393,18,"72.22%","77.78%","Peve_00031436",0.998066590605977,0.0395937858906724,0.909359886114279,"Q0P5B1","Peroxisomal membrane protein PEX13 (Peroxin-13)","Bos taurus (Bovine)","cerebral cortex cell migration [GO:0021795]; fatty acid alpha-oxidation [GO:0001561]; locomotory behavior [GO:0007626]; microtubule-based peroxisome localization [GO:0060152]; neuron migration [GO:0001764]; protein import into peroxisome matrix, docking [GO:0016560]; suckling behavior [GO:0001967]","GO:0001561; GO:0001764; GO:0001967; GO:0005778; GO:0007626; GO:0008320; GO:0016560; GO:0021795; GO:0060152; GO:1990429"
"13360",13360,"Cluster_796","Porites_evermani_scaffold_4604:2295-19484",155,-20.27,2,21,16569,16587,19,"78.95%","78.95%","Peve_00031940",-0.999663016871668,0.0165276609923165,0.773377054133803,"Q90WU3","ATP-dependent RNA helicase DDX1 (EC 3.6.4.13) (DEAD box protein 1)","Gallus gallus (Chicken)","DNA duplex unwinding [GO:0032508]; double-strand break repair [GO:0006302]; mRNA processing [GO:0006397]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]","GO:0003677; GO:0003682; GO:0003712; GO:0003724; GO:0004518; GO:0004527; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006302; GO:0006388; GO:0006397; GO:0008143; GO:0016887; GO:0032508; GO:0033677; GO:0072669"
"13377",13377,"Cluster_796","Porites_evermani_scaffold_474:37469-64742",150,-20.5,2,19,12745,12764,17,"76.47%","82.35%","Peve_00032517",0.999294723514205,0.0239111437943281,0.855533940161032,"B3EWZ6","MAM and LDL-receptor class A domain-containing protein 2 (Skeletal organic matrix MAM and LDL-receptor 2) (SOM MAM and LDL-receptor 2)","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0005576; GO:0016020"
"13394",13394,"Cluster_796","Porites_evermani_scaffold_48:276324-288418",152,-21.16,2,19,247,267,17,"76.47%","76.47%","Peve_00032741",0.998858866440977,0.0304161798288484,0.903929377050813,NA,NA,NA,NA,NA
"13422",13422,"Cluster_796","Porites_evermani_scaffold_496:214803-232783",143,-24.72,2,21,13975,14000,23,"60.87%","65.22%","Peve_00033364",0.999260034938896,0.0244921839031936,0.862029780817471,"P22045","9,11-endoperoxide prostaglandin H2 reductase (EC 1.1.1.-) (Prostaglandin F2-alpha synthase)","Leishmania major","prostaglandin biosynthetic process [GO:0001516]","GO:0000166; GO:0001516; GO:0005737; GO:0036130"
"13436",13436,"Cluster_796","Porites_evermani_scaffold_50:416997-456426",149,-21.33,2,21,14876,14901,23,"69.57%","73.91%","Peve_00033615",0.997011540117915,0.0492296843450919,0.950396228648067,"Q4KKX4","Nuclear receptor corepressor 1 (N-CoR) (N-CoR1) (xN-CoR)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","chromatin organization [GO:0006325]; negative regulation of DNA-templated transcription [GO:0045892]; rhythmic process [GO:0048511]","GO:0003677; GO:0005634; GO:0006325; GO:0045892; GO:0048511"
"13438",13438,"Cluster_796","Porites_evermani_scaffold_508:81019-104077",149,-22.6,2,21,292,311,19,"68.42%","73.68%","Peve_00033936",0.999380858601722,0.022403323633518,0.836588264687313,"Q5R592","DNA-directed RNA polymerases I, II, and III subunit RPABC2 (RNA polymerases I, II, and III subunit ABC2) (DNA-directed RNA polymerase II subunit F) (RPB6 homolog)","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","transcription by RNA polymerase II [GO:0006366]","GO:0003677; GO:0003899; GO:0005634; GO:0005665; GO:0006366"
"13472",13472,"Cluster_796","Porites_evermani_scaffold_52:656565-661097",152,-20.76,2,19,1299,1322,19,"73.68%","78.95%","Peve_00034383",-0.999988382607111,0.00306866782499649,0.477058746205851,"P26686","Serine-arginine protein 55 (SRP55) (52 kDa bracketing protein) (B52 protein) (Protein enhancer of deformed)","Drosophila melanogaster (Fruit fly)","defense response to virus [GO:0051607]; mitotic cell cycle [GO:0000278]; mitotic G1/S transition checkpoint signaling [GO:0044819]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178]; RNA splicing [GO:0008380]","GO:0000278; GO:0000381; GO:0000398; GO:0000791; GO:0001178; GO:0003723; GO:0003729; GO:0005634; GO:0005700; GO:0008380; GO:0010468; GO:0016607; GO:0031440; GO:0044819; GO:0048024; GO:0051607; GO:0071011; GO:0071013"
"13485",13485,"Cluster_796","Porites_evermani_scaffold_534:23666-90765",155,-22.05,2,21,60065,60087,20,"70.00%","75.00%","Peve_00034882",0.999032467114065,0.0280067690996117,0.900518559487794,"B3EWZ3","Coadhesin","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0016020"
"13519",13519,"Cluster_796","Porites_evermani_scaffold_564:135763-137774",153,-21.21,2,20,1614,1637,20,"75.00%","75.00%","Peve_00035917",0.999981018293529,0.00392250435471787,0.54328949385489,NA,NA,NA,NA,NA
"13539",13539,"Cluster_796","Porites_evermani_scaffold_575:99111-136911",158,-22.92,2,21,17798,17821,21,"76.19%","76.19%","Peve_00036254",0.999880035047393,0.00986112935939381,0.61624048679314,"Q9V410","Leucine-zipper-like transcriptional regulator 1 homolog","Drosophila melanogaster (Fruit fly)","gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of glycogen metabolic process [GO:0070875]; protein ubiquitination [GO:0016567]; sleep [GO:0030431]; triglyceride homeostasis [GO:0070328]","GO:0005794; GO:0007214; GO:0016567; GO:0030431; GO:0046580; GO:0070328; GO:0070875"
"13556",13556,"Cluster_796","Porites_evermani_scaffold_590:184463-225363",149,-22.71,2,21,10938,10962,22,"68.18%","77.27%","Peve_00036728",0.997360080379969,0.0462685682564016,0.936911796713976,"Q5XPI4","E3 ubiquitin-protein ligase RNF123 (EC 2.3.2.27) (Kip1 ubiquitination-promoting complex protein 1) (RING finger protein 123) (RING-type E3 ubiquitin transferase RNF123)","Homo sapiens (Human)","proteolysis involved in protein catabolic process [GO:0051603]","GO:0004842; GO:0005737; GO:0005829; GO:0031965; GO:0046872; GO:0051603"
"13557",13557,"Cluster_796","Porites_evermani_scaffold_590:184463-225363",149,-22.71,2,21,11009,11033,22,"68.18%","77.27%","Peve_00036728",0.997360080379969,0.0462685682564016,0.936911796713976,"Q5XPI4","E3 ubiquitin-protein ligase RNF123 (EC 2.3.2.27) (Kip1 ubiquitination-promoting complex protein 1) (RING finger protein 123) (RING-type E3 ubiquitin transferase RNF123)","Homo sapiens (Human)","proteolysis involved in protein catabolic process [GO:0051603]","GO:0004842; GO:0005737; GO:0005829; GO:0031965; GO:0046872; GO:0051603"
"13560",13560,"Cluster_796","Porites_evermani_scaffold_5914:109-8780",155,-20.93,2,12,2868,2889,10,"100.00%","100.00%","Peve_00036754",0.998289056177381,0.0372455967032224,0.909359886114279,"Q14161","ARF GTPase-activating protein GIT2 (ARF GAP GIT2) (Cool-interacting tyrosine-phosphorylated protein 2) (CAT-2) (CAT2) (G protein-coupled receptor kinase-interactor 2) (GRK-interacting protein 2)","Homo sapiens (Human)","brain development [GO:0007420]; regulation of ARF protein signal transduction [GO:0032012]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; synaptic vesicle recycling [GO:0036465]","GO:0005096; GO:0005654; GO:0005925; GO:0007420; GO:0008277; GO:0031267; GO:0032012; GO:0036465; GO:0045202; GO:0046872; GO:0098793"
"13571",13571,"Cluster_796","Porites_evermani_scaffold_602:149354-161663",160,-22.53,2,21,3083,3105,21,"80.95%","80.95%","Peve_00037143",0.997039206619985,0.0490011626023253,0.949533023346653,NA,NA,NA,NA,NA
"13591",13591,"Cluster_796","Porites_evermani_scaffold_615:197660-213100",151,-20.46,2,21,520,543,21,"66.67%","71.43%","Peve_00037461",0.999848047205772,0.0110982618086229,0.650685374622803,"Q54AX5","Leucine-rich repeat protein lrrA","Dictyostelium discoideum (Social amoeba)","aggregation involved in sorocarp development [GO:0031152]; cell-cell adhesion [GO:0098609]; cell-substrate adhesion [GO:0031589]; chemotaxis to cAMP [GO:0043327]; chemotaxis to folate [GO:0043326]; culmination involved in sorocarp development [GO:0031154]; establishment or maintenance of cell polarity [GO:0007163]; regulation of actin filament polymerization [GO:0030833]","GO:0005737; GO:0007163; GO:0030833; GO:0031152; GO:0031154; GO:0031589; GO:0043326; GO:0043327; GO:0045335; GO:0098609"
"13592",13592,"Cluster_796","Porites_evermani_scaffold_615:197660-213100",151,-20.46,2,21,652,675,21,"66.67%","71.43%","Peve_00037461",0.999848047205772,0.0110982618086229,0.650685374622803,"Q54AX5","Leucine-rich repeat protein lrrA","Dictyostelium discoideum (Social amoeba)","aggregation involved in sorocarp development [GO:0031152]; cell-cell adhesion [GO:0098609]; cell-substrate adhesion [GO:0031589]; chemotaxis to cAMP [GO:0043327]; chemotaxis to folate [GO:0043326]; culmination involved in sorocarp development [GO:0031154]; establishment or maintenance of cell polarity [GO:0007163]; regulation of actin filament polymerization [GO:0030833]","GO:0005737; GO:0007163; GO:0030833; GO:0031152; GO:0031154; GO:0031589; GO:0043326; GO:0043327; GO:0045335; GO:0098609"
"13593",13593,"Cluster_796","Porites_evermani_scaffold_615:197660-213100",151,-20.46,2,21,790,813,21,"66.67%","71.43%","Peve_00037461",0.999848047205772,0.0110982618086229,0.650685374622803,"Q54AX5","Leucine-rich repeat protein lrrA","Dictyostelium discoideum (Social amoeba)","aggregation involved in sorocarp development [GO:0031152]; cell-cell adhesion [GO:0098609]; cell-substrate adhesion [GO:0031589]; chemotaxis to cAMP [GO:0043327]; chemotaxis to folate [GO:0043326]; culmination involved in sorocarp development [GO:0031154]; establishment or maintenance of cell polarity [GO:0007163]; regulation of actin filament polymerization [GO:0030833]","GO:0005737; GO:0007163; GO:0030833; GO:0031152; GO:0031154; GO:0031589; GO:0043326; GO:0043327; GO:0045335; GO:0098609"
"13594",13594,"Cluster_796","Porites_evermani_scaffold_615:197660-213100",151,-20.46,2,21,928,951,21,"66.67%","71.43%","Peve_00037461",0.999848047205772,0.0110982618086229,0.650685374622803,"Q54AX5","Leucine-rich repeat protein lrrA","Dictyostelium discoideum (Social amoeba)","aggregation involved in sorocarp development [GO:0031152]; cell-cell adhesion [GO:0098609]; cell-substrate adhesion [GO:0031589]; chemotaxis to cAMP [GO:0043327]; chemotaxis to folate [GO:0043326]; culmination involved in sorocarp development [GO:0031154]; establishment or maintenance of cell polarity [GO:0007163]; regulation of actin filament polymerization [GO:0030833]","GO:0005737; GO:0007163; GO:0030833; GO:0031152; GO:0031154; GO:0031589; GO:0043326; GO:0043327; GO:0045335; GO:0098609"
"13595",13595,"Cluster_796","Porites_evermani_scaffold_615:197660-213100",151,-22.32,2,21,1756,1779,21,"66.67%","71.43%","Peve_00037461",0.999848047205772,0.0110982618086229,0.650685374622803,"Q54AX5","Leucine-rich repeat protein lrrA","Dictyostelium discoideum (Social amoeba)","aggregation involved in sorocarp development [GO:0031152]; cell-cell adhesion [GO:0098609]; cell-substrate adhesion [GO:0031589]; chemotaxis to cAMP [GO:0043327]; chemotaxis to folate [GO:0043326]; culmination involved in sorocarp development [GO:0031154]; establishment or maintenance of cell polarity [GO:0007163]; regulation of actin filament polymerization [GO:0030833]","GO:0005737; GO:0007163; GO:0030833; GO:0031152; GO:0031154; GO:0031589; GO:0043326; GO:0043327; GO:0045335; GO:0098609"
"13596",13596,"Cluster_796","Porites_evermani_scaffold_615:197660-213100",151,-33.18,2,21,1335,1365,28,"64.29%","64.29%","Peve_00037461",0.999848047205772,0.0110982618086229,0.650685374622803,"Q54AX5","Leucine-rich repeat protein lrrA","Dictyostelium discoideum (Social amoeba)","aggregation involved in sorocarp development [GO:0031152]; cell-cell adhesion [GO:0098609]; cell-substrate adhesion [GO:0031589]; chemotaxis to cAMP [GO:0043327]; chemotaxis to folate [GO:0043326]; culmination involved in sorocarp development [GO:0031154]; establishment or maintenance of cell polarity [GO:0007163]; regulation of actin filament polymerization [GO:0030833]","GO:0005737; GO:0007163; GO:0030833; GO:0031152; GO:0031154; GO:0031589; GO:0043326; GO:0043327; GO:0045335; GO:0098609"
"13597",13597,"Cluster_796","Porites_evermani_scaffold_615:197660-213100",151,-33.18,2,21,1611,1641,28,"64.29%","64.29%","Peve_00037461",0.999848047205772,0.0110982618086229,0.650685374622803,"Q54AX5","Leucine-rich repeat protein lrrA","Dictyostelium discoideum (Social amoeba)","aggregation involved in sorocarp development [GO:0031152]; cell-cell adhesion [GO:0098609]; cell-substrate adhesion [GO:0031589]; chemotaxis to cAMP [GO:0043327]; chemotaxis to folate [GO:0043326]; culmination involved in sorocarp development [GO:0031154]; establishment or maintenance of cell polarity [GO:0007163]; regulation of actin filament polymerization [GO:0030833]","GO:0005737; GO:0007163; GO:0030833; GO:0031152; GO:0031154; GO:0031589; GO:0043326; GO:0043327; GO:0045335; GO:0098609"
"13598",13598,"Cluster_796","Porites_evermani_scaffold_615:197660-213100",151,-35.19,2,21,1197,1227,28,"64.29%","64.29%","Peve_00037461",0.999848047205772,0.0110982618086229,0.650685374622803,"Q54AX5","Leucine-rich repeat protein lrrA","Dictyostelium discoideum (Social amoeba)","aggregation involved in sorocarp development [GO:0031152]; cell-cell adhesion [GO:0098609]; cell-substrate adhesion [GO:0031589]; chemotaxis to cAMP [GO:0043327]; chemotaxis to folate [GO:0043326]; culmination involved in sorocarp development [GO:0031154]; establishment or maintenance of cell polarity [GO:0007163]; regulation of actin filament polymerization [GO:0030833]","GO:0005737; GO:0007163; GO:0030833; GO:0031152; GO:0031154; GO:0031589; GO:0043326; GO:0043327; GO:0045335; GO:0098609"
"13599",13599,"Cluster_796","Porites_evermani_scaffold_615:197660-213100",158,-23.1,2,21,1489,1512,21,"71.43%","80.95%","Peve_00037461",0.999848047205772,0.0110982618086229,0.650685374622803,"Q54AX5","Leucine-rich repeat protein lrrA","Dictyostelium discoideum (Social amoeba)","aggregation involved in sorocarp development [GO:0031152]; cell-cell adhesion [GO:0098609]; cell-substrate adhesion [GO:0031589]; chemotaxis to cAMP [GO:0043327]; chemotaxis to folate [GO:0043326]; culmination involved in sorocarp development [GO:0031154]; establishment or maintenance of cell polarity [GO:0007163]; regulation of actin filament polymerization [GO:0030833]","GO:0005737; GO:0007163; GO:0030833; GO:0031152; GO:0031154; GO:0031589; GO:0043326; GO:0043327; GO:0045335; GO:0098609"
"13600",13600,"Cluster_796","Porites_evermani_scaffold_615:197660-213100",159,-23.44,2,21,382,405,21,"71.43%","76.19%","Peve_00037461",0.999848047205772,0.0110982618086229,0.650685374622803,"Q54AX5","Leucine-rich repeat protein lrrA","Dictyostelium discoideum (Social amoeba)","aggregation involved in sorocarp development [GO:0031152]; cell-cell adhesion [GO:0098609]; cell-substrate adhesion [GO:0031589]; chemotaxis to cAMP [GO:0043327]; chemotaxis to folate [GO:0043326]; culmination involved in sorocarp development [GO:0031154]; establishment or maintenance of cell polarity [GO:0007163]; regulation of actin filament polymerization [GO:0030833]","GO:0005737; GO:0007163; GO:0030833; GO:0031152; GO:0031154; GO:0031589; GO:0043326; GO:0043327; GO:0045335; GO:0098609"
"13601",13601,"Cluster_796","Porites_evermani_scaffold_615:197660-213100",162,-26.61,2,21,253,276,21,"76.19%","80.95%","Peve_00037461",0.999848047205772,0.0110982618086229,0.650685374622803,"Q54AX5","Leucine-rich repeat protein lrrA","Dictyostelium discoideum (Social amoeba)","aggregation involved in sorocarp development [GO:0031152]; cell-cell adhesion [GO:0098609]; cell-substrate adhesion [GO:0031589]; chemotaxis to cAMP [GO:0043327]; chemotaxis to folate [GO:0043326]; culmination involved in sorocarp development [GO:0031154]; establishment or maintenance of cell polarity [GO:0007163]; regulation of actin filament polymerization [GO:0030833]","GO:0005737; GO:0007163; GO:0030833; GO:0031152; GO:0031154; GO:0031589; GO:0043326; GO:0043327; GO:0045335; GO:0098609"
"13621",13621,"Cluster_796","Porites_evermani_scaffold_626:36642-44686",153,-20.62,2,20,4257,4284,24,"70.83%","70.83%","Peve_00037776",0.999479239377096,0.0205462722495551,0.812435710552529,"Q0V9W6","BTB/POZ domain-containing protein 6","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","","GO:0005737"
"13622",13622,"Cluster_796","Porites_evermani_scaffold_626:36642-44686",153,-20.62,2,20,5618,5645,24,"70.83%","70.83%","Peve_00037776",0.999479239377096,0.0205462722495551,0.812435710552529,"Q0V9W6","BTB/POZ domain-containing protein 6","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","","GO:0005737"
"13641",13641,"Cluster_796","Porites_evermani_scaffold_639:118021-127430",155,-24.7,2,20,7701,7722,18,"66.67%","77.78%","Peve_00038086",0.99928607481456,0.0240573237932185,0.856569794819485,NA,NA,NA,NA,NA
"13668",13668,"Cluster_796","Porites_evermani_scaffold_662:50111-75737",152,-20.99,2,20,5725,5750,22,"72.73%","77.27%","Peve_00038655",0.997432993613974,0.0456248597186151,0.93332862243605,"H9D1R1","Thioredoxin domain-containing protein 12 (EC 1.8.4.2)","Epinephelus coioides (Orange-spotted grouper) (Epinephelus nebulosus)","defense response to virus [GO:0051607]","GO:0005788; GO:0009055; GO:0019153; GO:0051607"
"13671",13671,"Cluster_796","Porites_evermani_scaffold_668:128954-186241",162,-25.28,2,21,17511,17534,21,"76.19%","80.95%","Peve_00038764",0.999984165927141,0.00358254796236332,0.524089804097317,"Q6DIC0","Probable global transcription activator SNF2L2 (EC 3.6.4.-) (ATP-dependent helicase SMARCA2) (BRG1-associated factor 190B) (BAF190B) (Protein brahma homolog) (SNF2-alpha) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 2)","Mus musculus (Mouse)","aortic smooth muscle cell differentiation [GO:0035887]; cell population proliferation [GO:0008283]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; fibroblast proliferation [GO:0048144]; hematopoietic stem cell homeostasis [GO:0061484]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fibroblast proliferation [GO:0048147]; nervous system development [GO:0007399]; nucleosome assembly [GO:0006334]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000785; GO:0000976; GO:0003677; GO:0003682; GO:0003713; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0006325; GO:0006334; GO:0006338; GO:0006357; GO:0007399; GO:0008094; GO:0008283; GO:0008284; GO:0008285; GO:0016514; GO:0016787; GO:0030071; GO:0030308; GO:0035060; GO:0035887; GO:0042393; GO:0043231; GO:0045111; GO:0045582; GO:0045596; GO:0045597; GO:0045663; GO:0045892; GO:0045893; GO:0045944; GO:0048144; GO:0048147; GO:0061484; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:0140288; GO:0140658; GO:1902459; GO:2000045; GO:2000781; GO:2000819"
"13673",13673,"Cluster_796","Porites_evermani_scaffold_6:695875-715308",153,-21.1,2,19,18208,18232,20,"70.00%","75.00%","Peve_00036964",0.997077513398696,0.0486829862370013,0.94805481250488,"Q80TN7","Neuron navigator 3 (Pore membrane and/or filament-interacting-like protein 1)","Mus musculus (Mouse)","negative regulation of cell migration [GO:0030336]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; positive regulation of microtubule polymerization [GO:0031116]","GO:0005524; GO:0005634; GO:0005635; GO:0005640; GO:0007026; GO:0007399; GO:0008017; GO:0016887; GO:0022008; GO:0030336; GO:0031116; GO:0032703; GO:1990752"
"13678",13678,"Cluster_796","Porites_evermani_scaffold_674:160865-184119",152,-20.95,2,21,18204,18225,19,"63.16%","73.68%","Peve_00038927",0.999994129428633,0.00218140105711895,0.379078774249685,"Q14832","Metabotropic glutamate receptor 3 (mGluR3)","Homo sapiens (Human)","chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; gene expression [GO:0010467]; negative regulation of adenylate cyclase activity [GO:0007194]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of synaptic transmission, glutamatergic [GO:0051966]","GO:0001640; GO:0001641; GO:0004930; GO:0005246; GO:0005886; GO:0007194; GO:0007216; GO:0007268; GO:0008066; GO:0010467; GO:0014069; GO:0030424; GO:0042734; GO:0043197; GO:0045211; GO:0051966; GO:0097110; GO:0097449; GO:0098978; GO:0099170"
"13679",13679,"Cluster_796","Porites_evermani_scaffold_674:160865-184119",152,-20.95,2,21,21996,22017,19,"63.16%","73.68%","Peve_00038927",0.999994129428633,0.00218140105711895,0.379078774249685,"Q14832","Metabotropic glutamate receptor 3 (mGluR3)","Homo sapiens (Human)","chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; gene expression [GO:0010467]; negative regulation of adenylate cyclase activity [GO:0007194]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of synaptic transmission, glutamatergic [GO:0051966]","GO:0001640; GO:0001641; GO:0004930; GO:0005246; GO:0005886; GO:0007194; GO:0007216; GO:0007268; GO:0008066; GO:0010467; GO:0014069; GO:0030424; GO:0042734; GO:0043197; GO:0045211; GO:0051966; GO:0097110; GO:0097449; GO:0098978; GO:0099170"
"13692",13692,"Cluster_796","Porites_evermani_scaffold_68:394756-410711",151,-20.66,2,21,8777,8799,20,"70.00%","70.00%","Peve_00039069",0.997317016749437,0.0466445867445898,0.938976395895687,"P60027","General transcription factor IIH subunit 4 (Basic transcription factor 2 52 kDa subunit) (BTF2 p52) (General transcription factor IIH polypeptide 4) (TFIIH basal transcription factor complex p52 subunit)","Pan troglodytes (Chimpanzee)","nucleotide-excision repair [GO:0006289]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; transcription by RNA polymerase II [GO:0006366]","GO:0000438; GO:0000439; GO:0001671; GO:0003690; GO:0005634; GO:0005669; GO:0005675; GO:0006289; GO:0006366; GO:0016251; GO:0016607; GO:0070816"
"13714",13714,"Cluster_796","Porites_evermani_scaffold_706:7463-55390",155,-22.05,2,21,35431,35453,20,"70.00%","75.00%","Peve_00039735",0.99924851937578,0.0246820492900172,0.864470993738875,"Q9Y2G3","Phospholipid-transporting ATPase IF (EC 7.6.2.1) (ATPase IR) (ATPase class VI type 11B) (P4-ATPase flippase complex alpha subunit ATP11B)","Homo sapiens (Human)","aminophospholipid transport [GO:0015917]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; phospholipid translocation [GO:0045332]","GO:0000287; GO:0005524; GO:0005637; GO:0005783; GO:0005802; GO:0005886; GO:0006811; GO:0015075; GO:0015917; GO:0016020; GO:0016887; GO:0031901; GO:0034220; GO:0035577; GO:0045332; GO:0055037; GO:0055038; GO:0090555; GO:0090556; GO:0140326; GO:1990531"
"13719",13719,"Cluster_796","Porites_evermani_scaffold_7:115760-160991",157,-24.38,2,21,33361,33386,23,"73.91%","78.26%","Peve_00039588",0.999983457432514,0.0036618215569645,0.529730745706329,NA,NA,NA,NA,NA
"13726",13726,"Cluster_796","Porites_evermani_scaffold_720:106352-112738",161,-20.69,2,18,322,343,16,"81.25%","81.25%","Peve_00040059",0.999626870838226,0.0173915472885537,0.782669382293497,NA,NA,NA,NA,NA
"13752",13752,"Cluster_796","Porites_evermani_scaffold_753:19542-52424",154,-21.19,2,21,13954,13978,22,"68.18%","77.27%","Peve_00040756",0.999742717620937,0.0144414052132105,0.731897665835973,"Q80TE4","Signal-induced proliferation-associated 1-like protein 2 (SIPA1-like protein 2)","Mus musculus (Mouse)","activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056]","GO:0005096; GO:0005737; GO:0051056; GO:0090630"
"13758",13758,"Cluster_796","Porites_evermani_scaffold_762:65925-73997",176,-22.4,2,21,5226,5247,19,"84.21%","84.21%","Peve_00040912",-0.999920563539171,0.00802431444871135,0.573710369894872,NA,NA,NA,NA,NA
"13767",13767,"Cluster_796","Porites_evermani_scaffold_771:175817-191793",170,-21,2,21,14717,14737,19,"84.21%","84.21%","Peve_00041095",0.999868996931266,0.0103048244251447,0.629647545468991,"Q8IS64","Endothelin-converting enzyme homolog (ECE) (EC 3.4.24.-)","Locusta migratoria (Migratory locust)","proteolysis [GO:0006508]","GO:0004175; GO:0004222; GO:0005886; GO:0006508; GO:0008270"
"13806",13806,"Cluster_796","Porites_evermani_scaffold_8:203738-252966",151,-22.39,2,21,12668,12685,19,"73.68%","73.68%","Peve_00041750",0.99983472343522,0.0115746199867111,0.663496317927119,"Q8BKX6","Serine/threonine-protein kinase SMG1 (SMG-1) (EC 2.7.11.1) (Lambda/iota protein kinase C-interacting protein) (Lambda-interacting protein) (Nonsense mediated mRNA decay-associated PI3K-related kinase SMG1)","Mus musculus (Mouse)","DNA repair [GO:0006281]; negative regulation of macroautophagy [GO:0016242]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of telomere maintenance [GO:0032204]; TOR signaling [GO:0031929]","GO:0000184; GO:0004674; GO:0004697; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006468; GO:0016242; GO:0018105; GO:0031929; GO:0031931; GO:0031932; GO:0032204; GO:0033391; GO:0042162; GO:0046777; GO:0046854; GO:0046872; GO:0106310; GO:2001020"
"13807",13807,"Cluster_796","Porites_evermani_scaffold_8:203738-252966",159,-21.09,2,21,11059,11081,20,"75.00%","75.00%","Peve_00041750",0.99983472343522,0.0115746199867111,0.663496317927119,"Q8BKX6","Serine/threonine-protein kinase SMG1 (SMG-1) (EC 2.7.11.1) (Lambda/iota protein kinase C-interacting protein) (Lambda-interacting protein) (Nonsense mediated mRNA decay-associated PI3K-related kinase SMG1)","Mus musculus (Mouse)","DNA repair [GO:0006281]; negative regulation of macroautophagy [GO:0016242]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of telomere maintenance [GO:0032204]; TOR signaling [GO:0031929]","GO:0000184; GO:0004674; GO:0004697; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006468; GO:0016242; GO:0018105; GO:0031929; GO:0031931; GO:0031932; GO:0032204; GO:0033391; GO:0042162; GO:0046777; GO:0046854; GO:0046872; GO:0106310; GO:2001020"
"13813",13813,"Cluster_796","Porites_evermani_scaffold_831:32653-45989",157,-20.95,2,21,8844,8868,22,"77.27%","77.27%","Peve_00042419",0.998150011594241,0.0387299200197762,0.909359886114279,NA,NA,NA,NA,NA
"13820",13820,"Cluster_796","Porites_evermani_scaffold_844:44303-49082",155,-25.28,2,21,129,151,20,"70.00%","75.00%","Peve_00042649",0.999999352596528,0.000724407029937386,0.239778920002343,NA,NA,NA,NA,NA
"13840",13840,"Cluster_796","Porites_evermani_scaffold_86:403954-432367",175,-28.05,2,21,22514,22536,20,"85.00%","85.00%","Peve_00042940",0.999893013165731,0.00931245444676547,0.600139271338457,"Q8IPH9","Slowpoke-binding protein","Drosophila melanogaster (Fruit fly)","modulation of chemical synaptic transmission [GO:0050804]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of ion transport [GO:0043271]; neuromuscular synaptic transmission [GO:0007274]; regulation of membrane potential [GO:0042391]; response to starvation [GO:0042594]","GO:0004672; GO:0005737; GO:0005886; GO:0007274; GO:0032780; GO:0042391; GO:0042594; GO:0043271; GO:0045202; GO:0050804"
"13841",13841,"Cluster_796","Porites_evermani_scaffold_864:160319-178538",163,-22.61,2,17,9183,9205,16,"87.50%","87.50%","Peve_00043040",0.997958237792955,0.0406884946615009,0.909359886114279,"P02459","Collagen alpha-1(II) chain (Alpha-1 type II collagen)","Bos taurus (Bovine)","anterior head development [GO:0097065]; cartilage condensation [GO:0001502]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cellular response to BMP stimulus [GO:0071773]; central nervous system development [GO:0007417]; chondrocyte differentiation [GO:0002062]; collagen fibril organization [GO:0030199]; embryonic skeletal joint morphogenesis [GO:0060272]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; heart morphogenesis [GO:0003007]; inner ear morphogenesis [GO:0042472]; limb bud formation [GO:0060174]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; notochord development [GO:0030903]; otic vesicle development [GO:0071599]; proteoglycan metabolic process [GO:0006029]; regulation of gene expression [GO:0010468]; roof of mouth development [GO:0060021]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; tissue homeostasis [GO:0001894]; visual perception [GO:0007601]","GO:0001501; GO:0001502; GO:0001894; GO:0001958; GO:0002062; GO:0003007; GO:0005201; GO:0005576; GO:0005581; GO:0005585; GO:0005592; GO:0005604; GO:0005615; GO:0005737; GO:0006029; GO:0007417; GO:0007601; GO:0007605; GO:0010468; GO:0030198; GO:0030199; GO:0030903; GO:0031012; GO:0042289; GO:0042472; GO:0042802; GO:0043394; GO:0046872; GO:0048407; GO:0060021; GO:0060174; GO:0060272; GO:0060351; GO:0062023; GO:0071599; GO:0071773; GO:0097065; GO:0097192; GO:2001240"
"13861",13861,"Cluster_796","Porites_evermani_scaffold_89:24135-66412",148,-20.7,2,21,16364,16385,19,"63.16%","68.42%","Peve_00043455",0.999999734253511,0.000464118519054011,0.239778920002343,"P91309","Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase (EC 2.7.4.24) (InsP6 and PP-IP5 kinase)","Caenorhabditis elegans","inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]; phosphorylation [GO:0016310]","GO:0000827; GO:0000828; GO:0000829; GO:0000832; GO:0005524; GO:0005737; GO:0005829; GO:0006020; GO:0016310; GO:0032958; GO:0033857; GO:0052723; GO:0052724"
"13873",13873,"Cluster_796","Porites_evermani_scaffold_915:121000-129340",160,-21.65,2,21,7820,7842,21,"80.95%","80.95%","Peve_00044008",0.997859048240646,0.0416654499063484,0.909359886114279,NA,NA,NA,NA,NA
"13880",13880,"Cluster_796","Porites_evermani_scaffold_9:229073-242928",149,-21.34,2,19,2694,2718,20,"70.00%","70.00%","Peve_00043688",0.997883962349723,0.0414222254288143,0.909359886114279,"Q6NXT4","Zinc transporter 6 (ZnT-6) (Solute carrier family 30 member 6)","Homo sapiens (Human)","cellular zinc ion homeostasis [GO:0006882]; insulin processing [GO:0030070]; regulation of zinc ion transport [GO:0071579]; zinc ion import into Golgi lumen [GO:1904257]; zinc ion import into organelle [GO:0062111]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829]","GO:0000139; GO:0005385; GO:0005794; GO:0006829; GO:0006882; GO:0015297; GO:0030070; GO:0032588; GO:0062111; GO:0071577; GO:0071579; GO:1904257"
"13889",13889,"Cluster_796","Porites_evermani_scaffold_932:89534-106659",155,-22.5,2,17,1510,1532,16,"81.25%","81.25%","Peve_00044304",0.999409654250644,0.0218760903670763,0.830089015811238,NA,NA,NA,NA,NA
"13890",13890,"Cluster_796","Porites_evermani_scaffold_932:89534-106659",155,-22.5,2,17,2313,2335,16,"81.25%","81.25%","Peve_00044304",0.999409654250644,0.0218760903670763,0.830089015811238,NA,NA,NA,NA,NA
